Info Thread Nanophase & Altair für das Jahr 2003 - 500 Beiträge pro Seite

[MRASTA]

Schön, dass WO einen Nanobereich aufgemacht hat, finde ich gut.

Zwei Werte, die den meisten mehr oder weniger bekannt sind, sollten hier mal ein wenig näher durchleuchtet werden. Wobei jeder der es denn möchte und die Knöpfe auf seiner Tastatur noch findet, bitte selber nach den relevanten Dingen, beonders der Vergangheit suchen möchte.

Leider gibt es Börsennotierte, wirkliche Nanowerte, nicht gerade viele. Die Frage ist auch, was ist denn nun wirklich Nano ?

Um bei den beiden Firmen Nanophase und Altair zu bleiben kann man diese in den Bereich der Partikelhersteller einordnen. D.h. diese fertigen mehr oder weniger kleinste Teilchen, die für die verschiedensten Dinge eingesetzt werden können.

Wozu ist dass nun gut ?

Zum einen kann man durch die feinen Strukturen eben, grob gesagt, die Eigenschaften einiger Dinge verbessern. Zum anderen sind völlig neue Anwendungen denkbar oder zum Teil schon möglich.

Eines soll mal gleich vorweg gesagt werden, es hat keiner bis jetzt etwas bei den beiden Firmen versäumt. Ganz im Gegenteil, die Erwartungshaltungen waren zu Anfang so hoch, dass es zwangsläufig in Hose gehen mußte. Bei der derzeitgen Bewertung und den Ausssichten der beiden Aktien sieht es aber vielleicht schon etwas anders aus.

Nanophase

Die Firma Nanophase hat z.B. mit der Firma BASF Ihren größen Kunden, der die Pigmente in Sonnenschutzcrems einsetzt, um die Wirkung zu verbessern. Der Vertrag wurde gerade für das nächste Jahr verlängert und spült um die 3.0 Mio$ in die Kassen. Der Name BASF wurde dabei aber nicht genannt, aber wer ein bischen wühlen geht, wird darüber schon stolpern. Das ist auch gleich einer der kritischen Punkte, da die Abhängigkeit mit ca. 70% extrem hoch ist.

Nanophase hat, wie so viele andere, mit der Zurückhaltung der Firmen bei den Investionen zu kämpfen. Es sind in der Vergangenheit viele Dinge angeleiert worden, z.B. für (Maler) farben, Fußbodenbeschichtungen und zu letzt zur Verbesserung der Waferoberflächen. Richtig was dabei rausgekommen ist aber bis jetzt nichts.

Somit müßen auf jedenfall neue Aufträge her. Zumindest wird ein bischen Umsatz generiert, der den Laden mehr oder weniger am laufen hält.

Altair

Zu Altair könnte man ganze Romane verfassen. Eigentlich war der Laden schon weg vom Fenster. Durch einen Wechsel in der Führungsspitze hat man aber wieder etwas mehr Schwung reinbekommen.

Altair hat sich so in die Richtung eines Gemischtwarenladens in der Partikelherstellung bewegt. D.h. Altair deckt so viele Felder ab, dass man sich schon die Frage stellen muss, ob wenigestens eines der Felder mal was wird.

So sind Sie neuerdings im Pharmabereich, Batterien LI-Ionen 42 V, Fuelll Cell sowie natürlich auch im reinen Pigmentbereich tätig.

Verschiedene Abkommen mit den unterschiedlichsten Firmen bestehen z.B: Ntera auf dem Gebiet der Li-Batterien etc. oder jetzt gerade vermeldet vor ein paar Tagen mit den Vietnamesen für eine neue TIO2 Farbik oder der Einsatz für die Swimming Pools und Fischfarmen (Algen Vernichtung) oder die Pharmabranche etc. Schaut mal selber nach was da so alles auf der Homepage steht.

Gerade der Deal mit den Viatnamesen ist eigentlich völlig abgefahren, wenn man nicht irgendwas in der Hinterhand hat.
Denn die Knete ist, wie bei vielen, nicht gerade üppig gestreuet. Also entweder haben die dass totale Rad ab oder Altair wird der Überflieger des nächsten Jahres.

Bei den Phases war ich mal zu 9 drin und bei 8.50 wieder raus, was ein Glück auch. Diese scheinen eine Art Boden bei um die 3.00 $ gefunden zu haben.

Bei Altair sieht es ähnlich aus, wobei Sie sich von Ihrem bis dato ATL schon wieder ein wenig entfernt haben. Aber was heißt dass schon.

Also Meinungen, wie auch immer, solange konstruktiv, sind gefragt.

gruß
mrasta

[micky1]

hi, wenn du nano magst, schau dir doch mal harris & harris an.

[MRASTA]

@micky1

Tiny ex Harris & Harris ist einer der ersten Fonds auf diesem Gebiet, dass ist richtig. Bis jetzt aber auch noch nicht so gelaufen, wie man es sich gewünscht hätte. Wenn die Konjunktur wieder anziehen sollte, werden zuerst die Grundsubstanzwerte davon profitieren und davon sind leider nicht sehr viele Börsen notiert.

Habe die Fundamentaldaten ganz vergessen :

Nanophase Market: NASDAQ-NM Sym: NANX

52 Wk High / Low $ 8.6995 $ 2.42
TSO 15,106,000
Market Cap $ 43,822,506
P/E Ratio NE
Earnings Per Share $ -0.41
Dividend Amount N/A
Ex Dividend Date N/A
Current Yield 0 %
Beta 0.76


Altair Market: NASDAQ-SCM Sym: ALTI

52 Wk High / Low $ 1.56 $ 0.30
TSO 30,038,000
Market Cap $ 16,220,520
P/E Ratio N/A
Earnings Per Share N/A
Dividend Amount N/A
Ex Dividend Date N/A
Current Yield 0 %
Beta 0.95

mrasta

[MRASTA]

Und hier noch die SEC Meldungen der beiden Firmen. Q-Berichte etc. kann sich jeder selber raussuchen.

Altair
http://www.nasdaq.com/asp/quotes_news.asp?symbol=ALTI%60&sel…

Phases
http://www.nasdaq.com/asp/quotes_news.asp?symbol=NANX%60&sel…

Nochmal ein paar Anmerkungen.

1. Bei den Phases und Altair handelt es sich, meiner Meinung nach, nicht um Technologiewerte im herkömmlichen Sinne, da beide Ihr Hauptaugenmerk auf der Partikelherstellung haben und dass sind Grundsubstanzen.

2. Bis jetzt hat man überhaupt nichts falsch gemacht, wenn man nicht dabei war, ganz im Gegenteil, bis jetzt waren beide Werte ein Flop und man konnte nur Geld verbrennen.

3. Nochmal 3 Jahre wird es nicht dauern, dann sind beide lange Pleite.

Von der Bandbreite her gesehen, ist Altair sicherlich der interessantere Wert. Und gerade für Altair wird das Jahr 2003 entscheidend sein.

mrasta

[MRASTA]

Altair Nanotechnologies Awarded Third Patent Pertaining to New Titanium Dioxide Manufacturing Process
30 Jan 2003, 09:00am ET
E-mail or Print this story
- - - - -

RENO, Nev.--(BUSINESS WIRE)--Jan. 30, 2003--

Patent Portfolio Protects Basic Technologies for
Commercial Development; Programs of Nano-Sized and Pigment-Sized Ti02

Altair Nanotechnologies Inc. (Nasdaq:ALTI) today announced that it
was awarded its third patent "Processing Aqueous Titanium Solutions To
Titanium Dioxide Pigment" by the US Patent Office.
The new patent describes the fundamental technology for a
hydrometallurgical process for producing pigment-grade titanium
dioxide ("Ti02") containing solutions. The process includes
hydrolyzing the solution via complete evaporation in controlled
conditions of temperature to form titania oxide of defined
characteristics. After hydrolyzing, the titanium oxide is calcined to
form either anatase or rutile pigment of the desired particle size. It
is then milled for final processing.
"Our patented process provides significant economies of scale and
considerable environmental advantages over the existing chloride and
sulfate processes," commented Altair President Dr. Rudi E. Moerck.
"Further, the manufacturing process provides pigment companies an
opportunity to improve their overall operations, reduce cost and
contribute to the betterment of the environment."
The new patent follows the award of two other patents covering the
environmentally friendly process for TiO2 pigment production, a $9
billion industry. Altair`s patent portfolio includes: (1) Processing
Titaniferous Ore to Titanium Dioxide Pigment; (2) Processing Aqueous
Titanium Chloride Solutions to Ultrafine Titanium Dioxide, and (3)
Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment.
"To date Altair has filed 12 additional patents that have been
developed on the foundation provided by our three patents," noted
Moerck. "These additional applications address materials in the fields
of pharmaceuticals, advanced batteries, fuel cells, and a variety of
other environmental uses. We are pleased with the issuance of these
patents as they demonstrate the originality and distinctiveness of our
technology platform and products."

Altair Nanotechnologies Inc.


wie immer ohne Gewähr.

Der Verkaufsdruck ist immer noch erheblich. Wer auch immer da ständig verkauft, keine Ahnung. Noch ist nichts in trockenen Tüchern, ein zweiter Pharmaladen testet auch schon. In 60 Tagen wissen wir alle mehr, ob der Gemischtwarenladen Top oder Hopp ist.

Also wer das Risiko liebt, kann mit einer kleinen Position langsam rein.

cu

[MRASTA]

Altair Nanotechnologies Invited to Present At the 47th Institutional Investor Conference in New York
5 Feb 2003, 09:02am ET
E-mail or Print this story
- - - - -

RENO, Nev.--(BUSINESS WIRE)--Feb. 5, 2003--

Dr. Rudi E. Moerck to Present Altair`s Drug Delivery Technology Platform and New Nano-Based Pharmaceutical, RenaZorb(TM), to the Analysts and Portfolio Managers Attending the Conference`s Drugs and Biotechnology Industry Sector Presentations

Altair Nanotechnologies Inc. (Nasdaq:ALTI) today announced that its President Dr. Rudi E. Moerck has been invited to present at the 47th Institutional Investor Conference organized by The Wall Street Analyst Forum.

The conference is being held at the Roosevelt Hotel in New York Feb. 10 through Feb. 13, 2003. Moerck will present Tuesday, Feb. 11 at 8:20 a.m. and at 12:30 p.m.

Both presentations will be followed by a 10-minute question and answer session and a separate room will be available for the investment community to meet with Moerck and Altair`s CEO Dr. William P. Long following the question and answer session. Approximately 100 public companies will be presenting at the conference.

Analysts and portfolio managers who wish to attend the
presentation should contact The Wall Street Analyst Forum at 802/253-7596.

In addition to discussing Altair`s technology for RenaZorb, the company`s new drug for phosphate control in kidney dialysis patients, Moerck will also talk about Altair`s nano-based drug delivery system for pharmaceuticals in general. The Altair drug delivery platform has the potential to reduce side effects and to improve efficacy of existing drugs.

The Wall Street Analyst Forum Inc. is the largest non-brokerage sponsor of analyst conferences in the United States. Each of their four annual New York industry-specific conferences brings together the
CEOs and CFOs of public corporations with approximately 800 buy- and sell-side analysts and portfolio managers and thousands of additional investors who listen via live or delayed webcast.

Bloomberg, First Call, E*TRADE, Zacks and other financial portals all promote webcast attendance of the corporate presentations.

Investors may access an Internet webcast of the presentation at: http://events.onlinebroadcasting.com/fdfn/wsaf/021003/index.… or by visiting Altair`s Web site, www.altairnano.com.

Simply click on the Corporate Information link at the top of the page and then click on the audio presentation link titled "Dr. Rudi E. Moerck at the Wall Street Analyst Forum Conference ... "

Altair Nanotechnologies Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary
technology for making nanocrystalline materials of unique quality both economically and in large quantities.

The company is currently developing special nanomaterials with potential applications in pharmaceuticals, advanced energy storage devices, thermal spray coatings, fuel cells, solar cells, catalysts, cosmetics, paints and environmental remediation. For additional
information on Altair`s nanoparticle materials, visit
www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks,
uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, biological testing of the
pharmaceuticals may not be successful, the pharmaceuticals may not obtain FDA approval and Altair, without the assistance of a strategic partner, may not be capable of funding the FDA approval cycle.

Additionally, the company may be unable to attract additional customers, fund additional research or product development through its sales and branding campaign. The company may never earn sufficient revenues to be profitable; its nanoparticle products may not be
integrated into any major market groups and products. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking
statements found herein to reflect any changes in company expectations or results or any change in events.

[MRASTA]

RENO, Nev., March 18, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) and Western Michigan University (WMU) have been notified of grant funding for their joint development of nanosensors for detecting chemical and biological weapons and an agent for the breakdown and concentration of radioactive nuclides. The approximately $1 million grant, for which WMU applied, was approved through President Bush`s signing of the fiscal 2003 Omnibus Appropriations Bill and should be available by the end of April.

Altair Nanotechnologies and WMU will utilize the funds equally. According to WMU`s Dr. Subra Muralidharan, Associate Professor of Chemistry and Director of WMU`s Nanotechnology Research and Computation Center, WMU and Altair plan to obtain additional grants worth $1 million or more per year.

"The monies will fund two related programs: nanosensor development for the detection of chemical, nuclear and biological weapons should have significant use for national defense applications and homeland security programs, while the remediation agent uniquely addresses the on-site reduction of radioactive waste," said Altair President Dr. Rudi E. Moerck. "Our partnering agreement with WMU, a renowned leader in nanobioenvironmental chemistry research and the founding entity of the Nanotechnology Research and Computation Center, presents an ideal venue to showcase our proprietary nanomaterial technologies. In addition to partnering with WMU, we plan to work with the University of Nevada, Reno for testing and analysis assistance pertaining to the development program."

"This research will make Nevada, and America, a better place to live," said Nevada Senator Harry Reid. "Nanotechnology will help protect and preserve our environment, and will give us cutting-edge tools to fight terrorism and improve Homeland Security. I`m proud that a Nevada company is leading the world in developing this vital technology, and I look forward to working with Altair in the future as well."

"We evaluated potential research program partners stringently as our success depends on their capabilities," noted Dr. Muralidharan. "Altair`s proprietary titanium dioxide nanoparticles exhibited the ability to maintain their integrity in extreme environments. We believe these nanoparticles, when melded with our technology, will allow the creation of nanosensors which, when dispersed on military vehicles or military and security uniforms could quickly sense the presence of warfare agents and instantaneously alert a control center.

"These same titanium dioxide nanoparticles can be formed in large-surface delivery systems and conjugated with our proprietary molecules," continued Dr. Muralidharan. "These molecules will be used for the concentration of radioactive nuclides in nuclear fuel and high-level radioactive waste on site.

"I believe it is important to note," added Dr. Muralidharan, "that Altair is one of a few companies with the technology and capacity to economically manufacture large quantities of titanium dioxide nanoparticles benefiting our development of nanosensors for detecting chemical and biological weapons and myriad other sophisticated civilian applications."

WESTERN MICHIGAN UNIVERSITY
WMU is a Carnegie-designated Doctoral/Research-Extensive university and one of only 102 public research universities to be included in this top classification. WMU is a national leader in nanobioenvironmental chemistry research and has established the Nanotechnology Research and Computation Center to further this research.

ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

[MRASTA]

Nur heiße Luft, oder kommt wirklich was ?



Altair Nanotechnologies Announces First Pigment Production Utilizing Cutting-Edge Pigment Manufacturing Process

Wednesday April 2, 9:00 am ET
Altair Manufactures Pigment Using First New Pigment Manufacturing Process Patented In Over 50 Years

RENO, Nev., April 2, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (NasdaqSC:ALTI - News) announced today that it has successfully produced kilogram quantities of titanium dioxide (TiO2) pigment base using its patented Altair Hydrochloride Pigment Process (AHPP) and to date several pigment companies have been sampled with this material. Altair was recently awarded the first new comprehensive TiO2 pigment process patents since Dupont`s chloride process patents were awarded in the 1950`s.

Altair`s process for manufacturing titanium dioxide is a unique combination of processes involving extraction, purification, and pigment formation. The initial pigment development program focused on pigment formation from a pure titanium oxy chloride feedstock.

Outstanding features of the process include lower operating costs, minimized environmental and health risks and the ability to recycle all of the chemical additives used in the process. Improved cost and environmental features potentially give Altair`s process a competitive advantage in the industry.

``We acquired Broken Hill Proprietary`s (BHP`s) technology knowing that its new pigment process had significant advantages over both the sulfate and chloride pigment processes currently in use,`` said Altair President Dr. Rudi E. Moerck. ``BHP, a multi-billion dollar global resources company and its Reno, NV-based scientists believed its pigment process would prove to be the `best available technology` within the industry to produce titanium dioxide pigment - and based on our findings, it is. Altair has focused on the production of a wide range of unique nanomaterial products while the TiO2 Pigment process patents were issued in order to protect the company`s intellectual property from other pigment manufacturers.

``Having the capability to produce quality titanium dioxide pigment, a product that has the potential to compete in the $9 billion pigment industry is a significant milestone for Altair,`` continued Dr. Moerck.

``While all testing has not been completed, results to date are extremely positive. We are interested in supplying kilogram samples to other pigment companies at no cost provided they share testing data with Altair.``

``We anticipate the dissemination of several significant news releases prior to our April 11th Investor Conference,`` added Dr. Moerck.

[MRASTA]

Altair Pigment from Ilmenite Ore Generates International Interest

Tuesday , April 08, 2003 09:01 ET

RENO, Nev., Apr 08, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has successfully completed phase I development and has produced phase pure rutile titanium dioxide (TiO2) entirely from ilmenite concentrates provided by a materials company in the Asia Pacific region. The pigment was produced for that company as part of their development agreement with Altair. The capability is important to companies within the pigment industry as Altair`s process takes readily available, inexpensive feedstock and, with its patented process, economically produces phase pure titanium dioxide pigment without the need of expensive intermediate upgrade technologies that include slagging or synthetic rutile production. This effectively reduces the operating cost for the AHPP by roughly US$150-200 per metric ton.

"As we continue to stress," commented Altair President Dr. Rudi E. Moerck, "our manufacturing process can utilize a wide variety of feedstocks with the end result being an inexpensively produced, pure quality TiO2 pigment. In using the process, pigment manufacturers can reduce their production costs and eliminate environmentally unfriendly waste by-products -- providing a highly competitive advantage in the marketplace. In addition, the Altair Hydrochloride Pigment Process is capable of producing both rutile and anatase TiO2 pigment base materials, nanomaterials, and other specialty titanates."

The company`s ability to produce pigment from ilmenite ore and other inexpensive feedstocks has generated strong interests from many sizeable pigment producing and natural resources companies domestically as well as in China, South Africa, Australia, India, Canada and Vietnam. "We have been making presentations at various conferences pertaining to the pigment industry and have recently submitted an abstract for Hydro 2003 to be held in Vancouver in August," said Dr. Moerck. "With our patents now fully protected we are becoming more active in presenting our technology in the global hydrometallurgical research and commercialization arena."

"The phase one report for this work will be issued to the Pacific Rim company later this month. Phase II of the development proposal has been submitted to our customer and we expect a response to the proposal pending their evaluation of the phase one data."
ALTAIR NANOTECHNOLOGIES, INC.

[MRASTA]

aha, geht wieder.

Danke an alle, die mich informiert haben.

[MRASTA]

Nanophase meldet sich auch mal wieder. ISO Zertifizierung und Stockholdermeeting.


Nanophase CEO Appointed to Industry Advisory Boards

Tuesday , April 08, 2003 15:28 ET

ROMEOVILLE, Ill., Apr 8, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced that the Company had successfully completed the ISO9001: 1994 transition audit to the new ISO9001: 2000 standards. After an extensive audit on both of its manufacturing facilities in Romeoville and Burr Ridge, Illinois, SGS International Certification Services, a RAB-ANSI accredited auditing firm, certified that Nanophase`s Quality Management System meets the requirements of the new standards.

"This recent external revalidation of our integrated quality management system is one of several Nanophase initiatives to be highly focused on our product quality, customers, and total commitment to lean manufacturing and continuous improvement," stated Bob Haines, Nanophase`s vice president of operations and engineering. "Having an internationally recognized quality system and operating our manufacturing facilities under the FDA cGMP system definitely provides the Company with a distinct competitive advantage as an innovator and commercial volume manufacturer of nanocrystalline materials."

Nanophase also noted that Joseph Cross, its president and CEO, has been appointed to the advisory boards of the NanoBusiness Alliance and the BCC NANOPARTICLES 2003 conference. Mr. Cross will be attending the second annual NanoBusiness conference in New York during May for the annual board meeting, participate in a panel discussion, and present a paper on "Successful Nanotech Business Models". For the BCC NANOPARTICLES 2003 conference in October, Mr. Cross has been invited to chair a conference session and participate in an expert panel discussion.



Tuesday , April 08, 2003 17:58 ET

ROMEOVILLE, Ill., Apr 8, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a leader in nanomaterials and nanoengineered products, announced that its 2003 annual stockholder meeting will be held on June 26 at 9:00 am CDT at its Romeoville facility for stockholders of record as of April 29, 2003. The meeting location is 1319 Marquette Drive, Romeoville, Illinois, and directions may be obtained from the company`s web site or by contacting the company by phone or in writing.

Nanophase wants to ensure that adequate facilities are available and requests that stockholders who plan to attend contact Susan Barrett, 630-771-6704 or [e-mail], at least 15 days prior to the meeting.

[MRASTA]

gibt wohl leider einige Probs mit diesem Thread.

Sollte wohl jetzt wieder gehen.

Da einige verschiedene Fragen gestellt haben, warum eigentlich nicht hier im Thread sondern per mail ?

Egal, möchte aus diesem Grund mal allgemein auf den TIO2 (Titanium Dioxid) Bereich aufmerksam machen. Habe dass schon an anderer Stelle getan, will es aber hier in Kurzform auch nochmal unterbringen. Vielleicht interessiert es den einen oder anderen, was so alles möglich ist, möglich zu sein scheint oder aber schon existiert.

Will hier keine wissenschaftliche Abhandlung über die Möglichkeiten des TIO2 Einsatzes erbringen, aber die Möglichkeiten und vor allem die frapierende Wirksamkeit in vielen Gebieten ist mehr als erstaunlich. Und was dass tolle ist, das Zeug ist vollkommen ungiftig.

Soweit ich weiß, benutzt Toyota die Partikel bereits in den hochpreisigen Fahrzeugen und zwar integriert in die Frontscheibe. Hat nichts mit Lotus Effekt oder dergleichen zu tun, wie einige vielleicht vermuten würden, sondern funktioniert vollkommen anders, nämlich mittels Photokatalyse. Der Dreck wird regelrecht vernichtet, funzt aber nur bei Tageslicht.

Die Japaner benutzen die Partikel in einigen Papiersorten gegen Bakterien, Geruch oder auch Formaldehyd usw. Ja, richtig gelesen. Forschungsergebnisse sind auch vorhanden.Und die Ergebnisse im Formaldehyd Bereich können sich wirklich sehen lassen.

Das Prinzip beruht darauf, dass die Schadstoffe angesogen werden und regelrecht vernichtet werden. Dazu braucht man nur z.B. ein Stück Tapete oder einen Kalender, das/der mit den Teilchen durchsetzt wurde, die man in den eigenen vier Wänden aufstellt oder hinhängt. Einfacher geht es wohl nicht mehr.

Will das Ganze jetzt nicht vertiefen.

Sollte interesse bestehen, kann ich aber gerne hierzu nochmal ein paar Links und Infos reinstellen.

Wer mal einen Überlick haben will, sollte sich die nachfolgende Seite anschauen. Federführend sind wohl die Japaner. Hier sind im letzten Jahr bis jetzt Versuche gelaufen, die ein Spektrum umfassen, dass man Bauklötze staunt.

http://www.kansai-ri.co.jp/trend/mcp/2002/05_FIG_02.html

Vielleicht hilft es ein wenig, das theroetische Potential von TIO2 und auch von Altair einzuordnen. Ob es mit Altair klappt oder auch nicht, weiß man natürlich immer erst später.

Gruß
mrasta

[MRASTA]

Von BASF ist ja bekannt, dass Sie auf diesem Gebiet am wirbeln sind. Ihre Sonnenblocker gibt es ja seit längerer Zeit. Scheint so, als wenn viele mit TIO2 experimentieren.

Scientists from chemical giant BASF have made prototypes of swimsuits that offer protection from UV rays. The polymer they have produced contains titanium dioxide particles that create a solar barrier, whether wet or dry. The clothing has the added advantage of being a specific sun protection factor, depending on individual requirements.

REF: Sunblock in a swimsuit. The Daily Telegraph; 9 April 2003: 16

[Klickman]

!

Dieser Beitrag wurde vom System automatisch gesperrt. Bei Fragen wenden Sie sich bitte an [e-mail]

[MRASTA]

Meldungen kommen im Moment ja fast täglich. Ob dass nun ein gutes oder schlechtes Zeichen ist, wird man sehen.

Heute News von Nanophase. Die jetzt mit Ihren neuen Produkten in die Testphase eintreten. D.h. es scheint zu dauern. Schaun wir mal.


Thursday , April 10, 2003 09:30 ET

ROMEOVILLE, Ill., Apr 10, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, today announced what it believes is the first commercial nanoscale availability of an innovative family of high surface area, very pure nanocrystalline rare earth oxides. These nanomaterials are targeted at a wide variety of potential applications, including fuel cells, chemical-mechanical polishing (CMP), ultrafine polishing, catalytic converters, and catalysis.
Available for the first time in commercial quality and quantities, these unique nanostructured materials are single or multi-element rare earth oxides that are combined in a single-phase crystal. Ratios of mixed rare earth oxides may be adjusted based on customer application. The nanomaterials are produced using Nanophase`s proprietary (patent pending) technology, NanoArc Synthesis(TM), which the Company developed over the past two years and initially commercialized for the CMP market with Rodel, a division of Rohm & Haas Corporation.

The new single-phase, multi-component, high surface area nanomaterials are available in discrete ranges of average particle sizes from 7 to 35 nanometers. The first three products in this NanoArc(TM) family of products are Ceria, Cerium/Lathanum/Zirconium (Ce/La/Zr) oxide, and Cerium/Praeseodymium/Zirconium (Ce/Pr/Zr) oxide. These NanoArc(TM) products are characterized as homogenous nanocrystals having a narrow particle size distribution, typically in a range of 7-12 nanometers, with the latter two nanomaterials displaying high thermal stability.

"The NanoArc(TM) mixed rare earth nanomaterials are unique in many ways, particularly in terms of maintaining high surface area at elevated temperatures, narrow nanoparticle distribution, high oxygen storage capacity, and ease of dispersion in both aqueous and organic systems," stated Dr. Dan Coy, Nanophase`s Director of Engineering. "The unique and highly engineered surface chemistry results from the Company`s patent-pending NanoArc Synthesis(TM) technology and yields high zeta potential, hydrolytically stable particles."

Dan Bilicki, Nanophase`s vice president of Sales and Marketing stated, "As a leading innovator in nanomaterials, we believe that Nanophase offers the first commercial availability of single-phase, mixed metal nanostructured oxides. Because of the unique technology employed for manufacturing, these materials also offer novel performance attributes that should provide distinct advantages in several markets. We are currently beginning the initial testing of these materials for several applications and believe that this new class of nanomaterials will greatly enhance the Company`s medium-term revenue opportunities."

Nanophase has annual full-scale commercial production capability for these materials in the metric ton(s) range. Additional nanomaterials in the NanoArc(TM) family of nanocrystalline rare earth oxides that are expected to be available shortly includes samarium doped ceria for solid oxide fuel cells, a variety of single-phase ternary and quaternary rare earth oxides systems for catalysis, and doped ceria for CMP and ultrafine polish. Nanophase expects to announce commercial availability of these new nanomaterials in the near future.

[MRASTA]

Uff, ist hier was los.

Bevor ich auf die neuen Meldungen von Altair komme, nochmal einer der möglichen Gründe, warum wir zur Zeit mit Meldungen regelrecht überschüttet werden.

Möchte in diesem Zusammenhang nochmal auf die im Juni entscheidene Phase bei Altair aufmerksam machen.

Seitens der SEC wurde Altair eine Art Duldung zugestanden, dass Sie bis Juni 2003 im Nasdaq Segment gelistet bleiben. Sollten Sie es nicht schaffen, bis dahin über 10 Tage lang einen Kurs von mindestens 1$ zu haben, fliegen Sie raus und es geht ab in den geliebten OTC Bereich. Und $5Mio. müssen wohl auch noch irgendwo herbekommen. Könnt Ihr in den SEC Meldungen nachlesen.

Dementsprechend sind vielleicht auch die gehäuften Meldungen zu wichten. Ohne eine Meldung mit Substanz, also echten Kontrakt, wird dass sehr schwer werden.


Und da haben wie die erste Meldung. Was Sie Wert ist, keine Ahnung, dass steht da nicht. Den Kurs hat es aber nicht beindruckt, wobei diese Meldung merkwürdigerweise nicht überall zu finden ist ?

Und ein paar Shares zu 0.40 gab es auch wieder.



Altair Nanotechnologies Signs Agreement with Flowco International for the Licensing of its Patented Pigment Process in China By Staff

RENO, Nev., Apr 09, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has entered into an agreement with Tulsa, OK-based Flowco International, Inc. naming Flowco as its exclusive agent in the People`s Republic of China (PRC). Flowco represents a number of American and European companies in the PRC. Under the terms of the agreement, Flowco will market Altair`s patented Hydrochloride Pigment Process (AHPP) licenses to companies in the PRC. Flowco International has successfully sold plants and services in the PRC for over ten years.

"Altair`s professional team has provided me with technology and process details that will enable me to competently represent Altair," said Flowco President Mu Fa Chen. "During my visit to Altair`s manufacturing plant and facilities in Reno, Nevada I was impressed with their technical capabilities and had an opportunity to completely evaluate Altair`s patented TiO2 pigment process. Altair`s ability to produce phase pure rutile titanium dioxide (TiO2) entirely from primary ilmenite ore is required in the PRC because of their large reserves of ilmenite ore. I believe it is also important to note," continued Chen, "that the PRC government will not approve new TiO2 plants using the old sulfate process for environmental reasons; therefore we believe an environmentally friendly process such as Altair`s AHPP will be favorably looked upon."

"During a recent trip to China, several companies, including the Government Engineering Agency overseeing TiO2 development in the PRC, expressed interest in Altair`s AHPP and the potential to license the process," continued Chen. "With China`s world class reserves of titanium ore and very favorable labor costs, a license from Altair may allow them to rapidly develop a substantial pigment industry in the PRC."

"China is potentially a vast market for our titanium pigment technology," said Altair President Dr. Rudi E. Moerck. "With three offices in mainland China, Flowco not only has the cultural expertise Altair believes is required but agents that understand how Chinese companies conduct business. Of course it is equally important that Mr. Chen and his team of engineers understand the PRC pigment industry. We look forward to a mutually beneficial business relationship with Flowco and Flowco`s clients."
FLOWCO INTERNATIONAL, INC.

Flowco International has offices in Tulsa, Oklahoma, Beijing, Wuhan and Luoyang, PRC. Flowco services companies within the refinery, petrochemical, fertilizer and chemical industries. Flowco`s business is divided into three segments: equipment sales, sourcing new technologies and relocating available manufacturing facilities to the PRC.

##########################################################

Thursday , April 10, 2003 15:44 ET

Altair Nanotechnologies Inc (Nasdaq NM: ALTI) filed an S-8 during Thursday?s session.

The Company is registering 500,000 shares of common stock issuable under its 2002 Wage Stock Purchase Plan.

[MRASTA]

Ah, ganz vergessen, wer noch Lust hat, kann ja heute mal bei Altair vorbeischauen.

RENO, NV. ? March 25, 2003 ? Altair Nanotechnologies, Inc. (NASDAQ:ALTI) announced that it will hold an open house for shareholders, investors and others with an interest in Altair?s proprietary technology. The open house will be held at Altair?s corporate headquarters located at 204 Edison Way, Reno, Nevada, on Friday, April 11, 2003, at 1:30 p.m.

cu

[MRASTA]

Echt keine Ruhe im Moment.

Zahlen von den Phases sind draußen.


Nanophase Technologies Announces First Quarter 2003 Revenue
11 Apr 2003, 09:30am ET
E-mail or Print this story
- - - - -

18% Increase Year-to-Year; 54% Increase in Sequential Quarters

ROMEOVILLE, Ill., April 11 /PRNewswire-FirstCall/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a leader in nanomaterials and nanoengineered product solutions, announced that its first quarter 2003 revenue was approximately $1.66 million, or about 4% above the high end of the Company`s previous revenue guidance. This represents an increase of approximately 18% compared to the first quarter of 2002 and a sequential quarterly increase of approximately 54% compared to the fourth quarter of 2002.

"Since we currently expect revenues to be higher during the second half of 2003, the start for the first quarter of 2003 is definitely encouraging for the full year," stated Joseph Cross, Nanophase`s president and CEO. "Considering the business development initiatives underway, the Company`s expanded and integrated family of nanotechnologies, and the new NanoArc(TM) nanoproducts just introduced and those in the pipeline, we remain optimistic on revenue growth for 2003."

First Quarter Earnings Release and Conference Call

Nanophase also announced that the Company plans to release earnings for the first quarter on April 23, 2003, at approximately 3:30 PM CDT, 4:30 PM EDT. Nanophase has scheduled its normal quarterly conference call for April 24, 2003, at 10:00 CDT. The call may be accessed though the Company`s website, www.nanophase.com , and clicking on the conference call link under Investor Relations and Calendar of Events, or dialing 706-634-7296 at least five (5) minutes before the start time.

[MRASTA]

Damit es ja nicht langweilig wird :

Friday , April 11, 2003 09:02 ET

RENO, Nev., Apr 11, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) reported today that data from laboratory testing and animal testing of RenaZorb(tm), the company`s new drug candidate for phosphate control in kidney dialysis patients, has demonstrated significant effectiveness in binding phosphate. The new laboratory test results, conducted by a pharmaceutical company, confirmed earlier in vitro testing conducted in Altair`s laboratory. Positive results from animal testing are required to progress to eventual testing in humans.

The recently completed study tested both RenaZorb "B" and RenaZorb "H" in rats. Over the entire testing period, rats treated with RenaZorb showed excellent reductions of phosphorus in urinary excretions. Reduced urinary phosphorus is considered positive proof of the drug`s efficacy in binding phosphate. RenaZorb reduced phosphate progressively according to the dose administered. There was no reduction in food intake by the animals and there were no negative observations regarding the animals during the duration of the testing program.

Test results showed that RenaZorb "B" was effective at a dosage level of 0.3 percent of diet resulting in a greater than 400 percent reduction in urinary phosphate excretion. RenaZorb "H" reduced urinary phosphate by approximately 200 percent at a dosage level of 0.3 percent of diet and displayed a 260 percent reduction at a dosage level of 0.6 percent of diet.

With the completion of the laboratory and initial animal testing of RenaZorb, Altair believes that RenaZorb has significant advantages when compared to Genzyme`s Renagel(tm), the only non-calcium based drug for phosphate control approved by the FDA. "These advantages could include," stated Altair President Dr. Rudi E. Moerck, "lower dosing, no acid burden, higher selectivity for phosphate and ultimately, lower patient cost." Dr. Moerck went on to add that the FDA has issued an approvable letter to UK-based Shire Pharmaceuticals for Fosrenal(tm), the first lanthanum-based pharmaceutical for phosphate control in dialysis patients. RenaZorb, also based on lanthanum chemistry, may offer cost, performance, and dosing advantages when compared to Fosrenal.

Altair also announced that it had received a separate report on testing of RenaZorb in rats and dogs from another pharmaceutical company. Confidentiality agreements do not permit Altair to disclose the results of this report.

"The conclusion of the first phase of in vivo testing represents a milestone in the development of RenaZorb," said Dr. Moerck. "The results achieved in the animal tests combined with our earlier laboratory results provide clear evidence that RenaZorb is a viable drug candidate for phosphate control in kidney dialysis patients. The results from the study also have allowed Altair to make adjustments in RenaZorb`s formulation that should further enhance its phosphate binding performance. We are in discussions with four pharmaceutical companies and will make our in vivo testing results available to potential licensees of RenaZorb." Dr. Moerck went on to note that the use of RenaZorb for phosphate control in feline and canine applications is currently being explored with interested companies.

[MRASTA]

Und schon wieder.


Friday , April 11, 2003 10:30 ET

RENO, Nev., Apr 11, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has retained RBC Capital Markets as its exclusive financial advisor to assist the company with a comprehensive evaluation of its strategic alternatives pertaining to RenaZorb(tm), Altair`s new drug candidate for the removal of phosphate ions in kidney dialysis patients. The two companies will develop and execute a strategy to maximize the value of Altair`s investment in RenaZorb.

"Our primary responsibility is maximizing shareholder value," said Altair President Dr. Rudi E. Moerck. "As such, we have engaged RBC to identify and introduce management to companies within the pharmaceutical industry that have an interest or a need for products addressing phosphate removal. RBC`s strong presence within the industry will be invaluable as we develop and evaluate our alternatives for licensing RenaZorb.

"We have made significant progress with RenaZorb and have received positive results from both in vitro and in vivo testing," continued Dr. Moerck. "There continues to be significant activity pertaining to RenaZorb within the pharmaceutical industry as we have signed several confidentiality agreements and are in discussion with four pharmaceutical companies. We believe RBC through its introductions and contacts within the industry will be able expedite a licensing agreement or the disposition of the product."

RBC CAPITAL MARKETS
RBC Capital Markets is the global brand for the corporate and investment banking businesses of RBC Dominion Securities, Canada`s leading investment bank, and Dain Rauscher Wessels, the U.S. equity capital markets arm of RBC Dain Rauscher (member of NYSE and SIPC). The firm offers focused industry expertise and global reach in its chosen products, markets and industry sectors through five business divisions and 3,000 employees including some 80 analysts covering more than 900 companies. It is a member of Royal Bank of Canada. Royal Bank of Canada (TSX, NYSE: RY) uses the initials RBC as a prefix for its businesses and operating subsidiaries, which operate under the master brand name of RBC Financial Group. Royal Bank of Canada is Canada`s largest financial institution as measured by market capitalization and assets, and is one of North America`s leading diversified financial services companies. It provides personal and commercial banking, wealth management services, insurance, corporate and investment banking, and transaction processing services on a global basis. The company employs 60,000 people who serve more than 12 million personal, business and public sector clients through offices in North America and some 30 countries around the world. For more information, please visit www.rbc.com.

[MRASTA]

Wednesday, April 23, 2003 18:26 ET
QUARTER RESULTS

Nanophase Technologies Corporation (NASDAQ NM: NANX) reported Q1 results ended March 2003. Q1 Revenues were $1.66M; +17.73% vs yr-ago; BEATING revenue consensus estimates by +10.67%. Q1 EPS was (9c); +18.18% vs yr-ago; BEATING EPS consensus estimates by +71.88%. Adjusted Q1 EPS was (9c).

[MRASTA]

Tuesday , April 29, 2003 11:48 ET
RENO, Nev., Apr 29, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has received the patent number for its third in a series of patents pertaining to Altair`s Hydrochloride Pigment Process (AHPP). The U.S. patent number is 6,548,039 and it is titled "Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment". This patent covers the art and science of manufacturing a wide range of pigment grade titanium dioxide (Ti02) from purified titanium-rich chloride solutions.

"In keeping with our commitment to maintain our lines of communications," said Altair Nanotechnologies President Dr. Rudi E. Moerck, "I am pleased to provide an update to our shareholders and the financial community of recent developments within the company."

Pharmaceuticals

RenaZorb(tm) is Altair`s drug candidate for phosphate control in kidney dialysis patients. Results from animal testing of RenaZorb by a third-party pharmaceutical company confirm Altair`s in vitro test results pertaining to the effectiveness of RenaZorb as a viable drug candidate for phosphate control in kidney dialysis patients with end stage renal disease (ESRD). The company estimates that there are over one million patients worldwide with ESRD that could benefit from phosphate control therapy. The results have provided data that enables Altair to make adjustments in RenaZorb`s composition and formulation that should further enhance its phosphate binding efficacy and performance.

Rats treated with RenaZorb "B" showed excellent reductions of phosphorus in urinary excretions. RenaZorb reduced phosphate progressively according to the dose administered. RenaZorb "B" administered at a concentration of 0.3% of ingested feed reduced urinary phosphate by 400%. There was no reduction in food intake by the animals tested and no negative observations regarding the animals during the duration of the testing program.

Test data indicates that RenaZorb has advantages when compared to existing or proposed drugs for phosphate control. These advantages include lower dosage, no acid burden, higher selectivity for phosphate and ultimately, lower patient cost. Shire Pharmaceutical`s Fosrenol(tm) has received an approvable letter from the FDA and is the first lanthanum-based pharmaceutical for phosphate control in dialysis patients. RenaZorb is also based upon lanthanum chemistry.

"I expected that Altair could announce a licensing agreement for RenaZorb in the second quarter of 2003," said Dr. Moerck. "Although testing was clearly successful and demonstrated that RenaZorb binds phosphate in vivo, the company conducting rat testing declined to proceed with a licensing agreement. This decision does not appear to be technical in nature and may be related to internal corporate reasons."

There are several companies in various stages of analyzing an effective business strategy for licensing RenaZorb. Some of these companies are still evaluating technical data while others are encouraged by the results and are in the process of verifying Altair`s two provisional RenaZorb patent applications. Copies of Altair`s patent applications have been provided to these companies under confidentiality agreements. Discussions concerning the licensing of RenaZorb are taking place during the next four weeks. Two pharmaceutical companies have requested term sheets for RenaZorb licensing and one company continues to show interest in RenaZorb for companion animal applications.

As new inquiries regarding RenaZorb continue, Altair has retained RBC Capital Markets to assist the company with a comprehensive evaluation of strategic alternatives pertaining to RenaZorb.

RenaZorb, a nanoparticle based drug, is expected to generate revenues for the company in 2003. The drug is based on a technology platform, which allows the customization of surface area and reactivity of the drug to target the proper speed and amount of phosphate binding in the human gastrointestinal tract. Altair will work with the RenaZorb licensee company to determine the exact pharmaceutical performance requirements needed to make RenaZorb successful in humans.

Altair Hydrochloride Pigment Process

The work under Phase l of the agreement with a materials company in the Asia Pacific region has successfully produced phase pure rutile titanium dioxide entirely from ilmenite concentrates. Within the pigment industry this is significant as Altair`s Hydrochloride Pigment Process (AHPP) takes readily available, inexpensive feedstock and economically produces phase pure titanium dioxide pigment without the need of expensive intermediate upgrade technologies that include slagging or synthetic rutile. The AHPP reduces the operating cost by roughly $150 - $200 per metric ton as compared to the chloride process. These savings are approximate and realized in the bottom line cost of pigment production. The Phase l report has been issued and a Phase II development proposal has been submitted for continued funding.

Altair has entered into an agreement with Flowco International to exclusively represent the company in the People`s Republic of China (PRC). Under the terms of the agreement Flowco will market AHPP licenses to companies in the PRC. The PRC has large reserves of low-grade titanium ore, low labor costs and an increasing consumer demand for TiO2 pigment. According to Flowco, PRC`s government will not allow new pigment production facilities to be constructed using the existing sulfate processing technology due to its well-known severe environmental impact. Altair management believes its environmentally friendly process, which can produce pure phase titanium dioxide pigment from low-grade ilmenite ore, coupled with favorable labor costs, large ore reserves, and very large consumer demands, could allow the PRC to rapidly develop a substantial pigment industry.

Commencement of work under the second titanium dioxide pigment development agreement announced by Altair based on an ore body located in Vietnam is waiting for funding. Management has been advised that the funding will be approved and the project should begin in late May or early June 2003.

United States Government Research Funds

The company announced in January that it had entered into a teaming/research agreement with Western Michigan University ("WMU"). Under the terms of the agreement, two research programs were defined using Altair`s nanomaterial science and production capabilities and WMU`s research expertise to develop nanosensors for detecting chemical and biological weapons and an agent for the concentration of radioactive waste. In March 2003 WMU and Altair were awarded a grant totaling approximately $1 million to begin the projects. WMU will continue to pursue a three-to-five-year Federal grant with Altair worth $1 million each year for continued development for a number of projects.

In conjunction with the grant, Nevada`s Senator Harry Reid visited Altair for a project update and a tour of the existing 90,000 square foot production and laboratory facilities. Senator Reid, a strong supporter of science and technology development used in the enhancement of homeland security, is the senior Democrat member of the Senate Subcommittee on Energy and Water.

Following a review of project priorities, management has determined to actively solicit funding for additional projects that may benefit from the company`s new, unique nanomaterials. A request to fund a joint project for hydrogen production research with University of Nevada Reno and a company with proprietary technology involving Altair`s nanomaterials has been submitted. In addition, representatives of Altair recently met with the National Institute of Health representatives regarding use of metals in medical research. Contacts with potential collaborators are being made now. Management is currently considering and intends to solicit various funds from the Department of Energy and the Department of Defense.

Other Projects

Several other projects are active and are being developed on an "as time permits basis". Such prioritization allows Altair to focus efforts on those projects with the highest likelihood for significant near-term revenue realization.

Altair Nanotechnologies Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the short run, and that animal testing or future testing on RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

[MRASTA]

Level II hat sich die letzte Zeit gefüllt, beide Seiten je rund 60.000 Teile. D.h. die heiße Phase bricht so langsam an. Es sind teilweise auch größere Einzelmengen zu sehen.

Der Kurs wird wie mit einer Kneifzange auf dem 0.3x Level gehalten. Hoffentlich geht dass alles gut und die Profis verlieren nicht die Nerven. Wenn von Altair keine Meldung kommt, die den Kurs explodieren läßt oder dass Sie im Nasdaq Segement gelistet bleiben, müssen die Profis aussteigen, so oder so. Und dann geht es rauschend abwärts. Nur bis wann machen Sie dieses Spiel mit ? Wenn man dass wüßte.



Tuesday , April 29, 2003 12:16 ET
This is the 1st VOLUME alert for ALTI in the past 7 calendar days.

Trading for Altair Nanotechnologies Inc (NASDAQ NM: ALTI) has been heavier than usual in today`s session. By 12:15 ET, the stock had already traded 232,300 shares via 98 trades. The cumulative volume is 28.30% above its 20-day average of 181,060. Normally the stock experiences around 110 individual trades per session.

So far, today`s volume surge has caused a net rise in ALTI`s stock price. At the time of this alert, the stock was trading at $0.350, up $0.020 (+6.06%).

One year ago, the Company`s shares closed at $0.900. The price has declined more than 61 percent since then.

Over the last 10 trading session ALTI has traded in a range between $0.300 and $0.400 and is currently trading 63.54% below its 52-week high of $0.960 set on May 08, 2002 and 16.67% above its 52-week low of $0.300 from April 25, 2003.

In the previous 3 sessions, ALTI trading has displayed a mixed trend. Closing results have been as follows:

April 28, 2003 --- closed at $0.330 up $0.020 (+6.45%) on 162,000 shares
April 25, 2003 --- closed at $0.310 down $0.020 (-6.06%) on 187,500 shares
April 24, 2003 --- closed at $0.330 up $0.010 (+3.12%) on 139,900 shares

[MRASTA]

USA Kommitee genehmigt größtes Nanotechprogramm aller Zeiten.

Das dürfte für einen enormen Schub sorgen.

05/01/03

House committee approves nanotechnology funding

By William Jackson
GCN Staff

The House Science Committee has approved a bill establishing a National Nanotechnology Research and Development Program, authorizing $2.4 billion in funding over the next three years.

Floor action for HR 766 has tentatively been scheduled for next week.

The bill, sponsored by chairman Sherwood Boehlert (R-N.Y.) and Mike Honda (D-Calif.), passed by a voice vote Thursday. The purpose is to ?ensure continued U.S. leadership in nanotechnology? R&D. The National Science Foundation has predicted there will be a $1 trillion market for devices and systems operating at the atomic and molecular level within a decade.

The bill would establish a National Nanotechnology Coordination Office to oversee the funding, through five federal agencies, of interdisciplinary research by individuals, teams and academic institutions. The office also would encourage the transfer of technology and development of commercial applications.

An advisory committee would evaluate the work of the office and address ethical concerns.

Agencies receiving funds would be the National Science Foundation, the Energy Department, NASA, the National Institute of Standards and Technology and the Environmental Protection Agency. The agencies would receive $713 million in fiscal 2004, $784.5 million the following year, and $864 million in 2006.



Wer sich die einzelnen Felder ansehen will :

http://thomas.loc.gov/cgi-bin/query/z?c108:H.R.766:

Gruß
mrasta

[MRASTA]

Nanophase Technologies Extends Innovative NanoArc(TM) Nanomaterials
5 May 2003, 1:40pm ET

- - - - -

Roberts Promoted to Vice President

ROMEOVILLE, Ill., May 5 /PRNewswire-FirstCall/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, today announced additions to its family of NanoArc(TM) nanomaterials. Nanophase is introducing what it believes is the first commercial nanoscale availability of an innovative family of high surface area, very pure nanocrystalline rare earth oxides. NanoArc(TM) nanomaterials are targeted at a wide variety of potential applications, including fuel cells, chemical-mechanical polishing (CMP), ultrafine polishing, catalytic converters, and catalysis.

(Photo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

NanoArc(TM) nanomaterials are single or multi-element rare earth oxides that are combined in a single-phase crystal. The nanomaterials are produced using Nanophase`s proprietary (patent pending) technology, NanoArc(TM) Synthesis, developed over the past two years and initially commercialized for the CMP market with Rodel, a division of Rohm & Haas Corporation.

These new single-phase, multi-component, high surface area nanomaterials are available in discrete ranges of average particle sizes from 7 to 35 nanometers. The first NanoArc(TM) products that have been announced are Ceria (Ce), Cerium/Lanthanum/Zirconium (Ce/La/Zr) oxide, and Cerium/Praseodymium/Zirconium (Ce/Pr/Zr) oxide. NanoArc(TM) nanoparticles are characterized as homogenous nanocrystals having a narrow particle size distribution, typically in a range of 7-12 nanometers, with the latter two nanomaterials displaying high thermal stability. Ratios of mixed rare earth oxides may be adjusted based on customer application.

New products recently introduced include Ceria/Zirconium (Ce/Zr) and Ceria/Samaria (Ce/Sm). Ceria/Zirconium is available in single-phase crystals with Zirconium ratios up to 50%. Ceria/Samaria is available in Ceria 85%/Samaria 15% and Ceria 80%/Samaria 20%. Customer sampling quantities are immediately available for both 15% Samarium doped Ceria and 20% Zirconium doped Ceria. NanoArc(TM) products are homogenous nanocrystals with tight particle size distribution, typical range of 7-12 nanometers, and high thermal stability. As such, NanoArc(TM) nanomaterials have unique properties including high temperature oxygen storage capability and ion mobility. NanoArc(TM) nanomaterials are available as nanoparticles or dispersions at various loading weights.

Nanophase has annual full-scale commercial production capability for these materials in the metric ton(s) range manufactured under its ISO-9001 quality system. Additional nanomaterials in the NanoArc(TM) family of nanocrystalline rare earth oxides that are expected to be available shortly includes a variety of single-phase ternary and quaternary rare earth oxides systems for catalysis, and doped ceria for CMP and ultrafine polishing.

For additional information, contact Dr. Ed Ludwig, Nanophase`s Vice President of Business Development at 630-771-6729, or email [e-mail] , or Ian Roberts, Vice President U.S. and International Sales, at 630-771-6730, or email [e-mail] .

Roberts Promoted to Vice President at Nanophase

Nanophase also announced that W. Ian Roberts has been promoted to Vice President, U.S. and International Sales. Ian joined the company in May 1999 and has been a major contributor to Nanophase`s product sales revenues, which have grown over 400%. Ian has also been instrumental in the development of the Company`s strategic business plan and sales force organization.

"Mr. Roberts` skills at building and developing relationships with our partners and major customers have been of great value to the Nanophase team as we work towards our business objectives" said Dan Bilicki, Vice President of Sales and Marketing.

Ian`s 31 years of sales and technical experience include executive positions at Crosfield Company, J.M. Huber Corporation and The Procter & Gamble Company. Mr. Roberts earned a B.S. in chemical engineering from Queen`s University, Kingston, Ontario, Canada.

Nanophase Technologies Corporation provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary core technologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 21 United States patents and patent applications, consisting of 8 owned United States patents, 7 owned United States patent applications, and 6 licensed United States patents. The Company also has 21 foreign patents and patent applications, consisting of 7 owned foreign patents and 14 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies. The Company trades on the Nasdaq NMS under the symbol "NANX". Visit the Company`s web site at www.nanophase.com .

[MRASTA]

Nanophase erwacht. +23%

Schott hat ja nun wirklich einen Namen und viel Erfahrung und vor allem Knete.



Tuesday , May 06, 2003 10:00 ET
ROMEOVILLE, Ill., May 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, has developed new NanoArc(TM) nanomaterials that improve the surface finish of photomask blanks used for integrated circuit production. Nanophase will be presenting these results, developed in a joint program with Schott Lithotec AG plant, Meiningen, Germany, at the Optifab 2003 conference. The Optifab is an international showcase for optical manufacturing technology -- including operations, machines, tools, materials, instrumentation, metrology, and processes. The paper is entitled "Nanocrystalline Ceria Dispersions for Ultrafine Polishing and Defect Reduction in EUVL (Extreme Ultraviolet Lithography) Photomask Blank Manufacture" and provides product performance for the application.

Working together, Schott and Nanophase developed the materials and process parameters to allow for final-stage, ultrafine polishing of quartz glass and Low Thermal Expansion Material (LTEM) photomask blanks, which are used to transfer precision images of an integrated circuit onto a silicon wafer. The program achieved an acceptable removal rate while meeting the extreme "Roughness" and "Flatness" requirements for next generation photomasks. Roughness, the peak-to-valley (P-V) heights over short distances, measured approximately three angstroms, while flatness, the P-V over broad areas of the substrate, measured approximately 34 angstroms. Additionally, the process produced essentially zero defects, or "microscratches".

"Nanophase is very pleased with the quality of our partnership with Schott Lithotec," stated Ian Roberts, vice-president, U.S. and international sales. "This program is a classic example of how effective, quality partnerships enable the benefits of nanomaterial technologies to be realized in a variety of process and product applications. We believe that the optical industry will be especially interested in a rather new and unique approach offered by our NanoArc(TM) materials."

During the program, Schott Lithotec introduced advanced technology steps to manufacture quartz glass substrates and EUV mask blanks in its plant -- including high quality substrate polishing, special cleaning steps, and low defect blank manufacturing. New polishing and cleaning technologies enabled Schott Lithotec to produce quartz glass and EUVL substrates meeting the requirements of the International Technology Roadmap for Semiconductors. Nanophase contributed key elements to the program through its integrated nanotechnologies. The polishing performance with Nanophase`s dispersion of NanoArc(TM) ceria is considered excellent in the industry.

Nanophase engineered the ceria nanomaterial to obtain the required average particle size and tight distribution -- this is critical since the most advantageous size is vital to optimize the polishing removal rate while minimizing substrate scratches and surface roughness. Nanophase`s proprietary NanoArc(TM) synthesis process (patent pending) produced the nanocyrstalline ceria used for the application and created unique nanoparticle surface chemistry to obtain a very stable dispersion of the nanomaterial.

Stable formulations were developed with no particle agglomeration due to pH changes, the influence of other additives to the polishing slurry, or the buildup of polishing byproducts, such as cerium silicates and other ions. With the ability to prevent agglomeration, the major source of polishing defects, before and during use, it became possible to virtually eliminate defects in the substrate. Given a broad operating window, the Schott team was able to redesign many of the other process parameters to optimize removal rates, cleaning behavior, and other critical parameters.

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 21 United States patents and patent applications, consisting of 8 owned United States patents, 7 owned United States patent applications, and 6 licensed United States patents. The Company also has 21 foreign patents and patent applications, consisting of 9 owned foreign patents and 12 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

Schott Lithotec is a member of Schott, a leading technology group (Germany), which employs nearly 20,000 people worldwide and has sales of approximately $1.8 billion. Schott Corporation is the Group`s North American headquarters. Its fourteen divisions and subsidiaries employ approximately 3,200 people for the manufacture and distribution of special glass and glass-related systems. Schott Lithotec is one of the world`s largest suppliers of semiconductor-grade quartz and calcium fluoride, a critical element of 193nm and 157nm lithography.

This press release contains words such as "expects", "anticipates", "plans", "forecasts" and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company`s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties. It is possible that the Company`s future performance may differ materially from current expectations expressed in these forward-looking statements due to a variety of important factors such as: a customer`s decision to defer, cancel or otherwise modify a purchase order or supply agreement; demand for, and acceptance of, the Company`s nanocrystalline materials; changes in our development, supply and distribution relationships; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost effective basis; the Company`s mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental regulations; disruption of commercial activities and threats associated with terrorism and efforts to combat it; protection and validity of patent and other intellectual property rights; the cyclical nature of the Company`s business; the outcome of pending and future litigation and governmental proceedings; and other risks described in the Company`s filings with the Securities and Exchange Commission. In addition, the Company`s forward-looking statements could be affected by general industry and market conditions and growth rates. The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

SOURCE Nanophase Technologies Corporation

[MRASTA]

So auch hier mal wieder eine kleines Update, da ich sehe, dass ja doch der eine oder andere mal rein schaut.

Altair :

Volumen hat ja die letzten Tage deutlich zugenommen. Und die 0.3x liegen wohl hinter uns, hoffe ich mal.

Nach gutem Start heute (0.48), zurück gefallen auf 0.44 bei rund 700.000 Stücken. Mal sehen wie es sich heute noch weiter entwickelt.

Noch ist gar nichts klar, aber zumindest stimmt die Richtung. Geld ist wohl auch nicht mehr gerade viel in der Kasse, aber immerhin konnte mit dem Geldgeber (Doral) eine Streckung auf das nächstes Jahr erreicht werden.

Sind ja nun schon einige Tage gut gelaufen aber bis 1$ sind es wohl noch ein paar Cent. Ziemlich spannende Geschichte.


Nanophase :

Gestern deutliche Gewinnmitnahmen. Heute nichts los, 4.07 bei 9.500 Teilen, bis jetzt, nichts weltbewegendes.

Gruß
mrasta

[MRASTA]

ich hoffe, dass alle, die drin sind besonders Altair heute verfolgen !!!!!!!

High war bis jetzt 0.93 in den USA, ist !!!kein Scherz.
Gehandelt im Augenblick über 1,2 Mio Teile.

Rücksetzer auf 0.77 jetzt gerade wieder 0.83.

Da geht heute die Post ab.

Phases sollen natürlich auchn icht vergessen werden 5.60 d.h. +14%.

Aber heute ist Altair Tag, mal sehen wie es sich noch entwickelt.

Gruß
mrasta

[MRASTA]

3,0 Mio Teile gehandelt, bei Altair. Kurs 0.83


Vielleicht schafft Altair es ja doch noch.

Wednesday, May 14, 2003 12:41 ET
This is the 1st 52 WEEK HIGH alert for ALTI in the past 7 calendar days.

The share price for Altair Nanotechnologies Inc (NASDAQ NM: ALTI) reached a new 52-week high today, trading at $0.940, up $0.470 (100.00%) from its previous close of $0.470.

The Company`s previous 52-week high of $0.930 was set 239 days ago on September 17, 2002.

One year ago, the Company`s shares closed at $0.900. The price has climbed more than 4 percent since then.

At the time of this alert, the stock had traded 2,722,800 shares via 1,647 trades, 606.14% above it`s 20day average of 385,590 shares.

This new 52-week high currently puts the stock:

163.67% above its 20day Moving Average of $0.356
153.10% above its 50day Moving Average of $0.371
130.62% above its 100day Moving Average of $0.408

Gruß
mrasta

[MRASTA]

so, kleines Abendupdate.

Altair kämpft so vor sich hin, schwierig, schwierig. Zur Zeit bei 0.79, also wieder den Rückwärtsgang eingelegt. Dann wieder Sprung auf 0.82. Dass ändert sich im Moment im Minuten Takt.

3,7 Mio Teile sind gehandelt. An eine solche Menge kann ich mich überhaupt nicht mehr erinnern.

Keine blasse Ahnung wo wir am Ende der Woche stehen. Es ist wirklich alles möglich. Für Infarktgefährdete ist es auf jedenfall nichts.

Die Phases mit 275 TSD Teilen, olala, bei 5.70.

Bis dann
mrasta

[Renditefalke]

Hallo mrasta,

heute ist premiere - habe mich endlich angemeldet.

ich beschäftige mich schon länger mit nanotechnologie -

altair scheint eine sehr breite und innovative produktpalette zu haben.

aber was zum geier ist denn heute los? hast du eine ahnung?

Gruß an alle nanofan´s

Renditefalke

[MRASTA]

@Renditefalke

sei willkommen,

gute Frage, kann an der Nanopanik in den USA liegen oder der Stock wird hochgepuscht.

Mußt Dich mal durch den Thread wühlen, dann kannst Du dazu einiges lesen.

Bin aber eher der Meinung, da auch die anderen Nano-Werte sehr gut gelaufen sind die letzten Tage, dass es wohl so ein bischen Angst ist zu spät zu kommen. Ob die Fonds das nur ausnutzen oder wirklich reinwollen, kann ich nicht beurteilen, darum immer ein Adlerauge offen halten.

Altair ist und bleibt ein High Risk Wert zur Zeit, damit dass nochmal ganz klar ist.

Schönen abend allen
mrasta

[Renditefalke]

@mrasta

meinst du das fonds in so einen wert einsteigen?

wie ist eigentlich deine einschätzung zu dem momentanen nanohype?
Wird dort in naher zukunft wirklich schon geld verdient oder kommt dies doch eigentlich durch den investitionsschub der regierung in den usa?

ich glaube man könnte auf sicht von einem jahr (!) schon mal mit 30-50% (des nanoportfolios) einsteigen.

Was denkst du?

war altair schon mal kurz vor der pleite?

[MRASTA]

@Renditefalke

Zumindest bei den Phases würde ich behaupten, dass da auch Fonds einsteigen. Bei Altair kommt die Musik IMHO im Moment aus einer anderen Richtung.

Die Frage der Nachhaltigkeit ist genau das Problem. Aber dieses spielt anscheinend im Moment keine Rolle. Wir haben es bei den Biowerten erlebt, dass wenn die tatsächlichen Entwicklungszeiten etc. rauskommen der ganze Markt zusammen bricht. Alles was nur im entferntesten mit Nano zu tun hat, und wenn es nur im Namen auftaucht, wird gepuscht.

Aus diesem Grunde habe ich auch nicht xyz Werte hier vorgestellt sondern mich auf zwei beschränkt. Überflieger wird es auch woanders geben, siehe z.B. SI Diamond.

Altair ist der große Speku Wert, die Phases dagegen eher schon solide zu nennen. Die Partikel sind seit Jahren erprobt, lieferbar und somit keine Fiktion.

Du hast vollkommen recht mit Altair. Meiner Meinung nach stehen Sie jetzt ganz tief am Abgrund, habe dass ja auch immer wieder betont aber dachte mir, könnte auch die Chance sein.

Die, die zu Anfang mit eingestiegen sind, können sich nun wahrlich nicht beschweren, beide Werte sind sehr gut gelaufen und bei Altair waren locker über 100% drin. Eine Art Risikobegrenzung muss aber jeder für sich vornehmen, bin ja kein Hellseher.

Heute kann ich leider nicht mehr posten.

Trotzdem wünsche ich allen einen aufregenden Tag.

mrasta

[MRASTA]

Zahlen sind ja schon draußen, sind aber im Moment eh unwichtig. Aber der guten Ordnung halber :


ERN(+): ALTI/Q1 (4c) vs (7c); EPS +43% Y/Y; No Guidance

Wednesday, May 14, 2003 17:46 ET
QUARTER RESULTS

Altair Nanotechnologies Inc (NASDAQ NM: ALTI) reported Q1 results ended March 2003. Q1 Revenues were $0.02M; -60.00% vs yr-ago. Q1 EPS was (4c); +42.86% vs yr-ago.

mrasta

[MRASTA]

Was soll man noch zu Altair sagen ?

Mir fällt im Moment nichts gescheites dazu ein.
Über 7 Mio gehandelte Aktien gestern und Kurs, nachbörslich, bei 1.05 $.



Zahlen der Phases sind draußen.

Auf den ersten Blick nichts neues. Leider keine Zeit im Moment intensiver zu lesen.

http://www.sec.gov/Archives/edgar/data/883107/00009501310300…

mrasta

[MRASTA]

Nanophase Announces Doped Zinc Oxide Nanomaterials
Thursday , May 15, 2003 08:01 ET
ROMEOVILLE, Ill., May 15, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products today announced commercial availability of doped zinc oxide nanomaterials. The zinc oxide dopants include aluminum, copper, and silver at dopant levels ranging from several ppms to several percent. Doped zinc oxide nanomaterials are targeted at a wide variety of potential applications including antimicrobial agents (antifungal, antibacterial, and antifouling), opto-electronics, and tailored UV absorption.


Dr. Ed Ludwig, Nanophase`s Vice President of Business Development, stated, "Zinc oxide based materials are known to offer significant benefits as antimicrobial agents. They have demonstrated antimicrobial activity, are non- irritating, and absorb moisture and odors. Their thermal stability imparts permanence to their activity and enables these materials to be incorporated into plastics and on surfaces that experience extreme processing or harsh application environments -- yet they remain active. In addition they are GRAS (`generally regarded as safe`) materials."

Dr. Ludwig also believes that doped zinc oxides may have applications as opto-electronic materials. Zinc oxide is a semiconductor; doping zinc oxide allows the band gap to be changed -- affecting the optical (absorption of UV radiation), electrical, and magnetic material properties. While still early in application development, the Company is interested in the potential to tailor doping levels of zinc oxide to nanoengineer materials for targeted applications, including semi-insulating substrates, UV LEDs, laser diodes, photodetectors, and conductive materials.

Nanophase`s doped zinc oxides are non-porous, dense, discrete, homogeneous, single-phase crystals. Doped zinc oxide nanomaterials are commercially produced using Nanophase`s patented PVS technology at varying compositions, which are adjusted to meet specific application requirements, in discrete nanoparticle size ranges less than 100 nanometers. Nanophase has annual commercial production capability for zinc oxide and doped zinc oxide nanomaterials in the metric tons range and offers these nanostructured materials as nanopowders and as dispersions using its proprietary (patent pending) dispersion technologies. All of Nanophase`s nanoengineered products are manufactured under the Company`s cGMP and ISO-9001: 2000 quality system.

For additional information, contact Dr. Ed Ludwig, Nanophase`s Vice President of Business Development at 630-771-6729, or email [e-mail], or Ian Roberts, Vice President U.S. and International Sales, at 630-771-6730, or email [e-mail].

[MRASTA]

na, alle schon weiche Knie ?

An Gewinnmitnahmen soll angeblich noch keiner gestorben sein. Jeder muss selber wissen, wann er was macht.

Alti -19 %
Nanx - 7 %

Mal sehen, wie es heute Abend aussieht. Wir schweben alle auf einer großen Blase, hoffe mal, dass da keiner zu früh reinsticht. Darum auch mal an einen SL denken.

Gruß
mrasta

[MRASTA]

 Improved Planarity and Defect Reduction in Photomask Manufacturing Using Nanophase`s Ceria Dispersions
Nanophase to Present at Optifab 2003, Rochester, NY, May 19-22
Friday , May 16, 2003 13:32 ET
ROMEOVILLE, Ill., May 16, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, has developed new NanoArc(TM) nanomaterials that improve the surface finish of photomask blanks used for integrated circuit production. These nanomaterials extend the Company`s new line of nanostructed polishing solutions for semiconductors, photomasks, hard disk drives, and optics. Nanophase will be presenting this novel nanocrystalline technology at Optifab 2003, North America`s premiere optical fabrication exhibit, sponsored by the International Society for Optical Engineering.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

Nanophase Technologies Corporation and Schott Lithotec AG partnered to develop a polishing process to meet the extreme "roughness" and "flatness" requirements for the next generation photomasks. Roughness, the RMS of peak-to-valley (P-V) heights, measured by AFM-microscopy, over 2-square microns, measured less than three angstroms (this is approximately the size of 3 atoms), while flatness, the RMS of P-V height over a 214 square centimeter substrate, measured approximately 34 angstroms. The developed process achieves this degree of planarity and produces essentially zero defects, or "microscratches". Schott Lithotech AG employs this process to manufacture state-of-the-art quartz glass substrates and EUV photomask blanks in Meiningen.

Nanophase`s nanoparticle cerium dioxide dispersions enable this process. Based on test data, Nanophase believes that these performance parameters cannot be met with other materials or processes currently on the market. Photomasks with this planarity are required to produce sub 100 nanometer semiconductor architectures. The nanosized cerium dioxide particles are produced by Nanophase`s patent pending NanoArc(TM) process and dispersed, on commercial scale, to form stable glass polishing dispersions with specific pH and rheology characteristics. The small particle size, narrow particle size distribution, and unique crystal morphology of this ceria allow these new performance benchmarks to be realized.

For additional information, contact Dr. Ed Ludwig, Nanophase`s Vice President of Business Development at 630-771-6729, or email [e-mail] , Ian Roberts, Vice President U.S. and International Sales, at 630-771-6730, or email [e-mail] , or Greg Palagi, Director of Business Development, at 630-771-6734, or email [e-mail] .

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 21 United States patents and patent applications, consisting of 8 owned United States patents, 7 owned United States patent applications, and 6 licensed United States patents. The Company also has 21 foreign patents and patent applications, consisting of 7 owned foreign patents and 14 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

Schott Lithotec is a member of Schott, a leading technology group (Germany), which employs nearly 20,000 people worldwide and has sales of approximately $1.8 billion. Schott Corporation is the Group`s North American headquarters. Its fourteen divisions and subsidiaries employ approximately 3,200 people for the manufacture and distribution of special glass and glass-related systems. Schott Lithotec is one of the world`s largest suppliers of semiconductor-grade quartz and calcium fluoride, a critical element of 193nm and 157nm lithography.

[ehrenwort]

Hallo MRASTA,

Deinen beiden Nano-Firmen haben ja in der Vergangenheit schon für viel Aufsehen gesorgt. Wo ist eigentlich Dein drittes Baby? In NanoPierce warst Du ja auch mal sehr aktiv, oder?

Wie siehst Du denn die Chancen, dass Altair noch im Nasdaq bleibt? Es wird viel an der Kohle hängen...wie lange hält die denn noch? Wie sieht`s denn mit der aktuellen Burnrate aus?

Gruß

EHRENWORT

[MRASTA]

@eherenwort, all

Der Titel des Thread ist ja nun bewußt auf die beiden begrenzt. Somit gehören die Pierces hier nicht rein. Da Sie außer dem Namen mit Nano nun wahrlich nichts zu tun haben. Wurde nur seinerzeit mal so in einem anderen Forum angefangen und deshalb haben wir es beibehalten. Da mußt Du in die OTC-BB Abteilung schauen.


Altair ist und bleibt ein Zockerwert. Nachbörslich am Freitag mit 0.97 geschlossen. Also die 1$ verfehlt. Ich weiß ja auch nicht wie es weiter geht. Darum ja auch meine Empfehlung lieber mal einen Teil an Gewinn mitnehmen, man weiß ja nie.

Die Burn Rate spielt im Moment eigentlich nur eine Nebenrolle, da es klar um dass Überleben von Altair geht. Und da stellen sich nur die beiden Fragen.

a) schaffen Sie es im Nasdaq zu bleiben ?
b) Wenn überhaupt, wann bekommen Sie Forschungsgelder ?

Ein mulmiges Gefühl bleibt auf jedenfall. Die Stützungskäufe der letzten Woche waren ja nicht zu übersehen. Und da Sie beim letzten Mal noch nicht mal die monatliche Rate von Doral zurückzahlen konnten, wurden wieder Aktien dafür ausgegeben, also dürfte die Knete mehr als knapp sein.

Solange eine Firma nicht auf gesunden Füßen steht, wird keiner die Technik dieser Firma einsetzen, bzw. wenn, dann mit Auflagen, die sicherstellen, das auch nach einer Pleite, das Produkt oder die Technik weiter verwendet werden kann. Siehe BASF und Nanophase. Die müssen Ihr gesamtes Equipment an BASF abtreten, wenn gewiße Rahmenbedingungen nicht eingehalten werden können. Im Moment nicht relevant, aber es zeigt die Problematik auf.

In ein paar Wochen sind alle sowieso wieder viel schlauer und haben es schon immer gewußt.... Ich weiß es aber nicht und kann auch zum jetzigen Zeitpunkt keine Empfehlung geben. Für mich war erstmal entscheidend, dass Sie in Richtung 1$ laufen müssen, um überhaupt noch eine minimale Chance zu haben und dass wollte ich gerne mitnehmen. Ist ja auch so gekommen. Wie es jetzt weitergeht werden wir sehen.


Phases
Die Zusammenarbeit mit Schott ist für mich ein gutes Zeichen. Die Photomask Geschichte wird aber wohl noch ein paar Monate dauern. Somit im Moment nicht relevant. Neue Verträge sind auch nicht in Sicht. Demnach haben Sie wohl erstmal nur von der Nanohype profitiert. Auch recht.


Gruß
mrasta

[MRASTA]

Abend, Altair ist ja erstmal ganz schön in den Keller gerauscht. Rudi baut auf Optimismus, was soll er auch sonst tun, wenn keine Aufträge da sind. Mal sehen ob es hilft.

Die Phases haben sich recht gut gehalten.


Altair Nanotechnologies Targets Government Grant Programs
For Development Revenue

Tuesday , May 20, 2003 10:01 ET
RENO, Nev., May 20, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) said today that the company is aggressively seeking revenues from government grant programs to support several of its nanotechnology development. To assist the company in obtaining this funding, Altair has engaged DykemaGossett, PLLC, a Michigan and Washington, D.C.-based law firm. The firm was instrumental in obtaining a recent grant of approximately $1 million to develop titanium dioxide nanoparticle sensors for the detection of chemical and biological weapons. Additional funding has been requested for the sensor program which involves Western Michigan University and the University of Nevada, Reno.

Altair also announced today that it is in negotiations with UK-based Hydrogen Solar to develop a program in Nevada which would demonstrate Hydrogen Solar`s technology for generating hydrogen using direct sunlight as the energy source. Hydrogen Solar has an exclusive worldwide license for the Tandem Cell(tm) technology invented and patented by a European university. All parties expect that the use of Altair`s nanomaterials will significantly improve the conversion efficiency and cost structure of hydrogen production using Hydrogen Solar`s technology. According to Altair`s President Dr. Rudi E. Moerck, the University of Nevada, Reno, which participated in the Desert Research Institute`s hydrogen production and demonstration project, is involved in the joint funding effort for the company`s hydrogen production technology program.

"Altair`s nanomaterials have already been used in the manufacturing of solid oxide fuel cells (SOFC)," said Dr. Moerck. "Altair demonstrated its technology in a small cell using single firing monolithic fabrication techniques made possible through the use of its nanomaterials. We are currently contacting the various National Laboratories and organizations such as the Solid State Energy Conversion Alliance (SECA) that need additional technology resources to meet the program objectives."

In addition to the company`s fuel cell development program, Altair has other programs that target the energy sector. The company has developed crystalline materials that have demonstrated significantly rapid charging and discharging rates. This is a significant benefit for advanced battery development within the automotive industry as well as other applications using hybrid or fuel cell systems. "We are currently in discussions pertaining to the funding of our nano-based battery materials with two separate groups," noted Dr. Moerck. "Both of these groups have already demonstrated the use of our materials in thin film batteries and super capacitors."

"This is a very exciting time for Altair," continued Dr. Moerck. "Altair`s patented nano-based material science will allow the company to take advantage of the additional opportunities offered under a multitude of programs including the National NanoScience Initiative led by the National Science Foundation and the Advance Technology Program at the U.S. Department of Commerce."

Altair Nanotechnologies, Inc.

[MRASTA]

So, melde mich auch mal wieder.

Gibt aber eigentlich nichts neues. Auffällig ist nur, das wohl gerade jemand versucht Altair wieder ein wenig nach oben zu bringen. Bid steigt gerade an. Wilde Nummer, Ausgang unbekannt.


Die Phases kommen nach morgentlichen Verkäufen irgendwie immer wieder bei 5,x $ an.

mrasta

[MRASTA]

was gibt es Neues ?

Bei den Phases ist mal wieder was fällig :

This prospectus relates to resales of 1,370,000 shares of our common stock or interests therein issuable from time to time. The selling stockholders received the common stock offered by this prospectus in a private placement from us on May 29, 2002 at a purchase price of $5.00 per share.

http://knobias.10kwizard.com/filing.php?repo=tenk&ipage=2167…

Schluß gestern : 5.20 $


Altair :

Keine klare Tendenz zu erkennen. Merkwürdig ist allerdings der nachbörsliche Handel, wo jetzt schon zum wiederholten male 100.000 Teile auf einmal über die Theke gingen. Also Holzauge sei wachsam.

Schluß gestern : 0.76 $ (nachbörslich 0.75)


Gruß
mrasta

[MRASTA]

oh ho,

zu 1.35$ und die 5 $ Mio. sind wohl auch dann da. Muss man nur noch die SEC überreden noch 90 Tage dran zu hängen.

Könnte vielleicht doch noch was werden.

Wednesday, May 28, 2003 10:02 ET

RENO, Nev., May 28, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has completed a $1.3 million private placement. Under the terms of the governing agreements, Altair issued 2,015,504 shares of common stock and 1,007,752 warrants to purchase common stock at an exercise price of $1.35 per share. The placement was done with a small group of institutional investors that have all invested previously in Altair Nanotechnologies.

According to Altair Chief Financial Officer Edward Dickinson, Altair will use a part of the funds to prepay a portion of debt under the company`s financing agreement to Doral 18, LLC. As a result of such payment, additional conversion rights will not accrue to Doral until at least September 1, 2003.

"Beyond providing near-term working capital, the private placement is an important accomplishment as it increased shareholders` equity beyond the $5 million that is required to maintain listing on the NASDAQ SmallCap Market system," said Dickinson. "We believe that as a result of having a pro forma shareholders` equity in excess of $5 million, Altair will qualify for an additional extension of 90 days beyond June 2, 2003 to meet the $1 minimum bid price requirement of the NASDAQ Small Cap Market."

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the possibility that, notwithstanding statements from Nasdaq staff to the effect that the company would receive a 90-day extension during which to come into compliance with the minimum bid price requirement if it meets the $5 million shareholders` equity requirement on June 2, 2003, the staff may determine for reasons not anticipated by the company not to grant the company the 90 day extension and may commence the delisting process on June 2, 2003 when the company`s current extension expires, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC.

Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

Gruß
mrasta

[MRASTA]

mit 1.35 $ sind natürlich die Optionen gemeint, die reinen Shares dürften wohl so bei 0.65 liegen.

Also dann mal hüh.

mrasta

[MRASTA]

scheint so, als wenn heute der nächste Anlauf in Richtung 1$ unternommen werden sollte. Mal sehen ob es diesmal klappt und vor allem etwas Bestand hat.

ALTI : 0.96 $ geht allerdings ziemlich wild hin und her.

Gruß
mrasta

[MRASTA]

Moin,

man muss im Moment ein bischen am Ball bleiben, nützt ja nichts.

Den ersten Pfeiler mit den 5$ Mio hat Altair geschafft. Jetzt müssen Sie noch bei der SEC jemanden überreden, noch mal 90 Tage ran zu hängen.

Schluß bei Altair gestern : 0.95 $
Volumen : fast 1,5 Mio Teile


Die Phases haben im Moment eigentlich keine richtige Richtung. Mal gerade wieder so bei der 5$ Marke gelandet.


Mal sehen, was der heutige Tag noch so bringt. Spätetstens nächste Woche muss wohl eine Entscheidung seitens der SEC her. Somit wird es bestimmt nicht langweilig.

mrasta

[MRASTA]

Sind wohl doch noch einige Profis drin. Da es mit der Zulassung bis jetzt unklar ist, müssen Sie heute raus.

Zwei dicke VK Orders sind im Second Level aufgetaucht :

61.800 zu 0.90
10.560 zu 0.91

sind immerhin über 10% des jetzigen Handelsvolumens.

Kurs zur Zeit abgesackt auf 0.86 $.

Mal sehen, wie das ausgeht.

mrasta

[MRASTA]

oh, Altair vorbörslich in den USA bei 1.11 $, kann dass sein, ich glaube ich brauche doch bald eine Brille. ??????????????????????

mrasta

[MRASTA]

aha, mußte ja was kommen.

Altair Nanotechnologies Receives Positive RenaZorb Animal Test Results; RenaZorb, A Nanotechnology-Based Drug Candidate For Phosphate Control in Kidney Dialysis Patients, Shows Phosphate Binding In Dogs And 5/6 Nephrectomized Rats

Tuesday , June 03, 2003 09:00 ET
RENO, Nev., Jun 03, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has negotiated an agreement allowing the disclosure of new animal testing data to interested third parties. Under the previous non-disclosure agreement with the participating pharmaceutical company, the animal testing data could not be disclosed. Altair developed three versions of RenaZorb designated RenaZorb "A", "B", and "H". The study, completed in early March 2003, was conducted in dogs and 5/6 nephrectomized rats utilizing three versions of the drug candidate.

"The test results demonstrate indisputably that RenaZorb is effective in lowering urinary phosphate in kidney impaired (5/6 nephrectomized) rats and in healthy dogs," said Altair President Dr. Rudi E. Moerck. "This new collection of test results provides potential licensees within the pharmaceutical industry a more extensive set of in vivo data for evaluating RenaZorb`s phosphate binding capabilities. "Additionally," continued Dr. Moerck, "the new test results have provided Altair with important data that will permit further improvement of the dosage form to enhance both the efficacy and potency of the drug candidate."

Altair continues active discussions pertaining to the licensing of RenaZorb with numerous pharmaceutical companies. These companies are in various stages of conducting due diligence of RenaZorb and management expects to receive their response in the near future. Altair estimates that the current market for phosphate binding drugs used for ESRD ranges from $400 to $600 million and could potentially reach $1 billion with a cost effective drug presenting improved dosing and patient compliance.

Non-calcium phosphate binders are indicated for patients who suffer from end-stage renal disease (ESRD). These patients have difficulty in eliminating dietary phosphate through their kidneys and elevated phosphate can cause bone pain and spontaneous fractures. Currently, the only FDA approved phosphate binder is Renagel(tm) (Genzyme). Shire Pharmaceuticals has received an approvable letter from the FDA for Fosrenol(tm), which like RenaZorb, is a lanthanum based pharmaceutical.

[MRASTA]

naja, die SEC Meldung, mit der Fristverlängerung, wäre mir im Moment lieber gewesen. Also weiter warten. Ist aber eigentlich auch egal wodurch der Kurs gehalten wird. Hauptsache ist nur das er nicht wieder abschmiert.


Gruß
mrasta

[MRASTA]

war ja mächtig was los bei Altair. Der 1$ hat gehalten.

ALTI
Last: 1.18
Change:+0.35
+42.17% !!!!!!!!
Volume: 4,392,400 !!!!!!

Nachbörslich letzter Kurs 1.20$.

After Hours: 1.20
+0.02
1.69%
50,957

Auch der Chart ist beeindruckend.



Mal sehen was uns da noch erwaret.

Die Phases sind mal wieder bei Ihren 5$ gelandet.

mrasta

[Wunram]

90 Tage Verlängerung

Altair Nanotechnologies Receives 90-Day Extension from NASDAQ

5 Jun 2003, 09:00am ET

RENO, Nev., June 5, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has received a letter from the NASDAQ Stock Market noting that the company meets the initial listing requirements for NASDAQ SmallCap Market Under Marketplace Rule 4310(c)(2)(A). Therefore, NASDAQ has provided the company with an additional 90 calendar days, or until September 2, 2003, to regain compliance with Marketplace Rule 4310(c)(8)(D), which requires the company securities to have a minimum bid price of $1.00.

If at any time before September 2, 2003, the bid price of the company`s common stock closes at $1.00 per share or more for a minimum of 10 consecutive trading days (or such longer period as NASDAQ deems appropriate), NASDAQ has indicated that it will provide written notification that the company complies with the $1.00 minimum bid rule. If compliance with this Rule cannot be demonstrated by September 2, 2003, NASDAQ has indicated that it will provide written notification that the Company`s securities will be delisted. At that time, Altair may appeal NASDAQ`s determination to a Listing Qualifications Panel.

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the possibility that the company will not come into compliance with the minimum bid price requirement by September 2, 2003 and that the company`s common shares could be delisted from the NASDAQ SmallCap Market, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at:http://media.primezone.com/prs/single/?pkgid=511

CONTACT: Altair Nanotechnologies, Inc.
Tracy LaFollette
[phone]
[e-mail]

Investor Relations
Marty Tullio
[phone]
[e-mail]

[AG19]

Nanophase über 6 Dollar!

[MRASTA]

Abend allerseits,

ist ja prima, dass auch noch andere posten, habe leider
wenig Zeit im Moment.

War ja ganz schön spannend.

Rudi hat es doch tatsächlich geschafft, noch eine 90 Tage Verlängerung und der 1$ scheint auch gerade so zu halten.

Doral hat das Spiel gespielt und einen Zwischensieg erungen, viel blieb Ihnen ja auch nicht übrig, sonst wären Ihre Anteile ja auch mit abgeschmiert. Jetzt kann man erstmal durchatmen.

Dann wollen wir mal hoffen, dass die nächsten Wochen die Meldung der Meldungen kommt und der erste Kontrakt geschlossen wird. Hauptsache den Jungs geht nicht die Puste aus, so kurz vor der Zielgeraden.



Die Phases stecken die Nase ja auch schon ab und zu über die 6$ Marke. MKT ist dadurch schon wieder reichlich heftig. Stabile 5$ würden mir reichen bis auch von der Seite mal eine Meldung kommt, gegen 6$ ist natürlich nichts einzuwenden, auch recht. Am 26. Juni ist ja erstmal Aktionärstreffen. Mal sehen, vielleicht kommt bis dahin ja noch eine Überraschung ?


Gruß
mrasta

[MRASTA]

Moin,

was soll man dazu noch sagen, Altair geschlossen bei 1.20 $, Phases bei 6.23 $.

Bei Altair ist man ja mittlerweile einiges gewöhnt aber das die Phases sich bei den 6$ halten ist schon heftig, damit hätte ich nicht gerechnet. Ok, das Potential ist nicht von Pappe aber noch ist auch dort nichts gebacken.
Besonders, da die Entwicklungszeit mit Schott ja noch so lang ist, ist halt Börse.

Altair braucht noch die 10 Handelstage, da muss der Kurs wohl noch ein wenig höher, um auch mal einen größeren Verkäufer verkraften zu können. Mal sehen ob es diesmal klappt.

Gruß
mrasta

[MRASTA]

Die schleppende Konjunktur geht auch an den Phases nicht spurlos vorbei.


Nanophase Technologies Provides Second Quarter 2003 Guidance

Wednesday, June 11, 2003 16:15 ET
ROMEOVILLE, Ill., Jun 11, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced second quarter and first half 2003 revenue guidance. The Company currently expects second quarter revenues of approximately $1.3 million and first half 2003 revenues of approximately $3.0 million.

"As we have stated previously in announcements and conference calls, we continue to expect that revenues will increase during the second half of 2003 and continue ramping through 2004 as several development efforts materialize into revenue," stated Joseph Cross, Nanophase`s president and CEO. "Second quarter and first half revenues have been unexpectedly impacted by order softness for abrasion-resistant materials for flooring and catalytic converters compared to the same period in 2002, but we expect revenues from these areas to return to more normal levels during the second half."

"Our market introduction of chemical-mechanical polishing (CMP) materials into the semiconductor market through our partnership with Rodel, part of the Rohm and Haas Electronics Materials Group, specifically for STI/SON applications, continues to demonstrate superior results, both in the US and in Europe. We continue to plan for significant revenue growth in this segment during the last part of 2003 and through 2004. Nanophase is also developing two further nanomaterial dispersions for additional technology nodes in semiconductor polishing and expects to begin market introduction of these materials later this year and early in 2004. Once this effort is complete, the Company believes it should have superior CMP products into semiconductor areas that are estimated to have annual CMP slurry market revenues over $200 million by 2005. The Company further expects to leverage this technology into CMP applications for additional semiconductor technologies, glass disk drives and read/write heads, as well as optical polishing.

"As we have also noted, through Nanophase`s new NanoArc(TM) Synthesis technology, the Company is introducing innovative, single-crystal mixed nanomaterials with unique surface chemistry and performance properties for target market applications that are currently under evaluation and testing by potential customers. We believe that this is the first commercial nanoscale availability of mixed metal oxides in a single crystal that is produced in discrete nanoparticle sizes from the 7 to 35 nanometer range and available either as a nanoparticle powder, or as a dispersion in either aqueous or organic systems. Nanophase is targeting these new generation nanomaterials for a wide variety of applications, including fuel cells, chemical-mechanical polishing (CMP), ultrafine polishing, catalytic converters, and catalysts.

"We plan to introduce new NanoArc(TM) nanomaterials for specific applications and target markets throughout 2003. Additionally, the Company has significant development efforts in antimicrobial applications for personal care and textiles, abrasion resistant coatings for plastics and electronics, and other significant markets. The Company`s business development initiatives and pipeline remains robust and is expected to drive revenues that meet its financial targets."

[MRASTA]

Die Phases bereiten schon mal die Anleger darauf vor, dass im Moment eher saure Gurkenzeit ist.

Die Geschichten mit Rodel und Schott sollte man aber nicht unterschätzen. Sind beide auf Ihrem Gebiet wirklich Weltspitze. Besonders Rodel ist technologisch im CMP Bereich wohl weltweit ungeschlagen, ist ja keine Pommesbude. Wenn die neuen Chipfertigungstechnologien anfangen sich zu etablieren, wird dass eine wirklich interessante Nummer. Und wenn Ihr Nanozeugs wirklich so gute Oberflächen schafft, dann ist es nur eine Frage der Zeit, bis die Hersteller aufspringen. Und Rodel wird nicht mit irgend einem Mist auf den Markt gehen, dafür sind Sie viel zu gut.

Dementsprechend sind auch die Aussagen zu wichten, da keiner so genau weiß, wann der große Umbruch erfolgt. Laut Roadmap 2005/06. Also könnten dieses Jahr schon die ersten Prototypen ausgeliefert werden, wenn die Firmen noch die Kohle haben. Nanophase ist mit den beiden Firmen IMHO sehr gut aufgestellt.


Und was macht Altair ?
Rauf und runter, kreuz und quer. 10% rauf, 10% runter, wird einem ja ganz schwindelig. Solange der 1$ hält, ist alles recht.

Gruß
mrasta

[Wunram]

zumindest kommen häufige news bei ALTI

Altair Nanotechnologies and Hyrodgen Solar Enter Into Teaming Agreement; Companies to Form New Nevada Corporation for Development of Solar Hydrogen Generation from Funding Provided by Both Federal Agencies and Private Entities

12 Jun 2003, 10:00am ET

RENO, Nev., June 12, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has entered into a teaming agreement with United Kingdom-based Hydrogen Solar Production Company Ltd. Under the terms of the agreement, the companies will form a new Nevada-based company, which they will own equally. Through the newly formed company the parties intend to collaborate in the development and commercialization of a solar hydrogen generator using the Tandem Cell(tm) technology invented at the EPFL in Lausanne, Switzerland. Hydrogen Solar owns the worldwide exclusive rights for this technology. Funding for the project(s) is expected to be secured by submitting formal applications to federal agencies and private entities.

The generation of hydrogen from light and water, has been demonstrated using conventional solar cells and electrolyzers. While successful, the technology cannot compete economically with other methods that generally use hydrocarbons. However, the availability of nanocrystalline semiconductor materials has generated significant interest in the tandem cell concept for direct production of hydrogen via water splitting. Dr. Michael Graetzel of the EPFL Lausanne, Switzerland, reported a novel, low-cost cell of this type in 1999. The Tandem Cell is made up of two sandwiched cells; the transparent front cell captures the blue/violet range of visible light and allows the green/red range of visible light to pass through to second cell behind it. The second cell utilizes a surface of dye-sensitized nanocrystalline titanium dioxide.

Hydrogen Solar successfully reproduced this cell in March, 2003, using industrial processes in a non-laboratory setting. The efficiencies of the Tandem Cell are expected to provide a more economic solar energy utilization of hydrogen production than the approach using separate solar cells and electrolyzers Altair and Hydrogen Solar`s joint development program will work to improve these efficiencies by optimizing the nanocrystalline compounds and the methods by which they are deposited on to the active surfaces of the Tandem Cell.

"The technology to generate hydrogen power from light and water would eliminate the environmental, sociological and economic problems associated with conventional hydrocarbon fuels - a top priority with the Department of Energy," said Altair President Dr. Rudi E. Moerck. "According to a February 24, 2003 article from CNN.com, Americans consume about 20 million barrels of oil a day, more than one half of which is imported. The article went on to note that government`s objective is to gradually reverse America`s growing dependence on foreign oil and it has initially set aside $1.2 billion in research funding for hydrogen power. As a team, we expect to play an important part in the development of this cutting edge technology."

"Finding a strategic partner with the ability to economically manufacture a wide variety of nanomaterials was vital to the success of our development program," said Hydrogen Solar Chief Executive Dr. David Auty. "We believe that the combination of Altair`s and Hydrogen Solar`s unique proprietary technologies will allow us to make great improvements to the Tandem Cell performance and thus demonstrate the viability of a commercial solar hydrogen generator. This project presents both companies with tremendous opportunity to become a leading force in this emerging industry."

The newly formed company will partner with the University of Nevada, Reno (UNR). The University is committed to industrial partnerships in the fields of nanotechnology, solar energy and materials science and has been collaborating with the Desert Research Institute (DRI) also located in Reno. The two organizations have collaborative projects such as the Renewable Energy Hydrogen Based System For Off-Grid Applications which was funded by the DOE NREL in 2002. UNR has requested $2 million in DOE funding for 2004 to accelerate and advance the research and demonstration program in Hydrogen Energy Systems using the Tandem Cell concept. Altair is currently working with UNR on several programs, one of which is funded by the DOE in conjunction with Western Michigan University.

According to an April 2003 article, "How Hydrogen Can Save America," published by Wired Digital, Inc. the automobile industry is already moving in the direction of bringing hydrogen-based vehicles to market. To date, DaimlerChrysler, Ford, and General Motors have invested approximately $2 billion developing fuel cell cars, buses and trucks with the first products to be launched in 2003. Like automobile manufacturers, oil companies also have made progress toward an oil-free future. Over the past several years, companies such as Shell Oil and Exxon have segued from oil production to refining crude oil and selling it to filling stations. They are aware that they could provide the same service in a hydrogen economy, which is why Shell and Beyond Petroleum, formerly British Petroleum, have invested heavily in hydrogen storage and production technology.

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Hydrogen Solar Production Company, Ltd.

Hydrogen Solar Production Company, Ltd, based in Reading, U.K., is building a portfolio of hydrogen technologies and intellectual property aimed at the new hydrogen economy. Hydrogen Solar owns the worldwide rights for Tandem Cell technology, as well as the rights to biological processes for generating hydrogen, and is seeking to acquire compatible technologies in hydrogen generation and storage. Hydrogen generated from sunlight and water in the Tandem Cell offers a renewable fuel with no carbon dioxide emissions. For additional information on Hydrogen Solar, please visit www.hydrogensolar.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information.......

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

CONTACT: Altair Nanotechnologies, Inc.
Tracy LaFollette
[phone]
[e-mail]

Investor Relations
Marty Tullio
[phone]
[e-mail]

[MRASTA]

na so was ?

Neue Firma gründen ? Dabei stehen Sie selber doch noch auf mehr als wackeligen Beinen. Wer soll dass denn alles machen ? Und wo soll die Knete herkommen ? Aus dem großen USA Topf ?

Klingt spannend und hat bestimmt Zukunft aber ob Altair & Co. das Rennen machen werden, weiß doch noch keiner.

Habe so ein bischen den Eindruck, dass bei den Jungs aus England auch so ein wenig Geldnot herrscht, da paßt es vielleicht ganz gut, da Sie ja Nanopartikel brauchen und die sind teuer.

Heiße Kiste, hoffentlich übernimmt sich Altair dabei nicht. Paßt eigentlich im Moment nicht so gut. Ein netter Kontrakt wäre mir lieber gewesen. Aber vielleicht kann man es sich nicht immer aussuchen und mußte jetzt zuschlagen, die Big Player sind doch wie die Geier, wer weiß, wer weiß.

mrasta

[MRASTA]

So, dass wäre dann wohl auch erledigt. Scheint seinerzeit eine Art Modeerscheinung gewesen zu sein. Bleibt nur die Frage ob die Versicherung die Vergleichskosten wirklich trägt ?


Nanophase Technologies Announces Tentative Settlement of Litigation

Monday , June 16, 2003 07:30 ET
ROMEOVILLE, Ill., Jun 16, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced that it has reached an oral agreement in principle to settle the securities class action lawsuit filed against it and certain of its current and former officers, pending in the United States District Court for the Northern District of Illinois, for $2,500,000. The tentative settlement will successfully resolve all claims against all defendants in this class action under the federal Securities Exchange Act of 1934 on behalf of certain persons who purchased shares of the Company`s common stock from April 5, 2001 through October 24, 2001. As more fully described in the Company`s Annual Report on Form 10-K, the suit arose from the Company`s public disclosures regarding its dealings with Celox, a British customer. The tentative settlement is not an admission of liability or other wrongdoing by any defendant.

The Company anticipates that this settlement will be funded by the Company`s directors and officers liability insurance, and that the settlement will not have a material adverse effect on Nanophase`s financial position or results of operations. The tentative settlement is subject to the parties preparing and signing a definitive Stipulation of Settlement, subsequent submission of that formal Stipulation to the court for preliminary approval, notice to settlement class members, and subsequent final judicial approval. The settlement will successfully resolve the only remaining litigation pending against the Company.

"Although the Company continues to regard the allegations made against defendants in this litigation as baseless, we believe that the decision to settle this class action for amounts within insurance policy limits promotes our stockholders` best interests," said Joseph Cross, Nanophase`s president and CEO. "Given the current environment and the potentially lengthy timeframe and cost to continue the litigation, the settlement will avoid continuing distraction and enable the Company to concentrate exclusively on business development initiatives and planned progress toward increasing product revenues during the last half of 2003 and through 2004. We recognize that growing revenue and extending our technology lead in the field of nanocrystalline material is the clearest path toward maximizing shareholder value."

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 22 United States patents and patent applications, consisting of 8 owned United States patents, 8 owned United States patent applications, and 6 licensed United States patents. The Company also has 24 foreign patents and patent applications, consisting of 8 owned foreign patents and 16 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

This press release contains words such as "expects", "anticipates", "plans", "forecasts" and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company`s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties. It is possible that the Company`s future performance may differ materially from current expectations expressed in these forward-looking statements due to a variety of important factors such as: a customer`s decision to defer, cancel or otherwise modify a purchase order or supply agreement; demand for, and acceptance of, the Company`s nanocrystalline materials; changes in our development, supply and distribution relationships; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost effective basis; the Company`s mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental regulations; disruption of commercial activities and threats associated with terrorism and efforts to combat it; protection and validity of patent and other intellectual property rights; the cyclical nature of the Company`s business; the outcome of pending and future litigation and governmental proceedings; and other risks described in the Company`s filings with the Securities and Exchange Commission. In addition, the Company`s forward-looking statements could be affected by general industry and market conditions and growth rates. The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

SOURCE Nanophase Technologies Corporation



CONTACT: Joseph Cross, President, CEO, [phone], Jess Jankowski,
VP, and Controller, [phone], or Nancy Baldwin, Investor Relations,
[phone], all of Nanophase Technologies Corporation
/Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, [phone] or [phone]

[MRASTA]

Und weiter geht der Reigen :

1. Es stehen Aktien zum Verkauf an :

S-3: ALTI Registers 4M Shares for Selling Holders
Monday , June 16, 2003 09:59 ET

Altair Nanotechnologies Inc (Nasdaq NM: ALTI) filed an S-3 prior to Monday?s session to register 4,029,588 shares of common stock for selling shareholders (2,050,504 are currently owned by the selling shareholders and the remaining 1,979,084 are issuable upon the exercise of outstanding warrants to purchase common shares). The Company will not receive any of the proceeds from the sale of the shares.




2. Rating Einschätzung.

Unterbewertet ????, na wenn Sie meinen. Werden wohl von Altair bezahlt, also leicht faler Beigeschmack.



Global Partners Securities Inc. Initiates Coverage of Altair Nanotechnologies, Inc. -- ALTI

Monday , June 16, 2003 12:48 ET

NEW YORK, Jun 16, 2003 (PRIMEZONE via COMTEX) -- The following investment opinion is being issued by Global Partners Securities Inc. regarding Altair Nanotechnologies, Inc. (Nasdaq:ALTI):

Current Price: $1.12
52-Week High/Low: $1.30 - $0.30
Float: 24.2M
Risk: High
Rating: Speculative


Recommendation: Accumulate

We are initiating coverage of Altair Nanotechnologies, Inc. with a 12-month price target of $2.50 to $3.00. It is our belief that the stock is significantly undervalued as the price does not reflect the company`s significant opportunities within the pharmaceutical industry or the growing market potential of nanotechnology, the science of the small. While the risks are high, this is an extremely interesting company as Altair, one of a handful of publicly traded pure nanotechnology companies in the U.S. and Europe, holds the leading patented process to cost-effectively produce commercial quantities of a wide variety of nanomaterials.

The Technology

Nanotechnology gets it name from the measurement called a nanometer, which is one-billionth of a meter. Altair derives its nanomaterials from inorganic elements utilizing its patented and patent-pending technologies to produce metal oxides, metal titanates and a combination of crystals ranging from 10 to 1,000 nanometers. These nanomaterials target numerous applications including pharmaceuticals, coatings, ceramic thermal sprays, energy (hydrogen), advanced battery and fuel cell) and homeland security. According to MIT Technology Review, nanotechnology is the most significant emerging materials technology for this century.

According to a NanoBusiness Alliance report published last year, venture capitalists are getting on the nanotechnology bandwagon as direct venture investments were predicted to reach $1 billion in 2002 and $1.2 billion in 2003. In May 2003, the U.S. House of Representatives passed the Science Committee legislation which authorizes a national nanotechnology research and development program, along with $2.36 billion over a three year period for funding the program. Altair has retained DykemaGossett, PLLC, a Washington, D.C. law firm, to aggressively seek grant monies. The firm recently assisted the company, together with Western Michigan University, with obtaining a $1 million grant to develop titanium dioxide nanoparticle sensors for the detection of chemical and biological weapons.

The Company

Three years ago, Altair Nanotechnologies repositioned itself to focus on the emerging nanotechnology sector. Altair believes that its patented and patent-pending processes offer a number of technological advantages over competing nanoparticle production technologies by enabling the economical production of commercial quantities of nanomaterials with precise control of particle size, shape, structure and chemical composition to a degree not attainable by other companies.

While there are myriad uses for nanomaterials - from self-cleaning tiles or glass, cosmetics, to futuristic microscopic devices that will be designed to enter our bodies and perform surgery, Altair has focused on markets that can benefit today and provide enormous potential in the very near future.

Target Markets

Pharmaceuticals

Altair`s nanomaterials have been used in the development of a new drug candidate, RenaZorb(tm). RenaZorb is a phosphate binder for the removal of phosphate in kidney dialysis patients. The market for phosphate binders is currently $400 to $500 million and could expand to over $1 billion with a cost-effective drug presenting improved dosing and patient compliance. Altair has engaged RBC Capital Markets as its exclusive financial advisor to assist the company in identifying and evaluating companies within the pharmaceutical industry that have an interest in developing RenaZorb with a development license. An initial development license should provide revenues ranging from $4 to $15 million.

The company has made significant progress with RenaZorb and has received positive results from both in vitro laboratory testing and in vivo testing in rats and dogs by two pharmaceutical companies. RenaZorb has attracted a number of pharmaceutical companies and they are in various stages of conducting due diligence on the company, the drug candidate and the test results. There is only one FDA approved competing product in the market, Renagel(tm) from Genzyme. Shire Pharmaceuticals has received an approvable letter from the FDA for Fosrenol(tm).

Pigment

Altair recently received a patent pertaining to its process for producing high-grade pigment, a $9 billion business. Altair has entered into an agreement with an agent with offices in the People`s Republic of China (PRC) to represent its process, called Altair Hydrochloride Pigment Process (AHPP), to the businesses in the PRC. The PRC has a world class reserve of titanium ore and favorable labor costs. Several companies, including the Government Engineering Agency overseeing pigment development in China, have expressed interest in licensing the process, but the SARS epidemic has slowed down the negotiations. Currently, the PRC will not approve new pigment plants using the old sulfate process for environmental reasons; therefore we believe that Altair`s process will be favorably looked upon.

Energy

Altair just announced a teaming agreement with UK-based Hydrogen Solar Production. The companies plan to form a new Nevada company to collaborate in the development and commercialization of a solar hydrogen generator using the Tandem Cell(tm) as the basis for their development. The goal of the development team is to generate hydrogen power from light and water. This process would eliminate the environmental and economic problems associated with conventional hydrocarbon fuels. The program will be funded by private and government grants. Altair`s nanomaterials have already been used in the manufacturing of solid oxide fuel cells. The company is contacting organizations such as the National Laboratories and the Solid State Energy Conversion Alliance that require additional technology resources to meet their program objectives.

In addition to Altair`s fuel cell development program, the company has other programs that target the energy sector. It has developed nanomaterials that have demonstrated significantly rapid charging and discharging rates. This is a huge benefit for advanced battery development within the automotive industry, as well as other applications using hybrid or fuel cell systems. The company is currently in discussions pertaining to the funding of its nano-based battery materials with two separate groups that have already demonstrated the use of Altair`s materials in thin film batteries and super capacitors.

Homeland Security

Altair and Western Michigan University (WMU) received a $1 million DOE grant to fund their joint development of nanosensors for detecting chemical and biological weapons and an agent for the breakdown and concentration of radioactive nuclides. The nanosensors should have significant use in national defense applications and homeland security programs, and the remediation agent addresses the on-site reduction of radioactive waste. WMU and Altair plan to obtain additional grants worth $1 million or more per year.

Risks

- While we believe the company should break even by year-end, the company may have to go back to the capital markets to fund its growth plan.

- Altair depends on key management and technical employees.

- Possible de-listing by NASDAQ due to stock price. The company currently has 90 days to meet the minimum bid rule. The stock is currently trading over $1.00

Note: All expenses to visit the company were paid by ALTI.





Peter Cardillo
Director of Research
June 15, 2003


The information contained herein is based on sources that we believe reliable, but its accuracy is not guaranteed. Westfalia Investments, Inc. or its officers, directors or employees may at times have a position in the securities described herein and may sell or buy them to and from customers. COPYRIGHT 1994 by: Westfalia Investments, Inc.
presently known as Global Partners Securities, Inc. The views expressed herein accurately reflect the research analyst`s personal views. The research analyst will receive compensation in the form of commission from transactions executed in the security referenced for
those accounts maintained by the firm. This compensation may influence the recommendation in the research report. There may be greater risks involved in securities recommended and should be discussed with a financial professional.


INVESTMENT OPINION

By Staff

CONTACT: Global Partners Securities Inc., New York
Peter Cardillo, Director of Research
212-391-7600

[Wunram]

ein bisschen Aufmerksamkeit erregen

Global Partners Securities Inc. Initiates Coverage of Altair Nanotechnologies, Inc. -- ALTI

16 Jun 2003, 12:47pm ET

NEW YORK, June 16, 2003 (PRIMEZONE) -- The following investment opinion is being issued by Global Partners Securities Inc. regarding Altair Nanotechnologies, Inc. (Nasdaq:ALTI):

Current Price: $1.12
52-Week High/Low: $1.30 - $0.30
Float: 24.2M
Risk: High
Rating: Speculative
Recommendation: Accumulate

We are initiating coverage of Altair Nanotechnologies, Inc. with a 12-month price target of $2.50 to $3.00. It is our belief that the stock is significantly undervalued as the price does not reflect the company`s significant opportunities within the pharmaceutical industry or the growing market potential of nanotechnology, the science of the small. While the risks are high, this is an extremely interesting company as Altair, one of a handful of publicly traded pure nanotechnology companies in the U.S. and Europe, holds the leading patented process to cost-effectively produce commercial quantities of a wide variety of nanomaterials.

The Technology

Nanotechnology gets it name from the measurement called a nanometer, which is one-billionth of a meter. Altair derives its nanomaterials from inorganic elements utilizing its patented and patent-pending technologies to produce metal oxides, metal titanates and a combination of crystals ranging from 10 to 1,000 nanometers. These nanomaterials target numerous applications including pharmaceuticals, coatings, ceramic thermal sprays, energy (hydrogen), advanced battery and fuel cell) and homeland security. According to MIT Technology Review, nanotechnology is the most significant emerging materials technology for this century.

According to a NanoBusiness Alliance report published last year, venture capitalists are getting on the nanotechnology bandwagon as direct venture investments were predicted to reach $1 billion in 2002 and $1.2 billion in 2003. In May 2003, the U.S. House of Representatives passed the Science Committee legislation which authorizes a national nanotechnology research and development program, along with $2.36 billion over a three year period for funding the program. Altair has retained DykemaGossett, PLLC, a Washington, D.C. law firm, to aggressively seek grant monies. The firm recently assisted the company, together with Western Michigan University, with obtaining a $1 million grant to develop titanium dioxide nanoparticle sensors for the detection of chemical and biological weapons.

The Company

Three years ago, Altair Nanotechnologies repositioned itself to focus on the emerging nanotechnology sector. Altair believes that its patented and patent-pending processes offer a number of technological advantages over competing nanoparticle production technologies by enabling the economical production of commercial quantities of nanomaterials with precise control of particle size, shape, structure and chemical composition to a degree not attainable by other companies.

While there are myriad uses for nanomaterials - from self-cleaning tiles or glass, cosmetics, to futuristic microscopic devices that will be designed to enter our bodies and perform surgery, Altair has focused on markets that can benefit today and provide enormous potential in the very near future.

Target Markets

Pharmaceuticals

Altair`s nanomaterials have been used in the development of a new drug candidate, RenaZorb(tm). RenaZorb is a phosphate binder for the removal of phosphate in kidney dialysis patients. The market for phosphate binders is currently $400 to $500 million and could expand to over $1 billion with a cost-effective drug presenting improved dosing and patient compliance. Altair has engaged RBC Capital Markets as its exclusive financial advisor to assist the company in identifying and evaluating companies within the pharmaceutical industry that have an interest in developing RenaZorb with a development license. An initial development license should provide revenues ranging from $4 to $15 million.

The company has made significant progress with RenaZorb and has received positive results from both in vitro laboratory testing and in vivo testing in rats and dogs by two pharmaceutical companies. RenaZorb has attracted a number of pharmaceutical companies and they are in various stages of conducting due diligence on the company, the drug candidate and the test results. There is only one FDA approved competing product in the market, Renagel(tm) from Genzyme. Shire Pharmaceuticals has received an approvable letter from the FDA for Fosrenol(tm).

Pigment

Altair recently received a patent pertaining to its process for producing high-grade pigment, a $9 billion business. Altair has entered into an agreement with an agent with offices in the People`s Republic of China (PRC) to represent its process, called Altair Hydrochloride Pigment Process (AHPP), to the businesses in the PRC. The PRC has a world class reserve of titanium ore and favorable labor costs. Several companies, including the Government Engineering Agency overseeing pigment development in China, have expressed interest in licensing the process, but the SARS epidemic has slowed down the negotiations. Currently, the PRC will not approve new pigment plants using the old sulfate process for environmental reasons; therefore we believe that Altair`s process will be favorably looked upon.

Energy

Altair just announced a teaming agreement with UK-based Hydrogen Solar Production. The companies plan to form a new Nevada company to collaborate in the development and commercialization of a solar hydrogen generator using the Tandem Cell(tm) as the basis for their development. The goal of the development team is to generate hydrogen power from light and water. This process would eliminate the environmental and economic problems associated with conventional hydrocarbon fuels. The program will be funded by private and government grants. Altair`s nanomaterials have already been used in the manufacturing of solid oxide fuel cells. The company is contacting organizations such as the National Laboratories and the Solid State Energy Conversion Alliance that require additional technology resources to meet their program objectives.

In addition to Altair`s fuel cell development program, the company has other programs that target the energy sector. It has developed nanomaterials that have demonstrated significantly rapid charging and discharging rates. This is a huge benefit for advanced battery development within the automotive industry, as well as other applications using hybrid or fuel cell systems. The company is currently in discussions pertaining to the funding of its nano-based battery materials with two separate groups that have already demonstrated the use of Altair`s materials in thin film batteries and super capacitors.

Homeland Security

Altair and Western Michigan University (WMU) received a $1 million DOE grant to fund their joint development of nanosensors for detecting chemical and biological weapons and an agent for the breakdown and concentration of radioactive nuclides. The nanosensors should have significant use in national defense applications and homeland security programs, and the remediation agent addresses the on-site reduction of radioactive waste. WMU and Altair plan to obtain additional grants worth $1 million or more per year.

Risks

- While we believe the company should break even by year-end, the company may have to go back to the capital markets to fund its growth plan.

- Altair depends on key management and technical employees.

- Possible de-listing by NASDAQ due to stock price. The company currently has 90 days to meet the minimum bid rule. The stock is currently trading over $1.00

Note: All expenses to visit the company were paid by ALTI.

Peter Cardillo
Director of Research
June 15, 2003

The information contained herein is based on sources that we believe
reliable, but its accuracy is not guaranteed. Westfalia Investments,
Inc. or its officers, directors or employees may at times have a
position in the securities described herein and may sell or buy them
to and from customers. COPYRIGHT 1994 by: Westfalia Investments, Inc.
presently known as Global Partners Securities, Inc. The views
expressed herein accurately reflect the research analyst`s personal
views. The research analyst will receive compensation in the form of
commission from transactions executed in the security referenced for
those accounts maintained by the firm. This compensation may
influence the recommendation in the research report. There may be
greater risks involved in securities recommended and should be
discussed with a financial professional.
CONTACT: Global Partners Securities Inc., New York
Peter Cardillo, Director of Research
212-391-7600

[MRASTA]

So, das ist geschafft. Und nun ?

Alles auf einmal, Tio2 und Pharma oder nichts von beiden ?

Mal sehen, was jetzt passiert.



Altair Nanotechnologies` Common Stock Regains Nasdaq Compliance

Wednesday, June 18, 2003 10:46 ET
RENO, Nev., Jun 18, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) has received a letter from Nasdaq stating that its common stock is in compliance with Nasdaq Marketplace Rule 4310(c)(8)(D), which requires that the company`s common stock maintain a minimum $1.00 bid price per share.

"We are pleased to receive Nasdaq`s compliance letter. The potential market for our nanomaterials and nano-products is now being recognized by the financial community," said Altair President Rudi E. Moerck. "We have made significant strides with our nanoparticle-based pharmaceutical product, RenaZorb(tm), Altair`s new drug candidate for phosphate control in kidney dialysis patients and with our strategy for obtaining government funding for DOE projects continues to be successful. Additionally, our patented Hydrochloride Pigment Process (AHPP) has been featured in the June issue of Chemical Engineering Progress."

The Chemical Engineering Progress magazine has a section entitled UPDATE, which includes a Process Technology section that features an overview of AHPP, Altair`s patented, low-cost titanium dioxide pigment production process. According to the article, the two common processes for currently manufacturing pigment, the chloride process, which costs approximately $1,350/metric ton of Ti02 and the sulfate process, which costs approximately $1,500/metric ton of Ti02, are coming under regulatory scrutiny because of waste generation and disposal. The article went on to mention that Altair`s AHPP process, which is projected to cost approximately $1,100/metric ton of Ti02, generates little waste. Additionally the article mentioned that Altair`s process uses low-cost ilmenite ores and produces crystallineTi02 in the desired form of either rutile or anatase with a waste product, iron oxide, which can subsequently be sold.

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com .

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, uncertainties regarding the company`s ability to enter into a licensing agreement pertaining to its pharmaceutical agent RenaZorb, the company`s ability to enter into an agreement to license its AHPP pigment process, the company`s ability to obtain the needed funding for its continuing nanotechnology development and other operations and the company`s continued compliance with the $1.00 minimum bid requirement for continued listing on the Nasdaq SmallCap Market, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

SOURCE: Altair Nanotechnologies Inc.

[cristrader]

Interessante Zusammenstellung einiger Nanotechs!
http://www.smallcapmarketwatch.com/article.asp?Article_Id=64…

[MRASTA]

@cristrader

danke, gute Übersicht.

Das Sie Nanophase mit Nanogen etwas durcheinander bringen, sei ihnen verziehn.

Westaim habe ich schon seit längerer Zeit auf der Watchlist. Allerdings hatte ich mich eher auf ihre Tochterfirma iFire Technology Inc. konzentriert. Mit Ihrem neuen Flatpanel für die TV Branche könnte Ihnen ein Durchbruch gelingen. Immerhin wollen Sie mit Dai Nippon Printing und Sanyo zusammen, ab 2005 in die Vermarktung eintreten.

Nucryst Pharmaceuticals hat wohl Ihr Acticoat ganz gut plazieren können. Die Verkaufszahlen sind steigend.

Hat nicht jemand Lust, sich mal näher mit Westaim zu beschäftigen. Habe leider nicht die Zeit dazu. Wäre bestimmt keine schlechte Idee.

Gruß
mrasta

[cristrader]

@mrasta
Habe Westaim auch auf meine Watchlist genommen. Leider wird die Aktie in Deutschland (Berlin WKN: 901769) so gut wie nicht gehandelt und der Handel in den USA ist nicht so mein Ding --> Teilausführungen bei DAB

[MRASTA]

Sieht so aus, als wenn etwas Beruhigung in den Markt kommt. Die meisten haben sich wohl erstmal ausgetobt im Zeitalter der Nanotechs.

Die Phases und Altair haben sich ja bis jetzt wacker geschlagen. Die Phases pendeln sich wohl so zwischen 5-6 $ ein und Altair vielleicht zwischen 1.10 - 1.20 $. Wer rechtzeitig mit eingestigen ist, kann sich ja nicht beklagen. Wer, wann und wo ein- oder aussteigt bleibt jedem selbst überlassen.

Jetzt fängt die Zeit des Nachdenks an.

Ich sehe dass ähnlich wie seinerzeit bei den Biotechs, einige werden sich noch wundern wie lange Entwicklungen von der Ankündigung bis zur Marktreife benötigen.

Um die Phases mache ich mir nur geringe Sorgen, obwohl mir die geschätzten Umsatzzahlen gar nicht gefallen haben. Sind mir schon viel zu hoch gegriffen, kann man schnell aus dem Fenster fallen. Aber die Mitstreiter sind solide Firmen, das wird schon werden. Außerdem darf man die ISO Zerfizierung bei den Phases nicht unterschätzen.

Altair muss jetzt zeigen, ob sie wirklich was vermarkten können. Bleibt ein Pokerspiel.

Gruß an alle
mrasta

[Wunram]

auch nicht schlecht

Altair Awarded Patent For Its Process to Manufacture Nano-Sized Yttria Stabilized Zirconia

24 Jun 2003, 10:02am ET

RENO, Nev., June 24, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has received a patent covering its process for manufacturing nano-sized yttria stabilized zirconia (YSZ). Altair`s YSZ is the ideal material for use in manufacturing solid oxide fuel cells (SOFC) as the company`s patented process allows particle size to be selected. Additionally, the cost per kilowatt hour is an important consideration for the continued success of fuel cell programs. Altair`s process uses low-cost, readily available zirconia and yttria commodity feedstocks. The process is flexible and, in addition to yttrium, the zirconia can be stabilized with calcium, scandium or magnesium.

According to Altair`s CEO, Dr. William P. Long, the company`s proprietary nano-sized YSZ is a major component in the company`s solid oxide fuel cell (SOFC) program. In this program, Altair uses its unique YSZ for construction of both the dense electrolyte and the base structure for the porous anode layer. SOFC applications have been attracting worldwide attention due to their high-energy conversion efficiency and their improved performance with regards to pollution and use of natural resources. Catalyst development at MIT demonstrated that Altair`s SOFC can potentially utilize a wide variety of hydrocarbon fuels, methane, ethane, butane, and ethanol while operating almost pollution free. The fuel cell market for SOFC applications, which includes on-site power systems, transportation applications and utility companies, is estimated to be $360 million by 2005.

SOFC development is challenging due to a lack of high quality durable ceramic materials. The electrolyte component of an SOFC, which conducts oxygen anions from the cathode to the anode of the fuel cell, must be dense, very thin and free of pores. Any microscopic openings will allow leakage of fuel in the anode compartment or air from the cathode compartment to intermingle lowering cell efficiency or completely halting cell function.

"We have successfully demonstrated that our nanomaterials will solve the classic "materials mismatch" problem experienced by other fuel cell manufacturers as we can monolithically manufacture the anode, cathode and electrolyte structure using our proprietary nano-particle manufacturing approach," said Altair`s Director of Research and Engineering, Dr. Bruce J. Sabacky. "Work continues in the development of our SOFC for stationary, always on, electrical power. Based on fundamental advantages discovered in Altair`s nano-sized YSZ, our R&D group was successful in building a small-scale working model SOFC for demonstrational purposes in about two and one half years. The goal of the company is not to manufacture fuel cells, but prototypes that showcase the company`s commercial nanomaterials. The company is selling small research quantities of materials including nano-sized yttria stabilized zirconia and nanoparticle slurries that can be used to manufacture fuel cells using tape-casting technology."

What is Stabilized Zirconia

Zirconia is a white powder used in making, among other things, furnace linings and pigments. When stabilized with yttrium, the zirconia is extremely strong and becomes a good oxygen ion conducting material that is able to sustain temperatures up to 2,000 degrees centigrade -- the perfect material for solid oxide fuel cell cores and the thermal spray industry.

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual and future results to be materially different than suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the company`s ability to attract funding for continued R&D or attract partners pertaining to the successful development of an SOFC utilizing Altair`s YZS, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

CONTACT: Altair Nanotechnologies
Tracy LaFollette
[phone]
[e-mail]

Investor Relation Resources
Marty Tullio
[phone]
[e-mail]

[MRASTA]

Hauptsache Rudi verliert bei den ganzen Meldungen nicht den Überblick, was er eigentlich wollte.

Genau, mal ein Geschäft in einem der Bereiche, dass wäre doch mal was. Aber alleine der Name ist schon cool, nano-sized "yttria stabilized zirconia" Auf was man so alles kommt.

Patente sind nun genug da, kosten ja auch alle Geld. Nun macht mal voran.

Was machen eigentlich die Phases, treten auf der Stelle und warten ab, auch recht.

Gruß an alle
mrasta

[MRASTA]

uns bleibt aber auch nichts erspart. Jetzt haben sich auch noch die Shorties auf die Werte eingeschossen. Hoffentlich geht das mit den Steigerungsraten nicht so weiter. Auch Tiny ist betroffen.


ALTI: Short Interest UP 2554.1% to 699.9K in Jun 2003
Tuesday , June 24, 2003 19:15 ET

According to new short interest data from NASDAQ, short interest for Altair Nanotechnologies Inc (NasdaqNM: ALTI) INCREASED 2554.1% to 699,888 shares for the month ended mid-June, 2003.

SYMBOL MAY JUNE CHANGE %CHANGE DAYS/COVER

-------- ------------- ------------- ------------- ------------ ----------

ALTI 26,370 699,888 +673,518 +2554.11% 1

Based on ALTI`s 20-day average daily share volume of 1,383,475, it would require approximately 1 day(s) of buying to cover this short interest.




NANX: Short Interest UP 48.2% to 166.5K in Jun 2003
Tuesday , June 24, 2003 19:20 ET

According to new short interest data from NASDAQ, short interest for Nanophase Technologies Corporation (NasdaqNM: NANX) INCREASED 48.2% to 166,473 shares for the month ended mid-June, 2003.

SYMBOL MAY JUNE CHANGE %CHANGE DAYS/COVER

-------- ------------- ------------- ------------- ------------ ----------

NANX 112,315 166,473 +54,158 +48.22% 3

Based on NANX`s 20-day average daily share volume of 77,711, it would require approximately 3 day(s) of buying to cover this short interest.





TINY: Short Interest UP 410.3% to 43.0K in Jun 2003

Tuesday , June 24, 2003 19:18 ET
According to new short interest data from NASDAQ, short interest for Harris & Harris Group, Inc. (NasdaqNM: TINY) INCREASED 410.3% to 42,991 shares for the month ended mid-June, 2003.

SYMBOL MAY JUNE CHANGE %CHANGE DAYS/COVER

-------- ------------- ------------- ------------- ------------ ----------

TINY 8,425 42,991 +34,566 +410.28% 1

Based on TINY`s 20-day average daily share volume of 89,622, it would require approximately 1 day(s) of buying to cover this short interest.

[Wunram]

ALTI macht ein bisschen Werbung in eigener Sache

Altair Nanotechnologies Featured in Industrial Minerals and in the Forbes/Wolfe Nanotech Micro Cap Roster

1 Jul 2003, 10:00am ET

RENO, Nev., July 1, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) today announced that it has been featured in the June 2003 issue of Industrial Minerals, a division of Metal Bulletin, plc., the only international publication devoted to non-metallic, non-fuel minerals. Industrial Minerals analyzes markets as diverse as ceramics, refractories, abrasives, metallurgy, paints and coatings, paper, plastics, construction, fertilizers, chemicals, glass, and absorbents. Additionally, Altair was one of the public companies featured in the June 2003 issue of the Forbes/Wolfe Nanotech Report, a publication that identifies the companies that will profit from the nanotech revolution. The Report keeps the public informed on the latest developments in that sector that, according to the publication, will be worth $1 trillion by 2015. Altair was featured in the publication`s Nanotech Micro Cap Roster section.

In the Industrial Minerals article, entitled Nanoparticles -- The power of fine, Senior Assistant Editor Penny Crossley commented, "The development of nano-scale mineral particles, measured in terms of nanometers (1nm = 10(-9) meters), is a fast-moving area of mineral processing and there are specialist markets available to those who can implement the technology." Crossley went on to add, "Nanoparticle technology is on the cutting edge of mineral processing due to the high value market opportunities open to nanosize minerals. Altair Nanotechnologies is one of the pioneers of nanoparticle development."

"We are one of a few public companies focusing primarily on the development of nanomaterials and nano products," said Altair`s President Dr. Rudi E. Moerck. "Over the last 12 to 18 months, we have seen significant media attention pertaining to nanotechnology, along with announcements from the materials industry discussing the improved, stronger and more protective plastics, coatings, ceramic thermal spray coatings that have all been made possible through the use of nanomaterials.

"I believe the discussions concerning the effect nanotechnology will have on our day-to-day lives effectively ended when the U.S. House of Representatives recently approved $2.36 billion for funding nanotechnology research and development," continued Dr. Moerck. "Altair`s patented nanomaterials technology will allow the company to take advantage of the additional opportunities offered by the DOD and the DOE, as well as multiple programs, including the National NanoScience Initiative led by the National Science Foundation and the Advance Technology Program at the U.S. Department of Commerce. Recently we received a $1 million grant in conjunction with the University of Western Michigan to develop titanium dioxide nanoparticle sensors for the detection of chemical and biological weapons. We have engaged DykemaGossett, PLLC, a Washington, D.C. law firm, to assist us in obtaining additional funding for our nanotechnology development."

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual and future results to be materially different than suggested by the forward-looking statements in this release as well as other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

CONTACT: Altair Nanotechnologies
Tracy LaFollette
[phone]
[e-mail]

Investor Relation Resources, LLC
Marty Tullio
[phone]
[e-mail]

[Wunram]

sind wohl einige auf die fast Namensgleicheit ALT -> ALTI reingefallen

Altair Nanotechnologies Management Comments About Price of Its Common Stock

18 Jul 2003, 10:07am ET

RENO, Nev., July 18, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) management has received numerous calls from shareholders and the financial community pertaining to the sudden drop in the price of the company`s common stock during the afternoon of Thursday, July 17, 2003.

Altair management is not aware of any reason for the drop in the price of the company`s common stock as Altair`s fundamentals remain unchanged. Favorable progress is being made with a number of significant projects involving Altair and it proprietary nanotechnology. Altair`s discussions with pharmaceutical companies interested in its drug candidate, RenaZorb(tm), are proceeding with a number of these companies. RenaZorb(tm), Altair`s new drug for phosphate control in kidney dialysis patients, has been shown to be effective in both animal and laboratory testing. RenaZorb remains a viable drug candidate for use for patients with End Stage Renal Disease (ESRD).

Thursday, July 17, 2003, a small pharmaceutical company with the name of Alteon (AMEX, ALT) similar to that of Altair (ALTI) was downgraded to a "sell" by a few industry analysts after the company reported less then favorable news relating to one of its drug candidates. Additionally, throughout the day, reports regarding the pharmaceutical company, their drug candidate and the price decline in the company`s stock were heavily disseminated to financial portals via news services.

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements, as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual and future results to be materially different than suggested by the forward-looking statements in this release, including the ability of Altair to provide the material size and composition of the sample materials required, the companies` ability to reach an appropriate licensing fee or royalty arrangement as well as other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

CONTACT: Investor Relation Resources, LLC
Marty Tullio
949.566.9860
[e-mail]

Altair Nanotechnologies
Tracy LaFollette
307.587.8245
[e-mail]

[Wunram]

Keiner mehr da?? Trotzdem mal wieder etwas handfesteres aus dem Hause Altair

Altair Nanotechnologies` Proprietary Battery Material Used in Prototype Battery That Exceeds Department of Energy Standards

22 Jul 2003, 10:00am ET

Telecordia Prototype Batteries Exceed Standards Established by PNGV

Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a manufacturer of proprietary nanomaterials and nano-based products, reported today that battery prototypes based on the company`s nano-sized lithium titanate spinel, have been developed by Telecordia™ Technologies. The prototype battery characteristics significantly exceeded Department of Energy (DOE) standards, according to a Telecordia research paper authored by Aurelien Du Pasquier, Irene Plitz, Serafin Menocal and Glen Amatucci and published in The Journal of Power Sources, 113 (2003) 62-71 and 115 (2003) 171-178.

The DOE standards, noted in the research report, were established by PNGV (Partnership for New Generation of Vehicles) through a cooperative research and development program between the federal government and the United States Council for Automotive Research for PNGV`s power assist program. The DOE has established a goal for battery specific energy storage of 7.5 Wh/kg and specific power delivery at 625W/kg. The prototype battery, a nonaqueous asymmetric hybrid incorporating the advantages of both Li-ion batteries and super capacitors, exhibited the following characteristics: stored energy of 11Wh/kg with delivery of 800 W/kg at 95 percent efficiency. The cycle life ranged between 10,000 and 100,000 cycles depending on cycling conditions. The appropriateness for automotive applications was evidenced by the study of several typical examples. No other battery materials tested by Telecordia met and/or exceeded the PNGV standards.

Altair`s battery materials were supplied to Telecordia by FMC Lithium (NYSE: FMC) under the terms of a development agreement entered into on November 13, 2001 between Altair and FMC. It is expected that nano-lithium titanate spinel-based batteries will be used for power assistance for lead-acid, nickel-cadmium, or metal hydride batteries for use in hybrid automobiles. Other applications will include uninterrupted power supplies, military applications and other specialized uses such as notebook computers, mobile phone and a variety of portable devices.

The advances made by Telecordia through the use of Altair`s nanomaterials are significant to the battery industry," said Altair`s President, Dr. Rudi E. Moerck. "Independent test results of our nanosized lithium titanate spinal have shown charging and discharging rates 10 to 100 times higher than with materials commercially available today. We have been confident that if organizations, such as Telecordia, would incorporate our battery materials into advanced battery configurations they could address the needs of advanced transportation requirements. A cost-effective battery with high energy and power density is required for the success of electric and/or hybrid vehicles, as well as other important applications. Using Altair`s battery materials and multiple technologies, Telecordia has overcome several major hurdles in the future commercialization of advanced batteries."

Altair Nanotechnologies Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements, as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual and as well as other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Contact: Marty Tullio
Company: Investor Relation Resources, LLC
Voice: 949-566-9860
Email: [e-mail]



Contact: Tracy LaFollette
Company: Altair Nanotechnologies
Voice: 307-587-8245
Email: [e-mail]

[MRASTA]

Klar doch, melde mich zurück, Urlaub mußte sein.

Die Shorties haben wohl im Moment klar die Oberhand. Allerdings scheint gerade einer massiv zu verkaufen und einer bei 0.96 aufzusaugen. Jetzt bereits über 470.000 Teile gehandelt !!!!!!!!

Die letzten Meldungen sind doch gar nicht so schlecht, zwar noch kein Umsatz aber das (Speicher)Energieproblem beschäftigt doch einige zur Zeit.

Hierzu kommt dann noch die Meldung, die ich gerade gefunden habe :





Altair Nanotechnologies Provides Hydrochloride Titanium Dioxide Pigment Update at The International Symposium on Hydrometallurgy

Dr. Dirk Verhulst to Present a Scientific Paper Pertaining to Enhancement of Altair`s TiO2 Pigment

Wednesday, July 30, 2003 10:01 ET
RENO, Nev., Jul 30, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI), announced today that Dr. Dirk Verhulst, Engineering Manager of the company`s Nanomaterials subsidiary will present a Scientific Paper entitled, "NEW DEVELOPMENTS IN THE ALTAIR HYDROCHLORIDE TIO2 PIGMENT PROCESS" at the International Symposium of Hydrometallurgy to be held August 24 -- 27, 2003 in Vancouver, Canada.

Process adjustments to Altair`s proprietary pigment process have resulted in a significant improvement in the purity levels of its commercial TiO2 pigment base. Chromophore impurities (elements that impart color to pure white TiO2 pigment) are a concern in TiO2 pigment base and these elements are typically found in most all naturally occurring titanium ore deposits. In particular, iron, chromium, nickel, vanadium, and manganese contribute to pigment discoloration and lower the whiteness and brightness. Chromophore impurities are problematic in most of the world`s known ilmenite ore reserves. It is costly and difficult to remove these impurities using the existing chloride or sulfate process.

Many of the world`s new ilmenite resources exhibit some or all of these impurity problems. High chromium concentrations in Australia`s newest titanium mineral resources in Murray Basin will require some chemical pretreatment prior to sale to chloride process pigment manufacturers. Global Resource estimates in Murray Basin will exceed 1 billion tons and contain approximately 30 million tons of heavy minerals. According to some industry analysts, the Murray Basin deposit could raise projected world chlorinatable ilmenite mining in 2004 by 5% (in TiO2 units). The total value in pigment TiO2 from this deposit is projected to be $16 billion. Chlorinateable ilmenite requires very low impurity levels to prevent operations problems and to produce pure white TiO2 pigment. Several chromium reduction strategies are now being examined but it is likely that blending, which is a costly process, may be required to produce products with impurities and TiO2 levels suitable for the chloride process TiO2 market. New technologies will be required to economically reduce high levels of chromium, magnesium and manganese in the ore for acceptance in the chloride or sulfate process TiO2 markets. As an alternative, the new Altair Hydrochloride Pigment Process (AHPP) can be used to economically produce pigment directly from ilmenite ore with difficult to remove impurities.

The enhanced AHPP employs digestion of ilmenite ore in concentrated hydrochloric acid, solvent extraction to concentrate titanium in a purified stream and spray hydrolysis to produce a TiO2 hydrate, followed by final calcining and milling. Hydrochloric acid gas is regenerated by pressure-swing distillation and re-injected in the leaching solution. All chloride streams are recycled and waste streams including digestion and iron oxide residues make the process environmentally friendly.

The process was previously tested at a five ton per day feed scale. Recent work at pilot scale has led to further improvements. Recovery of titanium in solution is now at least 90 percent from ilmenite ores, while crystallization at lower temperature reduces iron and impurities in solution to less than 5 grams per liter. This favorably impacts solvent extraction, which is now conducted in columns. Higher titanium and lower iron concentrations in the solvent extraction improves the process economics to a greater extent. Third party engineering and industrial interest groups have also confirmed that the AHPP process has a low operating cost and is an environmentally friendly process.

Dr. Bruce Sabacky, Altair`s Director of Research and Development commented, "The new solvent extraction columns recently installed to demonstrate impurity control are significantly more effective than the mixer settlers originally installed in Altair`s 5 ton per day demonstration plant. The 20`x 1" columns performed extremely well in testing application and have demonstrated the ability to reject essentially all the impurities of several low-cost ilmenites tested by Altair. The columns can be easily scaled up to accommodate a 100,000 ton per year pigment plant," added Dr. Sabacky.

Altair`s Dr. Dirk Verhulst will present the paper in collaboration with Dr. Bruce Sabacky, Mr. Timothy Spitler and Mr. Jan Prochazka at "2003 International Symposium on Hydrometallurgy" organized by The Metallurgical Society (USA), the Canadian Institute of Mining and Metallurgy, and the Society for Mining, Metallurgy and Exploration (SME). The conference takes place in Vancouver on August 24-27, 2003. His presentation titled NEW DEVELOPMENTS IN THE ALTAIR HYDROCHLORIDE TIO2 PIGMENT PROCESS updates these significant developments.

Altair Nanotechnologies is actively seeking potential licensees and industrial partners for the further development of its new TiO2 technology.

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the possibility that the companies (Altair and Hydrogen Solar Technologies) will not successfully obtain funding for their hydrogen project or that the project will be commercially successful, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC.

Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

SOURCE: Altair Nanotechnologies Inc

Gruß an alle
mrasta

[MRASTA]

tja, sieht ganz schön bescheiden aus.

Die 0.90 haben bei Altair nicht gehalten. Sieht nicht gut aus.


Die Phases haben wenigstens eine Einigung in Ihrem Prozeß erzielt muss aber im November noch bestätigt werden. Bleibt nur zu hoffen, dass die Privatversicherungen bei den betroffenen Personen da auch einspringen.

Hier die Kurzform :

http://www.knobias.com/individual/public/news.htm?eid=3.1.6f…

Zahlen der Phases sollen heute nach Börsenschluss kommen.

mrasta

[Wunram]

klingt nicht schlecht, allerdings hat Timet $35,29 Verlust pro Aktie in 2002 gemacht


Titanium Metals Corporation And Altair Nanotechnologies Enter Into A Memorandum of Understanding; Companies to Investigate Novel Titanium Dioxide Electrode Feedstock to Manufacture Lower Cost Titanium Metal Using A New Technology

13 Aug 2003, 10:30am ET

RENO, Nev., August 13, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) today announced that it has entered into a memorandum of understanding (MOU) with Titanium Metals Corporation (NYSE:TIE) (TIMET) to collaborate on a new development program for producing low-cost titanium metal. TIMET is one of the world`s largest suppliers of titanium and titanium alloys for the aerospace, military and manufacturing industries.

As previously announced, TIMET has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to lead a program for developing an innovative new titanium electrolysis technology originated at Cambridge University and now referred to as the FFC Cambridge Process. The process uses titanium dioxide (TiO2) feedstock.

Under the terms of the MOU, Altair will provide low-cost TiO2 to make customized electrodes for the TIMET project. Altair believes its ability to control TiO2 particle size, shape and crystalline structure, using its patented process to make TiO2 pigment and nanoparticles, could have a significant benefit to TIMET`s program. Altair`s new proprietary technology enables production of optimized porosity and custom shaped electrode precursors from either commercial titanium tetrachloride (TiCl4) or from titanium ore digestion solutions, and is described in Altair`s pigment patent, US Patent 6,375,923. Investigations of Altair`s TiO2 process and feedstock for applicability to the FFC Process will begin immediately. TIMET and Altair may decide to enter into a license agreement or other commercial relationship if Altair`s process and feedstock prove beneficial to the development program.

According to the AMPTIAC Quarterly, a Department of Defense-sponsored publication, current global production of titanium metal is approximately 50,000 tons per year at a market value of $600 million. AMPTIAC estimates that, due to the current state of manufacturing, titanium is produced at only about 1/20th of its current potential world volume. On July 8, 2003, The Financial Times of London reported on the U.S. DOD funding for the FFC Cambridge process indicating that titanium metal`s current price is about $12,000 per metric ton and that the FCC Cambridge process has the potential to reduce the price significantly, making titanium more cost competitive with high-grade stainless steel.

"Altair will initially facilitate TIMET`s development and implementation of the FFC Cambridge Process technology by providing a range of customized TiO2 feedstock and shaped electrode precursors," said Altair President Dr. Rudi E. Moerck. "Together, Altair and TIMET will explore additional funding opportunities for development work that would benefit both companies."

DARPA awarded TIMET $12.3 million for a four-year development program. TIMET leads a team of researchers from major defense contractors, including General Electric Aircraft Engines, United Defense Limited Partners and Pratt & Whitney, as well as the University of California at Berkeley and the University of Cambridge, in this development program. The FFC Cambridge Process has the potential to significantly reduce the cost of titanium metal and dramatically expand its use in a wider range of applications that include lightweight armored military vehicles, the manufacture of automotive components and components for utility plants, oil and gas drilling, and lightweight and durable consumer goods.

"Altair has been following the FFC Cambridge Process developments for making titanium metal from titanium dioxide with great interest," commented Altair Nanotechnologies Vice President of Sales and Marketing Douglas K. Ellsworth. "We saw a direct link between our patented process and the new titanium metal technology. Our flexible process can produce optimized TiO2 feedstocks from low-cost ilmenite ore or TiCl4 enabling lower cost titanium metal production. We are pleased to be partnering with TIMET in this development project."

Altair has developed a new manufacturing process, the first in over 50 years, for TiO2 powder. Engineering studies have verified the operating costs of Altair`s Hydrochloride Pigment Process (AHPP) to be two-thirds to three-quarters that of the standard chloride process, primarily due to the use of low-cost ilmenite feedstocks. Unlike the current chloride and sulfate processes, AHPP is environmentally friendly with no chlorinators, iron sulfate treatment or deep welling required.

TITANIUM METALS CORPORATION

Titanium Metals Corporation, headquartered in Denver, Colorado, is a leading worldwide producer of titanium metal products. TIMET`s production facility is in Henderson, Nevada. Information on TIMET is available on the Internet at www.timet.com.

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements, as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual and future results to be materially different than suggested by the forward-looking statements in this release, Factors that may cause actual results to differ from projected or possible results to differ from projected or possible results include the following: (a) TIMET may determine that sample TiO2 feedstock provided by Altair is not suitable for use in TIMET`s process; (b) even if testing results are positive, TIMET and Altair may be unable to agree upon terms governing a long-term license or other relationship; (c) even if a long-term agreement is reached, it may not involve significant payment to Altair in the short-term or long-term; (d) TIMET may be unable to develop a lower-cost process for manufacturing titanium; (e) even if developed, TIMET`s new process may not significantly lower the cost of titanium and/or expand the market for titanium, and (f) if implemented on commercial scale, Altair`s process may not prove cost-effective and/or Altair may face unanticipated quality or environmental control issues Additional risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC.

Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

CONTACT: Investor Relations Resources
Marty Tullio
[phone]
[e-mail]

Altair Nanotechnologies, Inc.
Tracy LaFollette
[phone]
[e-mail]

[Wunram]

Quartalsbericht

http://www.edgar-online.com/bin/cobrand/finSys_main.asp?nad=…

[MRASTA]

was gibt es Neues ?

Gewinnwarnung von den Phases und Altair war bei TIMET mit dem Herrn Senator, mal die Hand schütteln, toll nicht ?

http://www.knobias.com/individual/public/news.htm?eid=3.1.ed…

http://www.knobias.com/individual/public/news.htm?eid=3.1.5f…

Alles Käse.

Dabei müßte doch Altair eigentlich durch den Blackout in den USA und dem Run auf die Energiewerte bzw. Hersteller von Kabeln, Solartechnik etc. auch provitieren.

Der Kurs hat sich zwar wieder leicht gefangen, aber ob dass Bestand hat ?

cu

[MRASTA]

tausche ein "v" gegen ein "f", dann profitieren wir alle davon. ;-)

Kann mir irgendwer erklären, warum die Phases heute steigen, nach der Meldung ? Verstehe ich einfach nicht mehr.

cu

[MRASTA]

Etwas zum lesen,

für alle, die wissen wollen was im thermo-elektrischen-Nanobereich so läuft. Super Übersicht.

Ist eine PDF Datei zum runterladen (100 Seiten), herausgegeben von dem Nanoforum Consortium, welches durch die EU gesponsert wird. Also alles Fachleute aus ganz Europa, siehe Impressum. Stand 22. August 2003 !!

Besonders zu empfehlen für diejenigen, denen die Namen Grätzel oder NTERA was sagen. ;-))

http://www.istm.cnr.it/progetti/nanothermel/Nanothermelbroch…

cu

[MRASTA]

und noch ein paar Anmerkungen zu den Phases, die, für mich unverständlich, trotz der um ein Jahr nach hinten geschobenen Zeitschiene mit dem Polishing (Rodel), gestern gestiegen sind. Glaube einige brauchen echt eine Brille. ;-)).

Egal, wie dem auch sei, hier ein Auszug aus dem Konferenzcall, der zu den Q-Zahlen gemacht wurde. Stammt aus einem anderen Board, somit ohne jegliche Garantie für die Richtigkeit etc. !!! Wenn es denn stimmt, haben wir ja noch einiges vor uns.



!

In the SECOND QUARTER 2003 CONFERENCE CALL (07.08.2003), Cross described promising prospects, "... personal care, including sunscreens. In the later area, our nanomaterials are currently being used by consumers in both daily wear applications, and beachwear sunscreen products in the U.S. and Asia. An example of beachwear, is Coppertone?s new Spectra 3 line that contains our nanozinc oxide, while daily wear products are perhaps best noted by the Olay product line.

Additionally, with our partner, we are developing a generation two nanocoated material for sunscreens that is primarily directed towards the European market and has a targeted market introduction by mid-2004.

...The Company currently expects appreciable revenue growth in this market area during 2004-2006. While I am not making a forecast here, annual revenues for these products have the potential to at least double over the next 2-3 years.

....In initial testing, our nanomaterial dispersions appear to provide improved planarity, high selectivity, and a very low angstrom surface finish. One major disk drive manufacturer has indicated to the Company that it plans to use our nanoparticle dispersion for its 2004 product line launch.

"....Additionally, our nanomaterials are now being used in personal care products such as foot powder and skin care products. We are targeting additional applications in the personal care market working with several companies that are in various stages of the business development cycle. We are not at liberty to discuss specific applications."

Und dann passt auch das noch ganz gut :


Clodagh O`Brien, winner in the Science Writer competition last year, reports on the latest advances in UV protective clothing


How about being able to wear sunscreen without getting your hands sticky?

The messy business of slapping on factor 15 may soon be over, thanks to a new range of sporting and leisure clothing. The chemical giant BASF has made prototypes of swimsuits and bikinis that protect you while you play on the beach.

In a world where the ozone layer is thinning and UV exposure is rising, this new fabric may be a godsend.

BASF scientists have produced a polymer containing titanium dioxide particles that offers UV protection. This can be integrated into fabric to produce solar resistant trousers and shirts. Outdoor clothing companies such as North Face are making this fabric for hikers and trekkers.

The raw material of this fibre is one type of polymer, polyamide (nylon)-6, known by its brand name Ultramid. This polymer has the advantage that whether wet or dry the solar barrier still remains.

The polymer contains a granular nano-material, titanium dioxide, a whitener found in toothpaste and paint that absorbs and reflects solar radiation.

The secret lies not in the material but in its manufacture: to make particles measuring a few hundred nanometres and distribute them evenly within the polymer.

The crimping of the polymer thread means the fabric looks and feels like cotton with the ability to dry quickly, be light, resistant to abrasion and tear proof while providing first-class UV protection.

Enter the realm of nano super material.

This clothing - ranging from hats and trousers to jackets - has the added advantage of being a specific factor. Children or those with a sensitive complexion can stock up on a wardrobe for all occasions - factor 80 for the beach and 15 for a spring day.

According to Volker Rauschenberger, head of development projects Asia at BASF, the biggest demand for the fabric will be in water sports, such as diving and snorkelling.

"Many fabrics lose their UV protection when wet, especially cotton, which has given many unsuspecting snorkellers in a white cotton T-shirt a painful surprise."

Rauschenberger claims there are no limitations to what type of clothes you can make with a variety of colours and patterns. "Although you could make underwear using this material not many people will do so as the market for UV protective underwear is somewhat limited.`

Bikinis are more like it, although Rauchschenberger draws the line at Day-Glo leopard skin polyamide patterns for aesthetic reasons. "You can have a variety of colours and patterns but the fashion trends for outdoor use run to inconspicuous colours rather than brilliant ones.`


Clodagh O`Brien won the older category of the Daily Telegraph

cu

[MRASTA]

geht auch einfacher, der Conferenz Call befindet sich auch als Textdatei auf der Webseite der Phases.

http://www.nanophase.com/conferencecall_transcripts_2nd_quar…

cu

[MRASTA]

Nanophase Technologies Announces Commercial Availability of Nanocrystalline Bismuth Oxide

Thursday , August 28, 2003 10:39 ET

ROMEOVILLE, Ill., Aug 28, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, today announced commercial availability of bismuth oxide nanomaterials. The new bismuth oxide product is produced using NanoArc(TM) Synthesis technology, the Company`s most advanced nanomaterials manufacturing process. Bismuth oxide is incorporated into specialty polymers and materials for bone implants, dental prosthetic devices, catheters, sutures and surgical instruments to make them detectable by X-rays without the toxicity or carcinogenicity associated with other heavy metals. When incorporated into other plastics, benefits such as X-ray detection of toys and objects swallowed by children, or X-ray detection of plastic firearms at airport security stations, can be achieved.

Dr. Ed Ludwig, Nanophase`s Vice President of Business Development, stated, "We are very excited about our capability to commercially produce and supply high quality bismuth oxide nanoparticles. This marks Nanophase`s entree into the medical appliance industry and is another example of the use of nanotechnology to provide technology solutions in important applications in mainstay industries. Bismuth oxide has been used extensively for years in the medical appliance industry to impart X-ray opacity. As parts become smaller and thinner, it is difficult to incorporate bismuth oxide to achieve X-ray opacity without deteriorating the physical properties of the plastic or composite part. Because nanoparticles are so small, they can be incorporated at levels that provide the needed X-ray opacity without significantly effecting rheology, physical properties or surface characteristics."

Other applications for bismuth oxide include ceramic additives for varistors that are used for electrical surge protectors, additives to reduce processing temperatures for high-temperature ceramics that are used in gas and fluid detectors to improve automotive fuel efficiency and reduce smog, additives into optical glass formulations to increase refractive index and specific gravity, and as an additive in a variety of medical creams and ointments.

Nanophase`s bismuth oxide consists of non-porous, dense, discrete, homogeneous crystals that are commercially produced at the company`s facility in Romeoville, Illinois. Nanophase has annual commercial production capability for bismuth oxide and other nanomaterials in the metric tons range and offers these nanostructured materials as nanopowders and as dispersions using its patent pending dispersion technologies. All of Nanophase`s nanoengineered products are manufactured under the Company`s cGMP and ISO-9001: 2000 quality system.

For additional information, contact Dr. Ed Ludwig, Nanophase`s Vice President of Business Development at 630-771-6729, or email [e-mail] , or Ian Roberts, Vice President U.S. and International Sales, at 630-771-6730, or email [e-mail] .

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 22 United States patents and patent applications, consisting of 8 owned United States patents, 8 owned United States patent applications, and 6 licensed United States patents. The Company also has 24 foreign patents and patent applications, consisting of 9 owned foreign patents and 15 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

This press release contains words such as "expects", "anticipates", "plans", "forecasts" and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company`s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties. It is possible that the Company`s future performance may differ materially from current expectations expressed in these forward-looking statements due to a variety of important factors such as: a customer`s decision to defer, cancel or otherwise modify a purchase order or supply agreement; demand for, and acceptance of, the Company`s nanocrystalline materials; changes in our development, supply and distribution relationships; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost effective basis; the Company`s mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental regulations; disruption of commercial activities and threats associated with terrorism and efforts to combat it; protection and validity of patent and other intellectual property rights; the cyclical nature of the Company`s business; the outcome of pending and future litigation and governmental proceedings; and other risks described in the Company`s filings with the Securities and Exchange Commission. In addition, the Company`s forward-looking statements could be affected by general industry and market conditions and growth rates. The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

SOURCE Nanophase Technologies Corporation

[MRASTA]

man kann es auch übertreiben, die Meldung der Phases war ja ganz ok., für die Zukunft, aber erstmal muss ein Geschäft her für den Bereich. Bismut Oxide produzieren ja auch noch andere, allerdings kenne ich im Moment keinen, der dieses auf Nanobasis in den Mengen macht. Muss ich mich noch mal schlau machen. Aber bitte, wenn die Ami´s es so wollen, auch recht.


Nochmal kurz zu Altair. Wollte nochmal daran erinnern.

RENO, NV ? July 30, 2003 ? Altair Nanotechnologies Inc. (NASDAQ:ALTI), announced today that Dr. Dirk Verhulst, Engineering Manager of the company?s Nanomaterials subsidiary will present a Scientific Paper entitled , "NEW DEVELOPMENTS IN THE ALTAIR HYDROCHLORIDE TIO2 PIGMENT PROCESS" at the International Symposium of Hydrometallurgy to be held August 24 - 27, 2003 in Vancouver, Canada.

Und dann kommt auch noch dass :


ALTAIR NANOTECHNOLOGIES TO PRESENT AT THE WALL STREET ANALYST FORUM CONFERENCE IN NEW YORK

Reno, NV ? August 26, 2003 ? Altair Nanotechnologies Inc. (NASDAQ:ALTI) announced that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at The Wall Street analyst Forum?s pharmaceutical conference in New York on September 16, 2003. Dr. Moerck will provide an overview of Altair Nanotechnologies and an in-depth discussion of the company?s patent-pending pharmaceutical candidate, RenaZorb?, and its new nano-based drug delivery system.

RenaZorb is a new non-calcium pharmaceutical for removal of phosphate from patients with end-stage renal disease that are undergoing kidney dialysis. RenaZorb removed phosphate in laboratory tests using simulated stomach fluid and has also demonstrated phosphate binding in three animal models. The phosphate capacity and rapid rate of reaction is excellent for this class of drug. New testing of RenaZorb in animals with end stage renal disease will be reported.

A study of Altair?s nanomaterials and patented porous nano-structures for drug delivery systems and pharmaceutical sustained release pplications is underway. The study is for both existing pharmaceuticals and for new active harmaceutical ingredients. Altair?s delivery system has the potential of extending the patent life of existing drugs which could preserve important revenue streams for pharmaceutical companies.

The conference is being held at the Roosevelt Hotel located on Madison Avenue at 45th Street, second floor. Dr. Moerck will be presenting at 9:40 AM on Tuesday, September 16. For information or to RSVP, please call 802.253.7596

ALTAIR NANOTECHNOLOGIES INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair?s nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the ?safe harbor? provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company?s actual and future results to be materially different than suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the successful testing, FDA approval and commercialization of RenaZorb, the company may be unable to attract or form relationships with pharmaceutical companies, or have the funds necessary to development additional products or create product opportunities within the pharmaceutical industry, in addition to other risks identified in the company?s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Man beachte die Studien, die anscheinend vorgestellt werden sollen, da bin ich mal gespannt.

cu

[MRASTA]

[MRASTA]

+53% in der Spitze heute, d.h. 5.85 $.???????

Es wurde alles gekauft, was unter 5.80 zu haben war. Irgendwann wird der doch mal fertig sein. Dann dürften sich die Gemüter wohl wieder etwas abkühlen.

Aber wer weiß es schon so genau.

Gruß
mrasta

[Falke28]

Hallo MRASTA,

ich glaube diese Nachricht war aber doch ein wenig besser als "OK". Du hast schon recht, erst mal muß das Geschäft natürlich laufen, aber für die Phantasie war diese Nachricht nicht schlecht... . Ich denke folgende Absätze waren die wichtigsten:

Other applications for bismuth oxide include ceramic additives for varistors that are used for electrical surge protectors, additives to reduce processing temperatures for high-temperature ceramics that are used in gas and fluid detectors to improve automotive fuel efficiency and reduce smog, additives into optical glass formulations to increase refractive index and specific gravity, and as an additive in a variety of medical creams and ointments.

The new bismuth oxide product is produced using NanoArc(TM) Synthesis technology, the Company`s most advanced nanomaterials manufacturing process.

Sehr gut scheint der patentierte Herstellungsprozess für Nanopartikel zu sein. Hier könnte in Zukunft noch viel passieren...Wenn z.B. die Brennstoffeffizienz bei Verbrennungsmotoren gefördert werden kann, könnte diese Eigenschaft den Partikeln sehr schnell zu mehr Geschäft verhelfen.
Das Geschäft scheint sich hier gut zu entwickeln! Allerdings ist die Bewertung auch schon nicht von schlechten Eltern... Mal sehen, wie sich die Entwicklung fortsetzt. Kommen hier ernsthafte Aufträge rein, so glaube ich, ist die Firma finanziell erst mal durch.

Mal sehen, es bleibt spannend...

Gruß
Falke28

[MRASTA]

@Falke

jep, aber die Story ist nicht mehr so ganz neu. Aber wie man sieht, im Nanobereich eben doch was anderes.

Was Nanophase von allen anderen unterscheidet, habe ich schonmal erwähnt, ist die nicht zu unterschätzende ISO Zertifizierung. Nur mit einem gleichbleibenden Standard kann man in dem Markt erfolgreich sein. Dieses vor allem eben in Hinsicht auf die Güte und Qualität der Produktion der Partikel. Aber verkaufen müssen Sie auch mal was.

Altair hat sich auch wieder gefangen. Hoffe mal, dass Sie mit Ihrem AHPP wirklich so gut sind wie Sie behaupten. Wird auch mal Zeit, dass Sie was auf die Beine stellen.

Wird bestimmt noch einiges an Turbulenzen geben, somit bleibt es spannend die nächsten Monate.


Ich möchte an dieser Stelle auch mal allen anderen Danken, für die Vorstellungen von Flamel, Tegal und wie Sie alle heißen. Ist ja noch eine kleine Gemeinde, die sich um den Nonosektor kümmert, werden aber immer mehr. Potential haben sicherlich einige und in letzter Zeit kommen ja immer mehr dazu.

Also, weiter so,

Viel Spaß
mrasta

[MRASTA]

Rudi gibt mal wieder einen Überblick. Wenn auch nur eines der Projekte mal den Durchbruch schafft. ;-)))))





Altair Nanotechnologies` President Provides Shareholder Update

Wednesday, September 03, 2003 10:30 ET

RENO, Nev., Sep 03, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) is, in its commitment to keep shareholders and members of the financial community current on Altair`s activities, providing a project update.

Pharmaceuticals

Altair President, Dr. Rudi E. Moerck will be presenting to members of the financial community at the Wall Street Analyst Forum`s pharmaceutical conference in New York on September 16, 2003. He will be discussing RenaZorb(tm), the company`s drug candidate for phosphate control in kidney dialysis patients.

Results from animal testing of RenaZorb by two third-party pharmaceutical companies confirm Altair`s in vitro test results pertaining to the effectiveness of RenaZorb as a viable drug candidate for phosphate control in kidney dialysis patients with end-stage renal disease (ESRD). As new inquiries and interest regarding RenaZorb continues, Altair has retained RBC Capital Markets to assist the company with a comprehensive evaluation of strategic alternatives pertaining to RenaZorb.

Altair estimates that there are over one million patients worldwide with ESRD that could benefit from phosphate control therapy. The test results in dogs and rats have provided data that enabled Altair to make adjustments in RenaZorb`s composition and formulation that should further enhance its phosphate binding efficacy and performance.

Test data indicates that RenaZorb has advantages when compared to existing or proposed drugs for phosphate control. These advantages include lower dosage, no acid burden, higher selectivity for phosphate and ultimately, lower patient cost. RenaZorb is anticipated to generate revenues for the company in 2003.

Management expects to report the results of a new testing program pertaining to the use of RenaZorb in animals with end-stage renal disease.

TIMET

The agreement with Titanium Metals Corporation (TIMET) announced August 13, 2003 represents an opportunity for Altair to join with one of the world`s leading titanium metal manufacturers in developing a new, lower cost technology manufacturing titanium metal. The new technology is based on the "FCC Cambridge" process developed by UK-based Cambridge University. This is a "ground floor" position for Altair in a potentially rapidly expanding business sector.

Titanium metals have distinct quality and strength advantages over iron-based products but have been restricted in wide usage due to price. Titanium metals normally are used when superior characteristics of hardness, heat and chemical resistance are required - such as aerospace applications. According to the London Financial Times, the current production of titanium approximates 50,000 tons per year compared to 900 million tons of steel. While no one knows the price-quantity demand curve, AMPTIAC Quarterly, a Department of Defense-sponsored publication, estimates that titanium is produced at only five percent of its current potential world volume.

Altair`s participation in this project is a natural extension of our titanium dioxide processing technology. Key intermediates in the Altair process for making pigment and nano-sized TiO2 allow the manufacture of porous electrodes that may be highly suitable for the FCC Cambridge process. Altair`s TiO2 intellectual property forms the basis for its project contributions; additions to the company`s intellectual property portfolio may also be expected. In the near term Altair is seeking development contracts to offset cost, the first development contract will be announced shortly. Ultimately we expect the value to Altair to be realized through licensing agreements and development contracts in both the private and government sectors.

Altair Hydrochloride Pigment Process (AHPP)

Several reputable third party assessments of Altair`s AHPP process have shown cost and environmental advantages over existing processes. However, unlike the opportunity to develop a new titanium metal process, for which there is considerable "pull demand" from both the titanium metals industry and government agencies such as the DOD, the huge established capital and manufacturing base of existing titanium dioxide producers has stifled the entry of new technologies for making titanium dioxide pigment.

Asia Pacific Materials Company

The work under Phase l of the agreement with a materials company in the Asia Pacific region has successfully produced phase pure rutile titanium dioxide entirely from ilmenite concentrates. This is significant to the titanium dioxide industry since AHPP takes inexpensive feedstock and economically produces phase pure titanium dioxide pigment reducing the operating cost by roughly $150 -- $200 per metric ton when compared to the chloride process. These savings are approximate and realized in the bottom line cost of pigment production. Phase l of the agreement was successful and results are being evaluated. Phase II development proposal has been submitted for funding.

Flowco

Altair entered into an agreement with Flowco International to exclusively represent the company in the People`s Republic of China (PRC). Under the terms of the agreement Flowco will market AHPP licenses to companies in the PRC. The PRC has large reserves of low-grade titanium ore, low labor costs and an increasing consumer demand for TiO2 pigment. According to Flowco, PRC`s government will not allow new pigment production facilities to be constructed using the existing sulfate processing technology due to its well-known environmental issues.

Flowco President Mu Fa Chen recently returned from PRC after successful meetings with several companies. One of these companies has already shipped samples of their ilmenite ore for testing with Altair`s AHPP process. Altair management believes its environmentally friendly process, which can produce pure phase titanium dioxide pigment from low-grade ilmenite ore, could allow the PRC to rapidly develop a substantial pigment industry. There is significant potential for granting AHPP licenses to companies in third world markets.

Vietnam

Commencement of work under the second titanium dioxide pigment development agreement announced by Altair based on an ore body located in Vietnam is waiting for funding. Management expected funding in early summer but the funding agency budget has not yet been approved to move forward with the project.

United States Government Research Funds

Following a review of project priorities, management is more aggressively seeking revenues from Department of Energy and the Department of Defense. To assist, Altair has engaged DykemaGossett, PLLC, a Michigan and Washington, D.C., -based law firm. The firm was instrumental in obtaining a grant of approximately $1 million for Altair and WMU. In addition, Altair management recently met with the National Institute of Health representatives regarding use of transition metals such as lanthanum in medical research. Contacts with potential collaborators are being made now. Altair`s RenaZorb drug candidate is a lanthanum based pharmaceutical.

Western Michigan University ("WMU")

The teaming/research agreement with WMU is moving forward. The Department of Energy (DOE) issued the awards letter and terms August 15, 2003. Work between Altair and WMU is underway as defined by the terms of the agreement. The groups are currently working on the "lab-on-a-chip" elements which will comprise the technology being developed for detecting chemical and biological weapons, a homeland security program. WMU and Altair will continue to pursue a three-to-five-year Federal grant with Altair worth $1 million each year for continued development for a number of related projects.

Hydrogen Solar

Altair recently signed a teaming agreement with UK-based Hydrogen Solar under which the two companies would form a new, equally owned, Nevada-based company to collaborate in the development and commercialization of a solar hydrogen generator using the Tandem Cell(tm) technology which generates hydrogen via water splitting. A Tandem cell is comprised of two sandwiched cells; the transparent front cell captures the blue/violet range of visible light and allows the green/red range of visible light to pass through to the second cell. The second cell utilizes a surface of dye-sensitized nanocrystalline titanium dioxide.

A program to fund a joint project for hydrogen production research demonstration with the University of Nevada, Reno and UK-based Hydrogen Solar using Hydrogen Solar`s proprietary technology and Altair`s nanocrystalline titanium dioxide has been developed.

Hydrogen Solar recently formed their US-based company in Nevada. Under the teaming agreement, the next step is the joint formation of a new Nevada company equally owned by both Hydrogen Solar and Altair Nanotechnologies.

Rutgers Energy Storage Research Group (formerly Telcordia(tm) Technologies)

Rutgers has developed battery prototypes utilizing Altair`s nano-sized lithium titanate spinel.

According to a recent Rutgers` research paper published in The Journal of Power Sources, the prototype battery characteristics significantly exceeded Department of Energy standards.

The prototype battery, a nonaqueous asymmetric hybrid incorporating the advantages of both Li-ion batters and super capacitors, stored energy of 11wh/kg with delivery of 800 W/kg at 95 percent efficiency. The cycle life ranged between 10,000 and 100,000 cycles. No other battery materials tested by Rutgers met and/or exceeded the DOE standards. Altair is in discussions with Rutgers and has provided the group with additional nanomaterial samples.

Other Projects

Several other projects are active and are being developed on an "as time permits basis". Such prioritization allows Altair to focus efforts on those projects with the highest likelihood for significant near-term revenue realization.

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the short run, and that animal testing or future testing on RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

SOURCE: Altair Nanotechnologies Inc.

[MRASTA]

Man, oh man, Rudi läßt aber auch wirklich nichts unversucht. Zumindest dürfte der Bekanntheitsgrad von Altair in diesem Monat um einiges größer geworden sein.


Altair Nanotechnologies President to Speak at the Societe de Chimie Industrielle

Friday , September 05, 2003 09:02 ET

RENO, N.V., Sep 05, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced that its President, Dr. Rudi E. Moerck, will be speaking at the September 18 luncheon meeting of the American Section of the Societe de Chimie Industrielle. Dr. Moerck will be discussing "Nanotechnology in Chemicals, Pharmaceuticals and Drug Delivery Systems - Overview and Business Outlook."

"An invitation to speak before members and guests of the Societe de Chimie Industrielle is an honor," said Dr. Moerck. "Their sponsorship of a leading monthly speaker program with prominent government leaders, scientists and CEOs from companies such as Sumitomo Chemical, Cabot Corporation and Degussa, provides a platform for the sharing of views on important industry events that encourage the utilization of new scientific and engineering developments by a variety of industries worldwide."

"We know the science of nanotechnology will have a significant impact on industry," continued Dr. Moerck. "Nanotechnology provides the capability of altering component materials which will significantly impact the design and performance of products within the pharmaceutical industry, the production and storage of energy via fuel cell and hybrid batteries, telecommunications equipment and computers, and biotechnology and chemicals. With our partners and our intellectual properties, we believe Altair is positioned to take a leadership role in this emerging technology sector."

The luncheon is being held September 18, 2003, at the Yale Club, located on 50 Vanderbilt Avenue between East 44th and 45th Streets in New York City. The reception will begin at 11:30 a.m. with a lunch being served at 12:15 p.m. Dr. Moerck will be speaking at 1:00 p.m. For information or to RSVP, please call the Societe de Chimie Industrielle at 212.725.9539.

The Societe de Chimie Industrielle

The American Section of the Societe was founded in 1918 through the efforts of an American chemist, Jerome Alexander, and the Section`s first president, Leo H. Baekeland. Similar to the French organization, the original mission of the Societe was to aid and encourage the utilization of scientific and engineering developments by the industry and promotion of chemistry in public opinion, especially among the young and those within the education system. Today, the American Section is involved in a number of non-profit activities, including speaker programs, granting fellowships and scholarships to students pursuing the study of chemistry, and honoring individuals who have significantly contributed to the industry.

[MRASTA]

Aha, es kommt Leben in die Bude. Rudi´s Touren scheinen langsam zu fruchten.

Taglich Brothers Inc initiates coverage of Altair Nanotechnologies Inc (NasdaqSC: ALTI) with no rating.


So, so die Taglich Brüder ;-) nehmen sich Altair an. Interessant, interessant. Ein guter Überblick für alle, die mal eine Zusammenfassung lesen wollen.

Allerdings geben Sie noch kein offizielles Rating ab, obwohl, wer den Report bis auf Seite 11 verfolgt, dort in dem Diagramm eine 79% Buy Option zu erkennen ist. Ist Ihnen wohl noch zu heiß die Geschichte, um das intere Rating auch nach außen zu tragen. Ist ja auch logo, noch ist nichts in trockenen Tüchern.


http://www.taglichbrothers.com/equityuniverse/companies/alta…

Gruß
mrasta

[MRASTA]

Irgendjemand einen Plan was bei den Phases heute abgeht ? Könnte nach einer neuen Meldung riechen, ich sehe aber noch keine ?

Mal sehen.

cu

[MRASTA]

Wie denn, Altair auch am klettern ?

Ist ja beängstigend ;-))

Könnte vielleicht an der offiziellen Mitteilung des Rankings der Taglich Brother liegen, die Gestern erst so richtig Publik gemacht wurde.

Hoffentlich diemal nicht nur ein Strohfeuer oder ein MM Joke.



Aber was ist mit den Phases, kauft da nur so einer ein, zu den Kursen ? Kann ich nicht glauben.

cu

[MRASTA]

Bei Altair scheint es sich ja wieder zu beruhigen.

Aber bei den Phases blicke ich nicht mehr durch. Das ASK im Second Level ist teilweise wie leergekauft. Jetzt wird schon bei 6,45 $ geboten und rund 150.000 Teile sind bis dato gehandelt, dass ist für die Phases schon eine stattliche Anzahl.

????????????

cu

[TSIACOM]

@MRASTA
da sollte doch nicht etwa der morgige "World Nano-Economic Congress" in Washington D.C. dahinterstecken, bei dem auch CEO Joseph Cross ans Rednerpult tritt...?

[MRASTA]

@TSICAOM

wer weiß, wer weiß. Über 200.000 Teile sind aber schon ganz beachtlich für die Phases. Beruhigt sich aber auch schon wieder. Der Unterbau im Bid war zumindest die ganze Zeit recht dünn, so dass hier wohl nur einer ordentlich eingekauft hat.

Altair hält sich auch ganz wacker. Und die Bid und ASK Seiten sind schon seit Tagen ordentlich gefüllt. Hier fehlt jetzt nur noch der, der die Lunte anzündet.

Siehste ja auch bei Tiny heute, der Zug kommt ins rollen.

Denke mal, wir werden noch viel Spaß an den verschiedenen Werten haben. Mit dem einen mehr bei den anderen weniger.

cu

[TSIACOM]

400.000 Stk in den Staaten gehandelt (8facher Durchschnitt) und den Marktwert auf 100 Millionen USD getrieben. Ein klein wenig viel für NANX. Oder weiß da jemand mehr...

[MRASTA]

so kann es gehen.

Nanophase hat locker eine neues 52W High erreicht. Um und bei 7.30 $ wär hätte das gedacht. ;-)))

Was so ein privates Invest doch alles bringt.

8-K: NANX Files Sep-09 PR Regarding Completion of Pvt Plcmt

http://knobias.tenkwizard.com/filing.php?repo=tenk&ipage=233…



Altair um 1.30 $ kann man auch nicht nörgeln. Obwohl doch zwei Trusts Teile verkaufen wollen.

http://knobias.10kwizard.com/filing.php?repo=tenk&ipage=2332…

Tiny schießt auch durch die Decke.

Ziemlich grüne Angelegenheit. Ist mal wieder an der Zeit ein wenig Vorsicht walten zu lassen.

Gruß
mrasta

[MRASTA]

100 Beiträge sind geschafft, da paßt die Meldung doch ganz gut.

Altair Nanotechnologies Pays Off All Convertible Debt; With $588,000 payment to Doral 18, LLC, Altair regains all pledged assets

Monday , September 15, 2003 10:15 ET
RENO, Nev., Sep 15, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has repaid Doral 18, LLC, the remaining $588,000 in convertible debt. Pursuant to the terms of governing security agreements, Doral is required to release all of Altair`s pledged assets, which include titanium mineral leases and patents for pigment and nanomaterials.

With this transaction, Altair is debt free except for a promissory note to purchase the building that houses its Reno production facilities from BHP Minerals International, Inc. Under that agreement, interest begins accruing in August 2005 with the first payment due in February 2006.

Altair`s Chief Financial Officer Ed Dickinson said the company paid off the debt with funds received from the exercise of warrants. "We have sufficient resources to fund operations through the end of 2003," he said. "With our stock advancing, we anticipate warrant exercises that could provide adequate financing through 2004." Mr. Dickinson added, "We also expect income through additional government funding, increased product sales and product development contracts."

"With the exception of the building agreement, this marks the first time the company has been debt free since purchasing its pigment and nanomaterials technology from BHP Minerals four years ago," said Dr. William Long, Altair`s Chairman and Chief Executive Officer. "With no more convertible debt, we expect to emerge as a technological leader not only in nanotechnology and nanomaterials but also in titanium dioxide pigment." Dr. Long credits the company`s employees, shareholders, technology platform and economical production process for Altair`s survival through a challenging economic environment for technology companies.

[MRASTA]

ganz schön heiße Luft im Moment.

Leider nur für Mitglieder, somit keinen blassen Schimmer was Sie über Nanophase dort geschrieben haben, schade auch.

MEDIA: Today`s Wall Street Journal Mentions NANX
Wednesday, September 17, 2003 06:38 ET

The following article appears in today`s Wall Street Journal(tm) discussing Nanophase Technologies Corporation:

"Insider Trading Spotlight"



Und Forbes beschäftigt sich gleich mit allen Beiden. Aber auch mit kritischen Anmerkungen, die sollte man nie vergessen.


http://www.forbes.com/2003/09/16/cz_jw_0916soapbox.html

Zumindest eine feine PR für beide. Wobei das bei den Phases heute, zeitweilig wohl ein wenig übertrieben wurde.

Bin wirklich froh, das Altair endlich den Doral Sumpf verlassen hat. Diese Toxic Fianzierungen sind echt ein grauen. Teile für Lau haben die ja mehr als genug eingesammelt. Muss man auch ein Auge darauf haben, was Sie jetzt vorhaben, wenn Sie was vorhaben.

Frohes Gambling weiterhin

Gruß
mrasta

[MRASTA]

auch das noch :

Altair`s Nano-Sized Zirconium Oxide now Available for Dental Applications

Wednesday, September 17, 2003 13:50 ET
RENO, Nev., Sep 17, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced that commercial nano-sized zirconium oxide is available for dental applications including fillings and prosthetic devices.

Altair`s president, Dr. Rudi E. Moerck, said, "Nano-sized zirconium oxide is ideal for dental applications because of its strength and transparency to light, but it is opaque to x-rays, making it an excellent material for UV-cured dental fillings."

ALTAIR NANOTECHNOLOGIES INC.

cu

[MRASTA]

Und die Phases legen gleich mal eine Schippe nach :

Nanophase Technologies Announces Commercial Availability of Nanocrystalline Copper Oxide

Thursday , September 18, 2003 12:25 ET
ROMEOVILLE, Ill., Sep 18, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered product solutions, announces commercial availability of copper oxide nanomaterials. The new copper oxide is produced using NanoArc(TM) Synthesis technology, the Company`s most advanced nanomaterials manufacturing process, and is available in mean particle size ranges from 20-50 nanometers, either as nanoparticles or nanoparticle dispersions.

Nanosized copper oxide has a variety of uses as an industrial antimicrobial and antifungal agent that remains active for very long periods of time, even in harsh environments, and can be readily incorporated into specialty polymers and materials to impart extended antimicrobial character. Key applications that are envisioned for the new product include wood preservation, marine antifouling coatings, incorporation into various plastics and fibers and use as an additive in a variety of coatings formulations. Other applications for copper oxide include optical glass polishing agents, additives for ceramics processing and colorants and pigments for various materials

Dr. Ed Ludwig, Nanophase`s Vice President of Business Development, stated, "We have again been able to demonstrate the versatility of our NanoArc(R) Synthesis technology commercially, and are very excited about our capability to commercially produce and supply copper oxide nanoparticles. In parallel, Nanophase continues to produce zinc oxide doped with copper, silver and other metal oxides via our Physical Vapor Synthesis technology for personal care and antimicrobial applications. The introduction of copper oxide is another example of the use of nanotechnology to provide solutions in important applications in mainstay industries. Nanoparticles can be imbedded in materials or contained in formulations to impart permanent bacteriastat properties with little effect on physical properties."

"We have had several requests for nanocrystalline copper oxide for specific applications with potential customers," stated Joseph Cross, Nanophase`s president and CEO. "We have been co-developing applications in at least two distinct markets for some time and it is now prudent to commercialize the process under the Company`s ISO criteria. We are optimistic on market opportunities for this material."

Nanophase`s copper oxide consists of non-porous, dense, discrete, homogeneous crystals that are commercially produced at the company`s facility in Romeoville, Illinois. Nanophase has annual commercial production capability for copper oxide and other nanomaterials in the metric tons range and offers these nanostructured materials as nanopowders and as standard and customized dispersions using its patent pending dispersion technologies. All of Nanophase`s nanoengineered products are manufactured under the Company`s cGMP and ISO-9001: 2000 quality system.

[MRASTA]

eigentlich ist es immer das gleiche Spiel, kann man fast die Uhr nachstellen.

Altair hat sein Pulver erstmal verschossen. Der Verkaufsdruck hat zugenommen, siehe auch #101.

Die 1.20 $ scheinen im Moment noch zu halten, muss man wirklich scharf beobachten.


Die Phases sind eine Liga aufgestiegen und kämpfen mit der 7.00 $ Marke.




Nanophase Technologies Named One of Chicagoland`s Fastest Growing Technology Companies in Deloitte & Touche Technology Fast 50 Program

Wednesday, September 24, 2003 13:58 ET
ROMEOVILLE, Ill., Sep 24, 2003 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, has been named to Deloitte & Touche`s prestigious Technology Fast 50 Program for Chicagoland, a ranking of the 50 fastest growing technology companies in the area by Deloitte and Touche LLP, one of the nation`s leading professional services firms. Rankings are based on the percentage of growth in fiscal revenues over five years, from 1998-2002.

"We are pleased to be recognized by Deloitte and Touche as a technology leader," stated Joseph Cross, Nanophase`s President and CEO. "Nanophase continues to extend and increase its leading nanomaterial technologies and commercial capability towards new markets and opportunities. Despite a difficult economic environment over the last few years, the Company has grown revenues approximately 315% from 1998-2002 ranking Nanophase 14 overall in the Fast 50 for Chicagoland. With the increasing interest and attention to the potential for nanomaterials across a variety of industries and applications, we are optimistic for continued revenue growth over the next five years."

"The Deloitte & Touche Chicagoland Technology Fast 50 companies have shown the strength, vision, and temerity to succeed despite a very challenging technology environment," stated Gerald P. Sullivan, Managing Partner of Deloitte & Touche`s Chicagoland Fast 50. "To succeed during prosperous times is one thing; to succeed in adversity is much more challenging, and that is exactly what the Deloitte & Touche Technology Fast 50 winners have done. We applaud Nanophase Technologies for its tremendous accomplishments and for being one of the elite Fast 50 in Chicagoland."

Winners of the 20 regional Technology Fast 50 programs in the United States and Canada are automatically entered in the Deloitte & Touche Technology Fast 500 program, which ranks North America`s top 500 fastest growing technology companies.

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 22 United States patents and patent applications, consisting of 8 owned United States patents, 8 owned United States patent applications, and 6 licensed United States patents. The Company also has 24 foreign patents and patent applications, consisting of 9 owned foreign patents and 15 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

Deloitte & Touche, one of the nation`s leading professional service firms, provides assurance and advisory, tax, and management consulting services through 30,000 people in more than 80 U.S. cities. Known as an employer of choice for innovative human resources programs, Deloitte & Touche has been recognized as one of the "100 Best Companies to Work For in America" by Fortune Magazine for six consecutive years. For more information, visit Deloitte & Touche`s Web site at www.deloitte.com/us .

This press release contains words such as "expects", "anticipates", "plans", "forecasts" and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company`s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties. It is possible that the Company`s future performance may differ materially from current expectations expressed in these forward-looking statements due to a variety of important factors such as: a customer`s decision to defer, cancel or otherwise modify a purchase order or supply agreement; demand for, and acceptance of, the Company`s nanocrystalline materials; changes in our development, supply and distribution relationships; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost effective basis; the Company`s mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental regulations; disruption of commercial activities and threats associated with terrorism and efforts to combat it; protection and validity of patent and other intellectual property rights; the cyclical nature of the Company`s business; the outcome of pending and future litigation and governmental proceedings; and other risks described in the Company`s filings with the Securities and Exchange Commission. In addition, the Company`s forward-looking statements could be affected by general industry and market conditions and growth rates. The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

SOURCE Nanophase Technologies Corporation


mrasta

[Wunram]

mal wieder ein bisschen PR

Altair Nanotechnologies Scientist Invited to Present at the 204th Electrochemical Society Meeting

7 October 2003, 09:45am ET

RENO, Nev., Oct. 7, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that Jan Prochazka, Altair`s Senior Research Scientist, will be presenting at the Electrochemical Society Meeting in Orlando, Florida, October 12 - 16, 2003.

Prochazka will present a poster titled "Manufacturing of Nano-sized Ceramic Materials Using `Altair Thin Film` Industrial Process" on October 14, 2003, in Symposium A2, Nano Structured Materials. Prochazka`s poster focuses on the flexibility of Altair`s proprietary process to produce a variety of materials that exhibit a range of unique properties.

The presentation describes the industrial scale-up of nano-materials manufacturing capabilities and demonstrates the flexibility of the Altair proprietary thin film technology, the control of chemical composition, doping, crystal phase purity, particle size, morphology, sintering and other properties of nano products made by Altair`s novel process.

The fundamental principles of `nano-scale` diffusion, sintering properties and impact of morphology of nanoparticles will be demonstrated in practical examples of Altair`s nanotechnology used in commercial applications. These applications include lithium ion electrode grade battery materials, thermal coatings, solid oxide fuel cells and photocatalytic activity of Altair`s nano-based products.

Dr. Dirk Verhulst, Engineering Manager of Altair`s nanomaterials subsidiary, has recently presented two significant papers. In September, Dr. Verhulst presented a paper titled "A New Process for the Production of Nano-Sized TiO2 and Other Ceramic Compounds in Thin Film" at the 2003 International Conference on Nanotechnology and Powder Metallurgy in Providence, Rhode Island. This paper describes Altair`s novel nanomaterials technology, which separates Altair from other nanomaterials manufacturers. The paper highlighted the ability of Altair`s proprietary process to control chemical composition, morphology, particle size, and particle size distribution.

Mentioned Last Change
ALTI 1.22 0.03dollars or (2.52%)
In August, Dr. Verhulst presented a paper titled "New Developments in the Altair Hydrochloride TiO2 Pigment Process" at the 2003 International Symposium on Hydrometallurgy, organized by The Metallurgical Society (TMS), the Canadian Institute of Mining and Metallurgy (CIMM) and the Society for Mining, Metallurgy and Exploration (SME). Dr. Verhulst described recent advances in understanding the behavior of impurities in the Altair Hydrochloride Pigment Process (AHPP) and in pigmentary particle size TiO2 rutile formation. These key technology discoveries strengthen the environmental and low-cost advantages of the AHPP over existing chloride and sulfate processes.

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, that the company may not be able to obtain the capital to fund its operations in 2004 or otherwise, and that because of the lack of funding or other reasons, the company may be unable to fully exploit its technologies in a manner that they begin generating significant revenue.

Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511

CONTACT: McCloud Communications LLC
Marty Tullio
[phone]
[e-mail]


Altair Nanotechnologies, Inc.
Tracy LaFollette
[phone]
[e-mail]

[MRASTA]

tja, so langsam könnte mal einer ein Stückchen der Lunte bei Altair anbrennen. Mal stehen Sie kurz vor der Pleite, auf der anderen Seite kann wohl kaum noch einer an dem Know How vorbei.

Geht einem manchmal schon ganz schön auf die Nerven.

Nur eine der Entwicklungen, würde ja erstmal reichen.

cu

[MRASTA]

ziemlich dürftig bei Altair, der Schwung scheint raus zu sein. Schade auch.

Also, bitte aufpassen !!!!!

Die Phases wandern hingegen lustig weiter. Aber auch hier vorsicht, die Zahlen sollen am 22.10. kommen. Haben schon oft erlebt, dass man zuviel erwartet hat und danach ist das Teil wieder abgeschmiert. Mal sehen.

cu

[Wunram]

extra für die Kanadier

Altair Nanotechnologies Inc. Re-Files Interim Financial Statements WithCanadian Securities Regulatory Authorities

RENO, NV, Oct. 24, 2003 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies Inc. (NASDAQ: ALTI) announced today that as a company that is a reporting issuer in certain provinces of Canada, it has been asked to re-file its interim financial statements to include quarterly information in its Statements of Cash Flows for the periods ended June 30, 2002, September 30, 2002,and June 30, 2003. These revisions were made to reflect the use of Canadian Generally Accepted Accounting Principles (GAAP).

According to Altair Nanotechnologies` CFO Edward Dickinson, "U.S. GAAP requires only the reporting of cumulative year-to-date amounts in the Statements of Cash Flows, whereas Canadian GAAP also requires the reporting of comparative quarterly amounts. We have, therefore, re-filed our interim financials to add the quarterly information. We want to reassure our shareholders that no changes have been made to our reported numbers, accounting treatment or classifications in the Revised Financial Statements required by the Ontario Securities Commission. Our U.S. GAAP financial statements previously filed with the SEC are unchanged."

Altair is a Canadian company with its corporate headquarters and manufacturing facilities located in Reno, Nevada.

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, that the company may not be able to obtain the capital to fund its operations in 2004 or otherwise, and that because of the lack of funding or other reasons, the company may be unable to fully exploit its technologies in a manner that they begin generating significant revenue. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Contacts:
Marty Tullio
McCloud Communications LLC
marty@mccloudcommunications
949.566.9860

Tracy LaFollette
Altair Nanotechnologies, Inc.
307.587.8245
[e-mail]

SOURCE: Altair Nanotechnologies, Inc.

[MRASTA]

@Wunram

das hat die Aktie die letzten Tage belastet. Scheint sich aber nicht weiter auszuwirken.

Interessantes kommt von einer ganz anderen Seite.

Friday, October 24, 2003

ILUKA Resources has entered into a memorandum of understanding with Austpac Resources concerning the purchase of synthetic rutile from Austpac`s proposed SR plant located on the east coast of Australia.

Under the MoU, Iluka will also be entitled to acquire a 10.1% interest in Austpac, Austpac`s SR plant, and secure exclusive licensing rights in respect of Austpac`s ERMS SR Technology for synthetic rutile processing.

http://www.miningnews.net/storyview.asp?storyid=19600


Austpac sagt wahrscheinlich den wenigsten hier was, verfolge die aber schon eine Zeit, weil Sie auch mit Bemax ein Bundle haben. Kurz, die Austpac Technik stellt eine echte Konkurenz zu der Technik von Altair, für den Bereich TIO2 Gewinnung dar. Nachdem Altair mit TIMET zusammenarbeitet und Bemax nicht so richtig in die Puschen kommt, mußte sich Autstpac was einfallen lassen. Und Iluka ist nun wahrlich nicht die schlechteste Adresse. Aber exklusiv Rechte vergibt man nun auch nicht an jeden und schon gar nicht, wenn einem nicht das Wasser bis zum Hals steht. Tja, harte Zeiten.



Die Phases sind wie erwartet abgeglitscht. Der Umsatz stagniert nun schon seit einiger Zeit. Bleibt nur die Hoffnung, auf den Aufschwung. Wenn dass man alles gut geht.

cu

[Wunram]

Info update vom Dr. - die Amis nehmens gut auf

Altair Nanotechnologies Provides Shareholder Update

RENO, NV, Nov. 19, 2003 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies Inc. (NASDAQ: ALTI) is, in its commitment to keep shareholders and members of the financial community current on the company`s activities, providing a project update by Altair president Dr. Rudi E. Moerck.

RenaZorb(TM) -- Nano based drug for ESRD

Shire Pharmaceuticals presented a New Drug Application (NDA) for Fosrenol(TM) (lanthanum carbonate tetra hydrate) to the FDA in 2002. Fosrenol is intended for phosphate control in kidney dialysis patients with End Stage Renal Disease (ESRD) and represents the world`s first lanthanum based pharmaceutical. In March 2003, the US FDA issued an "approvable letter" to Shire and asked for more data before approving Fosrenol for marketing in the US. Shire has recently disclosed that it is submitting additional information concerning Fosrenol to the FDA this quarter. Generally, there is a high probability that drugs issued "approvable letters" are ultimately approved by the FDA.

Altair`s RenaZorb(TM) (lanthanum oxycarbonate) represents a second-in-class lanthanum based drug for phosphate control in patients with ESRD after Shire`s Fosrenol. The licensing of RenaZorb to a pharmaceutical company that would develop the drug through clinical trials and eventual marketing is highly dependent upon the action the FDA takes regarding Shire`s Fosrenol. For this reason, interest in RenaZorb among potential licensees has been high but we now realize that significant discussions on out-licensing RenaZorb will take place only after Fosrenol is approved.

Altair`s in vitro and in vivo data suggests that RenaZorb binds with phosphate faster than lanthanum carbonate tetra hydrate, the active ingredient in Fosrenol, and is up to 30 percent more chemically efficient at binding phosphate per gram of drug. RenaZorb`s possible advantages compared to existing or proposed drugs for phosphate control in patients with ESRD are fewer tablets per day, lower overall dose, lower acid burden, high phosphate selectivity and possibly fewer side effects.

Altair estimates that there are over one million patients worldwide with ESRD that could benefit from phosphate control therapy. The test results of RenaZorb in dogs and rats provided by third parties have enabled Altair to make adjustments in RenaZorb`s composition and formulation that further enhances its phosphate binding efficacy and performance.

Titanium Metal

The agreement with Titanium Metals Corporation (TIMET) announced August 13, 2003 represents an opportunity for Altair to join with one of the world`s leading titanium metal manufacturers in development of a new, lower cost technology manufacturing titanium metal. The new technology is based on the "FFC Cambridge" process developed by Cambridge University. Altair has begun selling developmental quantities of custom nano titanium dioxide and titanium alloy oxide electrode feedstock to TIMET for their development program. Over 1.67 pounds of TiO2 are required to produce one pound of titanium metal. In the future, Altair has the opportunity to supply enough TiO2 to produce 50 pounds of titanium metal per day to meet the DARPA (Department of Defense) titanium project goals.

White Titanium Dioxide Pigment -- Altair Hydrochloride Pigment Process (AHPP)

Discussions continue with several companies that have mineral deposits suitable for use with the AHPP to make white titanium dioxide pigment. These discussions have been particularly fruitful in North America.

Altair entered into an agreement with Flowco International to exclusively represent the company in the People`s Republic of China (PRC). Progress is being made with one Chinese company that has interests in producing white pigment for their home market.

Funding for the proposed Vietnam pigment project is still pending final approval; however, Altair and Avireco have entered into a development and licensing agreement and negotiations are underway to test the suitability of the proposed resources using the Altair AHPP technology. Arrangements have been made to ship over 100 kgs of ilmenite from several Vietnam sources for AHPP testing in Reno. The testing will be paid for in the first phase of this development program.

The Asian Pacific resource company that contracted Altair to perform a first-phase pigment development program for their by-product ilmenite had postponed with continued pigment development pending a demonstration of ilmenite resource extraction and beneficiation. This program is being carried out by others, is now underway and is scheduled to last 18 months.

United States Government Research Funds

Following a review of project priorities, management is more aggressively seeking revenues from Department of Energy and the Department of Defense. Assisting in this effort is DykemaGossett, PLLC, a Michigan and Washington, D.C.-based law firm. The firm was instrumental in obtaining a grant of approximately $1 million for Altair and Western Michigan University (WMU). Altair expects additional funding in 2004 for energy and DOD related projects.

The teaming/research agreement with WMU resulted in a contract between WMU and Altair for a project funded by the Department of Energy. Work between Altair and WMU is underway as defined by the terms of the agreement. The groups are currently working on the "lab-on-a-chip" elements which will comprise the technology being developed for detecting chemical and biological weapons, a homeland defense program. Billing by Altair/WMU under the approved DOE grant has begun.

WMU and Altair will continue to pursue a three-to-five-year Federal grant with Altair worth $1 million each year for continued development for a number of related projects.

Dental Nanomaterials

Altair has sold its first developmental quantities of nano-zirconia to a research consortium sponsored by the National Institute of Health. The consortium consists of a university, a company in the dental materials business, and a large contract research institution. The technology used to make our nano-zirconia products was developed from Altair`s fuel cell program.

Altair`s nano-zirconia can be used to strengthen polymer-based dental fillings and also provide opacity to x-rays. The efficient x-ray imaging of dental fillings is an important characteristic provided by these. materials. Commercial quantities of Altair`s nano-zirconia are available for immediate sale. While the size of the market for material for dental fillings is small from a tonnage perspective, the dollar value is considerable.

Drug Delivery -- TiNano Spheres(TM)

TiNano Spheres(TM) are "wiffle ball" like hollow and nano-porous structures that are derived from the patented AHPP technology. The inside, outside or both can be coated or filled with active pharmaceuticals to provide sustained release characteristics (timed release). Pharmaceutical developers have the option to use different drugs on the outside and the inside of the hollow and porous spheres. TiNano Spheres are intended for oral or dermal dosage form only and are made entirely of metal oxide particles such as titanium dioxide.

Altair is working with a major research institute to aggressively develop the TiNano Sphere platform. Our intention is to also seek National Institute of Health and pharmaceutical company funding for this project. The first project for use of the TiNano Spheres is a sustained release formulation of retinol/vitamin A for dermal applications.

Hydrogen Solar

The teaming agreement between Altair and Hydrogen Solar Production Company, LTD of the United Kingdom has led to the formation of a Hydrogen Solar subsidiary in Nevada. A three-party agreement is being reviewed by the Nevada University system, which is already involved in hydrogen development, for a demonstration project for Tandem CellTM technology. Hydrogen Solar holds the exclusive license for the Tandem CellTM. Funding for the three parties to develop the demonstration technology has been requested. The Tandem CellTM technology is a unique technology that makes hydrogen directly from sunlight and water. Nanoparticles of materials made by Altair are used in the development.

Rutgers Energy Storage Research Group (formerly Telcordia(TM) Technologies)

The Rutgers prototype battery, using Altair`s nanomaterial, met the `car of the future` power assist battery requirement as reported in Telcordia`s (now Rutgers Energy Storage Research Group) research paper published in The Journal of Power Sources. The prototype battery, a nonaqueous asymmetric hybrid incorporating the advantages of both Li-ion batteries and super capacitors, stored energy of 11wh/kg with delivery of 800 W/kg at 95 percent efficiency. The cycle life ranged between 10,000 and 100,000 cycles. The Rutgers` battery is the only prototype reported, to date, to meet these DOE standards. Altair is in discussions with Rutgers and has provided the group with additional nanomaterial samples.

Jig and Mining Assets

Altair has entered into a technology licensing agreement with Bateman Luxembourg SA for the manufacture, installation and operation of Altair`s Centrifugal Jig (ACJ). Bateman will have exclusive use of the ACJ for specifically identified applications in selected territories throughout the world. Altair will be compensated by Bateman through a licensing fee for each project managed by Bateman that utilizes the ACJ. The compensation will vary based on the size and scope of the individual projects. Head-quartered in the Netherlands, Bateman provides innovative solutions for conversion of natural resources into marketable products for global natural-resource industries such as mining, minerals and metals processing. The agreement is timely as there is renewed interest in natural resource projects worldwide.

The company is reviewing strategic alternatives including a possible sale of one or more of the mining assets or spinning off the assets to shareholders. Altair is focused on material science and participation in projects where our technology provides a significant advantage. Mining assets are no longer a critical component of the company.

Altair Nanotechnologies Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the short run, and that animal testing or future testing on RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Contacts:
Marty Tullio
McCloud Communications LLC
949.566.9860
[e-mail]

Tracy LaFollette
Altair Nanotechnologies
307.587.8245
[e-mail]

SOURCE: Altair Nanotechnologies

[MRASTA]

ja,

ziemlich lustig eigentlich. Rudi hat es schon drauf, zur richtigen Zeit eine aufgewärmte Zusammenfassung. Aber wenn es dem Kurs nutzt, soll es recht sein.

Mal sehen wie lange es anhält.

So ganz verstehe ich den Zusammenhang zu Fosrenol allerdings nicht, ist zwar so cirka der gleiche Wirkstoff aber anscheinend auch wieder nicht, wäre ja sonst unsinnig. Aber nehmen wir es mal so hin, solange Fosrensol keine Zulassung hat, ist auch nichts mit RenaZorb.

cu

[Wunram]

mrasta,

naja wenn for Fosrenol(TM) von Shire von der FDA zugelassen wird, besteht wohl große Hoffnung seitens ALTI, dass die Nachfrage nach RenaZorb(TM) seitens der Pharmaindustrie steigt.

Diese sollen dann die weitere Zulassung vorantreiben. Nach eigenen Ausssagen ist es ja effizienter in der Wirkung, kann niedriger dosiert werden, es genügen kleiner Gaben und es hat weniger Nebenwirkungen. (Eigentlich müsste RenaZorb(TM) also der Renner sein )

Gruss

[MRASTA]

@Wunram

jep, so hofft man aber eine Garantie ist damit auch nicht verbunden. Es muss dann ja auch erstmal die klinische Erprobung erfolgen etc.

Viele Baustellen und keine sieht so richtig nach dem Durchbruch aus. Aber wer weiß, vielleicht kommt ja doch noch was überraschendes aus einer Ecke. Oder Fosrenol bekommt doch noch dieses Jahr die Zulassung, dann geht es erstmal Steil bergauf. Bis man dann feststellt, dass ja doch noch einige Zeit ins Land geht für die Erprobungen.

Zumindest hat Rudi den Kurs damit erstmal wieder ein wenig nach oben gebracht, war ja so langsam am abbröckeln. Obwohl irgendwer den Kurs immer wieder gestützt hat, war schon sehr auffällig. Ist ja jetzt wieder etwas einfacher. Warten wir es mal ab.

cu

[Wunram]

@MRASTA

Zumindest hat Rudi den Kurs damit erstmal wieder ein wenig nach oben gebracht, war ja so langsam am abbröckeln

ist gut gesagt:

Last: 1.370
High: 1.390
Low: 1.180
Open: 1.180
Change: +0.19
Volume: 1,466,500


Bid: 1.370
Ask: 1.380
Bid/Ask Size: 6,300 / 5,000


52 Wk High: 1.650
52 Wk Low: 0.300
%Change: 16.1%


Market Cap: 52M
Price/Sales: 137.0
EPS: $-0.21
P/E Ratio: N/A

15:29:31 1.370 2300 Nasdaq Small Cap at Bid
15:29:31 1.370 2000 Nasdaq Small Cap at Bid
15:29:24 1.370 300 Nasdaq Small Cap at Ask
15:29:23 1.370 300 Cincinnati at Ask
15:29:21 1.369 300 Nasdaq Small Cap
15:29:19 1.369 300 Cincinnati
15:29:18 1.370 300 Nasdaq Small Cap at Bid
15:29:17 1.370 300 Nasdaq Small Cap at Bid
15:29:16 1.370 300 Nasdaq Small Cap at Ask
15:29:16 1.369 300 Cincinnati

[MRASTA]

Na sowas ?

Ist ja ordentlich Musi drin heute, wie schön.

Übrigends Shire Pharmaceuticals hat die geforderten Untersuchungen am 14.11.03 für Fosrenol abgeschlossen. Kann man auf deren Homepage nachlesen.

cu

[MRASTA]

#115

sorry war der 18.11.03. Immer diese Zahlen. ;-))

cu

[MRASTA]

tja, bei um die 0.50 Cent Cent habe ich diesen Thread bei Altair Ende 2002 begonnen. Zwischenzeitlich standen Sie ja sogar bei 0.30. Jetzt erklimmen Sie gerade die 1.50 $. Ist doch ganz nett gelaufen bis jetzt. Gerade heute ist die Bid Seite so stark gefüllt, wie selten zuvor. Es wird also gekauft, warum auch immer.

Bin mir nicht so sicher, ob dass so weiter läuft, ist schwer abzuschätzen, hängt von einer Menge von Faktoren ab. Geld konnte bis dato zumindest jeder verdienen. Schaun wir mal, wie es weiter geht.



Die Phases standen seinerzeit so bei 3.00 $ haben sich auch entwickelt, wenn auch nicht so wie ich es erwartet habe. Wird eine schwierige Zeit werden.

Bis dann
mrasta

[MRASTA]

VOLUME(+): ALTI Volume 41% > 20-adsv, Stock +12.06%
Friday , November 28, 2003 12:54 ET

This is the 1st VOLUME alert for ALTI in the past 7 calendar days.

Trading for Altair Nanotechnologies Inc (NASDAQ NM: ALTI) has been heavier than usual in today`s session. By 12:55 ET, the stock had already traded 740,900 shares via 587 trades. The cumulative volume is 40.51% above its 20-day average of 527,300. Normally the stock experiences around 395 individual trades per session.

So far, today`s volume surge has caused a net rise in ALTI`s stock price. At the time of this alert, the stock was trading at $1.580, up $0.170 (+12.06%).

One year ago, the Company`s shares closed at $0.710. The price has gained more than 122 percent since then.

Over the last 10 trading session ALTI has traded in a range between $1.170 and $1.650 and is currently trading 4.24% below its 52-week high of $1.650 set on November 25, 2003 and !!!! 426.67% !!!!! above its 52-week low of $0.300 from April 25, 2003.

[MRASTA]

Altair vorbörslich mit 1.70 $ gehandelt ?

Übernahme ? Oder was ist da seit ein paar Tagen los ?

Jemand einen Plan dazu ?

cu

[Wunram]

ich seh´s mit Freude habe aber keinen Plan

Gruss Wunram

[MRASTA]

Hi Wunram,

1.85 $ jetzt, die spinnen die Ami´s, aber uns soll es recht sein. Vielleicht kauft ja tatsächlich jemand alles auf ? Oder es kommt noch was ?

Muss man jetzt wohl aufpassen.

cu

[MRASTA]

ups, Volumen über 1,2 Mio Teile schon bei Eröffnung ??

cu

[MRASTA]

1,90 $ !!!! und über 3,4 Mio Teile.

Immer noch keine Meldung und es scheint lustig weiter zu gehen ????????????

cu

[MRASTA]

wau, schaut euch bloß mal die einzelnen Orders an. Vorhin wurden 184.500 Teile zu 1,81 gesucht, jetzt gerade 137.500 !!! Teile zu 1,96 auf einen Schlag. ? Irgend jemand kauft da richtig ein.

cu

[Wunram]

@mrasta



52 Wochenhoch und
heute werden die Umsätze vom 14./15. Mai getopt. Damals 7,783,686 (15.5) und 5,016,185 (14.5.)

Alles ohne news


Last: 1.960
High: 2.040
Low: 1.670
Open: 1.700
Change: +0.36
Volume: 5,000,900


Bid: 1.950
Ask: 1.960
Bid/Ask Size: 3,500 / 200


52 Wk High: 1.650
52 Wk Low: 0.300
%Change: 22.5%


Market Cap: 75M
Price/Sales: 196.0
EPS: $-0.21
P/E Ratio: N/A


12/01/03 - 12:39 p.m. Eastern -- No Quote Delay.

12:39:13 1.960 1200 Nasdaq Small Cap
12:39:13 1.960 100 Pacific
12:38:56 1.960 100 Pacific at Bid
12:38:56 1.960 100 Pacific at Bid
12:38:49 1.960 1500 Nasdaq Small Cap at Bid
12:38:49 1.960 500 Nasdaq Small Cap at Bid
12:38:46 1.960 4800 Nasdaq Small Cap at Bid
12:38:43 1.960 200 Nasdaq Small Cap at Bid
12:38:42 1.960 300 Nasdaq Small Cap at Bid
12:38:40 1.950 100 Nasdaq Small Cap at Bid

Mir gefällts

[MRASTA]

tja, die sind heute nicht zu stoppen. Locker über die 2,00 $ Hürde bei über 5 Mio Teilen.

Da kommt einfach Freude auf, mir soll es natürlich mehr als recht sein. Nur so ganz ohne Infos: ???

Man muss halt nicht alles verstehen, hauptsache die Richtung stimmt.;-)))

cu

[blb]

Hallo Leute!

Hab ALTI durch Zufall auf die Watchlist bekommen und die rennen jetzt seit Tagen.

Habt ihr ein paar Fundamentals für mich? Hab mir mal den Geschäftsbericht auf der Homepage angesehen, aber da war nicht viel rauszuholen. So gut wie keine Umsätze vorhanden, noch in den Miesen...

Wär euch echt dankbar für ein paar Infos!

Grüße
blb

[MRASTA]

@blb

Fundamentales, tja gute Frage, eigentlich im Moment nichts, vieeeeel Phantasie. Was da los ist, wissen wir hier zumindest nicht. An den Zahlen kann es bestimmt nicht liegen. ;-))) Bis dato fehlt auch der Durchbruch in einem der Geschäftsfelder. Vielleicht hängt es mit RenaZorb oder Timet zusammen, wer weiß es schon.

Am besten #110 von Wunram durchlesen. Da haste einen groben Überblick.

Vielleicht hilft es ja und Du entdeckst was, was wir alle übersehen haben ? ;-)))

Gruß
mrasta

[Wunram]

geiles finish

Last: 2.060
High: 2.120
Low: 1.670
Open: 1.700
Change: +0.46
Volume: 9,366,300


Bid: 2.060
Ask: 2.060
Bid/Ask Size: 3,000 / 8,600


52 Wk High: 1.650
52 Wk Low: 0.300
%Change: 30.0%


Market Cap: 79M
Price/Sales: 208.0
EPS: $-0.21
P/E Ratio: N/A

12/01/03 - 4:02 p.m. Eastern -- No Quote Delay.


16:02:40 2.060 1000 Nasdaq Small Cap at Bid
16:00:51 2.041 100 Cincinnati
16:00:51 2.040 2000 Pacific at Bid
16:00:51 2.060 900 Cincinnati
16:00:45 2.060 100 Cincinnati at Bid
16:00:40 2.060 1000 Pacific
16:00:40 2.050 2000 Pacific
16:00:40 2.050 1000 Pacific
16:00:36 2.050 2000 Cincinnati at Bid
16:00:34 2.050 5700 Nasdaq Small Cap at Bid

[MrRipley]

N8


NUR ZU, WIR SUCHEN NOCH BIS 24:00 UHR TEILNEHMER !!!

IHR KÖNNT HEUTE AUCH NOCH RESERVIEREN UND ERST MORGEN KAUFEN - FALLS IHR IN DER WAHL NOCH UNSICHER SEIN SOLLTET !!!





die Tabelle ist nicht ganz komplett und soll nur zur Anschauung dienen


Thread: Kein Titel für Thread 777423140

-Nicht erlaubt sind Pennystocks, die erst im Hinter-Komma-3er-Bereich anfangen,
-2 Papiere sind pro Tn erlaubt
-die Papiere dürfen nicht schon im Spiel vorhanden sein
-bitte Kaufdatum, evt. realistischen Kaufkurs und (Lieblings)Börsenplatz angeben!

-weiteres im Thread


Mr. Ripley

[MRASTA]

Moin allerseits,

nachbörslich sind nochmals 73.000 Teile über die Theke gewandert, Schluß dort 2.10 $ !!!!! Insgesamt wurden gestern fast 9,5 Mio gehandelt. Glaube, das gab es bis dato noch nie bei Altair.

Bin ja mal gespannt welchen Hintergrund das nun alles hatte.


Wollen dabei die Phases ja nicht ganz vergessen. Haben gestern auch 11% zugelegt.

Was dabei erstaunlich ist, Altair hat jetzt eine MKT von 84 Mio und die Phases von rund 98 Mio.

cu

[Wunram]

Gruss @all

nach schwacher Vorbörse, scheint es weiter nach oben zu gehen. Immer noch keine news!!

Last: 2.190
Close: 2.190
High: 2.200
Low: 2.020
Open: 2.030
Change: +0.11
Volume: 1,198,200


Bid: 2.188
Ask: 2.200
Bid/Ask Size: 100 / 100


52 Wk High: 2.120
52 Wk Low: 0.300
%Change: 5.2%


Market Cap: 83M
Price/Sales: 219.0
EPS: $-0.21
P/E Ratio: N/A



09:38:58 2.190 100 Nasdaq Small Cap
09:38:58 2.190 1000 Nasdaq Small Cap
09:38:56 2.190 500 Nasdaq Small Cap
09:38:56 2.190 200 Pacific
09:38:56 2.190 1500 Nasdaq Small Cap
09:38:56 2.200 300 Cincinnati
09:38:56 2.190 300 Nasdaq Small Cap at Ask
09:38:56 2.190 200 Nasdaq Small Cap at Ask
09:38:56 2.190 200 Nasdaq Small Cap at Ask
09:38:56 2.190 200 Nasdaq Small Cap at Ask

[MRASTA]

Mal sehen was heutige Tag so bringt,

im Moment sieht es so aus, als wenn es so weitergeht. 2.10, 2.18, 2.22 $. Voll das Rad ab.

Ich blicke da nicht mehr durch. Warum hört man denn nicht mal was, das macht einen ja völlig wuschig.

cu

[MRASTA]

siehste, vergesse schon ganze Wörter. Kaufe mal ein "der".

cu

[Wunram]

@mrasta

immer ruhig bleíben

..übrigens glaube ich, dass die TiO2 - Technologie von ALTI (Altair Hydrochloride Pigment Process (AHPP)) der Bringer sein könnte. TiO2 hat einen großen Anwendungsbereich und wird in vielen Branchen benötigt. Nur meine Meinung

Gruss Wunram

[MRASTA]

@Wunram

bin doch gaaanz ruhig. $$$$$$$$$$

Ne, im Ernst. Haste mal bei Austpac vorbei gesehen ? Auf dem Tio2 Sektor ist im Moment einiges los. Auch der Rest ist mehr oder weniger in Unruhe. Es passiert im Moment auf verschiedenen Bühnen eine ganze Menge.

Und die Phases steigen, wenn auch moderater, mit. Müssen Sie ja auch, sonst überholt ALTI Sie noch in der MKT. ;-))))))

Aber irgendwann wird damit auch mal Schluß sein, und dann muss man mal sehen, wo Sie einen Boden finden.

cu

[Wunram]

$2,45

1 1/2 stunden Handel und schon über 7,5 Mio Aktien haben den Besitzer gewechselt. Was läuft?? Ich habe mal per e-mail die IR von ALTI angefragt. Bin gespannt wie die Antwort lautet.

Gruss Wunram

[MRASTA]

@Wunram

sieht mir stark nach Buy Out aus. Alles andere ergibt keinen Sinn mehr, sonst hätte schon lange eine Meldung kommen müssen. Nehmen wir mal an es stimmt, dann stellt sich die Frage wer ???????? Vielleicht Timet ? Oder jemand ganz anderes ? Werden wir wohl dann erst in einer SEC Meldung sehen.

Mal sehen ob Du eine Antwort erhälst, könnte mir vorstellen, dass Sie im Moment alle Hände voll zu tun haben.

cu

[MRASTA]

2.64 $ bei knapp 8 Mio Teilen, nur die harten kommen in den Garten.

Wie lange halten wir denn noch durch ?

cu

[Wunram]

@MRASTA (hat das eigentlich was mit Rastafari zu tun?)

sind die Einzeltrades nicht ein bisschen klein für ein organisiertes buy out??

11:24:15 2.573 300 Cincinnati
11:24:11 2.580 100 Nasdaq Small Cap at Ask
11:24:11 2.577 1000 Cincinnati
11:24:11 2.570 500 Nasdaq Small Cap at Bid
11:24:11 2.580 300 Nasdaq Small Cap at Ask
11:24:10 2.580 500 Cincinnati at Ask
11:24:04 2.580 500 Nasdaq Small Cap
11:24:03 2.580 200 Nasdaq Small Cap
11:24:03 2.570 200 Nasdaq Small Cap at Bid
11:23:59 2.590 500 Nasdaq Small Cap at Ask

Gruss Wunram

[MRASTA]

@Wunram

ne, aber hiermit :
War zwar reichlich vor meiner Zeit, aber ich finde die Filme einfach cool,


Nick, Nora and Asta, "After the Thin Man" (1936)

Ja, ja sehe ich auch, dass meistens kleine Stückzahlen gehen, aber was soll es denn sonst sein ?

Übrigends jetzt 2.82 $

cu

[MRASTA]

Und die Phases, auch locker 20% im Plus ?????????????

Auch ohne Meldung. Gab es vielleicht irgendwas Umsonst heute oder gibt es Morgen keine Teile mehr ? ;-)))))

cu

[blb]

LEUTE, ICH FLIPP NOCH AUS!!!

WAS ZUM HENKER IS DA LOS???

[Wunram]

nobody knows

auf jeden Fall wird zur Mittagszeit kräftig geschüttelt um die Schwachen raus zu bekommen! Aktuell $ 2,58

Gruss Wunram

[blb]

Seid ihr schon drin?

Also ich hab mir geschworen, wenn ich nichts Genaueres über die Firma in Erfahrung bringen kann, investier ich dort auch nicht.
Und bei ALTI siehts ja in dieser Hinsicht wohl echt dürftig aus...

Mal ein Zock ist o.k., aber nichts Größeres...

[Wunram]

@blb

ich bin seit 2000 in ALTI

[MRASTA]

sage, dass ich nicht richtig sehe. Über 13 Mio Teile gehandelt bis jetzt ? Waren gestern schon so rund 25% des Freefloat und heute dürfte es ja wohl einiges mehr werden.

Jo, da wird einem echt schwindelig. Ganz heiße Kiste. Mal eben ein paar SL abgrasen, geht Ruck Zuck bei den Mengen. Da sind echte Profis am Werke.

Wo soll dass bloß noch Enden ?

cu

[MRASTA]

@blb

guter Witz, solltest vielleicht mal den Thread hier lesen. Nix für ungut.

cu

[blb]

Sorry, war mir nicht ganz klar. Was habt ihr für Kaufkurse?

[Wunram]

zwischen €0,35 und ich weiß nicht was -> Mischkurs € 1,09

[MRASTA]

@blb

macht ja nichts.

Gemittelt so 0.65 Cent. Weiß aber nicht wie lange ich das noch durchhalte, irgendwann werde auch ich schwach.

So, die Jungs sind gestärkt und die nächste Runde wird eingeläutet, mal sehen.

cu

[Wunram]

nachdem ich noch im Büro bin hab ich mal ein bisschen bei den Amiboards gesucht:

Bei RB gibts gar nix aber bei Yahoo habe ich eine interessante Nachricht gefunden:

I called investor relations. . .
by: rmv1958 12/02/03 01:03 pm
Msg: 18177 of 18212

This message is intended to deliver some real substance to this board, which otherwise engages in nothing but drivel and worthless personal attacks.

I called ALTI`s investor relations to find out if there was any particular news to explain the recent run-up in the stock price and spoke to a nice lady. Here are the points she made:

1)ALTI has moved substantially since its "November 19th release".

2)No specific news or explanation for the run-up over the last two days, except she noted that, a)Moerck (sp?)has been (is?)in New York talking to institutional investors, funds, etc. and additional meetings are scheduled next week, b)the rise has been somewhat sector driven, evidenced by the fact that others in the sector have risen in the last few days as well, and c) the passage of a recent bill in Congress earmarking $3 billion for nano research, etc, with the company hoping for other similar bills from the defense dept. etc.

My guess, and that`s all it is, is that Moerck has been particularly persuasive in his talks and these "institutional investors" and funds have been buying like crazy.

OK, all, bring on the personal attacks. I`m waiting. .



Mal sehen ob sich das in mneiner Antwortmail auch so darstellt.

Gruss Wunram

[MRASTA]

danke für die Info.

Von mir aus auch das. Ist mir mittlerweile wurscht warum der Kurs so gestiegen ist. Vielleicht schaukeln die sich auch gegenseitig auf. Ein bischen Bluna ist das aber schon.

Hätte ich, ohne eine substanzielle Meldung, nie für möglich gehalten. Kann aber auch ganz plötzlich Schluß sein, wenn die Ihre Teile beisammen haben. Vorsicht ist die Mutter usw. ....

cu

[blb]

Glückwunsch euch beiden!

Dann kann es euch ja fast wurscht sein, warum das Teil steigt!

[Wunram]

Mahlzeit

Vorbörslich fangen wir mit $ 2,49 an, + 5%.

Immer noch keine Nachrichten - auch noch keine Antwort von IR.

Na dann warten wir es mal ab, was der Tag so bringt.

Gruss Wunram

[Wunram]

schonwieder $ 2.60

08:20:07 2.590 200 Pacific
08:20:07 2.590 100 Pacific
08:19:49 2.580 100 Pacific
08:19:13 2.600 2500 Pacific at Ask
08:19:13 2.599 1000 Cincinnati
08:17:37 2.600 400 Pacific at Ask
08:17:14 2.600 400 Pacific at Ask
08:16:37 2.550 2000 Pacific at Bid
08:16:37 2.550 2000 Pacific at Bid
08:16:37 2.570 500 Nasdaq Small Cap


Offensichtlich will keiner was verpassen!

[MRASTA]

Auch hier Abend allerseits,

hat sich ja beruhigt, wie es aussieht. Aktienumsatz ist aber immer noch ganz anständig. Weltbewegend Neues scheint es ja nicht zu geben.

War ja auch ziemlich heftig die letzten Tage.

@Wunram
gibt es was Neues in Richtung E-Mail ?

Schönen abend noch,

mrasta

[Wunram]

@MRASTA

nein noch nichts

Derzeit 2,49 und über 8 Mio gehandelt.

Gruss Wunram

[Wunram]

@All

die Herren Dirctors JAMES I GOLLS und GEORGE E HARTMAN haben also am 28.11.2003 jeweils 10.000 Optionen mit Bezugspreis $ 1,41 erhalten.

Noch keine Antwortmail von IR.

Schlusskurs $2,32 bei rund 10Mio Stück.

Immer noch keien offiziellen Nachrichten.

Wir sind geduldig

Gute N8

Wunram

[MRASTA]

Vielleicht liegt der Anstieg der Nano´s daran, dass der Etat jetzt durch ist :



Secretary Abraham Applauds 21st Century Nanotechnology Research and Development Act; Attends Signing by President Bush at White House

12/3/03 5:50:00 PM

To: National Desk, Energy Reporter

Contact: Jana Toner, 202-586-4940, Jeff Sherwood, 202-586-5806, both of the U.S. Department of Energy

WASHINGTON, Dec. 3 /U.S. Newswire/ -- Secretary of Energy Spencer Abraham applauded the signing of the 21st Century Nanotechnology Research and Development Act by President Bush at the White House today.

"Imagine an automobile half the weight and twice the strength of today`s models," Secretary Abraham said. "As one of the lead agencies for nanotechnology research and development, the Department of Energy is delighted that the President signed legislation today that brings us closer to that future. This new science of very small things can revolutionize the way we produce, use, and deliver energy -- not to mention its applications to improving human health. DOE is proud it can play a critical role in President Bush`s National Nanotechnology Initiative."

The 21st Century Nanotechnology Research and Development Act authorizes funding for nanotechnology research and development over four years and puts into law programs and activities supported by President Bush`s National Nanotechnology Initiative (NIN).

"Nanoscale research will, in many respects, represent the new building blocks for new technologies and applications across the science and industry spectrum," Secretary Abraham said. "Understanding the properties of materials on the tiniest scale will have an impact on everything from medicine to manufacturing."

Nanomaterials -- typically on the scale of billionths of a meter or 1,000 times smaller than a human hair -- offer different chemical and physical properties than the same materials in bulk form, and have the potential to form the basis of new technologies. Understanding these properties may allow researchers to design materials with properties tailored to specific needs such as strong, lightweight materials, new lubricants and more efficient solar energy cells. By building structures one atom at a time, the materials may have enhanced mechanical, optical, electrical or catalytic properties.

The fundamental properties of materials and systems are established at the nanoscale. Melting temperature, magnetic properties, charge capacity, and even color are dictated not only by the arrangement of nanoscale structures, but also by the size of the structures. The realm of molecular biology -- life sciences -- also operates largely at the nanoscale.

Scientists have known about the physical properties and behavior of isolated molecules and bulk materials. The properties of matter at the nanoscale, however cannot necessarily be predicted from those observed at larger or smaller scales. Nanoscale research enables scientists literally to build novel structures atom by atom.

Some Nanotechnology Possibilities:

-- Carbon nanotubes are essentially sheets of graphite rolled into extremely narrow tubes - a few nanometers in diameter. Because of their nanoscale size and excellent conductivity, carbon nanotubes are being studied as the possible building blocks of future electronic devices.

-- Nanotechnology may one day enable the detection of disease on the cellular level and the targeting of treatment only to tissues where it is needed in a patient`s body, potentially alleviating many unpleasant and sometimes harmful side effects.

-- Nano-manufacturing of parts and materials "from the bottom up"-by assembling them on an atom-by-atom basis-may one day be used to reduce waste and pollution in the manufacturing process.

-- Nanosensors already are being developed to allow fast, reliable, real-time monitoring for everything from chemical attack to environmental leaks.

-- Woven into a cable, carbon nanotubes could provide electricity transmission lines with substantially improved performance over current power lines.

-- Certain nanomaterials show promise for use in making more efficient solar cells and the next-generation catalysts and membranes that will be used in hydrogen-powered fuel cells.

http://www.usnewswire.com/

[MRASTA]

siehste, geht ja auch in die andere Richtung. Ist halt keine Einbahnstrasse und an Gewinnmitnahmen ist bekanntlich noch keiner gestorben.


cu

[MRASTA]

@WUNRAM

haste denn wenigstens auch ein bischen Kasse gemacht ? Mußte man doch einfach.

Ein positiver Effekt ist wohl zumindest vorhanden. Es dürften wohl so ziemlich alle Optionen etc. ausgeübt worden sein, bei der Rally.

Mal sehen ob die 2$ Marke hält ?

Gruss
mrasta

[MRASTA]

und schwapp, wieder nach Norden. Ist ja wie in der Achterbahn hier.

cu

[Wunram]

Hallo MRASTA,

war 2 Tage unterwegs.

haste denn wenigstens auch ein bischen Kasse gemacht ? Mußte man doch einfach.


Nein, ich warte noch ab. Das Volumen der letzten Tage war so ungewöhnlich, dass da wohl mehr als ein Spielchen dahinter steckt. Leider habe ich keinen Zugriff auf meine emails - ich weiß also nicht ob eine Antwort da ist.

Gruss Wunram

[Wunram]

Latest Quote


Last: 2.320
High: 2.530
Low: 2.050
Open: 2.050
Change: +0.22
Volume: 4,434,300


Bid: 2.320
Ask: 2.330
Bid/Ask Size: 3,200 / 1,000


52 Wk High: 2.850
52 Wk Low: 0.300
%Change: 10.0%


Market Cap: 88M
Price/Sales: 231.0
EPS: $-0.21
P/E Ratio: N/A


16:00:29 2.320 500 Cincinnati at Bid
16:00:29 2.320 1100 Cincinnati at Bid
16:00:11 2.300 100 Nasdaq Small Cap
15:59:56 2.310 400 Cincinnati at Ask
15:59:56 2.310 1200 Cincinnati
15:59:49 2.309 200 Nasdaq Small Cap
15:59:43 2.310 300 Cincinnati at Ask
15:59:40 2.300 300 Pacific at Bid
15:59:38 2.300 1600 Pacific at Ask
15:59:37 2.300 15600 Nasdaq Small Cap at Bid



Schönen Nikolaus

[MRASTA]

wollen mal die Phases nicht ganz vergessen.



52W HIGH: New 52-Wk High for NANX @ $8.350 up 11.80%
Monday , December 08, 2003 16:05 ET

This is the 1st 52 WEEK HIGH alert for NANX in the past 7 calendar days.

The share price for Nanophase Technologies Corporation (NASDAQ NM: NANX) reached a new 52-week high today, trading at $8.350, up $0.881 (11.80%) from its previous close of $7.469.

The Company`s previous 52-week high of $8.340 was set 81 days ago on September 18, 2003.

One year ago, the Company`s shares closed at $3.210. The price has climbed more than 160 percent since then.

At the time of this alert, the stock had traded 501,400 shares via 922 trades, 158.95% above it`s 20day average of 193,630 shares.

This new 52-week high currently puts the stock:

44.20% above its 20day Moving Average of $5.791
29.56% above its 50day Moving Average of $6.445
44.46% above its 100day Moving Average of $5.780

The Company last released news on December 02, 2003:

"Court Orders Final Approval of Nanophase Technologies Litigation Settlement"

[Wunram]

Moin MRASTA,

hab derzeit viel zu viel arbeit - unsere ALTI bitte schön weiter hochhalten.

Gruss Wunram

[MRASTA]

Dito, moin,

tja, da muss dann aber bald mal eine Meldung kommen, die den Kurs auch rechtfertigt. Schaun wir mal.

bis dann
mrasta

[MRASTA]

gar nicht mitbekommen, hatten denn die schon die Zulassung bekommen ? Dann dürfte der Weg für RenaZorb ja frei sein, oder ? Ups, steckt ja ne Menge Knete drin. Ob Altair so ein Schachzug auch gelingen kann ?

Shire Pharmaceuticals schließt Lizenz-Abkommen mit Bayer

09.12.2003 14:44:00

Die britische Shire Pharmaceuticals Group Plc. meldete am Dienstag, dass sie mit der Bayer AG ein Lizenz-Abkommen geschlossen hat, nach dem der deutsche Pharmakonzern das Shire-Medikament gegen schwere Nierenkrankheiten Fosrenol in Japan entwickeln und verkaufen darf.

Wie der drittgrößte Pharmakonzern in Großbritannien weiter bekannt gab, hat das Lizenz-Abkommen ein Gesamtvolumen von bis zu 70 Mio. Dollar, einschließlich einer Vorauszahlung in Höhe von 12,5 Mio. Dollar.

Die Aktie der Shire Pharmaceuticals Group notiert in London derzeit bei 499,25 Pence (+0,76 Prozent), die von Bayer im Xetra-Handel bei 22,48 Euro (-0,88 Prozent).

[MRASTA]

jo, jo ganz schön geschröpft worden die beiden Teile.

Bei Altair war mir dass eigentlich klar, siehe auch #162.

Mal sehen wo der Boden gefunden wird, weiß man im Moment nicht.

mrasta

[MRASTA]

Knete bis Herbst 2004, Optionen etc. wurden reichlich ausgeübt, war doch klar. Siehe auch #162. Aber immer noch nix kontraktartiges (Gibt es das Wort eigentlich ?) ;-)


Congress Funds $2 Million in Omnibus Appropriations Bill for Altair Nanotechnologies` and Western Michigan University`s Nanoscience Research

Tuesday , December 16, 2003 10:33 ET
RENO, NV, Dec. 16, 2003 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) was notified by Western Michigan University (WMU) of grant funding for their joint development of nanosensors for detecting chemical, biological and radiological agents in the environment. The project is a collaboration involving WMU, Altair Nanotechnologies and the University of Nevada, Reno. The $2 million was included in the Omnibus Appropriations Bill passed by the U.S. House of Representatives December 9, 2003. WMU and Altair have a joint partnership for seeking Federal support for nanotechnology research and development and will utilize the new grant funding equally.

"We would like to sincerely thank Nevada Senator Harry Reid and Michigan U.S. Representative Fred Upton for their continuous support and hard work in assisting WMU and Altair in obtaining the funding for our joint nanotechnology research efforts, efforts that could have a significant impact on homeland security and national defense," said Altair President Dr. Rudi E. Moerck.

"In addition to being awarded government grant funding, Altair has improved its current cash position by approximately $2.1 million over the past few weeks," said Dr. Moerck. "As our stock price has continued to improve, shareholders have taken advantage of the share price increase by exercising warrants and stock options. Today, we have adequate funds available to the company through October 2004."

[Wunram]

Hi Mrasta,

du hättest die Meldung wohl nicht posten dürfen , selbst Rudi muss die Wogen glätten.

Altair Nanotechnologies Management Comments About Posting of News Releaseto Message Boards

RENO, NV, Dec. 18, 2003 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) management has received numerous calls from shareholders and members of the financial community pertaining to the extensive unauthorized posting of the company`s December 16, 2003 news release to message boards located on web-based financial portals.

Altair management would like to assure its shareholders and members of the financial community that these postings have not been authorized by the company. Management considers these postings annoying and offensive and certainly not in the best interest of Altair Nanotechnologies and its shareholders and is investigating the party or parties responsible for the postings with the hope of preventing or deterring similar events in the future.

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns and develops proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit www.altairnano.com.


Contacts:
Marty Tullio
McCloud Communications, LLC
949.566.9860
[e-mail] [e-mail]

Tracy LaFollette
Altair Nanotechnologies
307.587.8245
[e-mail]

SOURCE: Altair Nanotechnologies, Inc.


--------------------

Aber mal im Ernst, was war los, bin derzeit viel unterwegs und bekomme nichts mehr mit. Warum die heutige Meldung??

Gruss und Gute N8

Wunram

[MRASTA]

Hallo Wunram,

dann hättest Du diese auch nicht posten dürfen, Meldung ist Meldung. ;-)))))))

Soweit ich es mitbekommen habe, wurde die letzte Meldung, wie verrückt in die verschiedenen Boards reingestellt. Und zwar anscheinend überwiegend von neuen Usern oder sonst wem. Ist mir auch aufgefallen. Sieht arg nach organisierter Geschichte aus. D.h. nicht nur in die betreffenden Boards, wie hier sondern in ca. 800 !!! Boards bei Yahoo wurde diese Meldung gepostet.

Völlig neue Geschichte, soetwas habe ich bis jetzt auch noch nie gesehen. Es geht anscheinend nicht darum die Meldung da zu posten wo Sie auch sinnig erscheint sondern um diese SPAM Postings. Boards die mit Altair nichts zu tun haben wurden demnach mit der Meldung vollgemüllt.

Tja, da scheint jemand eine neue Idee zu haben, die uns das Leben wohl noch schwer machen könnte, wenn dass alle so machen, werden die Boards mit allem möglichen Müll vollgestopft. Dann kannste die Community vergessen.

Auf der anderen Seite dürfte Altair nun auch dem bekannt sein, der vorher die Firma noch nicht kannte. ;-)) Aber ich glaube dass solche Nummern einer Firma im Endeffekt nur schaden werden. Aber was sollen die Firmen dagegen tun ? Ziemlich unschöne Geschichte.

gruss
mrasta

[Wunram]

Hallo MRASTA,

danke für die Info.

Meine Frage an IR von ALTI wird offensichtlich nicht beantwortet, dafür bekomme ich jetzt emails mit den neuesten news (oder auch "nicht news"):

ALTAIR NANOTECHNOLOGIES RESTRUCTURES TO EXCLUSIVELY FOCUS ON NANOTECHNOLOGY AND MATERIALS SCIENCE


RENO, NV – December 19, 2003 – Altair Nanotechnologies, Inc. (Nasdaq: ALTI) ), a company engaged in developing metal oxide based nanomaterials, titanium dioxide pigment technology, and manufacturing techniques for novel nanomaterials and nanostructures, announced that management and the company’s Board of Directors have initiated a restructuring of the company.

Restructuring
The Board of Altair Nanotechnologies Inc. has approved a plan to restructure the company. Management has been directed to identify and effect one or more strategic transactions, most likely a sale or joint venture contribution, involving the disposition of the company’s rights in its exploration stage mining project in Tennessee as well as the centrifugal jig. The purpose of the restructuring is to permit the company to concentrate all of its resources on nanotechnology and materials science. Employees associated with these assets will be reassigned within the company.

Board of Directors
Dr. Rudi E. Moerck, currently President of Altair Nanotechnologies, has been appointed to the company’s Board of Directors. He will replace Edward Dickinson, who will continue in his function as Chief Financial Officer of the company. Dr. Moerck was named President of Altair in April 2002 and has assumed the responsibility for shaping the company into a leader in the emerging sector of nanotechnology and materials science.

Dr. Moerck received his Bachelors of Science in biology from Florida Southern College and holds a Ph.D. in physical organic chemistry from the University of Florida. He completed Postdoctoral Fellowships with the National Science Foundation and the National Institutes of Health at Ohio State University, and taught premedical organic chemistry at Ohio State and Ohio Wesleyan University. He has over 25 years of pharmaceutical and fine chemicals experience.

The company is seeking to augment its Board of Directors with individuals that reflect the focus of the restructured company.

Reorganization
The reorganization is intended to maximize management focus on nanomaterials, nanotechnology and material science in the most promising markets including: materials and technology for TiO2 pigment, TiO2 electrodes for titanium metal, pharmaceutical delivery structures (TiNano Spheres™), pharmaceuticals (RenaZorb™), dental materials and nanostructured materials for lithium ion batteries and fuel cells. When the restructuring is complete, the company will be organized into a one-division operation with a dedicated nanotechnology and advanced material science mission and focus.

“We are confident in the capability and enthusiasm of all employees and the commercial potential of our intellectual property,” said Dr. Moerck. “We are committed to make consistent progress toward the generation of revenue from commercial sales as soon as practicable.”

Dr. Moerck went on to note that Douglas K. Ellsworth was appointed Vice President of Business Development for Altair Nanotechnologies, Inc. and that C. Patrick Costin has resigned his positions as Vice President of Altair Nanotechnologies Inc. and as a Director of Altair Nanomaterials.

Termination of Mining Projects
Management has approved the sale or other disposition of all mining activities. In conjunction therewith, management is evaluating all obligations, including any environmental obligation that may be incurred in conjunction with such termination. Management does not believe that
any obligation would be material to its financial position.

ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company’s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the following: the company may be unable to effect a transaction involving the receipt of more than nominal value for its rights in its Tennessee mineral property and centrifugal jig; costs associated with the restructuring may exceeds the value of consideration received in connection with the restructuring; the company be unable to attract additional customers, funded research opportunities, product development opportunities or ventures through its sales and branding campaign; the company may never earn significant revenue from operations or create a significant demand for any of its products; and the company’s nanoparticle products may not be integrated into any major market groups and products, in addition to other risks identified in the company’s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

Gruss Wunram

[MRASTA]

Hi Wunram,

wo haste denn die Meldung her, kann ich noch gar nicht finden, egal, irgendwie kann einem der Laden schon auf die Schnürsenkel gehen. Da ja wohl die Finanzierung für den Bereich durch ist, klingt es zumindest logisch sich darauf auch zu konzentrieren. Aber bis dato haben die noch gar nichts auf die Reihe bekommen. Mal hüh mal hott, kann somit nur besser werden. ;-))))

Mal sehen wie der Markt das aufnimmt.

gruss
mrasta

[Wunram]

MRASTA,

jetzt wo du fragst -der Absender der email ist [e-mail] Ich habe bloss "CloudCommunications" gelesen und denke das kommt von Marty Tullio, Investor Relations

Die links, die in dieser mail sind führen alle zur ALTI IR Seite die auf www.businesstoinvestor.com läuft.

Wenn Du willst leite ich sie dir gerne weiter. email bitte per BM

Gruss Wunram

[MRASTA]

Wunram,

danke für die Info, die Meldung wurde heute Morgen offiziell verbreitet. War wohl mal wieder einer zu schnell mit der Meldung gestern.

cu

[Andus]

Versteht Ihr das?

Altair to offer 5 mln shares 5:50 PM

After Hours Trading
12/19/2003 6:28:00 PM
Last: 2.24 Change: +0.043

Da hätte der Kurs im Verhältnis zum Schlusskurs doch eher saftig fallen müssen, oder nicht.

Ob schon jemand drauf wartet, sich die Stücke unter den Nagel zu reissen? Hab zwar ALTI´s, bin mir aber immer noch nicht sicher, ob ich die Firma für unseriös halten soll.

[MRASTA]

@Andus

Ist so eine Sache. Zum einen wer 2.00 $ dafür ausgibt, wird wohl einiges dafür erwarten. Zum anderen scheinen Sie die Gelegenheit zu nutzen, bei dem Kurs noch Knete reinzuholen. Logo ist, dass je mehr Teile draußen sind der Wert pro Anteil sinkt, wenn man mal von der jetzigen MKT ausgeht. Es ist auch fraglich ob Sie die Teile so loswerden, es sei denn, einer steht da schon hinter.

Für Seriös halte ich Sie schon, ob Sie aber ein gutes Management haben, ist eine ganz andere Frage. Bis dato wurde nur hole Luft produziert und das Timing bzw. die damit verbundenen Aussagen konnte man auch vergessen. Somit bleibt nur zu hoffen, das die Umstrukturierung auch mal was bringt. Die neuen Teile dürften den Kurs aber drücken.


Offeriert werden :
5,000,000 shares á $2.09 = $10,450,000

We frequently have only enough working capital to support operations for a few months. For example, as of December 15, 2003, we had $3,059,972 in cash, which is sufficient to sustain our operations only through October 31, 2004. As a result, we are required to sell common stock, warrants and other securities on a periodic basis in order to obtain capital necessary to continue operations.

gruss
mrasta

[MRASTA]

Man muss ja nicht immer alles verstehen, aber beide haben heute, zumindest zeitweilig, ein neues 52W High erreicht.

Wie dem auch sei, allen schonmal einen guten Rutsch, eine Pulle vom Feinsten sollte wohl für die meisten drin sein. Auch wenn die echten Highlights fehlten.

bis dann
mrasta

[Wunram]

Hi Mrasta,




Keiner weiß warum - mir gefällts.

Hoffe alle haben ein Frohes Fest gehabt. Ich wünsche allen einen Guten Rutsch und gute Geschäfte im Jahr 2004.

Gruss Wunram

[MRASTA]

Schönes Neues allen,

Alti bei 3$ !!!!!!!!!!!!??????????????
Der Infarkt läßt grüßen.

mrasta

[MRASTA]

ja, ja jetzt kommen Sie alle aus der Muskiste :

2.01. 18:22
Bei NANOPHASE geht kurstechnisch der "Punk" ab
(©GodmodeTrader - http://www.godmode-trader.de)

NANOPHASE TECHNOLOGIES (NANX) - Intradaykursstand : +10,5% auf 8,94 $

Aktueller Wochenchart seit April 1999. (1 Kerze = 1 Woche)

Diagnose: In 2003 konnte die Aktie nachhaltig über ihre mehrjährige dominante Abwärtstrendlinie ausbrechen. Seit Anfang 2003 konnte sich ein breiter Aufwärtstrend etablieren, der bisher leicht "bearish-keilig" imponiert. In die Spitze des Keils läuft die Aktie langsam hinein. Und zwar bisher in Form eines bullishes Musters. Das heißt, daß die Aktie möglicherweise einen irregulären Ausbruch aus dem Keil nach oben vorbereitet. Das 8,65 $ Kursziel, das wir in der Vorgänger-Kommentierung benannt hatten, hat die Aktie bereits im Verlauf des Dezember 2003 erreicht. bei 8,375 $ liegt eine starke Widerstandslinie, gleichbedeutend mit einer BUY Triggermarke.

Prognose: Das zweite charttechnische Kursziel von 9,74 $ rückt langsam in Reichweite. An dieser Stelle kann bereits ein weiteres neues Kursziel in Höhe von 14,2 $ genannt werden.

Beachten Sie die beschriebene hohe Volatilität dieses Aktientitels.

[Wunram]

[MRASTA]

02.01. 19:53
"Let`s have nano" - ALTAIR NANOTECH
(©GodmodeTrader - http://www.godmode-trader.de)



Wenn wir schon dabei sind einige Aktien aus dem Nanotech-Sektor vorzustellen, dann sollte auch Altair Nanotech nicht ausgeklammert werden. Wie Sie sehen, beginnt sich der 2003er Nanotech-Hype bei diesen Aktien in 2004 fortzusetzen. Kontinuierliches charttechnisches Tracking finden Sie in der GodmodeTrader Member Area vor.

ALTAIR NANOTECHNOLOGIES (ALTI)

Intradaykursstand : +17,87% auf 3,1 $

Aktueller Wochenchart seit 2001. (1 Kerze = 1 Woche).

Diagnose: Die Aktie bewegte sich von August 2000 bis August 2003 in einem brachialen Abwärtstrend. Im August 2003 gelang der erste Ausbruch über die dominante Abwärtstrendlinie. Auf den ersten Ausbruchversuch folgte eine Pullbackbewegung zurück in den Bereich der überwundenen Abwärtstrendlinie. Wie Sie dem Chart entnehmen können, fiel die Aktie temporär sogar wieder unter die Trendlinie. Solche überschießenden Pullbacks sind nicht ungewöhnlich, werden doch so wichtige "Stoppnester" ausgeräuchert. Der Pullback verlief bei Altair Nanotech ebenso erfolgreich wie bei Nanophase und Nanogen. Das Kursgeschehen von August 2003 bis Ende November 2003 zeigt ein bullishes Kursmuster, nämlich eine relative inverse S-K-Formation mit BUY Trigger bei 1,48 $. Seit dem 28.November 2003 bricht die Aktie regelkonform aus diesem Pattern nach oben aus.

Prognose: Die Aktie beginnt einen steilen übergeordneten Aufwärtstrend zu etablieren. Zu beachten, ist die enorm hohe Volatilität dieser Aktie! Das charttechnische Mindest-Kursziel von 3 $ hat die Aktie in den vergangenen Wochen erreicht. Nächste übergeordnete Zielmarke ist die 4,35 $ Marke.

[Wunram]

@all

Gewinne mitnehmen ist nicht schlecht - heute habe ich meinen Einsatz und 50% rausgenommen. Mal schauen wie der Rest weiterläuft.

Gruss Wunram

[MRASTA]

Moin,

melde mich auch mal wieder zurück. Werden den Thread wohl unter dem Titel weiterführen obwohl, paßt ja nicht mehr so ganz aber egal.

Ist ja mächtig was los bei unseren beiden Nanos.

Die Phases haben nach der neuen Patentmeldung ja einen richtigen Abflug hingelegt, fein, fein. Und auch Altair läuft sich warm.

Dann wünsche ich mal allen, ein Happy Trading für 2004.

gruss
mrasta


Nanophase Technologies Announces New Patent
Tuesday , January 06, 2004 09:32 ET

ROMEOVILLE, Ill., Jan 06, 2004 /PRNewswire-FirstCall via Comtex/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced the Company was issued U.S. patent 6,669,823 on December 30, 2003 entitled "Process For Preparing Nanostructured Materials Of Controlled Surface Chemistry". This patent protects Nanophase`s novel plasma nanoparticle processes to prepare nanocrystalline materials with highly controlled surface chemistry. The patented process applies to both of Nanophase`s technologies: the PVS process, the Company`s original nanomaterials process; and, the new NanoArc(TM) technology, Nanophase`s recently commercialized nanomaterials process.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

The ability to control and engineer the surface chemistry of nanostructured materials is important because the proportion of atoms on the surface of a nanoparticle versus the nanoparticle`s bulk is much greater than for conventional materials, and is often a critical parameter in application performance. The Company`s recent, and now patented, technology advancement allows nanoparticle dispersions with substantially enhanced stability and enables the Company to engineer and manufacture materials with predictable, and often increased, process reactivity. The technology applies to single elemental oxides, as well as multi-element nanomaterials, including rare earth nanomaterials.

"This technology enables nanomaterials engineering at almost a molecular surface level and is vital to several key markets that require dispersion- based nanomaterial products," stated Joseph Cross, Nanophase`s president and CEO. "The unique capability to engineer nanomaterials and surface chemistry has direct application for several markets that the Company is pursuing. These include polishing for semiconductors, glass, and rigid memory; catalyst wash coats; cosmetics and personal care; and similar applications. The recently patented surface engineering technology also complements Nanophase`s patented and proprietary nanoparticle coating technologies. Nanophase has the commercial capability to supply nanomaterials as nanoparticles, coated nanoparticles, and highly stable nanomaterial dispersions.

"This rather important patent continues to enlarge and strengthen Nanophase`s inventory of intellectual property and leadership in the nanomaterials field. The Company believes that some of the eight patent applications in process may also issue during 2004 and fully expects to file additional patent applications during the coming year."

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 23 United States patents and patent applications, consisting of 9 owned United States patents, 8 owned United States patent applications, and 6 licensed United States patents. The Company also has 27 foreign patents and patent applications, consisting of 9 owned foreign patents and 18 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

[MRASTA]

Holla, schaut euch mal die Phases an, da kauft gerade einer kräftig ein. !!!!!!!!!!!!!!

cu

[MRASTA]

Aus einen USA Board, wenn es denn stimmt.

ALTI just featured on cnbc
by: alphamale111111 (29/M)
Long-Term Sentiment: Strong Buy 01/09/04 01:21 pm
Msg: 20828 of 20828

as a nanotech play




P.S. Und die Phases im Moment fast +20%

cu

[MRASTA]

Nanophase Announces Commercial Availability of Novel New Nanomaterials

Friday , January 09, 2004 12:57 ET
ROMEOVILLE, Ill., Jan 09, 2004 /PRNewswire-FirstCall via Comtex/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced commercial availability of a new class of cerium-based oxide nanomaterials from the Company`s patented NanoArc(TM) technology. The new nanomaterials, termed HSA nanoproducts, are approximately 5-15 nanometers with tight particle size distribution and are targeted to ultrafine polishing applications (CMP for semiconductors) and catalysts applications (catalytic converters).

(Logo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

Nanophase`s new HSA nanomaterials may also be combined with dopants, such as rare earths, to form single crystal multi-element nanomaterials. For example, Ceria may be combined with rare earths (Lanthanum, Samarium, and/or Praseodymium) or other elements (Zirconium), to form multi-element nanomaterials that are uniquely contained in a single nanocrystal. Nanophase`s NanoArc(TM) technology further allows the Company to tailor the nanoparticle surface and obtain highly concentrated, very stable dispersions of nanomaterials.

"This new class of commercially available nanomaterials, with novel physical and chemical properties, are more chemically active than the present nanomaterials produced for Nanophase`s CMP products that are currently being introduced to the market through our partnership with Rohm & Haas Electronic Materials (Rodel)," stated Joseph Cross, Nanophase`s president and CEO. "Nanophase is able to uniquely manufacture commercial quantities of multi- elemental nanoparticles that do not occur in nature as a single-phase solid solution. These new nanoproducts are homogenous nanoparticles with very tight particle size distribution and exhibit high thermal stability, including high temperature oxygen storage capacity, ion mobility, and chemical reactivity. We believe that these materials should have direct applications in ultrafine polishing, catalysts, and potentially fuel cells."

Nanophase has annual full-scale commercial production capability for these materials in the metric ton(s) range manufactured under its ISO-9001:2000 quality system. For additional information, contact Dr. Ed Ludwig, Nanophase`s vice president of business development at 630-771-6729, or email [e-mail] .

[MRASTA]

Tjä und dass gleich noch hinterher. Kennt jemand den Laden ? Und nun ???????????

Libertyville, USA ? January 9, 2004 Pluvia Securities Research BEGINS Coverage of ALTAIR NANOTECH, (Nasdaq SC: ALTI), at $3.60, with a STRONG SELL/SHORTSELL Rating and a target price of under $.10 (ten cents).

**PART ONE OF THIS REPORT WILL BE AVAILABLE January 15, 2003

OUR STRONG SELL RATING IS BASED ON:

1. Recent promotion of ALTI during a time the company is selling securities to investors, which we believe could result in a ?pump and dump?.

2. Past hyped promotion of business ventures, all of which have not only failed to meet claims and expectations, but all of which have failed completely.

3. Morphing of a failed mining business into what they now claim is a ?nano technology? business.

After review of ALTI?s business plan, we see no identifiable product that we believe has any potential to come to market. Until ALTI presents a product with an identifiable market and demonstrates any ability to develop and then manufacture and distribute a product, we give ALTI a less than 1% of success and a 99% chance of complete failure.

Pluvia Securities Research, their agents, associates, and or employees have investment positions consistent with the above-stated SELL RATING. Information provided herein should not be considered investment advice, only the findings of our research, which may or may not be accurate. We encourage persons to conduct their own due diligence and come to their own independent conclusions regarding any and all investments they make. All comments are the EXPRESS opinion of the Author(s) - All rights reserved.

CONTACT:
Pluvia Securities Research

[MRASTA]

Auch dass noch, d.h. die kennt keiner, weil anonym.



Pluvia & the Pluvia research organization have been doing securities fraud research on the internet since 1996. For security reasons we operate under a cloak of anonymity. There are multiple persons performing research that is posted under the nom de plume "Pluvia". Nobody will ever know who we are. We have always operated that way and always will. We suggest shareholders spend their time looking at the research we present rather than attacking the messenger. If our research does not hold up - obviously we have no credibility.

Unfortunately for ALTI we do have a strong history of results. We have never accused a company of specific fraud and been wrong. Not once. Good luck and happy reading.

**NOTE: there are other companies than these we have accused of fraud that have gone belly up, these are the few that are easiest for people to research.

[MRASTA]

na, da bin ich mal gespannt, was mit ALTI passiert, befürchte aber nix gutes. Eigentlich eine geile Idee, shorten und dann so einen Bericht anonym erstellen. Da keiner weiß, wer wirklich hinter "pluvia" steckt.

Allerdings sah es wohl in der Vergangenheit mit den Werten die Der oder Die am Wickel hatten meistens nicht so gut aus. D.h. Talfahrt. Naja, wir werden es ja erleben, so oder so.

cu

[Steigerwälder]

Das ganze in deutsch :

Nanophase startet Verkauf von neuem Nanomaterial

Der amerikanische Entwickler von Nanotechnologie-Produkten Nanophase Technologies Corporation hat am Freitag bekannt gegeben, dass man ein Nanomaterial auf Basis der seit kurzem als Patent geschützten NanoArc-Technologie auf den Markt gebracht habe. Die Partikel des Produkts sind etwa 5 bis 15 Nanometer dick und sollen beispielsweise bei ultrafeinen Polierarbeiten oder bei Katalysatoranwendungen zum Zug kommen.

Das neue Produkt lässt sich auch mit sogenannten Dotiersubstanzen vermischen, um Einkristall-Materialien aus verschiedenen Elementen zu generieren.

Erst am Dienstag hatte der Konzern bekannt gegeben, dass man zwei wesentliche Patente für Verfahren erhalten habe, die eng mit der NanoArc-Technologie zusammenhängen. Damals legten die Aktien anderthalb Dollar auf 11,50 Dollar zu, gaben im Laufe der Woche aber wieder etwas nach. Die Aktien können am Freitag um 2 Dollar auf 12,51 Dollar zulegen.

[MRASTA]

@Steigerwälder

Thanks.


Die Taglich Sisters haben sich mal wieder Altair angenommen und ein Update herausgebracht. Ein Rating haben sie sich aber, wie schon zuletzt, verkniffen. Wird wohl eine interessante Woche geben.

http://www.taglichbrothers.com/equityuniverse/companies/alta…

cu

[Gluewuermchen]

Press Release Source: StockPickReport.Com

Stock Market Ratings by StockPickReport.com for Applied Materials, Altair Nanotechnologies, Agere Systems, Charles Schwab and Reliant Resources
Sunday January 11, 9:00 am ET

SHREVEPORT, La.--(BUSINESS WIRE)--Jan. 11, 2004--StockPickReport.Com (IARD#119079) http://www.stockpickreport.com/?src=bwtop makes these short-term stock recommendations:

Applied Materials (Nasdaq:AMAT - News) - WEAK BUY
http://www.stockpickreport.com/rating.php?sym=AMAT

Altair Nanotechnologies (Nasdaq:ALTI - News) - SELL

http://www.stockpickreport.com/rating.php?sym=ALTI

Agere Systems (NYSE:AGRA - News) - WEAK BUY
http://www.stockpickreport.com/rating.php?sym=AGRA

Charles Schwab (NYSE:SCH - News) - WEAK BUY

http://www.stockpickreport.com/rating.php?sym=SCH

Reliant Resources (NYSE:RRI - News) - SELL
http://www.stockpickreport.com/rating.php?sym=RRI

If you`d like a complete list of all of our STRONG BUY stocks, visit: http://www.stockpickreport.com/creative/hilopr.asp?src=PR

WHAT THESE RATINGS MEAN:

StockPickReport.Com ranks stocks with a proprietary unbiased system of technical analysis. These ratings do not indicate a "long term" view of any company listed. These are ratings that reflect our opinion of a stock`s potential price movement over the next five to ten trading sessions. These ratings may change based on daily market conditions.

[MRASTA]

Scheint keinen weiter zu jucken, die Empfehlungen. Dann eben nicht, auch gut. Warten wir bis zum 15. Januar und sehen, was dann passiert, wenn überhaupt.

Die Phases machen ja auch wieder freude.

cu

[MRASTA]

@all

Blase hin, Blase her. Wird ja viel geschrieben in letzter Zeit, von Leuten die meinen den Durchblick zu haben. Wie dem auch sei, teilweise haben Sie recht, in machen Dingen bin ich völlig anderer Meinung. Aber so ist es nunmal, ist ja völlig normal, bin ja auch nur ein Mensch, sagt man zumindest. ;-))))

Da die Berichtszeit ansteht, sollte man auch bei den Beiden ein wenig aufpassen.

Zu Altair :
Ich habe einen weiteren Teil verkauft, da ich davon ausgehe, dass die Zahlen mal wieder grottenschlecht sein werden. Außer der Cash Position, die dürfte ganz ordentlich ausfallen. Aber nur von der Phantasie zu leben, ist auf Dauer schwer. Den Rest lasse ich liegen, tut nicht mehr weh. Vielleicht kommt es ja doch ganz anders als ich denke.


Zu den Phases :
Gaaaaanz schwierige Geschichte. Sind ja ebenfalls unglaublich gelaufen. Das Sie mal wieder Teile auf den Markt werfen kann ich Ihnen, bei dem Kurs, nicht übelnehmen ist eher vernünftig. Ich befürchte auch bei denen, dass die Zahlen, eben auch außer der Cashposition nicht sensationell sind. Aber durch die Produktfertigstellung der Beschichtungen mit Rodel ist wieder Phantasie dar. Nicht einfach, hier das Richtige zu machen. Kann so oder so ausgehen.

Besonders wenn man sich mal den Bericht auf deren Homepage aus dem November 2003 durchließt, der anscheinend an allen vorbei gelaufen ist, an mir auch. Habe den mal grob übersetzt, etwas kantig, da nur durch den Übersetzer gejagt, nicht genügend Zeit um es ganz genau zu machen, der Sinn und Zweck der Übung dürfte aber klar werden. Der Originaltext findet sich auf der Homepage von Nanophase. Damit dürfte wohl auch dem letzten klar sein, welches Potential hier drin steckt, auch wenn es sicherlich noch Jahre dauern dürfte, zumindest in diesem Bereich.

Also wie immer, ist nur meine persönliche Sicht der Dinge, entscheiden muss jeder für sich.

Gruß
mrasta



http://www.nanophase.com/news/content.asp?NEWS_ID=10

NanoParticle-Nachrichten 11/3/2003 -

Kann Ceroxid Alterung Hemmen?

Von Mindy N. Rittner, Redakteur, Nanoteilchen-Nachrichten, Direktor, Nanotechnologie-Forschung, Geschäfts-Nachrichtentechniken-Co. (BCC), Inc.

Anfängliche Studien, die zeigen, daß Ceroxidnanoteilchen das Leben von Gehirnzellen verdreifachen oder vervierfachen können, deuten an, daß die Nanoteilchen Leuten erlauben könnten, länger mit wenigen altersbezogenen Gesundheitsproblemen, entsprechend einem molekularen Biologen von der Universität von Zentralem Florida, zu leben (UCF).

Die Zell-longevity-Entdeckung wurde zufällig in den Frühstadien der Forschung gemacht, um Enzymlieferung zu Zellen zu verbessern, die Nanoteilchen als Träger benutzten. Als ein erster Schritt in der Untersuchung setzten Forscher, von Beverly Rzigalinski geführt, Assistentenprofessor in der Abteilung von Molekularer Biologie und Mikrobiologie, den Nanoteilchen Rattengehirnzellen aus, um zu sehen, was geschehen würde. Würden die Zellen beeinträchtigt werden? Würden sie sterben?

In der Tat, das Leben der Nano Teilchen-behandelten Zellen wurde merklich verlängert, ein vollkommen unerwartetes Ergebnis. Rzigalinskis Mannschaft fand daß die nano Teilchen-behandelte Rattengehirnzellen noch lebendig waren nach mehr als zwei Monaten - eine Verdoppelung der typischen Zell-Lebensspanne von 28 bis 30 Tagen. Zellen erreichen Reife und bilden funktionelle Synapsen, die Kommunikation miteinander innerhalb 15 bis 22 Tagen in vitro erlauben. Wenn Sie jenseits dieses Punktes alt werden, verlieren sie normalerweise Funktionalität, lösen sich auf und sterben.

"Nachdem zwei Monate vorbeigingen, fanden wir daß die nano Teilchen-behandelte Zellen noch lebendig waren. Wir dachten, sie können lebendig sein, aber sind sie auch so wie jüngere Zellen"? " sagt Rzigalinski.

Als sie die Qualität der betagten Neuronen prüften, entdeckten die Forscher, daß die zu einer sehr niedrigen Stufe (10 nM) von nanoparticulate-Ceroxid ungeschützten Zellen miteinander in der gleichen Weise kommunizierten wie ihre jugendlichen Gegenstücke.

"Wir fanden, daß sie mit der gleichen Robustheit, Geschwindigkeit und Amplitude signalisierten wie die jüngeren Zellen",, Rzigalinski sagt. "Dies zeigt daß es ein Potential gibt nicht gerade die Lebenshandspanne auszubauen aber Funktionen zu bewahren.

Dieses Ergebnis war so erstaunlich, daß die Forscher, "die Versuche mehrmals wiederholten, entsprechend Rzigalinski und fanden, daß Zellen mit einer einzelnen Dosis von Ceroxidnanoteilchen routinemäßig behandelt, als unbehandelte Zellen von drei bis vier Mal, mit der längsten sechs Monate dauerhaften Zelle, länger lebten.

Rzigalinskis Theorie bezüglich des Mechanismus hinter dieser zellularen Anti-Alterungswirkung ist daß die Ceroxidnanoteilchen als freie radikale "Aasfresser" über den Wertigkeitszuständen vom Cer oder Defekten beim Sauerstoffgitter handeln. Man glaubt, daß Schaden an freien Radikalen verursachten Zellen - im wesentlichen instabile Moleküle - ein größerer contributer dazu ist, alt zu werden.
Elektronenmikrotechnikstudien stützen weiter die Theorie der Gruppe. "Wir sehen die Teilchen in den Zellen, und sie neigen dazu, sich mit mitochondria zu verbinden, einem großen Standort von freier radikaler Herstellung", Rzigalinski sagt.

Die Nanoteilchen scheinen im Reinigungsprozeß, als Katalysatoren handelnd, die wiederholt freie Radikale neutralisieren, regenerieren. Rzigalinski vergleicht die Aktion der Ceroxidnanoteilchen im mitochondria - die "Verbrennungskraftmaschine" von Gehirnzellen - mit ihrer Aktion in Selbstmotivkatalysatoren, wo sie benutzt werden, um industriell Oxidationsleistungsfähigkeit zu verbessern. "Was sie für Katalysatoren tun, tun Sie für diese Zellen", sagt sie.

Die Wirkung kann auch nicht von mikromaßstabgetreuen Teilchen von Ceroxid erhalten werden. "Microparticles erweitern longevity nicht und plündern freie Radikale" nicht, sagt Rzigalinski. Die in der Studie benutzten sub-10-nm-Teilchen wurden im Labor von Sudipta Seal erzeugt, Kollegentechnikprofessor in der UCF-Abteilung, daß Materialien für die Raumfahrt von einem Mikroemulsionsprozeß konstruieren.

Gegenwärtig führt die UCF-Mannschaft Studien der Wirkung von Ceroxidnanoteilchen auf der Lebenshandspanne von Fruchtfliegen durch, die üblicherweise für Alterungsstudien benutzt werden, und bisher der "der endet versprechen", entsprechend Rzigalinski. Die Forschungsmannschaft hat auch Studien auf lebendigen Mäusen angefangen.

Sie müssen unter anderen Dingen die Bioverteilung der Nanoteilchen bestimmen (wieviel geht wo) und die Auswirkung von Änderungen der biologischen Umgebung, wie Temperatur, pH, und Kalziumionenkonzentration, auf die Nanoteilchen` Wirksamkeit. Diese Studien werden von einem kürzlich zuerkannten $1.4 Million Subvention von den Nationalen Instituten der Gesundheit unterstützt.

Rzigalinski stellt sich vor daß eine einzelne Dosierungen der regenerativen Ceroxidnanoteilchen benutzt werden könnten, um eines Tages die Alterung im Menschen zu hemmen. "Wir denken daß, wenn wörtlich genommen, [die Nanoteilchen] bioverteilt durch die Zellen des Körpers werden und die Lebensdauer und die Funktion der Zellen verlängern.

Überdies glaubt sie, daß die Nanokristalle benutzt werden könnten, um gewisse Alters-bezogene Erscheinungen - wie Alzheimer oder Parkinson - so gut wie Arthritis und andere gemeinsam-bezogene Probleme zu behandeln.

In einer bezogenen Entwicklung, hat Rzigalinskis Gruppe gefunden, daß die Ceroxidnanoteilchen durchschlagende antientzündliche Wirkung haben. Die Untersuchungsbeamten planen, die Möglichkeit zu erforschen, daß man einen Überzug von den Teilchen schafft, die für vaskulare und orthopädische Implantate benutzt werden könnten, stents und andere Geräte, die zu entzündlichen Reaktionen neigen.

[MRASTA]

Altair Nanomaterials, Inc. Enters Into Agreement With Titanium Metals Corporation

RENO, NV -- (MARKET WIRE) -- 01/15/2004 -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today that its subsidiary, Altair Nanomaterials Inc., has entered into a contract with Titanium Metals Corporation (NYSE: TIE) for development of a low-cost manufacturing process for titanium dioxide pellets, critical to the successful commercialization of the FCC Cambridge process for production of titanium metal. The contract will be funded under Titanium Metals Corporation`s primary U.S. Department of Defense (DOD), Defense Advanced Research Projects Agency (DARPA) contract. Altair will receive $150,000 during the initial six months phase of the agreement. Several follow-on phases should proceed concurrently and sequentially.

As previously announced, Titanium Metals Corporation has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to lead a program for developing an innovative new titanium electrolysis technology originated at Cambridge University and now referred to as the FFC Cambridge Process. The process uses titanium dioxide (TiO2) feedstock. Approximately 1.67 pounds of titanium dioxide feedstock are required to make one pound of titanium metal.

DARPA awarded Titanium Metals Corporation $12.3 million for a four-year development program. Titanium Metals Corporation leads a team of researchers from major defense contractors, including General Electric Aircraft Engines, United Defense Limited Partners and Pratt & Whitney, as well as the University of California at Berkeley and the University of Cambridge, in this development program. The FFC Cambridge Process has the potential to significantly reduce the cost of titanium metal and dramatically expand its use in a wider range of applications that include lightweight armored military vehicles, the manufacture of automotive components and components for utility plants, oil and gas drilling, and lightweight and durable consumer goods.

The agreement between Titanium Metals Corporation and Altair Nanomaterials follows the completion of a development program in which Altair provided Titanium Metals Corporation with samples of customized titanium dioxide cathodes under a July 30, 2003 Memorandum of Understanding.

Under the terms of the agreement, Altair will provide low-cost TiO2 to make customized electrodes for the Titanium Metals Corporation project. Altair believes its ability to control TiO2 particle size, shape and crystalline structure, using its patented process to make TiO2 pigment and nanoparticles, could have a significant benefit to the program. Altair`s new proprietary technology enables production of optimized porosity and custom shaped electrode precursors from either commercial titanium tetrachloride (TiCl4) or from titanium ore digestion solutions, and is described in Altair`s pigment patent, US Patent 6,375,923. "We are excited to be participating in this next-generation technology and are pleased to be working with one of the world`s largest titanium metal producers and aerospace and military industry leaders," says Altair`s president, Dr. Rudi Moerck.

Titanium is the 10th most abundant element in the earth`s crust and the 4th most abundant structural metal. Titanium metal has unique physical and chemical properties including high strength-to-weight ratio, good corrosion resistance and excellent ballistic armor protection while offering appreciable weight reduction over conventional steel and aluminum alloys. It is as strong as steel, but 45 percent lighter. It is 60 percent heavier than aluminum, but twice as strong. Titanium is expensive only because the current process for refining the ore to metal is a multi-step, high-temperature batch process.

According to the AMPTIAC Quarterly, a Department of Defense-sponsored publication, current global production of titanium metal is approximately 50,000 tons per year at a market value of $600 million. AMPTIAC estimates that, due to the current state of manufacturing, titanium is produced at only about 1/20th of its current potential world volume. It is widely believed that a reduction of cost in the manufacturing process will expand the use of titanium metal in a wider range of applications that include lightweight armored military vehicles, the manufacture of automotive components and components for utility plants, oil and gas drilling, and lightweight and durable consumer goods.

Altair Nanotechnologies Inc.

[MRASTA]

mach ich mal die #200 voll :


Stock Of The Week
Picks And Axes For Nanotech Gold
John Dobosz, 01.15.04, 10:59 AM ET

NEW YORK - Josh Wolfe, editor of the Forbes/Wolfe Nanotech Report, strongly recommends buying FEI, the Hillsboro, Ore.-based supplier of charged particle-beam systems used in electron microscopes. At $24.56 a share, FEI trades at the higher end of its 52-week range of $13.55 and $28.75. The company`s current market capitalization is $817 million and it has $252 million in cash; it burned through $25 million last year. FEIC is highly leveraged, with a debt/equity ratio of .91.


Although FEI (nasdaq: FEIC - news - people ) operates in the semiconductor and data storage markets, Wolfe likes it for its growing business as a "picks and axes" player in nanotechnology`s metaphorical "gold rush." FEI`s electron optics business manufactures and markets scanning electron microscopes and transmission electron microscopes, used by a growing number of firms, foundations, and academic institutions doing nanotechnology research. Last month, President Bush signed the 21st Century Nanotech Research and Development Act, which commits $3.7 billion to fund nanotech research over the next four years.


Several nanotechnology stocks have doubled since December, including Nanogen (nasdaq: NGEN - news - people ), Nanophase Technologies (nasdaq: NANX - news - people ), and nanotech investment firm Harris & Harris (nasdaq: TINY - news - people ). Altair Nanotechnologies (nasdaq: ALTI - news - people ) is up 60% in the four weeks since announcing a restructuring to focus their business on nanotechnology development.

[MRASTA]

Nanophase Announces Commercial Availability of New Nanomaterial

Friday , January 16, 2004 10:33 ET
ROMEOVILLE, Ill., Jan 16, 2004 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced commercial availability of a new nanomaterial from the Company`s patented PVS technology. The new nanomaterial, tin oxide, is approximately 30 nanometers with tight particle size distribution and is targeted for electronic applications and transparent conductive coatings.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

"Nanophase is on a fast-track to introduce several new nanomaterials for specific market applications based on market research and end-user feedback," stated Joseph Cross, Nanophase`s president and CEO. "During 2003, we significantly improved the new nanomaterial introduction cycle and expect to introduce several new nanomaterials in response to specific market applications during 2004."

Nanophase has annual full-scale commercial production capability for these materials in the metric ton(s) range manufactured under its ISO-9001:2000 quality system. Nanophase`s nanomaterial products are typically available as nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. For additional information, contact Dr. Ed Ludwig, Nanophase`s vice president of business development at 630-771-6729, or email [e-mail] .

Nanophase Technologies (NANX), www.nanophase.com , provides nanoengineered solutions of nanostructured materials for a variety of industrial product applications. Using patented and proprietary integrated nanotechnologies, the Company creates products with unique performance attributes. Nanophase Technologies currently owns or licenses 23 United States patents and patent applications, consisting of 9 owned United States patents, 8 owned United States patent applications, and 6 licensed United States patents. The Company also has 27 foreign patents and patent applications, consisting of 9 owned foreign patents and 18 owned foreign patent applications, all of which are counterparts to domestic filings covering its platform of nanotechnologies.

[Albatossa]

Hallo MRASTA,

danke für deine Bemühungen! Im Taipan steht darüber nicht soviel!

Gruß Albatossa

[MRASTA]

Tja, machmal kommt es anders als man denkt : Altair 3.90 $ im Moment. Damit ein neues 52W Hoch.

cu

[MRASTA]

Altair Nanotechnologies, Inc. Expands Engineering, Research, and Development Teams
Tuesday January 20, 9:00 am ET

Company Funds Technology Advancements Through the Exercise of $6.1 Million in Warrants to Purchase the Company`s Common Stock

RENO, NV--(MARKET WIRE)--Jan 20, 2004 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) announced today that it is expanding its engineering, research, and development teams. The expansion will be funded by the recent exercise of outstanding warrants by shareholders, which raised approximately $6.1 million over a two-month period beginning mid November 2003. Following the exercise of such warrants, the company has approximately 45.2 million common shares outstanding.

"As a leader in nanotechnology, it is imperative we continue to invest in product innovation and technology leadership," said Altair Nanotechnologies president Dr. Rudi E. Moerck. "We are seeing increased interest from a wide range of industries, in particular pharmaceutical and biotechnology, which are embracing the application of nanotechnology for the development of safer and more efficient sustained release dosage forms for topical and oral medications. The addition of dispersion chemists and material scientists to our already world-class research and development team furthers our strategic goal of positioning Altair at the forefront of this emerging science."

"Over the past eight weeks we have considerably strengthened our balance sheet," continued Dr. Moerck. "The current Altair cash position provides funding through the end of 2004 and beyond, allowing us to more aggressively market our products and services and attend important industry and financial conferences, all of which are expected to increase shareholder value."

[MRASTA]

4.00$ !!!!!!!!!!!!!!!!!!!!!!!!!!


ALTI: Volume Spike; 41% > 20-adsv, Stock +13.58%
Tuesday , January 20, 2004 14:00 ET

This is the 1st VOLUME alert for ALTI in the past 7 calendar days.

Trading for Altair Nanotechnologies Inc (NASDAQ SC: ALTI) has been heavier than usual in today`s session. By 14:00 ET, the stock had already traded 5,409,400 shares via 4,746 trades. The cumulative volume is 40.87% above its 20-day average of 3,839,865. Normally the stock experiences around 2,760 individual trades per session.

So far, today`s volume surge has caused a net rise in ALTI`s stock price. At the time of this alert, the stock was trading at $3.930, up $0.470 (+13.58%).

One year ago, the Company`s shares closed at $0.470. The price has gained more than 736 percent since then.

Over the last 10 trading session ALTI has traded in a range between $3.000 and $3.880 and is currently trading 1.29% above its 52-week high of $3.880 set on January 12, 2004 and 1210.00% above its 52-week low of $0.300 from April 25, 2003.

In the previous 3 sessions, ALTI trading has displayed a mixed trend. Closing results have been as follows:

January 16, 2004 --- closed at $3.460 down $0.090 (-2.54%) on 1,893,000 shares
January 15, 2004 --- closed at $3.550 up $0.180 (+5.34%) on 3,157,000 shares
January 14, 2004 --- closed at $3.370 down $0.280 (-7.67%) on 2,051,000 shares

[MRASTA]

MEDIA: Today`s Wall Street Journal Mentions NANX
Tuesday , January 20, 2004 06:28 ET

The following article appears in today`s Wall Street Journal(tm) discussing Nanophase Technologies Corporation:

"Heard On The Street: Nanotechnology Stocks Rise"

(NasdaqNM: NANX) last traded at $13.60, up $0.00 (0.00%), on 0 shares.

OTHER STOCK(S) MENTIONED:
-- Harris & Harris Group, Inc. (NasdaqNM: TINY)
-- Nanogen Inc (NasdaqNM: NGEN)
-- Veeco Instruments, Inc. (NasdaqNM: VECO)

[MRASTA]

geht doch prima, jetzt müssen die Phases mal wieder eine Schippe nachlegen, damit Altair Sie in der MKT nicht überholt. ;-))))))))

Über 6.6 Mio Teile bei Altair gehandelt. !!!

cu

[Wunram]

hi MRASTA,

habe ich wohl den ersten Teil ein bisschen früh verkauft - aber realisierter Gewinn ist besser als Buchverlust

Danke für deine Mühen der Informationssammlung; momentan habe ich nicht viel Zeit.

Irgendeine news mit Substanz sollte jetzt aber doch mal langsam seitens ALTI kommen, oder?

Gruss Wunram

[MRASTA]

@Wunram

bin auch etwas knapp in der Zeit, zuviel zu tun. Biste denn ganz raus ?

Wo dass alles noch hinläuft weiß doch keiner. Es wird soviel gemurmelt, aber konkret ist davon nix. Ich habe von dem Zeug soviel gehabt, dass mir manchmal ganz anders wurde. Habe immer noch mehr als genug Teile aber Einsatz raus und ab und zu mal ein paar Teile verkaufen hat noch keinem geschadet.

Den Rest bleibt stehen, kann man dann ja wesentlich gelassener angehen.

cu

[MRASTA]

Altair Nanotechnologies and Western Oil Sands Sign Technology Licensing Agreement for Altair Hydrochloric Pigment Process

Friday , January 23, 2004 10:02 ET

RENO, NV, Jan. 23, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a developer and manufacturer of innovative nanomaterial products, has signed an exclusive technology licensing agreement with Western Oil Sands Inc., pertaining to the use of the Altair Hydrochloride Pigment Process (AHPP) to extract heavy minerals from oil sands in Alberta, Canada, and produce titanium dioxide pigment.

Under the terms of the agreement, Western Oil Sands will initially evaluate the AHPP to recover titanium and zirconium in heavy mineral by-products from oil sands tailings taken from various oil sands operations in the Athabasca region in Alberta, Canada.

The license is predicated on Western Oil Sands meeting set development milestones and investment levels to enable further development and commercialization in a three-phased, five-year program. Western has the option upon successful completion of the first phase of the Agreement to expand the geographic region and type of resources to which the license applies, based on its level of investment in a demonstration plant and commercial facility utilizing AHPP technology.

"Alberta`s oil sands tailings will be an excellent demonstration of the AHPP," said Altair Vice President Doug Ellsworth. "These tailings contain an estimated 10 percent heavy minerals, as compared to 2-4 percent typical in heavy mineral sand deposits worldwide. In addition to producing titanium dioxide pigment, the joint venture will evaluate the economics to extract and sell zircon, and to monetize other valuable byproducts such as asphaltenes."

Altair`s proprietary AHHP technology is a comprehensive process for producing white titanium dioxide pigment from a variety of feedstock including hard rock ilmenite ore. It includes a novel combination of processes that extract, purify and form high-quality white titanium dioxide pigment. Distinctive features of the process include projected lower operating costs, minimized environmental and health risks and the recycling of all the chemical additives used in the process. The patented technology has also provided Altair the unique ability to produce a wide variety of nanomaterials with narrow particle size control, chemical purity and particle morphology, at reasonably priced tonnage qualities.

WESTERN OIL SANDS INC.

Western Oil Sands is a Canadian oil sands corporation which holds a 20 percent undivided interest in the Athabasca Oil Sands Project (AOSP). Western and its partners has completed construction of the $5.7 billion (Canadian) first phase of the AOSP. Operations commenced in April 2003 and production at the Project continues to progress towards design production rates of 155,000 barrels per day. At these rates, this initial stage of the project will supply the equivalent of 10 percent of Canada`s oil needs. For additional information on Western Oil Sands, visit www.westernoilsands.com.

[Wunram]

@MRASTA

da sind ja schon news -zwar ohne finanziellen Hintergrund, aber das erscheint doch ein realistisches Ding zu sein. Muss mich am Wochenende mal ein bisschen über Western Oil Sands Inc. und das Projekt schlau machen.

Ein paar ALTIs habe ich noch - zum Glück.

Schönes WE

Wunram

[MRASTA]

[Albatossa]

Hallo MRASTA,

what`s on?

[MRASTA]

ALTI 4.30 $
NANX 14.20 $

da darf man sich ja auch mal freuen, oder ?



ALTI: New 52-Wk High @ $4.400 up 7.32%
Wednesday, January 28, 2004 10:46 ET

This is the 4th 52 WEEK HIGH alert for ALTI in the past 7 calendar days.

The share price for Altair Nanotechnologies Inc (NASDAQ SC: ALTI) reached a new 52-week high today, trading at $4.400, up $0.300 (7.32%) from its previous close of $4.100.

The Company`s previous 52-week high of $4.350 was set 5 days ago on January 23, 2004.

One year ago, the Company`s shares closed at $0.460. The price has climbed more than 856 percent since then.

At the time of this alert, the stock had traded 1,405,800 shares via 939 trades, 69.79% below it`s 20day average of 4,653,650 shares.

This new 52-week high currently puts the stock:

26.01% above its 20day Moving Average of $3.492
74.42% above its 50day Moving Average of $2.523
132.49% above its 100day Moving Average of $1.893

cu

[Albatossa]

Alles klar!

[Albatossa]

Hallo Leute,

der Kurs von Altair stürzt ab! Morgen dürfte soagr die
2 $ Marke fallen. Ob jetzt wieder der Kurse von 0,3Euro getestet werden?


Strong Sell

[Albatossa]

Man sollte es nicht glauben das so eine harmlose Meldung Alti in den Abgrund stürzt! Dabei konnte ich nicht negatives heraus lesen!


Motley Fool
Nano Buzz at Keithley
Monday February 2, 2:45 pm ET
By Seth Jayson


Ah, the magic of a prefix. Thanks to the two following little syllables, "nano," I recently tuned in to the buzz around a small maker of measuring instruments for the semiconductor and wireless industries, Keithley Instruments (NYSE: KEI - News).
"Nano," of course, is Greek for "100% increase in market cap." But a recent newspaper article describing Keithley`s nano-prospects provided only a modest (and quickly reversed) boost to the company`s stock price. That`s pretty odd these days. Especially considering feeding frenzies like the one at Altair Technologies (Nasdaq: ALTI - News), a company with a dubious tech pedigree that seems to produce nothing more technologically advanced than very small rocks.

Keithley, on the other hand, produces the kind of products that could be of actual use in nanotechnology. The firm`s instruments measure tiny electrical charges, among other things, and are used in the semiconductor and wireless industries. Keithley`s current technology, scaled down, would allow for accurate analysis of these new wonder materials. At least, that`s the plan.

Right now, the nanotechnology field is still developing. The industry lacks measurement standards and equipment capable of scrutinizing nano-materials. (It`s difficult to know how much cargo your nanotube space elevator can haul into orbit if you don`t know how tough your nanotubes are.)

Keithley hasn`t exactly been a money-making powerhouse, however. The company just turned in a modest profit for its 2004 Q1, with big increases in orders from Asia and Europe. But a look at the past few years shows that earnings are pretty rare. Is nanotech the cure for Keithley? To its credit, management isn`t saying any such thing. Nobody`s screaming about an up-and-coming billion-dollar market -- a refreshing change from some of the industry hype.

The message here certainly isn`t "buy Keithley" on the hopes that it`s the next nanotech whiz kid. Just keep your eye on it, and the ongoing developments in the industry. Like any new and exciting field, there will be those who strike gold, and those who go bust. Investors will need to be careful to make sure that they end up on the right side.

[Albatossa]

Very small rocks!

[MRASTA]

Tjä, wer hätte dass gedacht ? Rudi will nicht warten, obwohl Forensol noch gar keine Zulassung hat. Haben wohl, im Moment, zuviel Geld in der Kasse oder die Flucht nach vorne. Wie man es nimmt.


Altair Nanotechnologies Announces New Preclinical Testing for RenaZorb(TM)

Company to File IND Drug Application for RenaZorb, Its Drug Candidate for Phosphate Control in Kidney Dialysis Patients

Thursday , February 05, 2004 10:02 ET
RENO, NV, Feb. 05, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a developer and manufacturer of innovative nanomaterial products, announced that it is planning to conduct new preclinical testing of its drug candidate, RenaZorb. The test will use an animal model directly comparing RenaZorb with existing and proposed drugs for phosphate control in patients with End Stage Renal Disease (ESRD) undergoing dialysis. The testing is expected to be initiated within 30 to 45 days. The company also announced that it plans to file an IND (Investigational New Drug) application with the U.S. Food and Drug Administration (FDA).

"Animal testing of RenaZorb (lanthanum dioxy carbonate) will directly compare its phosphate binding capabilities with those of Renagel(TM) (sevelamer) and to lanthanum carbonate tetra hydrate, the active ingredient used in Fosrenol(TM). The testing is designed to establish the dosing requirements for RenaZorb when compared to these drugs," said Altair President Dr. Rudi E. Moerck.

Dr. Moerck noted that previous laboratory testing conducted by Altair indicates dosage requirements to bind a given quantity of phosphate are lower with RenaZorb.

Altair expects the testing process to require approximately 30 days with availability of data analysis expected to require an additional 30 days. "Altair has already reported successful results for phosphate binding in dogs, rats and 5/6 nephrectomized rats and now we believe it is essential to establish the advantage of RenaZorb`s dosing requirements. Lower dosing requirements can lead to fewer side effects, fewer tablets per day, better patient compliance and ultimately a better drug," commented Dr. Moerck.

The Company plans to advance RenaZorb into Phase I clinical trials if the new animal testing is successful in establishing a lower dosage requirement. Phase I clinical testing for RenaZorb would be conducted by a independent Clinical Research Organization (CRO) and should be a minimal expense for the company. Entering into Phase l clinical trials is expected to greatly enhance RenaZorb`s value and the potential out licensing to a pharmaceutical partner.

Altair recently announced that it has significantly improved its cash position through the recent exercise of outstanding warrants by shareholders and currently has a balance of approximately $11.5 million with 48.2 million shares of common stock issued and outstanding. This represents in excess of two years working capital for the company and will assist in the further development of RenaZorb`s Phase l clinical trials and other important development projects.

Altair estimates that the current market for drugs that bind phosphate in patients with ESRD is approximately $600 million.

[MRASTA]

Unglaublich aber immer wenn es droht mal wieder den Bach runterzugehen, zaubern Sie wieder was aus dem Hut. Etwas fett aufgetragen aber wenns hilft, bitte : this could be the first "killer app" for nanotechnology,"

Reicht wohl nicht zu großen Sprüngen aber besser als nichts. So langsam sollte auch mal was umgesetzt werden.



Altair Nanotechnologies Awarded Fourth U.S. Patent
Newly Patented Process for Design, Development, and Production of Titanium Oxide Structures Customized for Titanium Metal Production

Wednesday, February 11, 2004 10:05 ET
RENO, NV, Feb. 11, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a developer and manufacturer of innovative nanomaterial products, today announced the Company was awarded its fourth patent entitled "Method for Producing Catalyst Structures" by the U.S. Patent Office. Patent number 6689716 was issued on February 10, 2004. The inventors of the process are Dr. Bruce J. Sabacky and Timothy M. Spitler, both of Altair Nanotechnologies.

"This patent, which further differentiates us within the rapidly growing nanotechnology market, underscores our commitment to bring nanotechnology out of the laboratory and into commercialization," said Altair President Dr. Rudi E. Moerck. "As previously announced, we were awarded U.S. Department of Defense Advanced Research Program (DARPA) subcontractor status. As a subcontractor, the underlying technology in this patent is already being applied in a development program to produce titanium dioxide electrodes for use in producing titanium metal by a more cost effective process under the DARPA contract."

The subcontract is part of a $12.3 million four-year DARPA prime contract to advance the FFC Cambridge Titanium Process technology for the electrochemical production of titanium metal that promises to significantly reduce the cost of manufacturing this metal and dramatically expand its use in a wider range of applications that include lightweight armored military vehicles, the manufacture of automotive components and components for utility plants, oil and gas drilling, and lightweight and durable consumer goods. "If testing confirms the suitability of our micro-structured electrode materials for titanium metal production -- this could be the first "killer app" for nanotechnology," said Dr. Moerck.

Titanium is the 10th most abundant element in the earth`s crust and the fourth most abundant structural metal. Titanium metal has unique physical and chemical properties including high strength-to-weight ratio, good corrosion resistance and excellent ballistic armor protection while offering significant weight reduction over conventional steel and aluminum alloys. It is as strong as steel, but 45 percent lighter. It is 60 percent heavier than aluminum, but twice as strong. Titanium is expensive only because the current process for refining the ore to metal is a multi-step, high temperature batch process.

According to the AMPTIAC Quarterly, a Department of Defense-sponsored publication, current global production of titanium metal is approximately 50,000 tons per year at a market value of $600 million. AMPTIAC estimates that, due to the current state of manufacturing, titanium is produced at only about 1/20th of its current potential world volume. It is widely believed that a reduction of cost in the manufacturing process will expand the use to approximately one million tons.

The new patent describes the process for making microporous structures that can be used as a catalyst support or for electrode material. The microporous structures have a high porosity and high thermal stability, combined with good mechanical strength and relatively high surface area. In addition to the structures being used in a process to make titanium metal, the process is useful for making titanium dioxide for catalyst structures used for fuel cells, sensors, and electrochemical cells.

ALTAIR NANOTECHNOLOGIES, INC.

[MRASTA]

Nanophase Technologies Announces Pilot Availability of Nanocrystalline Silver Doped Tin Oxide

Monday , February 16, 2004 16:41 ET
ROMEOVILLE, Ill., Feb 16, 2004 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced pilot availability of silver doped nanocrystalline tin oxide. The new nanomaterial is approximately thirty nanometers with a 3% by weight silver content. Nanophase is targeting the material for certain industrial antimicrobial applications such as wood preservation, marine antifouling, specialty paints and coatings, and plastic and rubber additives, as well as conductive coatings and electronic materials.

"Nanophase is targeting antimicrobial applications, both industrial and in personal care, as a potential growth area for nanomaterials," stated Dr. Ed Ludwig, Nanophase`s vice president of business development. "We expect to develop additional materials for these potential markets during 2004."

Nanophase`s silver doped tin oxide consists of non-porous, dense, discrete, homogenous nanoparticles in the thirty nanometer range. The nanomaterial is available in pilot quantities and the Company is interested in joint development opportunities for industrial antimicrobial or electronic materials applications. For additional information, contact Dr. Ed Ludwig at 630-771-6729, or email [e-mail] ; or Bo Kowalczyk at 630-771-6709, or email [e-mail] .

Nanophase Technologies (NANX), www.nanophase.com , provides innovative nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company has 23 United States patents and patent applications and 27 foreign patents and patent applications. Full details on Nanophase may be found in the Company`s public filings or on its website.

[Wunram]

Altair Nanotechnologies Appoints Dr. David King to Board of Directors

18 February 2004, 07:30am ET

Company Restructures Board to Further Its Focus on Nanotechnology

Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a developer and manufacturer of innovative nanomaterials and products, announced today that it has appointed Dr. David S. King to its board of directors.

"We are pleased to welcome such a high caliber talent as David to our board," said Altair Nanotechnologies President Dr. Rudi E. Moerck. "David`s nanotechnology, advanced materials and biotechnology industry expertise should prove invaluable in helping drive Altair`s overall business and product commercialization strategies."

"The opportunity to join Altair`s board of directors is truly exciting," said Dr. David S. King, Managing Partner at Advanced Technology Group. "Of all the nanoscience companies operating in this rapidly emerging market, Altair is among the best positioned to meaningfully deliver nanotechnology across multiple markets. I look forward to working closely with Altair`s senior management team, its existing directors and the investment community."

David King currently serves as Managing Partner for Advanced Technology Group, LLC, a Washington, D.C.-based company that works with research and development enterprises to review emerging technologies. The company also focuses on securing external funding to support technology advancements and accelerate the commercialization of innovative technologies, including nano-structured materials for photonics, opto-electronics, biochemical sensor applications, molecular and organic electronics; and biotechnology.

Prior to founding and managing Advanced Technology Group, David served as Science Advisor, Office of the Under Secretary of Commerce for Technology, for the U.S. Department of Commerce. He has also held scientific advisory, program management and research chemist positions with the National Institute of Standards and Technology. David is a graduate of the University of Pennsylvania, where he received a Doctor of Philosophy degree in Chemical Physics, an Executive Masters of Science and Engineering degree, and a Bachelor of Arts degree with a major in Chemistry.

King fills a board seat recently vacated by Robert Sheldon. Sheldon, a geological engineer and mining industry veteran, served as a director of the company since June 1997.

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


----------------------------------------------------------

Contacts:

Marty Tullio
McCloud Communications, LLC
949.566.9860
[e-mail]

Tracy LaFollette
Altair Nanotechnologies, Inc.
307.587.8245
[e-mail]

[MRASTA]

@Wunram

dat hilft im Moment auch nicht so richtig. Reicht immer nur für einen kurzen Zwischenstop auf der Fahrt nach unten. Es fehlen einfach die echten Aufträge. Das die kommenden Zahlen mehr oder weniger eine Lachnummer, im Verhältnis zur MKT, sein dürften, ist hoffentlich allen klar.

Auch die Phases können durch immer neue Ankündigungen keinen Boden gut machen. Sind doch nun genug Partikelprodukte da, nun müssen die mal an die Firmen gebracht werden.

War bis dato immer das gleiche, wenn die Zahlen sich nähern.

Wie immer alles nur IMHO, versteht sich.

bis dann
mrasta

[MRASTA]

Vietnamese Government Approves $25 Million Project to Produce Titanium Dioxide Pigment; Altair Nanotechnologies Contracts With Avireco USA to Evaluate AHPP for Project
Thursday , February 19, 2004 08:03 ET

RENO, NV, Feb. 19, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies (NASDAQ: ALTI) announced that, in a written statement issued February 5, 2004, the Vietnamese government has approved a $25 million project to exploit, process and export titanium dioxide pigment. Mineral Development Company No. 6 (Lidisaco), a subsidiary of the Vietnam Mineral Resource Department, will develop the project which is expected to produce approximately 10,000 tons of titanium dioxide annually. Deputy Prime Minister Nguyen Tan Dung has approved a plan by the Ministry of Industry and Lidisaco to find additional investment capital for the project by establishing a joint venture with an international partner.

"Phase one of the development program will be funded for approximately $250,000 and will take place over a five-month period," said Altair Nanotechnologies President Dr. Rudi E. Moerck. "The remaining phases of the project are dependent on the outcome of the first phase and the availability of project financing. We are optimistic that Altair`s technology will be very suitable for the Vietnamese titanium mineral deposits that are being considered for the project."

Altair entered into an agreement with Avireco USA, LLC to evaluate Altair`s technology for the $25 million project. Under the terms of the agreement, Altair will determine the suitability of Avireco`s feedstock for producing titanium dioxide pigment using the Altair Hydrochloride Pigment Process (AHPP) during phase one. Upon successful completion of phase one, the agreement provides that Avireco will enter into a licensing agreement with Altair under which Avireco will have an exclusive license to manufacture and market titanium dioxide pigment throughout Vietnam and other countries. Altair will receive royalties on all pigment sold by Avireco.

Under the current project plan, at the completion of phase one, Altair, in conjunction with Avireco, will select an engineering/construction management contractor to design and manage the construction of operational modular facilities for the manufacturing of titanium dioxide pigment using Altair`s patented process. Altair may use part of its existing plant for the demonstration phase to establish design data and project development information. This data will be provided to the general contractor to facilitate the engineering design and building process. The new facilities are planned to initially produce 5,000 tons of pigment per year with the capability to expand to 10,000 tons or more of pigment per year for export purposes.

Altair recently signed a technology licensing agreement for the use of its AHPP process with Alberta, Canada-based Western Oil Sands. Western Oil Sands and its partners have completed construction of the $5.7 billion (Canadian) first phase of the Athabasca Oil Sands Project. Operations commenced April 2003 and production at the Project continues to progress towards design production rates of 155,000 barrels per day. Under the terms of the agreement, Western Oil Sands will initially evaluate the AHPP to recover titanium and zirconium in heavy mineral by-products from oil sands tailings taken from various oil sands operations in the Athabasca region of Alberta, Canada.

Titanium dioxide is the most widely used white pigment in the world. Coatings, plastics, ceramics, inks, and fibers all depend on white pigments to impart color and opacity. This is accomplished either as part of a surface coating such as in paints or by incorporation into the materials themselves such as in plastics or fibers. The total market for titanium dioxide pigment is over 3,500,000 metric tons per year with an annual market value of approximately $9 billion.

[MRASTA]

Ganz schön was los.

Wenn Altair die 3$ nicht halten kann, dann wird es bitter. Und die Phases kämpfen ja auch schon unter der 10$ Marke, könnte auch noch auf 8$ gehen.

Denke mal zum einen, war eine Korrektur lange überfällig. Und dann stehen im März ja die Zahlen an, also sind Gewinnmitnahmen angesagt. Kann auch z.T. daran liegen, dass die NASD eine Verlängerung der Fristen für die Leerverkäufer (statt 20.02 jetzt 01.04) gegeben hat, die erst vor ein paar Tagen veröffentlicht wurde. Scheint so eine Art Misch-Masch aus allem zu sein. Haut natürlich dann richtig rein.

Ist im Moment schwer eine richtige Einschätzung abzugeben. Tendenz ist aber klar Richtung Süden im Moment.

So ist es halt.

mrasta

[MRASTA]

Holla, war ja turbulent.

Altair hat wohl die gestrige Meldung ein wenig gerettet auf der Talfahrt, wären sonst gnadenlos abgetaucht. War teilweise kaum noch ein Bid vorhanden und einige MM´s haben kräftig mitgemischt. Immer diese 100 er und 200 er Teile, da bekommt man schon Krisenanfälle. Und dann kam plötzlich die Wende. Wie weit dieses Bestand hat wird man sehen.


Die Phases haben ja auch erstmal eine Verschnaufpause eingelegt. Da habe ich gar keinen Plan wie das Geschäft gelaufen sein könnte, denke aber eher nicht so umwerfend, also wie gehabt.

mrasta



Altair Nanotechnologies to Present at the Wall Street Analyst Forum Pharmaceutical Conference in New York
Wednesday, February 25, 2004 08:06 ET

RENO, NV, Feb. 25, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies Inc. (NASDAQ: ALTI) announced today that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at the Wall Street Analyst Forum`s Pharmaceutical Conference in New York City on March 1, 2004.

Dr. Moerck will provide an overview of Altair Nanotechnologies` technology platform along with an in depth discussion and update of the company`s patent-pending pharmaceutical, RenaZorb(TM). Additionally, Dr. Moerck will discuss the company`s new nano-based drug delivery system that may possess properties that reduce the potential for the abuse of narcotics.

Altair`s nanomaterial technology has been used in the development of RenaZorb(TM), a phosphate binder for the treatment of elevated phosphate levels in kidney dialysis patients. The market for phosphate binders is currently estimated to be $400 to $600 million and could potentially reach $1 billion with a cost-effective drug that presents lower dosage, fewer side effects and improved patient compliance.

Altair has obtained positive results from both in vitro and in vivo testing in animal models and expects to file an Investigational New Drug (IND) application with the FDA. New animal testing of RenaZorb is planned.

Altair has developed a drug delivery system that differentiates itself from other sustained drug delivery systems currently in use. Altair`s system is comprised of novel micro-porous titanium dioxide spheres that possess customizable pores for sustained release of drugs. The TiNano Spheres(TM) can be combined with drugs that are easily abused and, since the spheres are difficult to mechanically "crush," the TiNano Spheres may represent a unique non-defeatable drug delivery system for use with certain narcotics.

The market for TiNano Sphere delivery systems is for existing pharmaceuticals and new active pharmaceutical ingredients. Altair`s delivery system has the potential of extending the patent life of existing drugs, which could preserve important revenue streams for pharmaceutical companies.

The conference is being held at the Roosevelt Hotel located on Madison Avenue at 45th Street, second floor. Dr. Moerck will be presenting at 9:00 A.M. on Monday, March 1, 2004. For information or to RSVP, please call 802.253.7596.

[MRASTA]

Hosokawa Micron Group, neuer Ableger in den USA (Hosokawa Nano Particle Technology Center USA) hat mit Altair bis zum 1 Januar 2005 einen Kooperationsvertrag geschlossen. Wenigstens mal ein anständiger Name und nicht so ein Fliegenfänger. Mit NanoProducts arbeiten die schon seit 2002 zusammen.

Ein knappes Jahr ist ja nun nicht gerade üppig. Vielleicht kaufen die Altair ja einfach, Knete haben die zumindest reichlich. Mal sehen, was dabei nun wieder heraus kommt.


Altair and Hosokawa Micron International Sign Memorandum of Joint Development Work

Companies Are Working Toward Development and Future Commercialization of Electrode Materials for Batteries, Capacitors and Supercapacitors Manufactured From Altair`s Patented Nanomaterials

Tuesday , March 02, 2004 08:03 ET
RENO, NV, Mar. 02, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies (NASDAQ: ALTI), a developer and manufacturer of innovative nanomaterials and material science-based products, today announced that it has signed a memorandum of joint development work with Hosokawa Micron International, a global leader of powder and particle processing technologies.

Under the terms of the memorandum, which continues through January 1, 2005, Altair Nanotechnologies and Hosokawa Micron will jointly focus on three strategic initiatives: (1) establish a development program using both companies` combined technologies to develop advanced electrode materials for electrochemical devices, which includes batteries, capacitors and supercapacitors from a variety of nanomaterials; (2) strengthen the technical and market position of the companies by combining technological and financial assets, including existing manufacturing capabilities; and (3) apply for U.S. government grants for the development and testing of the electrodes. If the testing is successful, the companies intend provide additional funding for commercialization activities, including erection of dedicated facilities to supply commercial quantities of treated or coated nano-sized cathode and anode materials for use in electrodes for advanced electrochemical devices.

"The agreement to work jointly with Hosokawa highlights our strategic focus of bringing commercial nanomaterial products to market, in particular for use in advanced battery applications," said Altair Nanotechnologies President Dr. Rudi E. Moerck. "Hosokawa`s expertise and intellectual property in the field of nano scale composite technologies compliment the nano-sized cathode and anode materials we currently manufacture, and should greatly reduce time-to-market for real world application of nanotechnology in this market."

"Altair`s success to date with institutions such as Telcordia / Rutgers University and Xoliox / Ntera has made it a nanomaterials leader both in the United States and Europe," said Dr. C.C. Huang, Director of the Hosokawa Nano Particle Technology Center (USA). "Hosokawa Mechano Chemical Bonding Technology is an enabling technique for nanoparticle applications, and it has a proven track of record of improving the performance of electrode material by bonding nanoparticles on it. We believe this agreement will afford both companies technical strategic advantage in securing a commercial position within the developing battery markets using nanoparticles and nanomaterials, and we are excited at the prospect of working with Altair in the coming months."

Studies done by third parties show that Altair`s nano-sized lithium titanate spinel battery material exhibited charge and discharge rates up to 100 times higher than materials used in batteries commercially available. Telcordia recently developed a non-aqueous asymmetric hybrid prototype battery incorporating Altair`s nano lithium titanate spinel. The prototype exceeded DOE/PNGV standards. The article can be found in The Journal of Power Sources, 113 (2003) 62-71 and 115 (2003) 171-178. Nanomaterials are expected to cause a quantum leap in performance, along with a rapid market adoption within the $42 billion battery industry.

HOSOKAWA MICRON GROUP (Hosokawa Micron Corporation is listed in Tokyo Stocks Exchange: 6277)

The Hosokawa Micron Group is a world leader in providing process solutions for powder and particle processing, blown film processing, and in Japan, environmental business. The company is continuing to advance its 88 years of market leadership with the application, development and commercialization of ultra fine composite particles in the rapidly expanding field of nanotechnology. Hosokawa Micron`s three Nano Particle Technology Centers (located in Japan and the USA) are dedicated solely to the development of new functional and value added materials for next generation. For additional information on the Nano Particle Technology Centers, visit our website at www.hosokawanano.com or our corporate website at www.hosokawamicron.com for more information about the Hosokawa Micron Group.

ALTAIR NANOTECHNOLOGIES, INC.

[MRASTA]

Zahlen der Phases sind draußen, lesen kann das jeder selber. ....net loss of $5.8 million, or $0.38 per share (fully diluted) ....

The same procedure as last Year or as every Year, James.


http://www.knobias.com/individual/public/news.htm?eid=3.1.2d…

cu

[MRASTA]

sage mal lieber nix, habe meine Meinung ja in #225 geschrieben.

Und Altair bleibt sich treu, nix konkretes. Übrigends die Zahlen sollen am 16. März nach Börsenschluss kommen.

cu

Altair Nanotechnologies` Algae Prevention Treatment Confirmed Effective in Testing

NanoCheck(TM) Proven in Both Independent and In-House Laboratory Testing

Thursday , March 11, 2004 08:32 ET
RENO, NV, Mar. 11, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies (NASDAQ: ALTI), a leader in nanotechnology, nanomaterials and material science announced today that the safety and effectiveness of its NanoCheck(TM) swimming pool algae prevention compound has been validated in independent testing. Altair also announced that it expects to support a large scale program for swimming pool testing this summer. The success of this testing could result in the commercial launch of NanoCheck in the first quarter of 2005.

"We are pleased to announce that independent testing confirms and validates our NanoCheck algae prevention technology," said Altair President Dr. Rudi E. Moerck. "The test results demonstrate the ability of NanoCheck to supplement and improve currently available swimming pool treatments to prevent algae growth. The results continue to reaffirm the growing acceptance and real-world applications of our nanotechnology platform across multiple vertical markets."

"The first phase of the microbiological performance testing confirms NanoCheck`s ability to retard and prevent algae growth through absorption of phosphates from water," continued Dr. Moerck. "The promising results serve as the springboard for additional testing focused on providing a safe, algae-free environment in swimming pools and spas. Testing of NanoCheck, which is not a biocide, confirmed that it is virtually insoluble in water, a necessary characteristic for materials used for the treatment of swimming pools."

Unwanted algae growth in swimming pools is a dilemma for pool owners worldwide. The National Swimming Pool and Spa Institute reports the market consists of approximately eight million pools and four million existing spas and hot tubs worldwide, with an additional 360,000 pools and approximately 260,000 spas and hot tubs being installed on a yearly basis.

ABOUT NANOCHECK

Altair`s NanoCheck(TM) is a unique nano-structured compound that effectively aids in the prevention of algae growth in swimming pools and reduces filter fouling caused by biomass accumulation. NanoCheck, when used with conventional swimming pool treatments, affords enhanced protection against algae infestation. The compound is highly insoluble in water and works in conventional pool filtration systems. The algae prevention compound is not a biocide, is safe and effective, and requires no pool downtime during the algae prevention treatment. NanoCheck, used with the check-mark symbol is a registered trademark of Altair Nanotechnologies.

[MRASTA]

Wohl schon ein Vorbote auf die prikelnden Zahlen heute, die nach Börsenschluss kommen sollen, oh weh, dürften wohl dann doch da liegen, siehe #223, also warm anziehen.




Altair Nanotechnologies Announces Plans to Form Life Sciences Division and Spin Off Mineral Recovery Systems Group

Tuesday , March 16, 2004 07:34 ET
RENO, NV, Mar. 16, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies Inc. (NASDAQ: ALTI)), a company engaged in developing nanomaterials, titanium dioxide pigment technology, and manufacturing technologies for unique nanostructures, announced four additional steps in its restructuring program: 1) The decision to form a new life sciences division alongside its existing nanomaterials division as part of its initiative to focus on specific vertical markets, 2) The decision to spin off its mineral assets to its shareholders, 3) The resignation of Altair Chief Executive Officer Dr. William P. Long, and 4) The appointment of Dr. Rudi E. Moerck to senior executive officer upon Dr. Longs resignation.

The new life sciences division will focus on the continued development of pharmaceutical delivery structures (TiNano Spheres(TM)), dental materials and new nano-based pharmaceuticals including Altair`s lead drug candidate, RenaZorb(TM). "We realized that with the diversity of our markets, we will better direct our development, sales, marketing and out-licensing efforts by organizing these various markets into two divisions led by industry-specific management," said Altair President Dr. Rudi E. Moerck. "Altair will immediately implement a search for a senior vice president for the new life sciences division."

The Altair nanomaterials division will focus on materials science and on markets such as TiO2 pigment, TiO2 electrodes for titanium metal, nano-structured materials for lithium ion batteries and fuel cells, along with NanoCheck(TM) for the prevention of algae growth. The division will continue under the direction of Senior Vice President Douglas K. Ellsworth.

Altair plans to distribute (or spin off) to its shareholders the capital stock of a subsidiary holding the assets of the current Mineral Recovery Systems (MRS) division. Altair intends to solicit shareholder approval for the spin off and complete the filings necessary to make MRS a reporting company. MRS will hold the rights to the exploration-stage mineral deposit in Camden, Tennessee, the ownership of the Altair centrifugal jig and related intellectual property for agglomeration of titanium dioxide.

Dr. William P. Long will resign his position as Chief Executive Officer and member of Altair`s board of directors as of May 1, 2004. Dr. Long is expected to serve as the President of MRS and, during the period preceding his resignation, will focus most of his efforts on structuring and effecting the spin off of MRS. "It has been my pleasure to serve as Altair`s CEO," said Dr. Long. "Our strategic focus and long-term revenue objectives are best served by this new division of labor, and I look forward to driving the success and growth of MRS."

Upon Dr. Long`s resignation, Dr. Rudi E. Moerck, President of Altair, will become Altair`s senior executive officer and will continue to be responsible for day-to-day operations of the company and for implementing its strategic plan. "We are indebted to Dr. Long for his leadership of the company, particularly for his insight in structuring the transactions necessary for Altair to acquire its nanomaterial and titanium processing technology," said Dr. Moerck.

The company intends to commence a search for a new non-executive Chairman of the Board of Directors to work with Dr. Moerck and the board in their efforts to focus Altair`s resources on generating revenue and increasing shareholder value. Dr. Moerck noted that Altair will capitalize on the significant expertise of its board and senior management and expects them to take a hands-on approach to establishing the company`s growth strategy and goals, while closely monitoring the progress of each.

[MRASTA]

Etwas spät dran die Herrschaften.

Altair Nanotechnologies Inc. Announces Fourth Quarter and Year-End Financial Results Conference Call
Wednesday, March 17, 2004 11:36 ET

RENO, NV, Mar. 17, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies Inc. (NASDAQ: ALTI), a company engaged in developing nanomaterials, titanium dioxide pigment technology, and manufacturing technologies for unique nanostructures, announced today it will hold a quarterly conference call to discuss fourth quarter and year-end financial results for fiscal 2003 on Thursday, March 25, at 11:30 a.m. Eastern Standard Time. Shareholders and members of the investment community are invited to participate in the call.

[MRASTA]

Altana steigt in Nanotechnik ein

Je kleiner, desto besser ? viele Investoren sehen in der Nanotechnologie das Geschäft der Zukunft. Nun setzt auch Altana auf diesen Trend und beteiligt sich an der US-Firma Nanophase.



Altana hofft auf die Nanotechnologie als künftiges Milliardengeschäft


Der Bad Homburger Pharma- und Spezialchemiekonzern erwirbt sieben Prozent der Anteile an Nanophase und übernimmt dazu Aktien im Wert von 10 Millionen Dollar. Damit wird Altana der größte industrielle Investor bei dem US-Unternehmen. Die Beteiligung untermauert eine gleichzeitig geschlossene "exklusive" Forschungskooperation: Gemeinsam sollen chemische Nano-Materialien entwickelt werden, die etwa in Holz- und Fahrzeuglacken zum Einsatz kommen könnten.

Nanophase an der Börse hoch bewertet
Die an der US-Hightech-Börse notierte Nanophase stellt Partikel her, die zum Beispiel in Autolacken oder Sonnencremes zur Abschirmung vor ultraviolettem Licht eingesetzt werden. Zwar hat das Unternehmen in den ersten neun Monaten des vergangenen Jahres den Umsatz auf 4,3 Millionen Dollar gesteigert, macht aber immer noch Verluste. An der Börse wird Nanophase mit 130 Millionen Dollar bewertet. Die Aktie hat zuletzt eine Berg- und Talfahrt erlebt. Anfang des Jahres kletterte der Kurs auf das Rekordniveau von 14 Dollar, bevor er auf rund acht Dollar abstürzte. Anderen Nano-Aktien wie Nanogen und Altair Nanotechnologies sowie den wenigen einschlägigen Fonds erging es ähnlich.

Langfristiges Mega-Potenzial
Doch die kurzfristigen Spekulationsblasen können nicht darüber hinwegtäuschen, dass die Nanotechnologie das Zeug zu einer gigantischen Boom-Industrie hat. Experten sehen in ihr die "nächste Biotechnologie". Bis zum Jahr 2010 prophezeien optimistische Studien einen Umsatz von einer Billion Dollar in der "Zwergen-Industrie".

Dabei ist Nanotechnologie ein sehr unscharfer Begriff. Vereinfacht gesagt, fasst er alles zusammen, was die Verkleinerung von Strukturen auf winzige Dimensionen zum Inhalt hat. Nano-Entwicklungen gibt es in der Chemie genauso wie in der Ingenieurtechnik oder der Medizin. Gemeinsam haben all diese winzigen Produkte, dass sie neuartige Strukturen auf molekularer Ebene schaffen, die um ein Vielfaches effizienter sind als andere Materialien. So können Nano-Chips tausend Mal mehr Daten speichern als klassische Halbleiter. Auch im Flugzeug- und Autobau sowie in der Medizin lassen sich Nano-Produkte gezielt einsetzen. In der Medizin könnten Nano-Roboter beispielsweise geschädigte menschliche Zellen reparieren. Wiederaufladbare Batterien mit Nanotechnik könnten Elektronikgeräte sehr viel länger mit Strom versorgen. Die Silbe ?Nano? kommt aus dem Griechischen und heißt "Zwerg"; ein Nanometer ist ein Millionstel Millimeter.

[MRASTA]

eigentlich gar keine Zeit heute, für die Börse, aber ist ja so einiges los.


Für Altair ist heute der Tag der Zahlen, sollen vor Börseneröffnung kommen. Einen solchen netten Deal haben Sie wohl nicht im Koffer, wird wohl eher betrüblich, es sei denn, Nano ist durch die Phases wieder in.

Erwartet wird in etwa folgendes :

ALTI: To Release Q4 Results Mar 25 [BMO]
Wednesday, March 24, 2004 13:00 ET

Altair Nanotechnologies Inc (NasdaqSC: ALTI) is scheduled to release its Q4 financial results on March 25, 2004, before the market opens (BMO).

CONSENSUS ESTIMATES:

Q4 Revenue: $0.07 million
Q4 EPS: $-0.09 per share

FY Revenue: $0.11 million
FY EPS: $-0.25 per share



Zumindest gibt es so den einen oder anderen der noch eine Meinung hat, wie auch immer er dazu kommt :

RATING(=): Shonstrom Keeps ALTI Rating @ Trading Buy; Keeps Tgt @ $6

Monday , March 22, 2004 15:41 ET
Issuer: Altair Nanotechnologies Inc (NasdaqSC: ALTI)
Analyst Firm: Shonstrom Research Associates LLC

Ratings Action: REITERATION
Current Rating: Trading Buy

Target Price Action: MAINTAIN
Target Price: $6.00

This rating information was reported by shonstrom research associates.

cu

[MRASTA]

nochmal das Wesentliche zu den Phases :

Altana has purchased 1,256,281 restricted shares of Nanophase common stock at a purchase price of $7.96 per share, or an aggregate of $10 million in cash.....trading of which will be restricted for a period of two years

The current stake of 7% will make ALTANA Chemie the largest industrial investor of Nanophase.

Based on the agreement, ALTANA Chemie will have exclusive access to Nanophase`s technology within the field of application. The agreement has a term of eight years.


cu

[MRASTA]

schon ganz schön Betrieb bei den Phases drüben, Kurs im Moment 10.25 $ , geht aber ziemlich wild hin und her.

Schwapp nun 10.40 $

Schaun wir mal.

cu

[MRASTA]

zu wilder Handel dort,

LAST MATCH
Price 10.2200
Time 8:14:42

Price 10.3700
Time 8:15:44

cu

[Wunram]

@all

Altair Nanotechnologies Reports Year-End Financial Results for 2003

25 March 2004, 10:00am ET

Altair Strengthens Balance Sheet by Approximately $11 Million Through Exercise of Options and Shareholder Warrants

Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures, today reported financial results for its year ended December 31, 2003.

The company reported revenue for fiscal 2003 of $72,851, a net loss of $6.2 million, and a net loss per share of $0.19, compared to fiscal 2002 revenue of $253,495, a net loss of approximately $10 million, and a net loss per share of $0.40


Also
Jahresumsatz: $72.851
Verlust: $6,2Mio
Verlust/Aktie: $0,19

aktuell +12% aber eher wegen der Nanophasemeldung als wegen der Zahlen, oder?

den Rest gibts hier: http://finance.lycos.com/qc/news/story.aspx?story=40930489&s…" target="_blank" rel="nofollow ugc noopener">

http://finance.lycos.com/qc/news/story.aspx?story=40930489&s…


Gruss Wunram

[MRASTA]

tja, was soll man dazu noch sagen.

Aber Rudi hat sich mit dem folgenden soweit aus dem Fenster gelehnt, IMHO, dass es jetzt keinen Weg zurück gibt, Sekt oder Selter heißt es, darum wohl nicht nur alleine durch die Phases der Anstieg heute.


As of December 31, 2003, Altair`s cash position was approximately $3.6 million;

Altair`s cash position as of March 25, 2004 is approximately $11.6 million.

dann kommt natürlich logischerweise dass, durch die Umwandlung : ....increased the number of common shares issued and currently outstanding to approximately 48.2 million.


..during 2003 and the first quarter of 2004, have been successful in securing development
contracts, grants, and licensing agreements with major companies.

Our sales backlog for 2004 is already approximately $780,000. In addition, our current pipeline of signed contracts to be performed during 2005 and contracts
with a high probability of success is approximately $1,500,000, for a total of approximately $2,280,000," continued Dr. Moerck. "These revenue contracts are
supplying work in areas with large long term potential payoffs, such as titanium metal, and funding development of our intellectual property portfolio.

Oha,


"We are only now beginning to realize the benefits of our business strategy," said Dr. Moerck. "The first quarter of 2004 has already begun to show
proof-of-concept of our technology, not only from the number of grants and strategic partnerships forged, but also from our progress toward potential
commercial sales for several products, including NanoCheck."


Dürft Ihr euch in Ruhe hier reinziehen :


http://knobias.tenkwizard.com/filing.php?repo=tenk&ipage=268…

mrasta

[MRASTA]

Für alle, die mal einen Überblick über Altair haben wollen, ist der Q-Bericht wirklich zu empfehlen. Es werden alle Gebiete dargestellt. Da hat sich aber diesesmal einer echte Mühe gegeben.

Die grotten schlechten Zahlen sind einfach so untergegangen, in dem ganzen Aufwind. Hauptsache aus dem Lüftchen entwickelt sich mal was.


http://knobias.10kwizard.com/filing.php?repo=tenk&ipage=2690…

cu

[MRASTA]

Merrill Lynch Creates `Nanotech Index` To Track Evolving Industry; Index Includes U.S. Shares, ADRs; American Stock Exchange Will Quote Measure Intraday

NEW YORK--(BUSINESS WIRE)--April 1, 2004--Merrill Lynch (NYSE:MER) today introduced the "Merrill Lynch Nanotech Index," which, effective immediately, will be quoted intraday on the American Stock Exchange under the symbol NNZ.



The Merrill Lynch Nanotech Index, designed to help investors track the developing area, is an equally-weighted index of 25 nanotechnology companies headquartered in the United States or traded through American Depositary Receipts (ADR).

Each company included in the index has a significant percentage of its future profits tied to nanotechnology. In addition, each company`s stock must trade largely based upon its nanotechnology business. Companies that have significant nanotechnology efforts, but are traded based primarily upon other business lines, are not included in the index. Types of companies involved in the index include: semiconductors, biotechnology, instrumentation, sensors, diagnostics, drug delivery, drug development, genomics, and materials.

Nanotechnology Could Be Next Growth Innovation

"We believe nanotechnology could be the next growth innovation," Steven Milunovich, Merrill Lynch`s Global Technology Strategist, said in a research report outlining the new index.

"Like the Internet, nanotechnology risks being overhyped," he said.

Mr. Milunovich noted that there are two significant differences between the Internet and nanotechnology. "Unlike the Internet, significant intellectual property and patents are barriers to entry, and yet barriers to adoption are low."

Nanotechnology is the science of fabricating things smaller than 100 nanometers. One nanometer is one-billionth of a meter. Merrill Lynch believes nanotechnology is the next logical step in miniaturization and that it is only a matter of time before the impact is felt in many industries. "Building at the nano-scale enables new interactions in materials, semiconductors, and biological agents," said Mr. Milunovich. "The new scale allows manipulation on the cellular level, which should enable new discoveries in pharmaceuticals, biodefense, and many healthcare industries."

Early-Stage Venture Capital Investor Sees Nanotech As "Next Great Wave"

"At Draper Fisher Jurvetson we believe nanotech is the next great wave in technology," said Managing Director Steve Jurvetson. "The challenge we face as early-stage venture capital investors is bridging the here and now with nanotech`s long-term future."

"Merrill Lynch`s new stock index allows investors and managements to track the progress of nanotechnology as it evolves. Nanotech is becoming the nexus of the sciences, so it`s appropriate that the technology strategy team at Merrill Lynch is taking the lead in researching this multidisciplinary field," he added.

Steven Milunovich ranked seventh in the March 2004 Forbes/Wolfe Nanotech`s Power Elite survey. For more information, please visit www.forbesnanotech.com.

Merrill Lynch is one of the world`s leading financial management and advisory companies, with offices in 35 countries and total client assets of approximately $1.5 trillion. As an investment bank, it is a leading global underwriter of debt and equity securities and strategic advisor to corporations, governments, institutions and individuals worldwide. Through Merrill Lynch Investment Managers, the company is one of the world`s largest managers of financial assets, with assets under management of $500 billion. For more information on Merrill Lynch, please visit www.ml.com.

Editors Note: A copy of Merrill Lynch`s research report on the new Merrill Lynch Nanotech Index can be found at http://www.cwes01.com/9093/24013/ds/4351_747.pdf

[MRASTA]

Kleiner Nachtrag.

Altair und die Phases sind natürlich auch dabei. Schaut euch mal den Handel an in USA.

cu

[MRASTA]

Unglaublich, die spinnen die Amis.

Altair +19%
Phases +12%

im Moment. Tok, tok, und kaufen wie die Blöden.

cu

[Albatossa]

Hallo MRASTA,

es sind sogar +27% geworden!

[MRASTA]

Hallo Albatossa,

wau, da ging fast bei allen die Post ab.

Das Sie Altair mit in dem Index haben, ist schon Sensationell zu nennen. Da fällt mir nix mehr zu ein.

Wie dem auch sei, was besseres konnte gar nicht passieren.
Über Nacht hat "Nano" einen ganz anderen Stellenwert bekommen. Sachen gibt es.

Schaun wir mal, was daraus wird.

gruss
mrasta

[MRASTA]

Prima Developments announces nanotechnology research and development agreement

TSX Venture Exchange Symbol: PID
Thursday , April 08, 2004 16:10 ET

VANCOUVER, Apr 08, 2004 (Canada NewsWire via COMTEX) -- Prima Developments Ltd. (TSX Venture - PID) through its wholly owned subsidiary Envirocoat Technologies Inc. the global owner, producer and distributor of high performance paint and coating products, today announced it has entered into a research and development agreement with U.S. based Altair Nanotechnologies Inc. (NASDAQ: ALTI).

Prima, in conjunction with Altair, will analyze how high surface area nanomaterial titanium dioxide (Ti02) products will help enhance the distinctive thermal barrier and moisture resistant properties of its Envirocoatings` Ceramic InsulCoat product, while providing Altair`s added benefits of superior UV absorption. Prima will also evaluate how the addition of Altair`s TiNano Spheres will help increase the insulation and hiding power capability of Prima`s flagship product, Ceramic InsulCoat. The agreement facilitates the integration of Altair`s Ti02 nanomaterials into Prima`s Ceramic InsulCoat product line for initial testing and evaluation.

"Management is constantly exploring new ways to improve our products and enhance their functionality," said Roland Langset, President and CEO of Prima. "We believe our agreement with Altair will provide a unique opportunity for Prima to continue augmenting the many features and benefits of our product suite, specifically with regards to our Ceramic InsulCoat Exterior and our Ceramic InsulCoat Roof product lines. Nanotechnology has a number of applications and this collaboration with Altair reflects our commitment to driving the commercialization of our products. We are excited to have established a relationship with a company that provides expertise in this new sector."

[MRASTA]

Wau, schaut euch mal das Volumen bei Altair an. Und es gehen echte Brocken über die Wupper, sowohl auf der einen als auch auf der anderen Seite. Da geht echt was ab heute.

Scheint als wenn einer aussteigt und ein großer einsteigt, bei dem Volumen.

67000 im Bid zu 3.54 und 14000 im Ask zu 3.55 im Moment.

cu

[MRASTA]

Boa, 110000 im Bid und das Ask ist futsch.

cu

[MRASTA]

Volume: 3,247,300

so, das große Umschichten scheint beendet. Und wenn dem so ist oder war, dann sollte sich der Kurs eigentlich auf diesem Nievau stabilisieren. Aber, was haben wir nicht alles schon erlebt, warten wir es ab.

cu

[MRASTA]

Pustekuchen, bei -5% gelandet.

War wohl eine short squeeze mit anschließender Marktanpassung. Sobald der Zwangs-Käufer weg war, ging es gen Süden. 4,4 Mio Teile gehandelt. D.h. der hat anscheinend seine Teile gleich wieder auf den Markt geworfen, um den Verlust so gering wie möglich zu halten. Shit happend.


cu

[Wunram]

Guten Morgen ALTI-Freunde

Empfehlung von Midas Research
10 Seiten

http://www.cortalconsors.de/research/magazin/_newsData/midal…

Gruss Wunram

[Wunram]

ALTAIR NANOTECHNOLOGIES ANNOUNCES NEW BOARD OF DIRECTOR APPOINTMENTS



RENO, NV – April 22, 2004 – Altair Nanotechnologies, Inc. (Nasdaq:ALTI) a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures, today announced the appointment of Dr. Christopher E. Jones to its board of directors. The company also announced the appointment of current board member, Jon N. Bengston, to the position of interim chairman of the board, replacing former chairman William P. Long. These appointments will be effective May 1, 2004.

“We are pleased to announce the addition of Dr. Chris Jones to our board of directors,” said Dr. Rudi E. Moerck, president and senior executive officer for Altair. “Chris’ extensive chemical and manufacturing industry background will serve Altair well as we continue our focus on taking nanotechnology out of the lab and into real world commercial production.”

Dr. Moerck continued, “We are also delighted to announce the appointment of Jon Bengston to interim chairman. Jon’s industry expertise and prior experience as an Altair board member make him a perfect candidate for interim chairman, as we move forward in building a world class nanotechnology-focused board of directors.”

“It is a pleasure to join the board of an emerging industry leader such as Altair,” said Dr. Christopher E. Jones. “The company has been gaining tremendous momentum in the marketplace, and its innovative technology has positioned Altair to lead the sector in the application of nanomaterials. I look forward to working closely with the entire team and board of directors.”

About Dr. Christopher E. Jones
Jones joins Altair after an extensive career in global manufacturing operations in the chemical and coatings industries. He currently holds the position of Senior Vice President of Manufacturing and Engineering for Behr Process Corporation, a division of Masco Corporation, where he is responsible for construction and operation of all coating plant operations for the largest DIY architectural coatings company in North America.

Prior to Behr, Jones held the positions of President of Kronos Louisiana and Vice President of Manufacturing for Kronos International, the fourth largest producer of titanium dioxide in the world, with plants in the U. S., Germany, Belgium, Norway, and Canada. Jones also served as Vice President of Manufacturing and Plant Manager for Degussa U.S. and Degussa A.G. Germany. During his tenure, Jones grew the U.S. operations to become the their largest plant site in North America, focusing on manufacturing a wide range of fine organic chemicals including amino acids, herbicide precursors, silica pigments, and many other organic and inorganic chemical products.

Jones received a Ph.D. in Organo-Metallic Chemistry from Michigan State University, a B.A. in chemistry from Oakland University, and engaged in post-doctoral work at both the University of Leeds, England and University of Alberta in Edmonton, Alberta.

About Jon N. Bengston
Mr. Bengston has been an Altair board member and Chairman of the Altair audit committee since 2003. Mr. Bengtson also serves as the Chairman of the Boards of Radica Games Limited and The Sands Regent, both NASDAQ National Market system companies.

Mr. Bengston is active in community organizations and is the Treasurer and member of the Board of Directors of the National CMP, a Director of Step 2 & Lighthouse of The Sierra, and is Chairman of the University of Nevada, Reno College of Business Advisory Board. Mr. Bengtson also serves as the Civilian Aide to the Secretary of the Army for the State of Nevada. Mr. Bengtson holds a B.S. in Business Administration and a Master of Business Administration from the University of Nevada, Reno.

ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Altair Investor Relations Information

To request an investor kit to be mailed to you, click here.

To receive email alerts on future news releases, attend online corporate events, and provide your valuable feedback directly to management, click here.

[MRASTA]

Hi Wunram,

hart ist das Zigeunerleben.

Die Phases kommen irgendwie nicht so richtig weiter, seit Jahren das selbe Lied. Ok, Cash haben Sie durch den Altana Deal, und auch eine Anwendung mit Rohm. Die müssen Sie nun aber auch erstmal an den Mann bringen.

Und Altair, versucht mit immer neuen Köpfen endlich mal ein bischen Ordnung und eine Linie in den Laden zu bringen. Wurde auch höchste Zeit. Aber solange Sie nix auf einem Feld mal wirklich beschicken, sondern sich stattdessen mit dem einen Shareholder rumschlagen, Mining Business raus oder rein oder auch nicht oder wie oder was, wird dass nix. Hoffe mal, das Sie durch die neue Ausrichtung noch so gerade die Kurve bekommen.

Große Sprünge nach oben sehe ich Moment aber weder bei den Phases noch bei Altair. Erst wenn mal eine wirklich substanzielle Meldung kommt, wird sich das ändern.

Bleibt zu hoffen, dass sich in dieser Hinsicht mal was tut.

gruss
mrasta

[Wunram]

Hallo MRASTA,

was sgt man dazu?

Major Shareholder of Altair Nanotechnologies, Inc. Calls for Termination of Mining Directors, Personnel and Projects

22 April 2004, 8:56pm ET

RENO, Nevada, April 22 /PRNewswire/ -- Lou Schnur, a major shareholder of Altair Nanotechnologies, Inc. (Nasdaq: ALTI), today called on Altair`s directors to instruct management to immediately sell or mothball its chronically unprofitable mining operations and focus exclusively on nanotechnology opportunities.

Altair is a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures.

Schnur has filed a Schedule 13D with the Securities and Exchange Commission outlining generally the views expressed in this release.

Schnur, a CPA, longstanding Altair investor, and 9.9% beneficial owner of Altair`s outstanding stock and warrants, said Altair`s mining operations appear to have generated economic losses of $30 million from 1973 through 2003. Also, Schnur criticized the proposed action by Altair to spin off the mining operations as a further distraction and waste of corporate assets.

Schnur said, "The continuing costs to maintain mining personnel and operations, together with attendant legal, accounting and shareholder solicitation costs necessary to implement a spin-off, are economic losers. The assets are carried on Altair`s books at zero value, have never produced significant revenues, much less profits, and they should either be sold or mothballed quickly."

Schnur said he supports Altair`s December 19, 2003 announcement of a restructuring program whereby the two development stage mining projects would be terminated, so that Altair could focus 100% of its personnel and other resources on its most promising business enterprise, the Reno, Nevada Materials/Nanotechnology Division.

But he says that a March 16, 2004 Altair announcement is contradictory to the stated goals of the restructuring in that there would be a continued focus on mining activities. That release states in part:

"Altair plans to distribute (or spin off) to its shareholders the capital stock of a subsidiary holding the assets of the current Mineral Recovery Systems (MRS) division. Altair intends to solicit shareholder approval for the spin off and complete the filings necessary to make MRS a reporting company. MRS will hold the rights to the exploration-stage mineral deposit in Camden, Tennessee, the ownership of the Altair centrifugal jig and related intellectual property for agglomeration of titanium dioxide.

Dr. William P. Long will resign his position as Chief Executive Officer and member of Altair`s board of directors as of May 1, 2004. Dr. Long is expected to serve as the President of MRS ... "

Altair`s SEC report on Form 10-K for the fiscal year ended December 31, 2003 disclosed aggregate losses of $17.6 million, by subsidiaries, relating to the centrifugal jig and the Tennessee mining projects. Schnur said he believes the reporting of "subsidiaries losses," as being indicative of total mining losses, is understated and misleading.

Schnur also said, "After reviewing the financial statements in the SEC filings, and as an active shareholder (and a CPA, formerly employed by Price Waterhouse & Co.), it is my opinion that a more realistic economic assessment of Altair`s $46 million loss, from inception in 1973 to December 31, 2003 (30 years) is:

Mining development projects division - 30 years $30 million
Reno materials/nanotech division - 3 years $16 million
Altair`s total loss from 1973 - December 31, 2003 $46 million."
Schnur said he believes shareholder value will be maximized by the immediate termination of mining personnel and of all controllable mining expenditures, and the disposal of the mining projects by public auction, prior to December 31, 2004. The auction should be advertised in "The Northern Miner," with project descriptions mailed to potential interested companies and investors. Altair alumni, suppliers, business prospects and others would have equal opportunity in a public auction.

A definitive, comprehensive disposal of the mining projects will bring closure to a long-term, failed business venture (and to Altair`s team of mining directors and managers), maximize Altair`s chances for commercial success, and hopefully set the stage for a long overdue return on investments made by Altair shareholders, Schnur said.

To explain his reasoning in estimating Altair`s mining losses, Schnur noted that Altair`s only business until November 1999 was mining, and that it did not have significant nanotech expenses until 2001. In November 1999, Altair purchased certain technology assets from BHP Minerals International, Inc. (BHP), including, for a one-year period, the services of certain BHP personnel involved in the development of the acquired technology. Accordingly, Altair did not incur salary expenses for the technology operation from November 15, 1999 through November 15, 2000, since these expenses ($1,535,985) were part of the total $9,625,560 purchase price Altair paid BHP.

Altair reported in its Form 10-K for 2000 that it had accumulated deficits during the development stage of $21,606,378, virtually all of which, Schnur says, was attributable to mining.

As to years following 2000, Altair reported in its annual report for 2003
that "management views the company as being three business segments:
Nanomaterials and Titanium Dioxide Pigment Technology, Tennessee Mineral
Property, and the Jig." The following "Loss from Operations" was also
reported:

Unallocated Tennessee Jig Mining Total
2003 $2,778,885 $155,709 $27,729 $183,438
2002 1,871,953 598,977 2,929,010 3,527,987
2001 2,006,198 930,777 300,913 1,231,690
TOTALS $6,657,036(B) $1,685,463 $3,257,652 $4,943,115(A)

Mining Deficits from April 9, 1973 through December 31, 2000 $21,606,378

Mining Deficits from 2001 through 2003 (A) 4,943,115

Estimated allocation of one-half of the $6,657,036
"unallocated expense" to the Tennessee Mineral Property
and the Jig. (B) 3,328,518

Actual Mining Loss from inception through 2003 $29,878,011
Together with the Reno building and cash realized from the exercise of warrants (as a result of investor enthusiasm for Altair`s Nanotech Division), the nanotech assets are the only significant assets on the December 31, 2003 Balance Sheet. The mining projects were written off. Schnur said he believes that Altair should have established a "Reserve for Loss on Disposal of Mining Projects" at December 31, 2003.

Schnur noted that the President`s Message in Altair`s 2000 annual report stated " ... the Camden titanium deposit, with its tremendous resource value, remains the financial underpinning of the company. We have continued with our deliberate development of the property as the world capacity for extraction of titanium mineral resources has continued to decline."

"After $30 million of losses, and diminished odds of obtaining necessary mining permits, as well as a viable operating partner," Schnur said, "it is time to cut the mining loss and give 100% to Materials/Nanotech. In my opinion, the losses actually attributable to the mining operations are greater than the amounts that have been reported."

All of Altair`s directors and senior management were mining personnel until Rudi Moerck was hired in March 2002, a move Schnur supports. The mining division had offices, in Cody, Wyoming and Reno, Nevada (complete with jig). The Tennessee pilot plant and tailings pond were constructed and operated in 2000-2001. The BHP purchase was mostly paid from $8,904,029 received for common stock sold in 2000 (at an average price of $2.36). Altair`s proceeds from the Doral 18 LLC loan provided very little net cash to Altair; the loan carried a very high interest rate; and the loan resulted in significant dilution since warrants were issued as part of the loan, and significant repayments were made in common stock, at historically low prices.

Schnur said that four months after the December 2003 restructuring announcement, Altair continues the mining payroll, lease payments to Tennessee landowners, engineering support for the jig in Africa, maintenance and environmental exposure for the pilot plant and tailings pond, an office in Cody, etc. Moreover, the spin-off might generate another $500,000 of expenses to be borne by Altair. Shareholders should demand that Altair directors order the immediate termination of this wasteful spending.

This release is not intended, and does not constitute a solicitation of proxies by Schnur or any other person or group. Instead, in the interest of open shareholder communications, and in accordance with applicable SEC rules, it is intended to promote open communication among all shareholders concerning their views on the policies and decisions of Altair`s management.

SOURCE Lou Schnur
-0- 04/22/2004
/CONTACT: David Margulies, [phone] or [phone], for Lou
Schnur/


Gruss Wunram

[MRASTA]

Hi Wunram,

in meinem nächsten Leben werde ich Hellseher, völlig klar.

Bin echt platt, Sachen gibt es.

Muss mir dass erstmal in Ruhe durchlesen. Weißte eigentlich wer dieser Schnur ist, weiß nicht ob es in der Meldung drinsteht ? Ne, kein Wunder, der gute Mann ist Besitzer eines Autohauses, gut nicht. D.h. der spekuliert anscheinend mit seiner gesamten Knete und nun geht Ihm, sorry, der Arsch, auf Grundeis.

Gefällt mir, so aus dem Bauch raus überhaupt nicht. Den Sektor aufzugeben, halte ich zum jetzigen Zeitpunkt, für keine kluge Entscheidung. Solche Verfahren werden dringend gebraucht und gerade TIO2 wird noch ein ganz wichtige Rolle spielen in Zukunft. Die Knete die da verbraten wurde, ist doch sowieso weg. Viel wichtiger ist doch, was in Zukunft Sache ist. Und nachdem nun einige Interesse gezeigt haben, warum denn gerade jetzt, da kann man doch auch noch 1 bis 2 Jahre warten, bis von denen mal ein Input kommt, ob das Verfahren nun was taugt oder auch nicht. Eine Deadline wäre mir da viel lieber.

Wie gesagt, ich habe die Meldung nur überflogen, werde Sie aber nochmal genauestens lesen. Eines ist für mich aber klar, wenn Sie das Business abstossen, dann weiß ich genau welchen Wert ich dann kaufe. Ein Verfahren zur Kostenreduzierung und Umweltentlastung brauchen man auf jedenfall, so oder so.

bis dann
mrasta

[Wunram]

Hallo MRASTA,

also wegen Louis H. Schnur hab ich mal ein bisschen rumgestöbert.

Lt. SCHEDULE 13D vom 14.4.2004 würde der liebe Mr. Schnur bei Ausübung aller seiner Optionen die er hat, 9,9% aller ausstehenden Aktien von Alti halten. Für einen Autohändler der mit seiner ganzen Knete spekuliert nicht schlecht.

Nach dem momentanen Stand könnte er auch ein bisschen Geld machen:

Unrestricted shares 566,300
Restricted shares 1,573,529
Exercisable warrants 1,536,493
Restricted warrants 1,573,529
---------
Total 5,249,851

Mr. Schnur has engaged in the following transactions in Altair common stock
during the 60 days preceding this filing:

Date Transaction Number of Shares Average Price

February 3, 2004 Purchased 44,970 $3.41
February 4, 2004 Purchased 276,411 $2.99
March 16, 2004 Purchased 138,035 $2.68
March 19, 2004 Purchased 70,765 $2.43
April 1, 2004 Sold 40,000 $3.15
April 2, 2004 Sold 20,000 $3.30

The Reporting Persons hold warrants as follows:

(a) A warrant to acquire 50,000 shares of common stock at $2.00 per share
was purchased by Mr. Schnur from Altair on December 14, 2001 and is
exercisable within 60 days of the filing of this Schedule 13D.

(b) A warrant to acquire 250,000 shares of common stock at $2.50 per share
was purchased by Mr. Schnur from Altair on December 14, 2001 and is
exercisable within 60 days of the filing of this Schedule 13D.

(c) A warrant to acquire 225,297 shares of common stock at $1.50 per share
was purchased by Mr. Schnur from Altair on April 26, 2002 and is
exercisable within 60 days of the filing of this Schedule 13D.

(d) A warrant to acquire 445,297 shares of common stock at $2.00 per share
was purchased by Mr. Schnur from Altair on April 26, 2002 and is
exercisable within 60 days of the filing of this Schedule 13D.

(e) A warrant to acquire 445,297 shares of common stock at $2.50 per share
was purchased by Mr. Schnur from Altair on April 26, 2002 and is
exercisable within 60 days of the filing of this Schedule 13D.

(f) A warrant to acquire 120,602 shares of common stock at $1.00 per share
was purchased by Mr. Schnur from Altair on May 9, 2003 and is
exercisable within 60 days of the filing of this Schedule 13D.

(g) A warrant to acquire 1,573,529 shares of common stock at $1.00 per
share was purchased by Western on Toyota from Altair on March 31, 2003
and is exercisable within 60 days of the filing of this Schedule 13D,
assuming that the underlying shares of common stock have been
registered (they have not) or that an exemption from registration is
available.
Quelle:
http://knobias.10kwizard.com/filing.php?repo=tenk&ipage=2728…

Gruss Wunram

[MRASTA]

Hi Wunram,

dass ist ja interessant, mit unserem Mr. Schnur. Ist aber wirklich so, dass der ein Autohaus hat, ich suche dass mal raus, hat Altair mal so veröffentlicht.

Ein echter Chaot. Mann oh Meter, was will der denn jetzt überhaupt ? Die Knete für die Entwicklung etc. ist doch sowieso versenkt worden. Ich glaube, der hat ganz andere Probleme. Ich habe schon befürchtet, dass da noch was kommt, darum habe ich es ja mal angesprochen in #252.

Wie schon gesagt, ich werde mir dass alles nochmal in Ruhe zu Gemüte führen, denke aber, dass das es jetzt ein echter Fehler wäre, aus diesem Gebiet auszusteigen.

Öfter mal was neues, obwohl, auf eine Dinge kann man wirklich verzichten.

gruss
mrasta

[MRASTA]

kicher, wollte euch das nicht vorenthalten, danke an BACA von Nanoinvest. Kannst ja auch nix dafür, dass einige überhaupt keinen Plane haben und trotzdem durch Zufall ab und zu das Richtige schreiben. Man beachte den Absatz mit den "Börsenkennern", also mich hat keiner gefragt.


Anleger, die an Nanotechnologie interessiert sind, können sich nach Meinung der Experten der "Prior Börse" ein paar Aktien von Altair Nanotechnologies ins Depot legen. Die Börsenkenner würden auf den hochspekulativen Charakter dieses Investments hinweisen.

mrasta, der immer noch lachen muss

[Albatossa]

Heute haben wir wieder einmal die 3 $ gesehen!

[tntxrxwelle]

@Mrasta

Da wühle ich mal verwegen auf WO rum und finde hier den
Mörderthread von Dir. Die Welt ist klein ;-))))

Habe meine ALTI vor ein paar Monaten zu 2,96 EUR geglättet.
Warte auf einen Reentry unter 2,00 EUR :-b

Bei der Mining Geschichte soll sich m.E. nur von der Camdenmine und dem Jig getrennt werden. Wieso hälst Du das für einen Fehler ? Jig sind Peanuts und in Camden ist entweder nix zu holen o. der Kapitalaufwand für eine Ausbeutung zu groß. Insofern hat der Autohändler nix Neues
erzählt und das Problem ist vom Management auch erkannt -> Spin off. Oder habe ich was übersehen ?

Habe mir mal den letzten Conference Call reingetan. Im Juni/Juli wirds wieder interessant. Wenn der EUR nicht dauernd abkackt, bekomme ich u.U. auch unter 2,00 EUR welche.

cu

[MRASTA]

Erstmal die Neuigkeiten :


Altair Nanotechnologies` New Thermal Spray Product Demonstrates Superior Functionality

TiNano Coat(TM) Outperforms Existing Commercially Available Competitive Spray Products

Wednesday, April 28, 2004 08:32 ET

RENO, NV, Apr. 28, 2004 (MARKET WIRE via COMTEX) -- Altair
Nanotechnologies, Inc. (NASDAQ: ALTI) a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures, today announced that its novel nanomaterials thermal spray grade powder, TiNano Coat(TM), demonstrated significantly superior mechanical properties in a competitive study performed by the National Research Council (NRC) of Canada. The study was performed at NRC`s state-of-the-art Industrial Materials Institute facilities in Boucherville, Quebec, from November 2003 through February 2004.

"The outstanding test results from the NRC further validate not only our TiNano Coat product itself, but provide additional proof-of-concept of our patented technology platform as the foundation from which we can drive commercialization of nanotechnology," said Dr. Rudi E. Moerck. "With testing complete, we are now focused on revenue generation, and have retained a leading international business development firm, Global Strategy, to assist us in aggressively marketing and distributing both TiNano Coat and ZNano Coat(TM) products worldwide."

Testing Methodology and Results

The competitive performance study compared two versions of TiNano Coat powders to commercially available titania products, both nano and standard powders, in air plasma spray (APS) and high velocity oxygen fuel (HVOF) coating applications. Tests included porosity (the percentage of pores that could absorb harmful fluids or gases), hardness, abrasion resistance, and bond strength. Altair`s nano-structured TiNano Coat produced the optimal mechanical properties for either HVOF or APS spray devices, compared to conventional materials. Test results also determined that HVOF is the best application process for Altair`s TiNano Coat materials, as the low bond strength problem associated with conventional coatings is completely eliminated by Altair`s materials, while simultaneously producing the low porosities typical of HVOF grade materials.

Thermal Spraying

Thermal spraying is a process in which powders (metal and non-metallic) are deposited on surfaces using either high velocity oxygen fuel or air plasma spray "guns". The powder is melted in the heated zone and forcibly ejected and splattered on the metal surface, where it provides a mechanical and chemical resistant protective barrier to safeguard against extreme conditions that the metal alone could not withstand. The process is widely used in heavy duty applications requiring abrasion and chemical resistance, and also as a thermal barrier. These include heavy industrial, chemical, petroleum, hydrometallurgical and aerospace applications to enhance the protection properties of metal alloys. Altair produces TiNano Coat products using its proprietary TiO2 ultrafine nanomaterial process. In addition, Altair produces and sells ZNano Coat(TM), a yttria stabilized zirconium oxide, for other thermal spray applications.

THE NATIONAL RESEARCH COUNCIL

The National Research Council (NRC) is the Government of Canada`s premier organization for research and development. In operation for more than 80 years, the NRC is composed of 19 different institutes and national programs, spanning a wide variety of disciplines and offering a broad array of services. The NRC is located in every province in Canada and plays a major role in stimulating community-based innovation. NRC institutes and programs are organized into three key areas: (1) Physical Sciences and Engineering, (2) Life Sciences and Information Technology, and (3) Technology and Industry Support.

GLOBAL STRATEGY, INC.

Global Strategy is an international business development consulting firm with specialized expertise in the life science, personal care, chemical, nanotechnology, and engineering industries. The firm offers services to domestic and foreign organizations in the formulation and implementation of strategic objectives, through in-license, out-license, distribution, joint venture, and acquisition and divestment programs. Related services provide world-class strategic information, via market intelligence, technology assessment, and competitive intelligence reporting, based on internal primary research capabilities. For additional information on Global Strategy, visit www.globalstrategy.biz.

ALTAIR NANOTECHNOLOGIES, INC.

[MRASTA]

und nun hallooo Welle,

nett mal wieder was von Dir zu hören, jo, war mir so langweilig, da drüben. Bin da nur noch bei den beiden RFID´s und Fingerprints und dem neuen Thread, aktiv. Hatte das mal parallel dort und hier, aber einfach zu wenig Zeit für Beides.

Darum habe ich mir dass mit dem Mining Business auch noch nicht richtig durchlesen können, ob auch die TIO2 Produktionstechniken davon betroffen sind, dass fände ich nämlich schade. Wo doch einige Anwendungen so langsam im werden sind. Ich muss mir dass nochmal in Ruhe durchlesen, was nun alles betroffen ist. Die Mine und JIG können Sie von mir aus einstampfen, ist mir recht, wenn es nur darum geht. Ich werde mich nochmal am Wochenende darin vertiefen, was nun genau gemeint ist.

Nachdem der Laden ja nun fast komplett umgekrempelt wurde, besteht wohl wieder Hoffnung.

Zumindest läßt die neue Meldung mal aufhorchen, ob 3 -4 Monate testen ausreichen ? Naja, die genauen Ergebnisse würden mich schon interessieren. Mal sehen, was Sie daraus machen.

Im Gegensatz zu Altair, wo nun endlich mal was zu keimen scheint, haben die Phases wohl Ihr Pulver erstmal verschossen.

bis dann
mrasta

[tntxrxwelle]

@Mrasta

Bewertung von 140 Mio. Marktkap. ist derzeit ein wenig
sportlich. Bist Du fett drin oder auf Sparflamme ?

cu

[MRASTA]

@tntxrxwelle

Schwimme noch so mit meinen restlichen Altbeständen mit zur Zeit. Waren ja mal mehr als genug da und bei dem damaligen Einstand ist ja noch reichlichst Luft.

Weiß auch nicht, ob man da jetzt rein muss. Denke mal es müssen erstmal auch Umsätze generiert werden. Ankündigigungen waren nun mehr als genug da und reichen zur Zeit meist nur für einen kleinen Zwischenstop. Also im Moment eher Sparflamme.

Aber das kann sich ja auch wieder ändern.

cu

[MRASTA]

So, nun soll dass ganze Hick-Hack offiziel ausgetragen werden :

Schnur ist für die Ausgliederung und einer teilweisen Neubesetzung bei Altair und die Jungs von Altair ? :

The Board of Directors recommends that you vote AGAINST the Shareholder Proposal for the following reasons:

den Rest kann ja jeder selber nachlesen, wäre vielleicht etwas zu lang. Aber dürfte ja mehr oder weniger bekannt sein.

http://knobias.10kwizard.com/filing.php?repo=tenk&ipage=2757…

mrasta

[Albatossa]

Altair Nanotechnologies Inc., Annual and Special Meeting Of Shareholders on June 24, 2004!

[Wunram]

wen es interessiert:

Revenue for First Quarter Exceeds Revenue for Fiscal 2003

Altair Nanotechnologies, Inc. (NASDAQ: ALTI) a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures, today reported financial results for its first quarter ended March 31, 2004.

The company reported revenue for the first quarter of 2004 of $139,749, a net loss of $1.7 million, and a net loss per share of $0.04 compared to first quarter of 2003 revenue of $20,277 a net loss of $1.3 million and a net loss per share of $0.04.

"The increase in revenue for the first quarter is a significant milestone for the company," commented Altair President Dr. Rudi E. Moerck. "In our first fiscal quarter of 2004, we have reported revenue growth that surpassed our entire reported revenue for fiscal 2003. Our sales backlog continues to be strong, with approximately $642,000 in orders and development work to be delivered this year. Additionally, our current pipeline of signed contracts to be performed during 2005 and contracts with a high probability of success is approximately $1.5 million, for a total of approximately $2.1 million," continued Dr. Moerck. "These contracts call for Altair to supply work in areas with large long term potential payoffs, such as titanium metal, titanium dioxide and funding the development of our intellectual property portfolio."

Operating expenses of $1.7 million for the first quarter of 2004 were substantially higher than operating expenses of $1.2 for the first quarter of 2003 due in part to non-cash expenses associated with the issuance of options to non-employee service providers and an increase in the fair value of stock options re-priced in prior periods. According to Altair CFO Edward Dickinson, "First quarter expenses also included salaries for new employees and long over-due salary increases for existing employees. We expect our cash operating expenses to average around $400,000 per month during the second quarter," added Dickinson.

As of March 31, 2004, Altair`s balance sheet was strong, with a cash position of approximately $11.5 million compared to that of $3.9 million at December 31, 2003. Altair`s long term debt consists only of a promissory note to purchase the building that houses its corporate headquarters and production facilities in Reno, Nevada. Under that promissory note, interest begins accruing in August 2005, with the first payment due in February 2006.

"Over the last two years we have developed and refined a technology platform which is the spring board for our future growth," said Altair President Dr. Rudi E. Moerck. "This strategy has allowed Altair to secure partnerships, development contracts, grants, and licensing agreements with major companies. We believe our recent restructuring and the establishment of the new Life Sciences division will allow Altair to aggressively pursue industries that will produce revenue growth for the company in the near term."

As part of its restructuring, the company has engaged industry veteran and consultant, Richard R. Mauser, to head up its new Life Sciences group. Mr. Mauser has previously served as a board member analyzing, judging and approving Advanced Technology Program awards for the US Department of Commerce. He has also been responsible for various aspects of business and technology development at Binax Corporation, Cetus Corporation and at the Lawrence Berkeley Laboratory. In order to accommodate Mr. Mauser`s prior consulting commitments and be sure that the relationship works out for all involved, the company has initially entered into a consulting agreement with Mr. Mauser. The company expects to convert the consulting agreement and employ Mr. Mauser as its full-time Senior Vice President of Life Sciences after a four-month period.

In addition to bringing Mr. Mauser on board, Altair has also retained Alan Gotcher as a senior consultant for its Nanomaterials division. Mr. Gotcher`s consulting agreement may also be converted into an employment agreement by mutual agreement of the parties. Mr. Gotcher was previously senior vice president, Manufacturing and Technology and chief technology officer of Avery Dennison Corporation.

"We are especially pleased with the renewed interest from pharmaceutical and biotechnology companies in our drug candidate for patients undergoing kidney dialysis, RenaZorb(TM)," continued Dr. Moerck. "This is due in part to Shire Pharmaceutical`s recent licensing agreement with Bayer AG for distribution of its lanthanum-based drug for end stage renal failure, Fosrenol® into Japan along with Fosrenol`s approval in Sweden, which is the European Union (EU) reference state. Additionally, Shire announced its expectation that Fosrenol would be approved and launched in the United States in 2004. We expect to have a RenaZorb partner by the end of 2004."

Dr. Moerck went on to note that in addition to the renewed interest in RenaZorb, the marketing and out-licensing efforts of company`s TiNano Sphere drug delivery system is being directed at pharmaceutical companies that have Class 4 narcotics products along with government agencies such as the DEA (Drug Enforcement Agency) and the FDA.

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


FINANCIAL SUMMARY

ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF OPERATIONS
(Expressed in United States Dollars)

Three Months Ended
March 31,
2004 2003
---------- ----------
Sales $ 139,749 $ 20,277
Cost of Sales 110,392 14,950
---------- ----------
Gross Margin 29,357 5,327
---------- ----------
Operating Expenses
Mineral exploration and development 27,226 28,714
Research and development 255,399 212,793
Professional services 252,594 184,358
General and administrative expenses 955,956 557,838
Depreciation and amortization 221,196 218,625
Asset impairment - -
---------- ----------
Total operating expenses 1,712,371 1,202,328
---------- ----------
Loss from Operations 1,683,014 1,197,001
---------- ----------
Other (Income) Expense:
Interest expense 47,282 120,173
Interest income (19,938) (180)
Loss (gain) on foreign exchange 399 -
Loss on extinguishments of debt - -
Gain on forgiveness of debt - -
Loss on redemption of convertible
debentures - -
---------- ----------
Total other expense, net 27,743 119,993
---------- ----------
Net Loss 1,710,757 1,316,994
Preferential Warrant Dividend - -
---------- ----------
Net Loss Applicable to Shareholders $1,710,757 $1,316,994
========== ==========

Loss per Common Share - Basic and Diluted $ 0.04 $ 0.04
========== ==========

Weighted Average Shares - Basic and Diluted 47,333,219 30,527,826
========== ==========


--------------------------------------------------------------------------------

For Additional Information:
Marty Tullio
McCloud Communications, LLC
949.566.9860
[e-mail]

Gruss Wunram

[MRASTA]

Moin, will mich hier ja auch mal wieder blicken lassen.

Zahlen wie gehabt, zwar ganz nette Steigerung aber in Anbetracht der Vorschusslorbeeren bei weitem nicht genug. Bischen die Luft raus im Moment.

Bis dato war die Sparflamme ok. Fragt sich nur, ob und wenn, wann man wieder mal nachlegen sollte. Bis dato ging es eigentlich immer ab Dezember bis Mai/Juni mehr oder weniger den Bach runter.

Glaube, man sollte die beiden in nächster Zeit mal wieder ein wenig mehr in der Optik behalten.

mrasta

[tntxrxwelle]

@Mrasta

Du hast es halt drauf und erkannt ;-)))

Zahlen waren für mich o.k. und ein non-event. Interessant
wird es ohnehin erst in 1-2 Jahren.
Die Aktie hat kursmäßig ein wenig viel Vorschußlorbeeren
bekommen. Wir sind ja jetzt unter 2 EUR, habe aber trotzdem
nix gekauft. Denke da geht noch was nach unten.

Wenn man den Nanobonus abzieht, müßte sogar unter 1,00 EUR drin sein.
In letzter Zeit war zuviel "dummes Geld" im Markt, was wohl so langsam in die Taschen der Intelligenten geflossen wird. Wenn im Sommer an den Weltbörsen die saure Gurkenzeit
läuft, wird man bei Altair wieder zuschlagen können.

Mindestens eine Talfahrt und einen Megarun wird dieser Wert
noch machen.

[Aproxxima]

Mrasta, wie hast Du es eigentlich geschafft, durch ein schwarzes Loch zu fliegen und in die Zukunft zu reisen? dein Posting ist vom 19.Mai und wir haben immer noch den 18. looool
Zu Nanophase kann ich nur sagen: habe bei 6 gekauft und bei 11 verkauft.. war aber auch ne heisse Spekulation dabei! (hätte mich auch schön verbrennen können, bei der Vola...)

Wer noch drin ist, dem rate ich, das mit den Nanokügelchen noch mal genauer unter die "Lupe" (das passt) zu nehmen! ob die Nano-Partikel den Durchbruch bei Phase erwirken, darf bezweifelt werden!

[Aproxxima]

sorry Mrasta, war eine optische Täuschung! Hast Albert E.
doch nicht diffamiert! *schäm*
War` Parallaxenfehler!

[MRASTA]

Jep, so is dat mit den optischen Täuschungen. Hellsehen kann ich noch nicht, arbeite aber dran.

Sonst gibt´s ja nix neues.


cu

[Wunram]

ALTAIR NANOTECHNOLOGIES, INC. RECEIVES GRANT FROM THE U.S. NATIONAL SCIENCE FOUNDATION

Company to Develop Nano-structured Electrodes for Next Generation Super Capacitors

RENO, NV – June 22, 2004 – Altair Nanotechnologies, Inc. (Nasdaq:ALTI), a company engaged in developing high performance materials and life sciences products using its pigment and nanomaterials technology platforms, today announced that it was awarded a grant from the National Science Foundation (NSF), effective July 1, 2004. Under terms of the grant award, Altair will initially receive $100,000 for work to be completed within six months of the July 1, 2004, effective date. The grant is in support of a project entitled “SBIR Phase I: Carbon-Coated Nano-Structured Electrodes for Next-Generation Lithium-Ion Ultra Capacitors.”

“We are pleased to announce Altair’s first stand-alone grant, spearheaded by our new board member, Dr. David King,” said Dr. Rudi E. Moerck, president of Altair. “The NSF’s peer review process is consistently recognized as the gold standard among government agencies and private foundations in terms of setting the bar for quality proposals and funding awards, making this grant further validation of our nanotechnology expertise and uniqueness of our technology platform. This grant builds upon the progress Altair has made in bringing nanotechnology to super capacitor and battery applications.”

Under terms of the Small Business Innovation Research (SBIR) Phase I grant award, Altair will use the proceeds to fund joint development work with Hosokawa Micron’s Nano Particle Technology Center and Rutgers University’s Energy Storage Research Group. According to Dr. Moerck, Altair’s nano-sized cathode and anode materials are perfect compliments to Hosokawa’s unique powder coating technology and equipment and Rutgers’ existing hybrid battery patents, advanced battery design and testing expertise, all of which should provide for the successful design and development of high-capacity, next generation lithium ion power sources.

Third-party studies have shown that Altair’s nano-sized lithium titanate spinel battery material exhibited charge and discharge rates up to 100 times higher than materials used in current commercially available batteries. In the third quarter of 2003, Altair announced that Telcordia Technologies (now Rutgers Energy Storage Research Group) developed a non-aqueous asymmetric hybrid prototype battery incorporating Altair’s nano-lithium titanate spinel. The Rutgers prototype battery, using Altair`s nanomaterials, met the `car of the future` power assist battery requirement as published in The Journal of Power Sources, 113 (2003) 62-71 and 115 (2003) 171-178. The Rutgers’ battery is the only prototype reported, to date, to meet these Department of Energy (DOE) standards. Altair is currently in discussions with Rutgers regarding commercialization and is providing the group with additional nanomaterials samples for further development work.

Nanomaterials are expected to provide an improvement in lithium ion battery and super capacitor performance, making it possible to use these systems in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles. In addition to use in hybrid automobiles, nano-lithium titanate spinel-based batteries may also be incorporated into uninterrupted power supplies, military applications and specialized uses, such as notebook computers, mobile phones, and a variety of portable devices. Rapid charge/discharge times are important in all these applications.

Altair Nanotechnologies, Inc.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.


Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair’s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair’s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Gruss Wunram

[Wunram]

ALTAIR NANOTECHNOLOGIES PROVIDES SHAREHOLDER UPDATE


RENO, NV – June 24, 2004 – Altair Nanotechnologies Inc. (Nasdaq:ALTI) is providing a Company update from Altair President Dr. Rudi E. Moerck, in its commitment to keep shareholders and members of the financial community current on the company’s activities.

Corporate Update
Altair has completed its reorganization and the creation of the Life Sciences and the Performance Materials Divisions. “This reorganization, and the creation of two divisions, has allowed Altair to focus on leveraging its proprietary technology to bring pioneering product technology to market,” commented Dr. Moerck. “Further, both Divisions have made significant progress in taking product concepts and developments to commercialization.”

Life Sciences Division Update
This division utilizes Altair’s patented processes in developing rare earth compounds and metal oxide technology for the development of pharmaceutical, drug delivery and biologically important ion exchange processes. Altair’s novel rare earth ion exchange processes remove specific target compounds from fluids and other process streams to almost non-detectable levels. Altair’s hollow, porous, high surface area, rigid ceramic microstructures (TiNano Spheres™) are currently made from titanium and zirconium and show promise as drug delivery and dental compounds.

• RenaZorb™ - Nanotechnology-based drug for ESRD
On May 26, 2004, Shire Pharmaceutical’s CEO announced he expects Fosrenol®, the company’s lanthanum carbonate tetra hydrate-based drug candidate for phosphate control in kidney dialysis patients with End Stage Renal Disease “ESRD” to receive approval from the FDA in June 2004. Approval of Fosrenol has already been granted in Sweden as a European Union Reference country. Shire has also announced that it had licensed Fosrenol to Bayer AG, giving them the exclusive rights to develop, market and sell Fosrenol in Japan. The total potential value of the Fosrenol deal has been reported to be in excess of $70 million, which includes up-front license fees.

Altair’s RenaZorb™ (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug for phosphate control in patients with end-stage renal disease (ESRD). Interest in RenaZorb among potential licensees has increased significantly over the past several months. Altair has instituted additional non-clinical testing in animal models to directly compare RenaZorbTM to lanthanum carbonate tetra hydrate, (the active ingredient in Fosrenol) and sevelamer (the active ingredient in Renagel™). The results will not be available until late July, but the company is optimistic about preliminary data and the outcome of these tests.

• Drug Delivery – TiNano Spheres™ and No-Defeat™ Drug Delivery Systems
TiNano Spheres™ are hollow, porous, high surface area, rigid ceramic microstructures that are derived from Altair’s patented technology. The inside, outside or both can be coated with active pharmaceuticals to provide controlled release characteristics. The differentiating characteristic of
Altair’s TiNano SpheresTM compared with commonly available polymer-based drug delivery systems is that Altair’s system may produce a sustained drug delivery system for narcotics and other Class IV drugs that is both non-abuseable and non-defeatable.

TiNano SpheresTM are in the early stage development for drug applications. Altair plans to out-license the technology and conduct co-development work on the No-Defeat™ system for licensees and potential licensees. Discussions are ongoing with pharmaceutical companies that are interested in incorporating their active pharmaceutical ingredients into the TiNano SpheresTM and No-DefeatTM systems.

• Dental Nanomaterials
Altair continues to work with a research consortium sponsored by the National Institutes of Health to strengthen polymer-based dental fillings utilizing Altair’s nano-zirconia. While the size of the materials market for dental fillings is small, from a tonnage perspective, the dollar value is considerable. The development process is moving forward and management now expects to have a suitable product available in the fourth quarter of 2004.

Performance Materials Division Update
The Performance Materials Division is taking pioneering nanotechnology to market. This business unit uses novel chemical processes to manufacture nano-to-micron-sized ceramic materials with specific performance enhancing characteristics.

• Titanium Dioxide Pigment – Altair’s Hydrochloride Pigment Process (AHPP)
Discussions continue with several companies that have interest in producing white titanium dioxide pigment. Titanium dioxide pigment is a $9 Billion global market.

In January 2004, Altair entered into a license agreement with Western Oil Sands, Inc. for the production of titanium dioxide pigment at the Athabasca Oil Sands Project in Canada. Altair is now well into phase one of the agreement, with bulk samples of the oil sands’ tailings in the Reno plant for testing and processing into white titanium dioxide pigment.

Altair has also entered into a licensing agreement with Avireco USA to evaluate the Altair Process utilizing feedstock from Vietnam to produce titanium dioxide pigment. The government of Vietnam has approved $25 million to develop a domestic titanium dioxide pigment infrastructure. However, work under the contract has not yet been authorized.

Altair continues to work with Flowco International, Altair’s exclusive representative in the People’s Republic of China (PRC). Altair is in ongoing negotiations with a Chinese company and several Indian companies that have interest in producing white pigment for distribution in those respective countries.

• Titanium Metal
Under Altair’s January 2004 agreement with Titanium Metals Corporation (NYSE:TIE), the company has begun providing development services and selling developmental quantities of custom nano titanium dioxide and titanium alloy oxide electrode feedstock to Titanium Metals for their development program pertaining to the manufacture of titanium metal based on the patented FFC Cambridge process.

DARPA (Department of Defense), the agency funding the development program through a $12.4 million grant, has awarded Altair Nanotechnologies subcontractor status. The development program provides Altair the opportunity to supply enough TiO2 to produce 50 pounds of titanium metal per day to meet the DARPA titanium project goals as outlined by the program. Altair believes the success of the testing program could result in a licensing agreement for the production of titanium dioxide and titanium alloy oxide electrode feedstock.

• NanoCheck™
Altair’s unique nano-structured compound, NanoCheck™, has been proven to safely and effectively prevent algae growth in swimming pools in both independent and in-house laboratory testing. There are approximately eight million pools and four million existing spas and hot tubs worldwide with an additional 360,000 pools and approximately 260,000 spas and hot tubs being installed annually.

The first phase of microbiological performance testing confirmed NanoCheckTM compound’s ability to retard and prevent algae growth through absorption of phosphates from water. Field-testing focused on evaluating NanocheckTM’ compound effectiveness in providing an algae-free environment for swimming pools is currently under way. If the tests are successful, Altair or a licensee could commercially launch NanoCheck™ in the first quarter of 2005.

• United States Government Research Funds
Work between Altair, Western Michigan University (WMU) and University of Nevada is underway, under the terms of a joint development agreement funded by the Department of Energy`s Office of Science, Biological and Environmental Research. Altair and WMU are currently working on the “lab-on-a-chip” elements, which will comprise the technology being developed for detecting chemical and biological agents, a homeland defense program.

In December 2003, Altair was notified by WMU of additional grant funding for their joint development of nanosensors for detecting chemical, biological and radiological agents. The $2 million grant was included in the Omnibus Appropriations Bill and will commence August 2004. WMU and Altair will continue to jointly seek Federal support for nanotechnology research and development and will utilize the new grant funding equally.

Altair recently received at $100,000 grant from the National Science Foundation to fund the joint development work with Hosokawa Micron’s Nano Particle Technology Center and Rutgers University’s Energy Storage Research Group. The Team is working on the design and development of an advanced hybrid battery as a high capacity, next generation lithium ion power source. Altair expects to apply for additional funding for the development of Phase ll of the development program.

• Lithium Ion Battery Electrode Development
The Rutgers prototype battery, using Altair’s nanomaterials, met the ‘car of the future’ power assist battery requirement as reported in Telcordia’s (now Rutgers Energy Storage Research Group) research paper published in The Journal of Power Sources. The prototype battery, a nonaqueous asymmetric hybrid incorporating the advantages of both Li-ion batteries and super capacitors, stored energy of 11wh/kg with delivery of 800 W/kg at 95 percent efficiency. The cycle life ranged between 10,000 and 100,000 cycles. The Rutgers’ battery is the only prototype reported, to date, to meet these DOE standards. Altair is in discussions with Rutgers regarding commercialization and is providing the group with additional nanomaterials samples for further development work and prototype production.

Altair has signed a memorandum of joint development work with Hosokawa Micron International to combine the technologies of both companies to develop advanced electrode materials for electrochemical devices such as batteries, capacitors and supercapacitors from a variety of nanomaterials.


ALTAIR NANOTECHNOLOGIES INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a robust proprietary technology platform for making a wide variety of nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.


Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.


Forward-Looking Statements .....


Gruss Wunram

[Wunram]

ALTAIR NANOTECHNOLOGIES REPORTS PROGRESS ON DRUG DELIVERY SYSTEM AND FILES TWO NEW PATENTS PERTAINING TO DRUG DELIVERY



Progress on TiNano Spheres Drug Delivery System Brings Interest from Potential New Pharmaceutical Partners


RENO, NV - July 27, 2004 - Altair Nanotechnologies, Inc. (Nasdaq: ALTI) today announced that it filed two new patent applications, which extend the company`s intellectual property protection for its TiNano Spheres drug delivery system.

Recent laboratory testing results show the ability to control the level of loading of drugs onto and into the TiNano Spheres, which provides for high drug and chemical loading levels. This capability is important for developing a broad platform of drug delivery systems that can address a multitude of market opportunities. Testing also confirmed that drugs loaded into the TiNano Spheres delivery system matrix can be released at significant therapeutic concentrations. Additional laboratory testing indicated that TiNano Spheres resist crushing, making “street” methods commonly used to abuse drugs like amphetamines or pain management drugs and narcotics difficult or impossible.

Altair continues discussions with potential market partners interested in novel drug delivery systems or companies seeking to extend product life cycles of existing drugs. Altair is targeting markets for use of its TiNano Spheres technology, which uses rigid, hollow ceramic structures, as a drug delivery platform for pain management, inflammation, coronary indications, analgesia and microbial infection. The TiNano Spheres drug delivery platform has the advantage of using materials such as titanium dioxide, which are recognized as being biologically benign and safe. The Freedonia Group estimates that the market for drug delivery systems is approximately $54 billion in the U.S.

“We are confident that Altair has reached a watershed point in building a viable life sciences capability," commented Altair Nanotechnologies President Dr. Rudi E. Moerck. "Our scientists have made significant progress with our lead drug candidate and novel drug delivery system. Our sales and marketing strategy is to continue developing key market partnerships as we expand our product capabilities and pipeline in the Life Sciences Division."

ALTAIR NANOTECHNOLOGIES INC.
Although an emerging field, Nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in paints and coatings (titanium pigments and thermal spray coatings), process technologies (titanium metal manufacturing, catalysts and water treatment), alternative energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com

Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair’s numerous development stage products including TiNano SpheresTM will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), TiNano SpheresTM, RenaZorbTM or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair’s operations in the short run, and that animal testing or future testing on TiNano SpheresTM, RenaZorbTM or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

[Wunram]

irgendeiner hat ihn mal Autohändler genannt - jetzt trennt er sich wieder von knapp 70% seiner Anteile


http://www.edgar-online.com/bin/cobrand/finSys_main.asp?nad=…


Gruss Wunram

[tntxrxwelle]

@Mrasta

Hmmm, als wenn ich es nicht geahnt hätte ;-)
Das Teil sackt wieder Richtung 1,00 EUR und genau in den Bereichen werde ich mir wohl mal ein paar gönnen.<p>
Wenn im Irak die Pipelines explodieren und der Ölpreis nach oben heizt, haben die Investoren natürlich eine absolute Risikoaversion. Wenn wundert es da, dass ALTI abkackt ? Wohl niemanden.

[MRASTA]

Moin zusammen,

Erhoffe das Beste und sei gefasst auf das Schlimmste.

@Welle

Und nun ?



@Wunram

stimmt, war ein Autohöker.


Tja was macht man denn jetzt ? Handlungsbedarf gegeben ? Mal wieder einsteigen ? Sieht irgendwie alles nicht so berauschend aus.

Immer noch eine immens hohe Berwertung ohne echtes Business. Ok, die Phases wuseln jetzt mal in Richtung Bodenbeschichtung los. Wenigstens etwas neues.

Bin mir zur Zeit nicht im klaren wie lange der Abwärtstrend noch anhält. Habe mir trotzdem wieder eine erste (kleine) Prise ALTI bei 1.16 reingelegt. Die Zahlen dürften wohl wieder das gewohnte Bild ergeben, vielleicht ist danach noch ein guter Zeitpunkt.

Und bei den Phases ? Wenn unter 4.50 $ auch zu beachten. Mal sehen.

Wie schätzt Ihr die Lage denn so ein ?

mrasta

[MRASTA]

Altair Nanotechnologies Reports Financial Results for Second Quarter of Fiscal 2004
8/12/04

RENO, NV, Aug. 12, 2004 (MARKET WIRE via COMTEX) --

Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today reported financial results for its second quarter ended June 30, 2004.

The company reported that revenue for the second quarter of fiscal 2004 increased to $154,233 compared to revenue of $4,434 for the seco

nd quarter of fiscal 2003. The net loss for the second quarter was $2.2 million, or a loss per share of $0.04 versus a net loss of $1.5 million, or a net loss per share of $0.04 for the comparable quarter in 2003.

For the six-month period ended June 30, 2004, revenue increased to $293,982, with a net loss of approximately $3.9 million, or a net loss per share of $0.08 compared to revenue for the six-month period ended June 30, 2003 of $24,711, with a net loss of $2.8 million, or a net loss per share of $0.09.

"The increase in revenue on both a comparable and consecutive quarterly basis indicates improved orders and an increase of paid development work funded by customers and government grants," commented Altair President Dr. Rudi E. Moerck. "Our pipeline continues to be solid, with approximately $1.1 million in orders and development work to be completed and billed."

Operating expenses of $1.9 million for the second quarter of 2004 were higher than operating expenses of $1.2 million for the second quarter of 2003. Increased operating expenses are a result of increased research, development, marketing, and sales emphasis for both the Life Sciences and Performance Materials Divisions.

Altair CFO Edward Dickinson noted, "Our net cash operating expenses have averaged around $425,000 per month for the first half of 2004 and we expect a modest increase in net cash operating expenses for the third and fourth quarters due to increased investments in product development."

In order to enhance revenues on new cost reimbursement contracts, beginning in 2004 the facility overhead costs were allocated between research and development, cost of sales and general and administrative expenses. Cost of sales for the second quarter ending June 30, 2004 increased due to a change in Altair`s method of recording overhead costs associated with the company`s facilities and has resulted in a negative gross margin. Prior to 2004, these costs were recorded entirely as general and administrative expenses. This allocation reflects a more accurate classification of costs. It is anticipated that new research and development contracts will provide a positive gross margin.

As of June 30, 2004, Altair`s balance sheet was strong, with a cash position of approximately $10.2 million compared to $3.9 million at December 31, 2003. Altair`s long-term debt consists only of a promissory note of $3.0 million to purchase the building that houses Altair`s corporate headquarters, research laboratories and production facilities in Reno, Nevada. Under the terms of the promissory note, interest begins accruing in August 2005 with the first payment due February 2006.

[MRASTA]

Ganz schönes Sell Out, wie schon befürchtet.

0.98 Cent zweiter Zuschlag.

Der Rest wird sich zeigen.

mrasta

[tntxrxwelle]

@Mrasta

Eine gute und eine schlechte Nachricht :

Den Umsatz finde ich überraschend ordentlich.
Allerdings sind die Kosten für den Umsatz überproportional
stark gestiegen.
Kann natürlich sein, dass das bei einem Unternehmen in der
Business-Startphase ganz normal ist, aber was vor 4 Monaten noch gefeiert worden wäre, wird nun abgestraft.

Immerhin, die Kohle dürfte noch 2 Jahre reichen.

Stehe immer noch an der Seitenlinie. Aber es juckt ;-)

[MRASTA]

@Welle

Ist ja auch alles ne Frage wie sich ÖL und der DOW entwickelt und überhaupt. Ist ja alles etwas angespannt.

Die 1.16 waren nur ne kleine Prise, bei 0.98 waren es dann doch schon einige mehr, dachte zumindest an einen Rebound. Dito Phases bei 4.45 ein paar reingelegt. Ob das alles Bestand hat, weiß man nicht. Bin skeptischer diesesmal, mal sehen. Habe zumindest enge Grenzen gesetzt.

Naja, Knete hin oder her, irgendwas sollten Sie vielleicht mal auf die Reihe kriegen. Bei dem jetzigen Kurs läuft man doch wieder gefahr aus dem NASDAQ zu fliegen, hatten wir doch alles schon einmal. Und ob die Instis dass wollen, möchte ich doch mal arg bezweifeln, also könnte es in Richtung Herbst wieder reichlich turbulent werden.


cu

[MRASTA]

@Welle

Na und, haste Deinen inneren Schweinehund überwunden ? Die 1$ Marke war doch erstmal klar definiert.

Ist schon erstaunlich was die Meldung des Wechsels des CEO´s so bewirken kann. Long ist nicht mehr dabei dafür nun Gotcher. Ob dass nun der Hieb in Tüten ist, wird man sehen. Einen Vorschuß hat er ja mit dem Kursanstieg bekommen, dass generiert aber noch keine Kontrakte. Komische Zeiten, diese Zeiten.

Die Phases haben sich ja auch mal wieder gen Norden bewegt.

Als generellen Aufwärtstrend sehe ich dass aber noch nicht, zuviel Unruhe im Markt. Aber immerhin haben sich beide Einstiege erstmal gelohnt.

Also schauen wir mal weiter.

mrasta

[MRASTA]

na was denn, hatte keiner den Mut zur Lücke ?

Das war doch alles mit Ansage, the same procedure as last Year, James.

Selbst die Phases sind mitgezogen, nicht so gewaltig, war eigentlich auch klar aber immerhin.

mrasta

[MRASTA]

so, ein paar habe ich jetzt für 1.82 wieder rausgeworfen, dass ist mir dann doch etwas zu heftig.

cu

[Wunram]

Altair Nanotechnologies Begins Work on Nano-Structured Electrode Materials With U.S. National Science Foundation Small Business Innovation Research Grant

24 August 2004, 11:07am ET

Technology From Altair Nanotechnologies, Hosokawa Micron and Rutgers University Targets $1.5 Billion Battery Materials Market

Altair Nanotechnologies Inc. (NASDAQ: ALTI) today announced that it has begun work on a development project entitled "SBIR Phase l: Carbon-Coated Nano-Structured Electrodes for Next-Generation Lithium-Ion Ultra Capacitors." The Small Business Innovation Research (SBIR) Phase l grant, initially for $100,000, provides the opportunity to receive an additional $500,000 Phase ll grant which, if the development program is successful, leads to a Phase lll commercialization.

Altair and Hosokawa Micron`s Nano Particle Technology Center produced the first advanced carbon coated materials for this program, which were tested under a contract with the Energy Storage Research Group at Rutgers, the State University of New Jersey. Based on that work the final research testing protocol was determined. The Phase l grant work is scheduled for completion in December 2004.

This program, with the ultimate objective of commercialization of a high-power, fast-charge battery within the automotive industry, is the product of successive inventions and development agreements that have been published and announced over a period of several years. A summary of these technology advances provides insight into opportunities created by Altair`s unique, functional nanomaterials.

Nano-structured electrodes, using Altair`s proprietary materials, combine the high-speed capabilities of capacitors with the energy storage features associated with batteries. The work is expected to lead to significant commercialization opportunities within the automotive industry for batteries using hybrid Ultra Capacitor/Battery concepts and Altair`s electrode materials. The potential for commercializing these technologies was first reported by Altair in its November 2001 news release in which Dr. K.M. Abraham, an independent consultant, confirmed that Altair`s new nano-sized lithium titanate spinel could achieve lithium ion charging and discharging rates 10 to 100 times higher than with materials commercially available at that time.

This superior performance of Altair`s lithium titanate spinel in a prototype battery was first reported by Telcordia (now Rutgers University`s Energy Storage Research Group) in the Journal of Power Sources, published in March 2003. Telcordia`s new thin film hybrid battery / Ultra Capacitor technology used Altair`s advanced materials. This hybrid battery met the performance standards established by the U.S. Department of Energy (DOE) for the power assist batteries required for cars of the future using fuel cells or hybrid internal combustion engines/battery drives.

The advancement in charging and discharging capabilities of Altair`s materials were published in the July 2003 issue of Journal of Electrochemistry through a joint collaboration with Altair, Switzerland-based Xoliox and Czechoslovakia-based J. Heyrovsky Institute. The report demonstrated that Altair`s nanomaterials could be fully charged in only a few seconds and that Dr. Abraham`s assessment proved to be correct. The Rutgers team utilized the technology in their unique prototype battery and is now participating in the current test work. Based upon the results of Rutgers` prototype battery, Altair has taken the necessary steps to improve both its technology and its ability to supply commercial quantities of its nanomaterials to the marketplace.

Using information available from the Telcordia/Rutgers` publications, Altair and Hosokawa Micron International joined forces to overcome the limitation of electrical transport and lithium ion availability in electrodes made of high performance nano-materials, and to provide the battery industry with a sufficient supply of the advanced materials. The agreement between the companies was jointly announced in February 2004 and stated that the two companies would undertake to achieve the following goals:

1. Establish a development program using both companies` combined technologies to develop advanced electrode materials for electrochemical devices, including batteries, capacitors and supercapacitors, using a variety of nanomaterials;

2. Strengthen the technical and market position of the companies by combining technological and financial assets, including existing manufacturing capabilities.

3. Apply for U.S. government grants for the development and funding of commercialization activities.

Altair and Hosokawa agreed that if testing and commercialization prove to be successful, additional funding would be committed and sought to provide dedicated facilities for the production of the advanced materials. Both Altair and Hosokawa are currently seeking battery manufacturers that can utilize the advanced materials for participation in the next development stages and potential commercialization.

Altair is committed to participating in advanced/alternative energy industries and uses a similar approach for developing projects related to hydrogen generation and fuel cells. Each program offers the potential for advanced materials, but must overcome the limitations imposed by existing products or markets that were not initially structured to use these new materials. Altair is building upon its experience in the advancement of its battery materials as a basis for the development of its fuel cell, solar cell and hydrogen production materials.

ALTAIR NANOTECHNOLOGIES INC.

Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.®, Altair Nanomaterials?, TiNano®, RenaZorb?, NanoCheck?, TiNano Spheres?, No Defeat? and the Hydrochloride Pigment Process? are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

HOSOKAWA MICRON GROUP (Hosokawa Micron Corporation is listed in Tokyo Stocks Exchange: 6277)

The Hosokawa Micron Group is a world leader in providing process solutions for powder and particle processing, blown film processing, and in Japan, environmental business. The company is continuing to advance its 88 years of market leadership with the application, development and commercialization of ultra fine composite particles in the rapidly expanding field of nanotechnology. Hosokawa Micron`s three Nano Particle Technology Centers (located in Japan and the USA) are dedicated solely to the development of new functional and value added materials for next generation. For additional information on the Nano Particle Technology Centers, visit our website at www.hosokawanano.com or our corporate website at www.hosokawamicron.com for more information about the Hosokawa Micron Group.

Forward-Looking Statements
......


For Additional Information:
Marty Tullio or Mark Tullio
McCloud Communications, LLC
949.566.9860
[e-mail]
[e-mail]

Gruss Wunram

[MRASTA]

Hallo Wunram,

hoffe, alles ist im grünen Bereich.

Bei Altair braucht man eine Menge Kaugummi, zieht sich alles so hin. Klar dass Sie die Phase I schnell erreichen werden, ist ja schon seit geraumer Zeit eigentlich fertig. Arbeiten ja schon seit 200X daran. Denke mal an Xoliox, Ntera etc. Und die 100.000 $ gehen wohl auch durch die 3 beteiligten Firmen bzw. Institute.

Viel wichtiger ist die Phase II, wie ist die denn definiert ? Zeitplan ?

Wäre doch mal eine Gelegenheit gewesen alle mal auf den aktuellen Stand zu bringen oder haben die die letzten Monate geschlafen ? Stattdessen nochmals ein kleiner Geschichtsausflug auch nett bringt aber nicht so richtig nach vorne.

Schaun wir mal, wie es andere aufnehmen und wie lange es Bestand hat.


Apropos, kann sich noch jemand an die Grätzel Zelle erinnern ?
Hatte gerade vor ein paar Tagen einen Bericht darüber gelesen, war ja auch seit einiger Zeit ruhig. Scheint so, dass die Technik als solches funktioniert nur die Dinger halten nicht so lange, war so von 2 Jahren die Rede, dass ist natürlich viel zu wenig.


mrasta

[Wunram]

@MRASTA, viel arbeit, wenig Zeit für Aktien

news, hier hauen sie schon auf den Putz im Verleich zu den Konkurrenzprodukten

ALTAIR NANOTECHNOLOGIES REPORTS RESULTS OF TESTING AND LIKELY PATIENT DOSING FOR PHOSPHATE BINDING DIALYSIS DRUG




RenaZorb™ Outperforms RenagelTM and the Active Ingredient in Fosrenol(TM) for Phosphate Binding


RENO, NV – September 1, 2004 – Altair Nanotechnologies, Inc. (Nasdaq: ALTI), reports the results of a pre-clinical animal study performed by an independent laboratory for Altair’s lead drug candidate, RenaZorbTM. The study was conducted to determine the phosphate binding efficiency of existing and proposed non-calcium containing phosphate binding drugs for phosphate control in kidney dialysis patients with end stage renal disease (ESRD).

Animal studies indicate the measurement of phosphate concentration in urine from rats fed a diet of predetermined phosphate levels demonstrated that gram-for-gram RenaZorb administered to the test rats bound more phosphate than Renagel, Genzyme’s drug for ESRD, and significantly more phosphate than lanthanum carbonate tetrahydrate, the active ingredient in Fosrenol, Shire’s proposed drug for ESRD.

Renagel, an approved FDA drug for ESRD, is forecast to have sales of approximately $350 million in 2004. The Fosrenol product, already approved in the European Union reference country of Sweden, is expected to receive FDA approval for use in the U.S. in October 2004. The studies indicate that RenaZorb may offer a better solution for patients with ESRD.

”The testing confirms previous Altair laboratory results that compared RenaZorb to competing phosphate binding drugs and confirms the results of previous independent testing in dogs and 5/6 nephrectomized rats,” said Altair President Dr. Rudi E. Moerck. “RenaZorb may control serum phosphate levels with only one small tablet per meal compared to two or three large tablets per meal required by competing drugs. We believe that this reduction in the number of tablets taken each day will improve patient compliance and reduce phosphate levels more reliably. Our goal is to improve patient compliance and quality of life.”

According to an article in Dialysis and Transplantation Journal Volume 33, Number 5, Page 236-240, phosphate binder therapies currently approved by the FDA required an average of 8-plus tablets per day. Overall patient compliance was only 37.8 percent in this study. The National Kidney Foundation Kidney Disease Outcome Quality Initiative (K/DOQI) suggests that more effective binders (i.e. fewer pills to achieve a similar effect) may aid in achieving the K/DOQI guidelines’ therapeutic goals for serum phosphate levels.

Altair’s RenaZorb (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug candidate for phosphate control in patients with ESRD. Altair is seeking to partner with a pharmaceutical company to further advance RenaZorb as a drug candidate and to conduct necessary clinical development programs for worldwide regulatory approval. Preparations for out-licensing are advancing with the assistance of RBC Capital Markets Corporation.

ALTAIR NANOTECHNOLOGIES INC.
Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of nano-material technology and nano-materials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Renagel® (sevelamer hydrochloride), is a trademark of Genzyme Corporation. Fosrenol® (lanthanum carbonate tetrahydrate) is a trademark of Shire Pharmaceuticals.

Forward-Looking Statements
......


Gruss Wunram

[MRASTA]

@Wunram

weiß nicht so genau, was ich von den letzten Meldungen wirklich halten soll.

Das Ihr Produkt anscheinend besser ist als die beiden anderen, ist vielleicht noch das einzige Highlight an der Geschichte. Ansonsten wäre es ja auch mehr oder weniger sinnlos.

Dass Sie Renazorb lieber heute als Morgen loswerden wollen ist ja kein Geheimnis. Scheint aber wohl nicht so ganz einfach zu sein.

Fragt sich, ob da jemand anbeißt und die weitere Entwicklung übernimmt. Irgendwie habe ich den Eindruck als wenn Sie sich ziemlich festgefahren haben, einfach zuviele Baustellen.

Da müssen Sie arg aufpassen, dass nicht Firmen aus der zweiten Reihe plötzlich an Ihnen vorbei rauschen.

Schaun wir mal, was sich so ergibt. Aber so richtig Mut macht dass alles nicht. Nur der technische Rebound, wie jedes Jahr, war zumindest ein positives Zeichen.

bis dann
mrasta

[MRASTA]

nanü, nanu, hatte wair dass nicht gerade erst ? Siehe #286

Sachen gibt es.

cu



Dr. Michael Graetzel Joins Altair Nanotechnologies` Scientific Advisory Board

Company Expands Advisory Board to Bolster Expertise in Semiconductor and Alternative Energy Nanotechnology Application Development

Monday , September 13, 2004 08:05 ET
RENO, NV, Sep. 13, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that Dr. Michael Graetzel has joined the company`s Scientific Advisory Board. Dr. Graetzel, a professor at the Swiss Federal Institute of Technology in Lausanne, Switzerland, is a pioneering researcher in nanomaterials, particularly in the field of semiconductors, solar cells, batteries, and related alternative energy applications.

"It is an exciting time to be joining Altair`s Scientific Advisory Board," said Dr. Graetzel. "The field of nanotechnology is well on its way to moving from an emerging technology to one of commercial products. I believe Altair`s enabling technology platform shows tremendous promise, particularly for improving processes and increasing efficiencies necessary for making a wide range of solar cells and next-generation batteries both technologically competitive and economically viable. I look forward to working closely with management and the other members of the advisory board."

"We are pleased to have someone of Dr. Graetzel`s caliber join our Scientific Advisory Board," said Altair Chief Executive Officer Dr. Alan J. Gotcher. "Michael is widely recognized as a visionary in the field of solar energy as well as other alternative energy opportunities. Dr. Graetzel`s research and development acumen, coupled with his direct experience in applying nanotechnology to alternative energy solutions will serve Altair well as we continue our focus on bringing revenue-generating products to market."

The Scientific Advisory Board provides a wealth of scientific, and industrial technology expertise that Altair`s management, research and product development teams can draw upon as the company drives toward commercialization of nanotechnology products.

About Dr. Michael Graetzel

Dr. Michael Graetzel is currently a Professor at the Swiss Federal Institute of Technology in Lausanne, where he directs the laboratory of Photonics and Interfaces. He has pioneered research in nano-materials, in particular the field of semiconductor nanocrystallites and mesoscopic oxide films and their energy and display-related applications. His extensive research and development track record includes the development of new ionic liquids, used as "green" electrolytes, and high power lithium ion batteries based on mesoporous films. He has also discovered a new type of solar cell based on dye sensitized nanocrystalline oxide particles, which could ultimately prove a new and viable alternative energy source.

A published author of more than 500 publications, two books and over 40 patents, Dr. Graetzel counts amongst the top 50 most cited scientists in the world. He has been an invited professor and lecturer at the University of California at Berkeley, the University of Tokyo, the Ecole National Superieur de Paris, the Delft University of Technology, and more than one dozen other leading institutions. He has received numerous awards including the Millennium 2000 European Price of Innovation, the 2001 Faraday Medal of the British Royal Society, the 2001 Dutch Havinga Award, two McKinsey Venture awards in 1998 and 2002, the 2002 IBC award in Supramolecular Science and Technology.

Dr. Graetzel holds a doctoral degree in Natural Science from the Technical University, Berlin, and has received honorary doctoral degrees from the Universities of Uppsala (1996) and Turin (2004) in recognition of his scientific achievements. He serves on the editorial board of several scientific journals, is a member of New Swiss Chemical Society, and is an Honorary Member of the Societe Vaudoise de Sciences Naturelles.

[MRASTA]

sorry, Tastatur klemmte.

cu

[MRASTA]

Und nun ?

Die Grätzel Zelle hat seinerzeit für viel aufsehen gesorgt, keine Frage. Kann sogut wie jeder in der eigenen Küche herstellen. Wenn es denn so einfach ist, warum gibt es die noch nicht in einer Massenproduktion ?

Über das Verfahren wurde ja nun mehr als nur ein Bericht veröffentlicht. Es scheint nachwievor diverse Probleme zu geben.

Zum einen die Haltbarkeit, wie schon berichtet, die Versiegelungt der Zellen, sowie noch einige andere Punkte.

Es hat zumindest den Anschein, als dass man die Zelle zwar einfach herstellen kann, der Folgeprozeß zum erreichen einer ausreichenden Lebensdauer und Stabilität aber mit so hohen Kosten verbunden ist, dass man keinen Vorteil mehr gegenüber Silizium hätte.

Ob man dass alles jemals in den Griff bekommt, steht somit in den Sternen. Besonders da er nun seit 1991 daran gebastelt hat und Altair bis dato wohl den Grundstoff (TIO2) geliefert hatte.

Stellt sich somit die Frage, warum Grätzel jetzt eine engere Bindung zu Altair eingeht oder umgedreht ?

cu

[Wunram]

mal eine news mit $$$

ALTAIR NANOTECHNOLOGIES, WESTERN MICHIGAN UNIVERSITY, AND UNIVERSITY OF NEVADA RECEIVE SECOND AWARD FROM U.S. DEPARTMENT OF ENERGY

DOE Awards Additional $2 Million Contract to WMU, Altair to Receive $672,000 as Subcontractor for Joint Development of Nanosensors

RENO, NV – September 30, 2004 – Altair Nanotechnologies, Inc. (NASDAQ:ALTI), in collaboration with Western Michigan University (WMU) and the University of Nevada, Reno today announced the consortium has received a Notice of Financial Assistance Award from the U.S. Department of Energy (DOE) for the joint development of nanosensors for detecting chemical and biological weapons. Under terms of the Stage 2, two-year contract, Altair will receive $672,000 for collaborative research and development efforts through its subcontractor agreement with WMU.

“Altair is pleased to receive additional support and funds from the Department of Energy,” said Altair chief executive officer Dr. Alan J. Gotcher. “This new contract builds upon the Stage 1 grant funding that Altair announced in 2003 and the progress our company has made thus far in developing nanosensors and related nanotechnology applications for the DOE. We look forward to working closely with these leading educational centers to advance nanotechnology solutions for our homeland security.”

“This kind of private/public collaboration is paramount to society’s ability to tackle emerging global threats to public health and safety,” said Tom Bell, professor of chemistry at the University of Nevada, Reno. Professor Bell and a team of fellow researchers are spearheading the project to develop methods that detect potential agents of terrorism, including radioactive materials that can be released into the air by a “dirty bomb” or the deadly nerve toxins such as sarin and tabun.

Under terms of the award agreement, the project comprises joint development work for the design, synthesis and characterization of nanosensors for chemical, biological and radiological agents. The resulting nanosensors will be designed to detect chemical, nuclear and biological agents, and for related national defense applications and homeland security programs. Altair received $356,000 for subcontract work, which has one year remaining on the initial research and development effort. Both of these ongoing awards were the result of the teaming agreement between Altair and WMU announced in January 2003.

“We would also like to extend our thanks to Senator Reid and Representative Upton for their continued support of Altair and our research efforts,” added Dr. Gotcher.

UNIVERSITY OF NEVADA, RENO
Founded in 1864 as Nevada’s land-grant institution, the University of Nevada, Reno is a component of the University and Community College System of Nevada. The Carnegie Classification of Institutions of Higher Education lists Nevada as a “Doctoral / Research Universities-Extensive” institution, its highest rating. UNR offers more than 65 undergraduate degree programs, 60 master`s degree programs, and 30 doctoral degree programs. For more information, visit www.unr.edu.

WESTERN MICHIGAN UNIVERSITY
WMU is a Carnegie-designated Doctoral/Research-Extensive university and one of only 102 public research universities to be included in this top classification. WMU is a national leader in nanobioenvironmental chemistry research and has established the Nanotechnology Research and Computation Center to further this research. For more information, visit www.wmich.edu.

ALTAIR NANOTECHNOLOGIES, INC.
Altair Nanotechnologies pioneers the discovery and development of nano-materials of unique structure, performance, quality and cost. The company is positioning itself through product innovation to become a leading supplier of nano-materials technology and nano-materials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.


Forward-Looking Statements
....

Gruss Wunram

[MRASTA]

?????????????

ALTI: Volume Spike; 14% > 20-adsv, Stock +8.79%
Wednesday, October 06, 2004 10:51 ET

This is the 1st VOLUME alert for ALTI in the past 7 calendar days.

Trading for Altair Nanotechnologies Inc (NASDAQ SC: ALTI) has been heavier than usual in today`s session. By 10:50 ET, the stock had already traded 547,500 shares via 216 trades. The cumulative volume is 13.87% above its 20-day average of 480,820. Normally the stock experiences around 495 individual trades per session.

So far, today`s volume surge has caused a net rise in ALTI`s stock price. At the time of this alert, the stock was trading at $1.980, up $0.160 (+8.79%).

One year ago, the Company`s shares closed at $1.200. The price has gained more than 65 percent since then.

Over the last 10 trading session ALTI has traded in a range between $1.450 and $1.940 and is currently trading 55.00% below its 52-week high of $4.400 set on January 28, 2004 and 108.44% above its 52-week low of $0.950 from August 12, 2004.

[MRASTA]

Dr. Ravi I. Thadhani Joins Altair Nanotechnologies Scientific Advisory Board

Award-Winning Harvard Medical School Professor and Kidney Dialysis Research Specialist Brings Focused Expertise to Advisory Board

Thursday , October 07, 2004 08:03 ET
RENO, NV, Oct. 07, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that Dr. Ravi I. Thadhani has joined the company`s Scientific Advisory Board. Dr. Thadhani, an award-winning clinical instructor, researcher, and medical practitioner, will lend his expertise to the company`s life sciences division, in particular the ongoing development of nano-based pharmaceutical and biotechnology applications.

"I am enthusiastic to be joining Altair`s Scientific Advisory Board at this particular juncture in their business strategy," said Dr. Thadhani. "Nanotechnology-based research has already shown tremendous promise for applications in traditional medicine and I anticipate nanotechnology to truly change the future of all aspects of life sciences. I look forward to working closely with the Altair team and board as they continue development of their drug candidate for end stage renal disease as well as their advanced drug delivery systems."

"The appointment of Dr. Thadhani to our Scientific Advisory Board will prove invaluable to our life sciences efforts," said Altair Chief Executive Officer Dr. Alan J. Gotcher. "Ravi is an established clinician, with widely regarded expertise in researching and developing new therapeutic techniques for kidney-related ailments including chronic and acute renal failure. We are honored to have him join our board."

The Scientific Advisory Board provides a wealth of scientific and industrial technology expertise that Altair`s management, research and product development teams can draw upon as the company drives toward commercialization of nanotechnology products.

About Dr. Ravi I. Thadhani

Dr. Ravi I. Thadhani is currently an active practioner, medical researcher, and an Assistant Director of the Massachusetts Institute of Technology (MIT) Clinical Research Center. He has pioneered research in both pregnancy and dialysis outcomes, having recently received several grants from the NIH and foundations for this work. Dr. Thadhani spends a significant amount of time teaching at some of the world`s leading medical institutions. In addition to his role at MIT, he also currently acts as Director for Harvard Medical School`s Core Medicine rotation at Massachusetts General Hospital and Assistant Director of the Pasteur Program at Harvard Medical School, where he received Harvard`s highest award in clinical teaching.

A board-certified physician, Dr. Thadhani is a member and Vice Chair, Clinical Research Committee of the National Kidney Foundation, a member of the International Society of Hypertension in Pregnancy, and a member of the American Society of Nephrology. He is also a published author of more than 35 original publications, including several publications in the New England Journal of Medicine, and he is a recipient of numerous awards and honors from both the University of Pennsylvania and Harvard Medical School.

Dr. Thadhani holds a medical degree from the University of Pennsylvania, a master`s degree in public health from Harvard School of Public Health, and a Bachelor of Science degree, summa cum laude, from the University of Notre Dame.

ALTAIR NANOTECHNOLOGIES, INC.

[MRASTA]

Altair Nanotechnologies, Inc. Announces European Patent Award Notification
10/14/04

Latest Patent protects Manufacturing Process for Lithium Titanate
Spinel Materials Used in High Power Battery Applications

RENO, NV, Oct. 14, 2004 (MARKET WIRE via COMTEX) --

Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that the European Patent Office has notified Altair that it has approve

d Altair`s patent application for a "Process For Making Lithium Titanate." This European patent application describes the process and underlying technology for producing lithium titanate spinel materials of high purity and tightly controlled particle size over a range of 5 to 2,000 nanometers.

The processes protected by the patent were used to make materials that have been formed into electrodes which exhibit high charge and discharge rates in lithium ion batteries and in super capacitors being used in the National Science Foundation`s SBIR grant announced in June 2004. The SBIR grant is funding a joint program under which Altair, Hosokawa Micron`s Nano Particle Technology Center and Rutgers, The State University of New Jersey`s Energy Storage Research Group are using their combined technologies with the objective to develop and commercialize high-power, long life, fast-charge lithium ion batteries.

"Over the past five years, Altair has expended significant resources to pioneer and develop metal oxide nanotechnology and as of today, Altair owns four issued U.S. Patents, 12 issued foreign patents and 45 additional pending U.S. and foreign patent applications," said Dr. Alan J. Gotcher, Chief Executive Officer of Altair Nanotechnologies. "This European patent is significant to the company, as the European and Asia-Pacific regions are a crucial part of our global business strategy," continued Dr. Gotcher. "We are aggressively pursuing licensing and business development programs with our technology, nanomaterials and products in European countries and in India, China, Japan and Vietnam."

"Our Performance Materials Division, in conjunction with various industry partners, is involved with alternative energy development programs that include lithium ion batteries, super capacitors, fuel cell development and a solar hydrogen generator using Tandem Cell(TM) technology," commented Gotcher. "We believe nanomaterials, in the near future, can significantly improve lithium ion battery and super capacitor performance, making it possible to use these systems in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles, as well as military applications and specialized uses such as notebook computers, mobile phones, and a variety of portable devices."

ALTAIR NANOTECHNOLOGIES, INC.

[MRASTA]

ALTANA and Nanophase to Present and Exhibit at ICE 2004
10/14/04

ROMEOVILLE, Ill., Oct 14, 2004 /PRNewswire-FirstCall via COMTEX/ --

Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, announced that the Company would assist BYK-Chemie, a company of ALTANA Chemie AG, during the International Coatings Exposition Oct

ober 27-29 in Chicago, IL. During the exhibition and conference, BYK-Chemie plans to introduce its new product line: the NANOBYK series that incorporates Nanophase`s nanoparticles into BYK-Chemie`s additives for coatings, printing inks and plastics.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

BYK-Chemie, a market partner of Nanophase, and Nanophase jointly created the NANOBYK products. The first such products in the family, NANOBYK-3600 and NANOBYK-3601, were developed to improve the scratch and wear resistance in all types of UV-curable coatings.

During ICE 2004, Dr. Thomas Sawitowski, BYK-Chemie`s Manager of Nanotechnology, and Dr. Roger Cayton, Nanophase Senior Scientist, are scheduled to make a joint presentation on nanomaterials and nanocomposites.

"We are excited to be co-presenting and assisting in the introduction of BYK-Chemie`s new line of coating additives incorporating Nanophase`s nanomaterials," stated Joseph Cross, Nanophase`s president and CEO. "There has been considerable market interest and product testing already and we expect ICE 2004 to generate additional interest and opportunities for the NANOBYK products."

Nanophase Technologies (NANX), http://www.nanophase.com , provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 25 United States patents and patent applications and 49 foreign patents and patent applications. Information about Nanophase may be found in the Company`s public filings or on its website. Other information on our website is not incorporated by reference into, and not be considered a part of, this press release.

BYK-Chemie is one of the world`s leading suppliers in the field of paint and plastic additives with major markets in the USA, Europe, and the Far East. Additives are chemical substances that are used in the manufacture of coatings, printing inks and plastics. BYK-Chemie is a company of ALTANA Chemie AG, Wesel, Germany. ALTANA Chemie develops and produces high-quality, innovative products in the field of specialty chemicals.

This press release contains words such as "expects," "shall," "will," "believes" and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company`s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company`s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risk and uncertainties include the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company`s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company`s nanocrystalline materials; the Company`s manufacturing capacity and product mix flexibility in light of customer demand; the Company`s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company`s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other risks described in the Company`s registration statement on Form 10-Q filed August 13, 2004 and other filings with the Securities and Exchange Commission. In addition, the Company`s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies

SOURCE Nanophase Technologies Corporation

[MRASTA]

Altair ist mal wieder bei 2$ angekommen, ist doch sympatisch.


@WUNRAM, tntxrxwelle

seid Ihr überhaupt noch da ?

cu

[MRASTA]

Hilft das ?

Westrock Advisors, Inc. Initiates Coverage on Altair Nanotechnologies, Inc., Gives Company Buy Rating
Thursday , October 21, 2004 08:03 ET

NEW YORK, NY, Oct. 21, 2004 (MARKET WIRE via COMTEX) -- Westrock Advisors, Inc. today announced it has initiated coverage on Altair Nanotechnologies, Inc. (NASDAQ: ALTI) and, after conducting in-depth research on the company, its patented technology, and strategic plans for commercial success, gives the company a speculative BUY rating.

"Nanotechnology holds the potential for significant change in the marketplace, and we believe the first investment opportunities will be among nanotech developers such as Altair," said Debra Fiakas, research consultant for Westrock Advisors. "The company has reached an inflection point with its new management, a business restructuring, and a refocused priority list, bringing commercial viability within its grasp. Should any one of its processes or products prove viable and reach volume production, Altair offers significant return potential to investors."

Westrock Advisors, Inc. is a full service broker-dealer, offering a broad range of institutional and retail investments and services. To request a copy of the full report, please contact either Don Hunter at 212-922-1995, or McCloud Communications at 949.566.9860.

The information in this report is provided for general information purposes only and should not be considered an individualized recommendation. All investors are encouraged to use multiple sources of investment information and to actively monitor their holdings. Altair Nanotechnologies or the industry sector discussed may not be a suitable investment for everyone. This report is based on information from a variety of sources and the statistical data is believed to be reliable but in no way are warranted as to accuracy, timeliness, completeness or reliability.

The report and rating are the final opinion of Westrock Advisors, Inc. and does not guarantee that any target price will be met or that the predicted business results will occur. Any and all revenue and earnings estimates and projections assume certain conditions and industry developments, which are subject to change and no guarantee is made as to the suitability or potential value of any investment.

This report is published for informational purposes only and is not to be construed as a solicitation or an offer to buy or sell any security. Opinions expressed are subject to change without notice and Westrock Advisors does not undertake to advise the public, nor is Westrock under any obligation to advise the public as to any changes in its projections or views of the industry or Altair Nanotechnologies. Past information is no guarantee or indication of future results.

WESTROCK ADVISORS, INC.

Westrock Advisors is a New York based Full Service Broker-Dealer offering a comprehensive range of high quality financial services for individuals as well as institutional investors. For more information, please visit www.westrockadvisors.com.

[MRASTA]

@all

wer auch das immer hier noch ist. Aber 100% seit August, da kann man doch nicht meckern. Falls kein Interesse mehr besteht, stelle ich den Thread aber gerne ein. Bin ja kein Alleinunterhalter.

cu

[Wunram]

@MRASTA

nein, nein, mach weiter - bin schon noch da, habe aber momentan wenig zeit für recherche und austausch im thread.

wünsche ein schönes restwochenende - bei 20°C ist gartenarbeit angesagt.

gruss wunram

[MRASTA]

Nanophase Offers New Range of Mixed Rare Earth Oxide Nanocrystals

Wednesday, November 03, 2004 10:40 ET

ROMEOVILLE, Ill., Nov 3, 2004 /PRNewswire-FirstCall via COMTEX/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanoengineered products, announces the commercial availability of NanoArc(TM) Zinc Oxide. NanoArc(TM) is a patented process that employs a novel plasma technology to prepare nanocrystalline materials with highly controlled surface chemistry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030422/NANXLOGO )

Typical attributes of NanoArc(TM) Zinc Oxide are non-porous, discrete, homogeneous, single-phase crystals; available at controllable particle size less than 35 nanometers; with a narrow particle size distribution; high purity; and dispersion stability. The NanoArc(TM) Zinc Oxide can also be doped with a variety of materials to obtain modified electrical and/or chemical properties.

"The new products produced using the NanoArc(TM) technology significantly expand market opportunities for zinc oxide-based nanomaterials," states Dr. Ed Ludwig, Nanophase`s Vice President of Business Development. "The small particle size enables highly transparent, UV blocking coating systems. In addition, NanoArc(TM) Zinc Oxide may be used in systems requiring a high level of clarity and good antimicrobial characteristics." Applications anticipated for the NanoArc(TM) Zinc Oxide include: substantially transparent UV protective coatings, chemical catalysts, chemical adsorption, superior dielectric and mechanical properties for polymers containing zinc oxide and/or doped-zinc oxide additives, passive and active electronic components, enhanced antimicrobial materials, and certain unique personal care applications.

Nanophase has annual full-scale commercial production capability for NanoArc(TM) Zinc Oxide nanomaterials in the metric ton(s) range manufactured under its ISO 9001:2000 quality system. Nanophase currently produces and sells several hundred metric tons annually of a 65 nm zinc oxide through its patented PVS process that is used primarily for certain personal care applications.

For additional information, please contact Dr. Ed Ludwig, Nanophase`s Vice President of Business Development at 630-771-6729 and email [e-mail] , or Ian Roberts, Vice President U.S. and International Sales, at 630-771-6730 and email [e-mail] .

Nanophase Technologies (NANX), http://www.nanophase.com , provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 25 United States patents and patent applications and 49 foreign patents and patent applications. Information about Nanophase may be found in the Company`s public filings or on its website. Other information on our website is not incorporated by reference into, and not be considered a part of, this press release.

[MRASTA]

Altair Nanotechnologies Reports Financial Results for Third Quarter of Fiscal 2004
11/12/04

Company Reports Third Consecutive Quarter of Revenue Growth With Significant Improvement in Gross Profit Margins

RENO, NV, Nov. 12, 2004 (MARKET WIRE via COMTEX) --

Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today reported financial results for its third quarter ended September 30, 2004.

The company reported that revenue for the third quarter of fiscal 2004 increased to approximately $347,000 compared to revenue of approximately $17,000 for the third quarter of fiscal 2003. The net loss for the third quarter 2004 was $1.4 million, or a loss per share of $0.03, versus a net loss of $1.7 million, or a net loss per share of $0.05 for the comparable quarter in 2003. The gross margin for the third quarter was approximately $53,000, a considerable improvement when compared to a gross margin of approximately ($46,000) on sales of approximately $154,000 for its second quarter ended June 30, 2004.

For the nine-month period ended September 30, 2004, revenue increased to approximately $641,000, with a net loss of $5.3 million, or a net loss per share of $0.11, compared to revenue for the nine-month period ended September 30, 2003 of approximately $42,000, with a net loss of $4.6 million, or a net loss per share of $0.13.

"This has been a solid year of improved performance for the company," commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "We are on track to successfully transition from a research and development company into a nanotechnology company with commercial products and a variety of development services. We believe that we can announce one or two new commercial contracts by the end of fiscal 2004. Currently we have booked orders of $1.5 million and, depending upon our market partners, we expect to invoice more than twenty-five percent of these orders by the end of fiscal 2004."

Operating expenses for the third quarter, which ended September 30, 2004, were approximately $1.5 million, versus operating expenses for the comparable quarter in 2003 of approximately $1.2 million. The increase in operating expenses over the comparable period in 2003 is a result of expansions in research, development, marketing, and sales.

Altair CFO Edward Dickinson noted, "Our net cash used in operations has averaged around $460,000 per month for the first three quarters, and we expect a modest increase in net cash used in operations for the fourth quarter as we add additional personnel and increase investments in product development." As of September 30, 2004, Altair`s balance sheet was strong, with a cash position of approximately $9.0 million compared to $3.9 million at December 31, 2003.

"When comparing Altair to other nanotechnology companies," continued Dickinson, "it is important to note that Altair`s long-term debt consists only of a promissory note of $3.0 million to purchase the building that houses Altair`s 80,000 square foot corporate headquarters, research laboratories and production facilities in Reno, Nevada." Under the terms of the promissory note, interest begins accruing in August 2005 with the first payment due February 2006.

Altair Nanotechnologies Corporate Update


-- Dr. Alan J. Gotcher joins Altair as Chief Executive Officer

and a Director.

-- Dr. Ravi I. Thadhani, a professor at Harvard Medical School and kidney

dialysis research specialist, joins Altair`s Scientific Advisory

Board.

-- Dr. Michael Graetzel, a professor at the Swiss Federal Institute of

Technology in Lausanne, Switzerland and nanomaterials research

pioneer, joins Altair`s Scientific Advisory Board.

-- Westrock Advisors, Inc. initiates coverage on Altair Nanotechnologies,

Inc. with a BUY rating.

-- Altair CEO, Dr. Alan J. Gotcher presents at the 15th annual New York

City Analyst Pharmaceutical Conference.


Life Sciences Division Update

Pharmaceutical Products

RenaZorb(TM) Products - Nanotechnology-based Drug Candidate for Phosphate Binding in End Stage Renal Disease

Altair`s RenaZorb (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug candidate for phosphate control in patients with end-stage renal disease (ESRD).


-- October 26, 2004, Shire Pharmaceutical`s CEO announced that the FDA

had approved Fosrenol(R), Shire`s lanthanum carbonate tetra

hydrate-based drug for phosphate control in kidney dialysis patients

with ESRD. FDA approval of the first lanthanum-based drug candidate

is likely to facilitate the development of RenaZorb.

-- Preparations for the out-licensing of RenaZorb are underway. Altair,

with the assistance of RBC Capital Markets, has sent the license

marketing package for RenaZorb to over forty pharmaceutical and

biotechnology companies. Several of these companies have expressed

interest.


Drug Delivery Products

TiNano(R) Spheres(TM) Drug Delivery Systems

TiNano Spheres are rigid, hollow, porous, high surface area, ceramic microstructures proposed for use in drug delivery systems, including systems to mitigate diversion and abuse of drugs.

-- Two patent applications have been filed for the TiNano Sphere drug delivery technology platform.

Dental Nano-materials

-- Altair continues to work with a research consortium sponsored by the National Institutes of Health to strengthen polymer-based dental fillings utilizing Altair`s nano-zirconia.

Performance Materials Division Update

Advanced Materials for Paints, Coatings and Sensors

Titanium Dioxide Pigment - Altair`s Hydrochloride Pigment Process (AHPP)

-- Altair has now completed approximately 50 percent of Phase l of the Western Oil Sands Project. -- Altair was awarded a third contract from a (confidential) Fortune 100 company to supply testing quantities of customized nano-sized coating material.

Nanosensors


-- Western Michigan University and Altair received a $2 million contract

from DOE for joint development of nanosensors for detecting chemical

and biological weapons. Under terms of the Stage ll contract

scheduled to commence this quarter, Altair will receive $672,000 over

a two-year period for collaborative research and development as a

subcontractor.


Advanced Materials for Improving Process Technologies

Titanium Metal Manufacturing via Electrolysis Processing


-- Altair`s development agreement with Titanium Metals Corporation

(NYSE: TIE), provides Altair the opportunity to supply enough TiO2

micro porous electrodes to produce 50 pounds of titanium metal per day

to meet the DARPA titanium project goals as outlined by the program.

Altair has met its goals and work plan and the project continues to

successfully move forward.


NanoCheck(TM) Products for Binding Phosphate in Water


-- Independent and in-house laboratory testing has proven that Altair`s

unique nano-structured compound, NanoCheck, safely and effectively

removes phosphate from water preventing algae growth in swimming pools

and reduces the quantity of chemicals currently required for algae

prevention.

-- Field testing, focused on evaluating NanoCheck`s effectiveness in

providing an algae-free environment for swimming pools, was delayed

due primarily to hurricanes in the field testing areas. Testing has

been reinitiated and results will be made public when available.

Negotiations with major pool chemical companies for licensing of the

product are underway.


High Performance Materials for Alternative Energy

Lithium-Ion Battery Electrode Development


-- Altair is completing research work scope under a $100,000 SBIR Phase I

grant and intends on applying for a $500,000 SBIR Phase ll grant from

the U.S. National Science Foundation to continue work on

carbon-coated nano-structured electrodes for next-generation

lithium-ion ultra capacitors with partners Hosokawa Micron and

Rutgers University.

-- Altair was awarded a European patent for its "Process for Making

Lithium Titanate" a product used in the development of lithium-ion

batteries and super capacitors.


ALTAIR NANOTECHNOLOGIES INC.

Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of ceramic, metal oxide-based nanomaterial technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.(R), Altair Nanomaterials(TM), TiNano(R), RenaZorb(TM), NanoCheck(TM), TiNano Spheres(TM) and the Hydrochloride Pigment Process(TM) are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market: the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Selected Financial Data Unaudited)

September 30, December 31,

2004 2003

----------- -----------

ASSETS

Total Current Assets $ 9,200,992 $ 3,962,180

Property, Plant and Equipment, net 6,322,783 6,618,805

Patents, net 996,299 1,060,569

Other Assets 18,200 18,200

----------- -----------

Total Assets $16,538,274 $11,659,754

=========== ===========

LIABILITIES AND SHAREHOLDERS` EQUITY

Total Current Liabilities $ 920,647 $ 397,141

Note Payable, Long-Term Portion 2,830,488 2,686,130

Total Shareholders` Equity 12,787,139 8,576,483

----------- -----------

Total Liabilities and Shareholders` Equity $16,538,274 $11,659,754

=========== ===========

ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Selected Financial Data Unaudited)

Three Months Ended Nine Months Ended

Sept. 30, Sept. 30,

2004 2003 2004 2003

----------- ----------- ----------- -----------

Sales $ 346,907 $ 17,318 $ 640,889 $ 42,029

Cost of Sales 293,685 16,706 604,517 32,594

----------- ----------- ----------- -----------

Gross Margin 53,222 612 36,372 9,435

Total Operating Expenses 1,473,277 1,189,056 5,268,477 3,583,556

----------- ----------- ----------- -----------

Loss from Operations 1,420,055 1,188,444 5,232,105 3,574,121

Other (Income) Expense: 20,269 141,027 73,008 406,935

----------- ----------- ----------- -----------

Net Loss 1,440,324 1,329,471 5,213,338 3,981,056

Preferential Warrant

Dividend - 416,014 - 592,486

----------- ----------- ----------- -----------

Net Loss Applicable

to Shareholders $ 1,440,324 $ 1,745,485 $ 5,305,113 $ 4,573,542

=========== =========== =========== ===========

Loss per Common Share

- Basic and Diluted $ 0.03 $ 0.05 $ 0.11 $ 0.13

=========== =========== =========== ===========

Weighted Average Shares

- Basic and Diluted 49,121,984 38,129,702 48,401,745 34,676,028

=========== =========== =========== ===========



For Additional Information:

Marty Tullio

McCloud Communications, LLC

949.553.9748

[e-mail]

For Additional Information:

Mark Tullio

McCloud Communications, LLC

949.553.9748

[e-mail]


SOURCE: Altair Nanotechnologies, Inc.

[MRASTA]

Altair Nanotechnologies Reports Financial Results for Third Quarter of Fiscal 2004

Company Reports Third Consecutive Quarter of Revenue Growth With Significant Improvement in Gross Profit Margins
Friday , November 12, 2004 08:03 ET

RENO, NV, Nov. 12, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today reported financial results for its third quarter ended September 30, 2004.

The company reported that revenue for the third quarter of fiscal 2004 increased to approximately $347,000 compared to revenue of approximately $17,000 for the third quarter of fiscal 2003. The net loss for the third quarter 2004 was $1.4 million, or a loss per share of $0.03, versus a net loss of $1.7 million, or a net loss per share of $0.05 for the comparable quarter in 2003. The gross margin for the third quarter was approximately $53,000, a considerable improvement when compared to a gross margin of approximately ($46,000) on sales of approximately $154,000 for its second quarter ended June 30, 2004.

For the nine-month period ended September 30, 2004, revenue increased to approximately $641,000, with a net loss of $5.3 million, or a net loss per share of $0.11, compared to revenue for the nine-month period ended September 30, 2003 of approximately $42,000, with a net loss of $4.6 million, or a net loss per share of $0.13.

"This has been a solid year of improved performance for the company," commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "We are on track to successfully transition from a research and development company into a nanotechnology company with commercial products and a variety of development services. We believe that we can announce one or two new commercial contracts by the end of fiscal 2004. Currently we have booked orders of $1.5 million and, depending upon our market partners, we expect to invoice more than twenty-five percent of these orders by the end of fiscal 2004."

Operating expenses for the third quarter, which ended September 30, 2004, were approximately $1.5 million, versus operating expenses for the comparable quarter in 2003 of approximately $1.2 million. The increase in operating expenses over the comparable period in 2003 is a result of expansions in research, development, marketing, and sales.

Altair CFO Edward Dickinson noted, "Our net cash used in operations has averaged around $460,000 per month for the first three quarters, and we expect a modest increase in net cash used in operations for the fourth quarter as we add additional personnel and increase investments in product development." As of September 30, 2004, Altair`s balance sheet was strong, with a cash position of approximately $9.0 million compared to $3.9 million at December 31, 2003.

"When comparing Altair to other nanotechnology companies," continued Dickinson, "it is important to note that Altair`s long-term debt consists only of a promissory note of $3.0 million to purchase the building that houses Altair`s 80,000 square foot corporate headquarters, research laboratories and production facilities in Reno, Nevada." Under the terms of the promissory note, interest begins accruing in August 2005 with the first payment due February 2006.

Altair Nanotechnologies Corporate Update



-- Dr. Alan J. Gotcher joins Altair as Chief Executive Officer
and a Director.
-- Dr. Ravi I. Thadhani, a professor at Harvard Medical School and kidney
dialysis research specialist, joins Altair`s Scientific Advisory
Board.
-- Dr. Michael Graetzel, a professor at the Swiss Federal Institute of
Technology in Lausanne, Switzerland and nanomaterials research
pioneer, joins Altair`s Scientific Advisory Board.
-- Westrock Advisors, Inc. initiates coverage on Altair Nanotechnologies,
Inc. with a BUY rating.
-- Altair CEO, Dr. Alan J. Gotcher presents at the 15th annual New York
City Analyst Pharmaceutical Conference.


Life Sciences Division Update

Pharmaceutical Products

RenaZorb(TM) Products - Nanotechnology-based Drug Candidate for Phosphate Binding in End Stage Renal Disease

Altair`s RenaZorb (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug candidate for phosphate control in patients with end-stage renal disease (ESRD).



-- October 26, 2004, Shire Pharmaceutical`s CEO announced that the FDA
had approved Fosrenol(R), Shire`s lanthanum carbonate tetra
hydrate-based drug for phosphate control in kidney dialysis patients
with ESRD. FDA approval of the first lanthanum-based drug candidate
is likely to facilitate the development of RenaZorb.
-- Preparations for the out-licensing of RenaZorb are underway. Altair,
with the assistance of RBC Capital Markets, has sent the license
marketing package for RenaZorb to over forty pharmaceutical and
biotechnology companies. Several of these companies have expressed
interest.


Drug Delivery Products

TiNano(R) Spheres(TM) Drug Delivery Systems

TiNano Spheres are rigid, hollow, porous, high surface area, ceramic microstructures proposed for use in drug delivery systems, including systems to mitigate diversion and abuse of drugs.



-- Two patent applications have been filed for the TiNano Sphere drug
delivery technology platform.


Dental Nano-materials



-- Altair continues to work with a research consortium sponsored by the
National Institutes of Health to strengthen polymer-based dental
fillings utilizing Altair`s nano-zirconia.


Performance Materials Division Update

Advanced Materials for Paints, Coatings and Sensors

Titanium Dioxide Pigment - Altair`s Hydrochloride Pigment Process (AHPP)



-- Altair has now completed approximately 50 percent of Phase l of the
Western Oil Sands Project.
-- Altair was awarded a third contract from a (confidential) Fortune 100
company to supply testing quantities of customized nano-sized
coating material.


Nanosensors



-- Western Michigan University and Altair received a $2 million contract
from DOE for joint development of nanosensors for detecting chemical
and biological weapons. Under terms of the Stage ll contract
scheduled to commence this quarter, Altair will receive $672,000 over
a two-year period for collaborative research and development as a
subcontractor.


Advanced Materials for Improving Process Technologies

Titanium Metal Manufacturing via Electrolysis Processing



-- Altair`s development agreement with Titanium Metals Corporation
(NYSE: TIE), provides Altair the opportunity to supply enough TiO2
micro porous electrodes to produce 50 pounds of titanium metal per day
to meet the DARPA titanium project goals as outlined by the program.
Altair has met its goals and work plan and the project continues to
successfully move forward.


NanoCheck(TM) Products for Binding Phosphate in Water



-- Independent and in-house laboratory testing has proven that Altair`s
unique nano-structured compound, NanoCheck, safely and effectively
removes phosphate from water preventing algae growth in swimming pools
and reduces the quantity of chemicals currently required for algae
prevention.
-- Field testing, focused on evaluating NanoCheck`s effectiveness in
providing an algae-free environment for swimming pools, was delayed
due primarily to hurricanes in the field testing areas. Testing has
been reinitiated and results will be made public when available.
Negotiations with major pool chemical companies for licensing of the
product are underway.


High Performance Materials for Alternative Energy

Lithium-Ion Battery Electrode Development



-- Altair is completing research work scope under a $100,000 SBIR Phase I
grant and intends on applying for a $500,000 SBIR Phase ll grant from
the U.S. National Science Foundation to continue work on
carbon-coated nano-structured electrodes for next-generation
lithium-ion ultra capacitors with partners Hosokawa Micron and
Rutgers University.
-- Altair was awarded a European patent for its "Process for Making
Lithium Titanate" a product used in the development of lithium-ion
batteries and super capacitors.


ALTAIR NANOTECHNOLOGIES INC.

Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of ceramic, metal oxide-based nanomaterial technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.(R), Altair Nanomaterials(TM), TiNano(R), RenaZorb(TM), NanoCheck(TM), TiNano Spheres(TM) and the Hydrochloride Pigment Process(TM) are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market: the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.



ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Selected Financial Data Unaudited)
September 30, December 31,
2004 2003
----------- -----------
ASSETS
Total Current Assets $ 9,200,992 $ 3,962,180
Property, Plant and Equipment, net 6,322,783 6,618,805
Patents, net 996,299 1,060,569
Other Assets 18,200 18,200
----------- -----------
Total Assets $16,538,274 $11,659,754
=========== ===========
LIABILITIES AND SHAREHOLDERS` EQUITY
Total Current Liabilities $ 920,647 $ 397,141
Note Payable, Long-Term Portion 2,830,488 2,686,130
Total Shareholders` Equity 12,787,139 8,576,483
----------- -----------
Total Liabilities and Shareholders` Equity $16,538,274 $11,659,754
=========== ===========
ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Selected Financial Data Unaudited)
Three Months Ended Nine Months Ended
Sept. 30, Sept. 30,
2004 2003 2004 2003
----------- ----------- ----------- -----------
Sales $ 346,907 $ 17,318 $ 640,889 $ 42,029
Cost of Sales 293,685 16,706 604,517 32,594
----------- ----------- ----------- -----------
Gross Margin 53,222 612 36,372 9,435
Total Operating Expenses 1,473,277 1,189,056 5,268,477 3,583,556
----------- ----------- ----------- -----------
Loss from Operations 1,420,055 1,188,444 5,232,105 3,574,121
Other (Income) Expense: 20,269 141,027 73,008 406,935
----------- ----------- ----------- -----------
Net Loss 1,440,324 1,329,471 5,213,338 3,981,056
Preferential Warrant
Dividend - 416,014 - 592,486
----------- ----------- ----------- -----------
Net Loss Applicable
to Shareholders $ 1,440,324 $ 1,745,485 $ 5,305,113 $ 4,573,542
=========== =========== =========== ===========
Loss per Common Share
- Basic and Diluted $ 0.03 $ 0.05 $ 0.11 $ 0.13
=========== =========== =========== ===========
Weighted Average Shares
- Basic and Diluted 49,121,984 38,129,702 48,401,745 34,676,028
=========== =========== =========== ===========



For Additional Information:
Marty Tullio
McCloud Communications, LLC
949.553.9748
[e-mail]



For Additional Information:
Mark Tullio
McCloud Communications, LLC
949.553.9748
[e-mail]


SOURCE: Altair Nanotechnologies, Inc.

[MRASTA]

sorry, doppelt hält besser. Irgendwas war bei W : O wohl nicht in Ordnung.

Aber sieht doch das erste mal ganz passabel aus. Nicht die Zahlen aber zwei Verträge sollen möglicherweise noch kommen dieses Jahr. Na dann. Leider bleibt unklar welcher Umsatz damit verbunden sein könnte. Und nach der Zulassung von Shire für Ihr Produkt könnte auch RenaZorb vielleicht einen Interessenten finden. Solange die 2$ halten ok.

mrasta

[MRASTA]

ALTI: Volume Spike; 26% > 20-adsv, Stock +9.30%
Monday , November 15, 2004 10:35 ET

This is the 1st VOLUME alert for ALTI in the past 7 calendar days.

Trading for Altair Nanotechnologies Inc (NASDAQ SC: ALTI) has been heavier than usual in today`s session. By 10:35 ET, the stock had already traded 611,500 shares via 179 trades. The cumulative volume is 26.11% above its 20-day average of 484,895. Normally the stock experiences around 398 individual trades per session.

So far, today`s volume surge has caused a net rise in ALTI`s stock price. At the time of this alert, the stock was trading at $2.350, up $0.200 (+9.30%).

One year ago, the Company`s shares closed at $1.200. The price has gained more than 95 percent since then.

Over the last 10 trading session ALTI has traded in a range between $1.960 and $2.190 and is currently trading 46.59% below its 52-week high of $4.400 set on January 28, 2004 and 147.39% above its 52-week low of $0.950 from August 12, 2004.

[MRASTA]

ALTI: Jumps +10.97%; Vol +295%; Last 90 Min of Trading
Friday , November 19, 2004 16:22 ET

During the last 90 minutes of today`s session, shares of Altair Nanotechnologies Inc (NasdaqSC: ALTI) demonstrated a strong UPWARD close relative to its 13:30 ET statistics. "Strong Closers" are determined by proprietary Knobias calculations performed during the last segment of each trading day.

Last Price 2.6200
Percent Change +10.55% -0.76 (AH)

[Wunram]

Hi MRASTA,

was war da los gestern um kurz nach 21:00??
Über die Hälfte des Tagesumsatzes in einer 3/4 Stunde. Kann keine Nachrichten finden.

#305 du hast im August nochmal zugeschlagen?

Glückwunsch und schönes WE
Wunram

[MRASTA]

Hallo Wunram,

weiß auch nicht, was da los war.

Vielleicht sind Sie ja bei der Geschichte etwas weiter, als wir denken. Mal sehen, was dahinter steckt.

Altair Nanotechnologies, Inc., of Reno, Nevada, is testing its hollow, porous, high-surface area, rigid, ceramic microstructures (TiNano Spheres) in drug delivery and dental compounds. Made from titanium and zirconium, these structures can be coated on the inside, outside, or both with active pharmaceuticals to provide controlled-release characteristics. According to the company, the differentiating characteristic of TiNano Spheres compared to commonly available polymer-based drug delivery systems is that the Altair system can produce a sustained drug delivery system for narcotics. The company plans to license the technology with pharmaceutical companies interested in incorporating their active pharmaceutical ingredients in the TiNano Spheres.



ne, danach nicht mehr, habe aber noch ne ordentliche Position, #281 u. #284 habe seinerzeit ja nur einen Teil wieder rausgehauen.

Also mal schauen, ob die Woche News kommen.

bis die Tage
mrasta

[MRASTA]

Tja, irgendwas musste da wohl kommen und da isses schon :

Altair Nanotechnologies, University of Nevada Research Foundation and Hydrogen Solar LLC Lead Alternative Energy Consortium With $3 Million Grant From U.S. Department of Energy

Tuesday , November 23, 2004 11:36 ET

RENO, NV, Nov. 23, 2004 (MARKET WIRE via COMTEX) --Altair Nanotechnologies, Inc. (NASDAQ: ALTI), in collaboration with the University of Nevada, Las Vegas, Research Foundation (UNLVRF) and Hydrogen Solar LLC, today announced the consortium has received a $3 million grant award from the U.S. Department of Energy (DOE). The fund is for joint research activities related to solar hydrogen production at a refilling station that is under development in Las Vegas. Vehicle integration testing and demonstration will also be included in the project.

Under the terms of the multi-year grant Altair will receive $400,000 for collaborative research and development efforts through its subcontractor agreement with UNLVRF. Additional project partners include University of Nevada Center for Energy Research (UNLVCER), Proton Energy Systems (PES), and the Las Vegas Valley Water District.

"This grant award marks a groundbreaking event for the development of alternative energy sources," said Dr. Alan J. Gotcher, chief executive officer of Altair Nanotechnologies. "The consortium`s two-pronged approach -- that of developing new Tandem Cells(TM) for power, along with related vehicle refilling stations -- should serve to rapidly commercialize alternative energy vehicles throughout Nevada and ultimately the entire U.S. We are proud to be part of a project supporting the National Hydrogen Fuel Initiative."

"The hydrogen refilling station project is a positive step toward achieving the national goal of energy independence," said Thomas Williams, Executive Director of the UNLV Research Foundation. "We are pleased to work with such prestigious companies in advancing the hydrogen economy. We are also addressing related factors, such as how to achieve higher efficiency for electrolysers, and the development of new and expanding technologies that will alleviate our dependence on fossil fuels."

Hydrogen Solar`s CEO, Dr. David Auty, added, "This project is the first step to commercializing our Tandem Cell technology in the American arena. We believe we have a highly efficient and world leading product for producing inexpensive, carbon-free hydrogen. We expect this to be a key technology as we move towards a future hydrogen economy, and are delighted to be working with such high caliber partners."

"Hydrogen is the fuel of the future and solar applications to produce hydrogen are a good way to become energy independent," said Senator Harry Reid, Senate Minority Leader and a long-time supporter of hydrogen research and development at UNLV. "We have the capabilities in Nevada to bring these cutting-edge technologies to the market. The research performed by this grant will bring us a step closer to achieving our goals."

Under the terms of the grant, UNLVRF, a non-profit affiliate of UNLV, and UNLVCER will lead a team of industrial and technology partners to spearhead multiple research and development projects that will lead, in the future, to production and commercialization of solar-based hydrogen technologies. UNLVCER serves as the technical lead, with PES as the electrolyser developer, supplier and subcontractor. Hydrogen Solar LLC and Altair will act as research and product development partners in utilizing nanotechnology processes. The Las Vegas Valley Water District will provide vehicles for conversion, as well as continuing site support and coordination.

Phase I of the project, entails the development of a hydrogen refilling station, and work is already underway on this by the UNLVRF.

Phase II comprises the expanding of capabilities of the existing station by developing a high pressure, more efficient electrolyser. Phase II also includes the use of the Tandem Cell(TM), which converts light and water directly into hydrogen fuel in a highly efficient, renewable and carbon-free process.

Hydrogen Solar LLC believes the Tandem Cell will provide hydrogen at a significantly lower cost than the current photovoltaic / electrolyser routes being developed.

Central to the Tandem Cell technology is the very high performance of the photo-catalytic nano-crystalline thin films developed by Hydrogen Solar LLC. These are used to gather photons of incident light and convert them into electrons to directly split water into its constituent elements. Altair Nanotechnologies, Inc. will use their nanomaterials synthesis technology to develop low cost processing for and further improve the performance of the thin film electrode in the front section of the Tandem Cell. Altair`s efforts will focus on iron oxide-based materials and include development of film deposition methods and synthesis routes for the optimized metal oxide nanomaterials.

The Tandem Cell concept was co-invented by the Swiss Federal University of Technology in Lausanne (EPFL) and the University of Geneva (UoG), and was made possible thanks to research and development support by the Swiss Federal Office of Energy over a considerable period of time. The Tandem Cell(TM) concept is the subject of a patent by Prof. Michael Graetzel (EPFL) and Jan Augustynski (UoG). Hydrogen Solar LLC is a wholly owned subsidiary of Hydrogen Solar Ltd UK, which holds the world-wide exclusive rights to the Tandem Cell(TM). Prof. Graetzel is a scientific advisor to both Hydrogen Solar Ltd and Altair.

[MRASTA]

Wollte noch kurz anmerken, nun wissen wir ja auch was Grätzel bei Altair will. Der kommt ja nun mal nicht einfach so dahergelaufen, wenn nicht was in Aussicht steht.

Das dürfte aber wohl noch ein wenig dauern. Ob das reicht den Kurs zu halten ? Wird man sehen.

Vielleicht kommt ja noch was aus der anderen Ecke dazu, siehe #308.

Zumindest bewegt sich mal wieder was. Und die Zahlen liegen auch hinter uns. Also eigentlich gar nicht mal so übel. Wie immer, schaun wir mal.


cu

[MRASTA]

Wurde doch ganz ordentlich aufgenommen die Meldung. Naja, kann uns ja nur recht sein. Würde mir persönlich wünschen, dass das jemals was wird, nicht nur aus Aktiensicht sondern überhaupt und allgemein. Aber das dürfte wirklich noch ne Ecke dauern.

Wie dem auch sein, der Anfang ist gemacht.

cu



ALTI: Volume Spike; 40% > 20-adsv, Stock +7.82%
Tuesday , November 23, 2004 11:55 ET

This is the 1st VOLUME alert for ALTI in the past 7 calendar days.

Trading for Altair Nanotechnologies Inc (NASDAQ SC: ALTI) has been heavier than usual in today`s session. By 11:55 ET, the stock had already traded 785,200 shares via 575 trades. The cumulative volume is 40.32% above its 20-day average of 559,565. Normally the stock experiences around 454 individual trades per session.

So far, today`s volume surge has caused a net rise in ALTI`s stock price. At the time of this alert, the stock was trading at $2.620, up $0.190 (+7.82%).

One year ago, the Company`s shares closed at $1.470. The price has gained more than 78 percent since then.

Over the last 10 trading session ALTI has traded in a range between $2.060 and $2.650 and is currently trading 40.45% below its 52-week high of $4.400 set on January 28, 2004 and 175.82% above its 52-week low of $0.950 from August 12, 2004.

[MRASTA]

ist euch eigentlich schon aufgefallen, dass :

Altair jetzt erstmalig eine höhere MKT hat als die Phases ?

cu

[MRASTA]

und irgendwer ist mal wieder auf Einkaufstour, zumindest im Moment.

+10%, 2.90 $

cu

[MRASTA]

November 29, 2004 KST 18:34 (GMT+9)
???????????????

Team finds production method for nano-bits

November 29, 2004
A team of Korean scientists led by a Seoul National University professor, Hyun Tae-ghwan, have developed a technology that enables the mass production of nanoparticles of identical size. The team said yesterday that the details of the low-cost mass nanoproduction discovery will be published in the December issue of the monthly journal "Nature Materials." Nanoparticles are used in creating displays and lasers.

"The price of nanoparticles that are created using existing technology is as much as 2 million won ($1,908) per gram on average," Mr. Hyun said. "According to our research results, we can produce nanoparticles for about 250 won per gram. Our manufacturing method is entirely different from preceding technologies."

Mr. Hyun said the existing methods created random-sized nanoparticle and then divided them into particles of the same size. The current research, however, allows the creation of nanoparticles of the same density and size without a separate "cutting" process. "Nano" is the prefix designating one-billionth of a meter; a nanometer is one-millionth of one millimeter.

http://joongangdaily.joins.com/200411/28/2004112822121697099…

[MRASTA]

Betrifft dass auch Nanophase ?


Posted November 18th, 2004
BASF and Shiseido Collaborate to Develop UV Protective Cosmetic Materials


To address the growing market need for cosmetics that help protect the skin against the harmful effects of ultraviolet (UV) rays, Shiseido and BASF have agreed to collaborate on joint development of new UV protection materials for use in cosmetic sun protection products.

UV rays are part of the non-visible portion of sunlight and are split into two categories based on their wavelengths. The longer wavelength UVA spans from 320 to 400 nanometers, and the shorter wavelength UVB spans from 280 to 320 nanometers. UVA is mainly responsible for skin tanning, but also penetrates deep into the skin causing damage associated with skin wrinkles as well as increasing the risk of skin cancer. The effects of UVB can cause skin inflammation in a short exposure time known as erythema, which is commonly referred to as a sun burn. Long UVB exposure can also lead to a higher risk of skin cancer.

“In order to create sun protection cosmetics which have both high Sun Protection Factor (SPF) and high UVA protection, it is necessary to combine different types of UV filters and formulation expertise to achieve broad spectrum performance with high transparency on the skin,” said a representative of Shiseido. “In joint development of new UV protection materials with BASF, Shiseido aims not only to enhance performance and effectiveness of existing cosmetics products, but also to develop novel product concepts enabled by the new technology.”

“We’re combining our respective strengths, Shiseido’s powder modification technology and BASF’s expertise in UV filters to create a revolutionary new UV protection technology,” said a representative of BASF Cosmetic Ingredients. “We will use our broad knowledge of organic as well as nano-inorganic UV filters like Z-COTE micronized zinc oxide to help achieve this collaborative innovation goal with Shiseido.”

In addition, Shiseido and BASF have announced that they have reached a licensing agreement under BASF`s sunscreen patents in the United States, Europe and Australia regarding micronized zinc oxide-based cosmetic formulations in Shiseido sun protection products.

For more information on zinc oxide, click here.

[MRASTA]

Das hat wohl auch die Phases zeitweilig mitgezogen. Nur Altair humpelt heute hinterher.


Last Trade: 3.900 Change: 1.550 ( +65.957 %)


Arrowhead Research Corporation Announces Research Report on Nano Patent Portfolio

Thursday , December 02, 2004 07:00 ET

PASADENA, Calif., Dec 2, 2004 (BUSINESS WIRE) --Arrowhead Research Corporation (Nasdaq:ARWR)(Nasdaq:ARWRW) announced today that CHI Research, a worldwide leader in intellectual property analysis, recently conducted a review of Arrowhead`s patent portfolio. The final report stated: "In general, it appears that Arrowhead`s nanotechnology IP already locks up, or is well on the way to locking up, those areas of nanotechnology that it has set out to control. Furthermore, we find that Arrowhead`s entire nanotechnology patent portfolio is more broadly distributed across invention art classifications than that of its main competitors. In other words, among its main competitors, Arrowhead has the most diversified portfolio of patents in the nanotechnology space." Arrowhead has exclusive rights to 33 issued U.S. patents and, in total, over 180 U.S. and international patents and patent applications.

[MRASTA]

Monday , December 13, 2004 11:40 ET

Dec 13, 2004 (streetinsider.com via COMTEX) --Nanotech stocks are finding interest again as CNBC kicks off its weeklong series on the topic. Stocks in Merrill Lynch`s Nanotech Index (NNZ) could be a good place to get some ideas: Accelrys Inc (Nasdaq: ACCL), AMCOL International (NYSE: ACO), AMCOL International (Nasdaq: ALTI), Biosante Pharmaceuticals (AMEX: BPA), Acacia Research CombiMatrix (Nasdaq: CBMX), Cabot Corp (NYSE: CBT), FEI Co (Nasdaq: FEIC), Flamel Technologies (Nasdaq: FLML), Headwaters Inc (Nasdaq: HDWR), Immunicon Corp (Nasdaq: IMMC), JMAR Technologies (Nasdaq: JMAR), Kopin Corp (Nasdaq: KOPN), Lumera Corp (Nasdaq: LMRA), MTS Systems Corp (Nasdaq: MTSC), Nanophase Technologies (Nasdaq: NANX), Nanogen, Inc (Nasdaq: NGEN), Novavax Inc (Nasdaq: NVAX), NVE Corp (Nasdaq: NVEC), Skyepharma PLC (Nasdaq: SKYE), Symyx Technologies Inc (Nasdaq: SMMX), Tegal Corp (Nasdaq: TGAL), Harris & Harris Group (Nasdaq: TINY), Ultratech Inc (Nasdaq: UTEK), Veeco Instruments (Nasdaq: VECO), Westaim Corp (Nasdaq: WEDX).

[telltom]

Altair wird die Microsoft der Nanotechnologie. Das hat mir ein Freund aus den USA gesagt.

Altair ist in der Grundlagentechnologie der Nanotechnologie. Egal, ob in der Rüstung, Fahrzeugtechnik, Materialforschung, Altair hat die Grundlagen.

Allerdings wird die Nanotechnologie erst in 3 Jahren so richtig boomen und da werden wir viele Unternehmen sehen, die in den 3-stelligen Dollarbereich vorstoßen werden.

Altair sollte man sich auf jeden Fall ins Depot legen, aber ein langer Atemzug ist notwendig.

[MRASTA]

Sportliche Aussage.

Erstmal kämpfen sie seit Tagen mit der 3$ Marke. Und dann fehlen ja noch die angekündigten Aufträge, die ja noch in diesem Jahr kommen soll(t)en.

Also, immer Step by Step. Erstmal brauchen die irgendwas, was man richtig vermarkten kann, dann sieht man weiter.

Auch die Phases machen ja ganz schöne Hüpfer, fallen aber auch immer wieder vom Barren.

Also, wie schon in den letzten Jahre, die Phantasie scheint immer noch vorhanden. Nur richtig tolles, kam dabei bis dato nicht rum.

cu

[MRASTA]

Altair Nanotechnologies, Inc. Announces US Patent Award Notification

Friday , January 07, 2005 09:45 ET

RENO, NV, Jan. 07, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today announced that the US Patent Office has notified Altair that it has allowed Altair`s patent application for a "Process For Making Lithium Titanate." This US patent application describes the process and underlying technology for producing lithium titanate spinel materials of high purity and tightly controlled particle size over a range of 5 to 2,000 nanometers.

The processes protected by the patent were used to make materials that have been formed into electrodes which exhibit high charge and discharge rates in lithium ion batteries and in super capacitors being used in the National Science Foundation`s SBIR grant announced in June 2004. The SBIR grant is funding a joint program under which Altair, Hosokawa Micron`s Nano Particle Technology Center and Rutgers, The State University of New Jersey`s Energy Storage Research Group are using their combined technologies with the objective to develop and commercialize high-power, long life, fast-charge lithium ion batteries.

"Over the past five years, Altair has expended significant resources to pioneer and develop advanced ceramic nanotechnology and as of today, in addition to this patent award, Altair owns four issued U.S. Patents, 12 issued foreign patents and 46 additional pending U.S. and foreign patent applications," said Dr. Alan J. Gotcher, Chief Executive Officer of Altair Nanotechnologies. "We are aggressively pursuing licensing and business development programs with our technology, nanomaterials and products worldwide.

"Our Performance Materials Division, in conjunction with various industry partners, is involved with alternative energy development programs that include lithium ion batteries, super capacitors, fuel cell development and solar hydrogen generation," continued Dr. Gotcher. "We believe nanomaterials can significantly improve lithium ion battery and super capacitor performance, making it possible to use these systems in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles, as well as military applications and specialized uses such as notebook computers, mobile phones, and a variety of portable devices."

[MRASTA]

So sieht die Version der Meldung aus, die von Spectrum herausgegeben wurde.



Spectrum Pharmaceuticals Licenses RenaZorb(TM) From Altair Nanotechnologies

Monday , January 31, 2005 08:50 ET

IRVINE, Calif., Jan 31, 2005 /PRNewswire-FirstCall via COMTEX/ --Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) announced today that it has acquired worldwide exclusive rights to RenaZorb(TM) (two second-generation lanthanum-based phosphate binding agents) from Altair Nanotechnologies, Inc. (Nasdaq: ALTI). These novel non-aluminum, non-calcium phosphate binders which utilize Altair`s proprietary lanthanum nanomaterial technology have the potential to treat hyperphosphatemia, i.e., high phosphorus levels in blood, in patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD), with potentially as little as one tablet per meal while currently approved therapies require as many as several tablets per meal. There are an estimated 340,000 ESRD patients in the U.S. who are on kidney dialysis, and the market for phosphate binding agents was in excess of $600 million in 2004. According to the National Kidney Foundation, the number of ESRD patients in the U.S. is expected to double over the next decade. In addition, there are an estimated 8.4 million CKD patients, representing a potential multi-billion dollar market opportunity, who are candidates for phosphate binder therapy under the National Kidney Foundation`s Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines, issued in 2003.

Under the terms of the agreement, Spectrum acquired an exclusive worldwide license to develop and commercialize RenaZorb(TM) for all human therapeutic and diagnostic uses. Spectrum will pay to Altair an upfront payment of 100,000 shares of restricted Spectrum common stock and will make an equity investment of $200,000 for 38,314 shares of Altair common stock. In addition, Altair is eligible to receive payments upon achievement of a clinical development and certain regulatory and sales milestones, in addition to royalties on potential net sales. Additional financial details were not disclosed.

"This in-licensing of RenaZorb is an important step in our continued effort to build an extensive and well-diversified portfolio of drug product candidates that span all stages of development and address significant unmet medical needs," stated Rajesh Shrotriya, M.D., Chairman of the Board, Chief Executive Officer and President of Spectrum Pharmaceuticals, Inc. "We are extremely pleased to establish this alliance with Altair. We look forward to advancing RenaZorb(TM) into clinical trials, and pursuing the appropriate regulatory strategy to maximize its potential."

"We are delighted to have the opportunity to work with the Altair team and look forward to developing and commercializing RenaZorb," stated Luigi Lenaz, M.D., of Spectrum Pharmaceuticals, Inc. "We believe there is a significant unmet medical need for the treatment of hyperphosphatemia, a condition that leads to significant bone disorders and cardiovascular disease, and is associated with a significantly higher death risk in patients with chronic and end-stage kidney disease. According to K/DOQI Guidelines, fewer than 30 percent of dialysis patients are able to achieve and maintain serum phosphorus levels in the optimal range, despite dietary phosphorus restriction and treatment with currently marketed phosphate binders. As a non-aluminum, non-calcium phosphate binder, RenaZorb has the potential to become one of the preferred first-line treatment options for hyperphosphatemia under the new K/DOQI Guidelines because it has the potential to significantly improve patient compliance by lowering the daily pill burden to the lowest-in-class dosage, namely one tablet per meal, and smaller-sized tablets, in addition to a potentially more favorable safety and efficacy profile."

"We are delighted to have a collaborator for the first of our Life Sciences initiatives, RenaZorb, with the drug development, regulatory and commercialization expertise of Spectrum`s management," stated Alan J. Gotcher, Ph. D., Chief Executive Officer of Altair Nanotechnologies, Inc. "We look forward to working with Spectrum to enhance and expedite the development of this promising compound."

"RenaZorb represents a new generation of high performance phosphate binding drugs that have significant promise in terms of dose and compliance," stated Dr. Ravi Thadhani, M.D., M.P.H. Department of Medicine and Renal Unit, Massachusetts General Hospital, Boston, MA. "The partnership between Altair and Spectrum is an excellent complementary marriage of leaders in their respective fields."

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a specialty pharmaceutical company engaged in the business of acquiring, developing and commercializing proprietary and generic drug products for various indications. The Company`s current proprietary drug products are primarily focused on the treatment of cancer and related disorders. The Company`s lead drug, satraplatin, is a phase 3 oral, anti-cancer drug being co-developed with GPC Biotech AG, and has been granted fast-track status by the United States Food and Drug Administration (FDA) for its initial indication, second-line chemotherapy for hormone-refractory prostate cancer. Elsamitrucin, a phase 2 drug, is being studied for its initial indication, refractory non-Hodgkin`s lymphoma. EOquin(TM), a phase 2 drug, is being studied in the treatment of superficial bladder cancer. SPI-153 (formerly, D-63153), a phase 2 drug, is a 4th generation LHRH antagonist with the potential to treat hormone-dependent cancers as well as benign proliferative disorders, such as benign prostatic hyperplasia and endometriosis. The Company`s Abbreviated New Drug Application for ciprofloxacin, a broad-spectrum antibiotic and the generic version of Bayer Corporation`s Cipro(R) tablets, received approval from the FDA in September 2004. In addition, the Company has six Abbreviated New Drug Applications pending at the FDA. For additional information, including SEC filings, visit the Company`s web site at www.spectrumpharm.com.

Spectrum Pharmaceuticals, Inc. forward-looking statements

This press release may contain forward-looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, the success of our oncology drug candidates in their initial indications and future indications, sales of ciprofloxacin, RenaZorb`s potential to treat hyperphosphatemia and be the preferred therapy, the size of the market opportunity, the number of ESRD and CKD patients in the future, the size of the tablet, the daily bill burden, the Company`s efforts to build an extensive and well-diversified portfolio, advancing RenaZorb into clinical trials, developing and commercializing RenaZorb, the experience of the Company`s management, the safety and efficacy profile of RenaZorb, patient compliance and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates may not prove safe or effective, the possibility that our existing and new drug candidates may not receive approval from the FDA in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be more effective, safer or more cost efficient than competing drugs, the early stage of the development of RenaZorb, the possibility that RenaZorb may not be able to effectively treat hyperphosphatemia, the possibility that an effective dose of RenaZorb may require more than one pill, the possibility that the National Kidney Foundation may modify their guidelines, the possibility that price and other competitive pressures may make the marketing and sale of our proprietary and generic drugs not commercially feasible, the possibility that our efforts to acquire or in-license and develop additional oncology drug candidates may fail, our lack of revenues, our limited experience in establishing strategic alliances, our limited marketing experience, our limited experience with the generic drug industry, our dependence on third parties for clinical trials and other risks that are described in further detail in the Company`s reports filed with the Securities and Exchange Commission.

[MRASTA]

Uns so die Variante von Altair :

Altair Nanotechnologies Licenses RenaZorb(TM) to Spectrum Pharmaceuticals

Monday , January 31, 2005 10:07 ET

RENO, NV, Jan. 31, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today that a licensing agreement has been signed with California-based Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), giving Spectrum the exclusive worldwide rights for human therapeutic and diagnostic applications to develop, market and sell its RenaZorb(TM) product line. Altair`s RenaZorb(TM) products, which target an emerging billion-dollar-plus market, are for phosphate control in patients with Chronic Kidney Disease (CKD) and hyperphosphatemia, high phosphate levels in blood, associated with End Stage Renal Disease (ESRD). These products are non-aluminum-, non-calcium-based phosphate binders, which utilize Altair`s proprietary lanthanum nanomaterial technology.

Under the terms of the licensing agreement, an initial payment will be made consisting of restricted shares of Spectrum`s common stock and a cash purchase by Spectrum of Altair common stock at a 100 percent premium to market price. Upon the successful completion of animal studies later this year confirming specified results, Spectrum will make an additional payment of restricted shares of Spectrum`s common stock, for a projected total first year value of approximately $1.3 million. Although no further financial details have been disclosed, the terms of the licensing agreement follows industry norms for drug candidate licensing, with most of the potential consideration coming in the form of milestone payments and royalty rate payments over time. A multi-year collaborative research and development program between Altair and Spectrum is a component of the licensing agreement. Assuming a drug containing Renazorb receives timely FDA approval, the market for phosphate controlling drugs continues to grow at projected rates, and the product becomes a leader in the market place, the total revenues to Altair over the life of this agreement could exceed $100 million.

It is estimated that 340,000 people in the U.S. have ESRD and are on kidney dialysis. Worldwide sales of phosphate binders are estimated at $600 million to $750 million per year. This market is anticipated to grow significantly with the recommendation by the National Kidney Foundation`s K/DOQI guideline, which states that patients with Chronic Kidney Disease could benefit from beginning the use of phosphate binders during earlier stages of the disease. With the implementation of the K/DOQI guidelines by the healthcare industry, there would be the potential for an additional 8.4 million patients that many of which could benefit from phosphate binding therapy, driving the potential market to over one billion sales per year within the U.S. alone.

"Spectrum is known for its ability to rapidly assess preclinical research, clinical data, and the commercialization potential of drugs such as RenaZorb," commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "Our team is pleased to be working with Spectrum and its people, who have a solid reputation and expertise in taking promising products through the complex development and regulatory approval process to successful commercialization. We are delighted to see RenaZorb, the first of our Life Sciences initiatives, attract an excellent commercial partner."

"This in-licensing of RenaZorb is an important step in our continued effort to build an extensive and well-diversified portfolio of product candidates that span all stages of development and address significant unmet medical needs," stated Rajesh Shrotriya, M.D., Chairman of the Board, Chief Executive Officer and President of Spectrum Pharmaceuticals, Inc. "We are extremely pleased to establish this alliance with Altair. We look forward to advancing RenaZorb(TM) into clinical trials, and pursuing the appropriate regulatory strategy to maximize its potential."

"RenaZorb represents a new generation of high-performance phosphate binding drugs that have promise of lowest dose in class and excellent patient compliance," stated Dr. Ravi Thadhani, M.D., Ph.D. Department of Medicine and Renal Unit, Massachusetts General Hospital, Boston, MA, "The partnership between Altair and Spectrum is an excellent complementary marriage of leaders in their respective fields."

RenaZorb

RenaZorb is a lanthanum-based phosphate binding drug compound that has demonstrated effective phosphate removal in laboratory and animal tests with excellent binding capacity. Based upon independent research and laboratory testing in simulated human stomach fluid, RenaZorb exhibited new performance standards and may potentially offer the following advantages over existing phosphate control drugs:

-- Lower dosage requirements due to higher phosphate binding levels per
gram of drug and high selectivity for phosphate;
-- Fewer and less severe side effects due to lower dosage, less gassing
and higher acid neutralization capacity; and
-- Better patient compliance due to fewer tablets required per day.

[MRASTA]

Moin,

falls hier überhaupt noch einer mitliest.

Und, ei, warum fällt das Teil, wie ein Stein ?

Wer die beiden Meldungen durchgelesen hat, wird es doch wohl gepeilt haben, oder ?

Einfach formuliert, es kommt erstmal sogut wie überhaupt keine Knete rein. Und das war ja nun völlig am Ziel vorbei geschossen. Was da mal in xyz Jahren folgen mag, interessiert zur Zeit überhaupt keinen.

Somit "The same procedure as every Year".

mrasta

[Wunram]

moin MRASTA,

bin nicht mehr in ALTI, hab sie nur noch auf der WL und lese gelegentlich was sich hier tut.

Irgendwann werden die schon nochmal richtige Umsätze machen.

Bei einem Dollar bin ich wieder dabei.

Gruss Wunram

[MRASTA]

Hi Wunram,

kann man irgendwie die Uhr nach stellen.

Irgendwann haben die und auch die Phases Ihr Vorschuß-Potential mal aufgebraucht, wenn da nix bei rumkommt.

Aber war doch ein schöner run bis zur 3.

Irgendwie ulkig, dass es immer nach der gleichen Masche läuft. Nun schauen wir mal, wie es weitergeht, ne kleine Verschnaufpause scheint wohl angesagt.

bis dann
mrasta

[MRASTA]

Altair Nanotechnologies Partners With Genesis Air to Develop Breakthrough Air Cleaning System
2/8/05

Genesis Air Introduces Innovative System Employing Nano-Titanium
Dioxide Produced Using Altair`s Patented Manufacturing Process

RENO, NV, Feb. 08, 2005 (MARKET WIRE via COMTEX) --

Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today that it is partnering with Texas-based Genesis Air to produce specialized surface activated, nano-sized titanium dioxide compounds for use in an innovative HVAC air cleaning system. The system, based on Genesis Air Photocatalysis (GAP(TM)) technology, is marketed by Genesis Air domestically and internationally.

Under the terms of the partnership agreement, Altair will provide Genesis with product design services, proprietary nano-sized titanium dioxide materials and ongoing chemical engineering support services.

"Teaming with Genesis Air demonstrates how our nanotechnology and chemical engineering capabilities can be applied to achieve an industry breakthrough," commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "This is another opportunity to validate Altair`s ability to apply its innovative advanced ceramic nanotechnology materials to practical, revenue producing solutions that improve the lives of thousands of people working in office buildings, factories, schools and their own homes."

"Altair is an excellent partner providing high quality products and excellent customer support allowing us to rapidly get our GAP system in the marketplace," said Genesis Air President and CEO Dan Briggs. "We currently have installations of our GAP systems, using Altair`s unique, proprietary advanced ceramics, in environments with diverse atmospheric conditions such as casinos, tanning salons and army barracks. Early response to our system has been remarkable as we continue to break new ground in air quality improvements."

Altair`s multi-patented production process enables the manufacturing of materials that are optimized for the air cleaning market. By controlling particle size and other physical and chemical characteristics, Altair can deliver nanotechnology-based, advanced ceramic products customized for Genesis` specific applications.

[MRASTA]

Na, dass hört sich doch aber mal, nach langer Zeit, nach etwas an.



Altair Nanotechnologies Achieves Breakthrough in Battery Materials

Thursday , February 10, 2005 09:45 ET

RENO, NV, Feb. 10, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today that it has achieved a breakthrough in Lithium Ion battery electrode materials, which will enable a new generation of rechargeable battery to be introduced into the marketplace, as well as create new markets for rechargeable batteries. These new materials allow rechargeable batteries to be manufactured that have three times the power of existing Lithium Ion batteries at the same price and with recharge times measured in a few minutes rather than hours.

The technical achievements are being praised by the battery community as truly remarkable and will likely enable a new generation of rechargeable battery to be produced. Altair has confidentiality agreements in place with some of the world`s leading battery development companies to evaluate and commercialize these battery electrode materials.

Altair`s research and development efforts were allowed two new patents (announced on January 7th and 14th, 2005) and a National Science Foundation grant was successfully completed in January, 2005, by Altair. New markets for fast charging batteries will include the handheld power tools market increasing the productivity of, for example, construction workers while lowering their overhead costs. Other markets include hybrid electric vehicles, portable electronics and medical surgery tools -- solving the problem of electrical wires all over the operating room floor.

Endorsements for Altair`s work in this area have come from many quarters. Two eminent experts in battery technology, Dr. K. M. Abraham and Dr. Vassilis G. Keramidas, have expressed strong support for Altair`s work

"The nanomaterials Altair is developing are the next generation of electrode materials for lithium-ion batteries and Altair`s research and product development is laying the ground work for a new generation of ultra high power lithium ion batteries," commented Dr. K. M. Abraham. "A key requirement to the above applications is the ability to recharge the battery very quickly, for example in a few minutes. Current Li Ion batteries are incapable of such quick charge times because of the chemistry of the anode materials. Altair has found a solution to this with their nano-sized lithium titanium oxide."

"Altair`s nanomaterials, which have a virtually zero strain crystal lattice, eliminate the main cause for battery electrode material fatigue, which limits rechargeable battery life, increasing the number of recharge and discharge cycles from a few hundred to many thousand cycles," said Dr. Vassilis G. Keramidas. "I find Altair`s development strategy and proposed research direction sound and a necessary step in establishing the Li-Ion electrochemistry as a viable contender for large battery applications."

"Our research in battery electrode materials is a further indication of how Altair`s scientists are able to apply their nanomaterials science knowledge to solving real world needs," commented Altair CEO Dr. Alan J. Gotcher. "Many of the technology and product development initiatives that we have been working on for the last few years are now coming to the commercialization stage. Each step is another validation of our business strategy and product technology platform. Altair`s nanomaterial based, micro porous electrode technology has performance and stability advantages that appear to be unmatched when compared to the best commercialized technology in the market today."

Dr. K. M. Abraham

Dr. Abraham, the principal of E-KEM Sciences, has over 28 years of experience in lithium battery research and development. He has made pioneering contributions to the development of the rechargeable battery industry. Dr. Abraham has authored and co-authored over 150 publications and 16 US patents in battery technology. He received his Ph. D. from Tufts University and conducted post-doctoral research at Vanderbilt University and MIT. In 2000 he was elected a Fellow of the Electrochemical Society. Dr Abraham is on Altair`s Scientific Advisory Board.

Dr. Vassilis G. Keramidas

Dr. Keramidas, Managing Director of Keramidas International, provides management consulting to major corporations on the formulation and execution of their research and development. Prior to founding Keramidas International, he was Vice President of Applied Research at Telcordia Technologies (formerly Bellcore). His division at Telcordia made seminal contributions in the fields of photonic and electronic materials. The Bellcore research on energy storage ushered in the polymer battery Li-Ion technology with the invention of the Bellcore Plastic Li-Ion (PLiON) technology. Dr. Keramidas sits on the Board of two battery companies.

[MRASTA]

Oha,

da sind wohl einige auf dem falschen Fuß erwischt worden.

Hatten wir eigentlich schonmal so einen Aktiendurchsatz ? Kann ich mich nicht dran erinnern.

cu

[MRASTA]

+80% !!!!!!!!! bei über 18 Mio an gehandelten Teilen.

Die scheinen sich da förmlich um die Teile zu reißen, gibt wohl Morgen keine mehr.

Da fällt selbst mir nix mehr zu sein.

Außer, schönen Abend noch.

mrasta

[Albatossa]

Mir fällt dazu auch nichts mehr ein!

[Wunram]

sauber!

und ich wollte bis 1$ warten

[MRASTA]

Moin zusammen,

Mensch Wunram, 1$, dass vor einem Jahr. 2$ dass war die Marke, wenn auch nur für einen Wimpernschlag lang.

Wie dem auch sei, dass war ne starke Nummer ohne Frage.

Und, wat nu ?

mrasta

[Wunram]

@MRASTA

abwarten ...

so konkret ist die Meldung nicht - es sollten mal Hersteller benannt werden, Verträge, Mengen.... ein paar konkrete Zahlen eben.

Gestern wär ich gern dabei gewesen

Gruss Wunram

[[KERN]Codex]

Jetzt haben auch die letzten den Braten gerochen und steigen ein, ich hab mich schon gewundert, vorhin gabs die ALTIs die ganze Zeit für 3,8 bzw. 3,77 Mein Depot dankt


Auf den AMI Boards geht es rund

Island schloss gestern auf 5,2$ (ca. 4,05€)

Aktuell in Frankfurt:

Geld 3,92
Brief 3,98
Zeit 11.02.05 12:31:45
Geld Stk. 10.000
Brief Stk. 8.000


gruß codex

p.s. da geht heut die luzzzzzi

[MRASTA]

Hi Wunram,

jep, da haste vollkommen recht. Konkret ist wie immer nix aber dass ist ja auch nix neues bei Altair. Vor allem über die Kosten und die Langlebigkeit hält man sich ja vornehm zurück.

Bin mal gespannt was heute abgeht, so zum Wochenende, wollen doch viele sich glatt stellen in der Regel. Nur Regeln gibt es hier im Moment wohl kaum noch. Hatten wir alles vor kurzer Zeit bei den Defense Werten erlebt, was da passieren kann. Reine Nervensache.

Aber wie auch immer, war erstmal eine coole Nummer.

bis dann
mrasta

[[KERN]Codex]

ALTI eben kurz auf 5,3$ vorbörslich hochgezuckt!

Das entspricht ca. 4,14€, Strong Buy in germany (!)

[[KERN]Codex]

5,35$

[[KERN]Codex]

5,48$

STROOOOOOONG BUY!

[[KERN]Codex]

5,65$



Kursziel Heute 10$

[[KERN]Codex]

5,7$

DIE USAAAA MACHEEEEN DIEEE STAUUUUB eeeerm NAAAAANOSAUUUUUGER AAAAAN

[MRASTA]

Immer mit der Ruhe,

erstmal abwarten. Das wird heute eine reine Nervensache, so oder so. Klar scheint, es dürften wieder reichlich Teile umgehen.

Also immer sachte.

cu

[[KERN]Codex]

Vorbörslich schon 2 MIO Shares umgesetzt, immer mit der Ruhe?

[MRASTA]

in der Ruhe liegt die Kraft oder so.

Sind übrigends bis dato über 8 Mio an Teilen, wau.

cu

[Wunram]

wow

die, die zu börsenbeginn in USA eingestiegen sind haben schon 30% miese!!

Wie weit gehts wohl noch runter?

[MRASTA]

Hi Wunram,

war doch klar wie Kloßbrühe oder meinste die MM´s gehören der Wohlfahrt an, mit nichten. 2$ im Top zu gestern, da kann man doch nicht nöckeln, d.h. bei 6.20 sind einige geflogen.

Darum habe ich ja versucht auch den anderen Herren und Meister hier etwas zu beruhigen. Mann überlegt doch mal, bei dem Tempo und den Mengen haben die richtig Knete geschaufelt.

Nun kommt Phase 3, wie lange und wohin, keine Ahnung, geht ja recht zügig. Aber 4.20 war es mir wert mit ein paar Teilen. Vielleicht zu früh, wer weiß es, keine Ahnung.

mrasta

[balboa]

hi,
was ist los mit altair?
fallen die wieder?
kann den absturz einer begründen?

[Wunram]

@MRASTA

na klar war das klar wie Kloßbrühe - und auch noch vor dem Wochenende.

Ich für meinen Teil warte noch, vielleicht nicht $1 aber doch ein bisschen weniger als $4!

Schönes WE
Wunram

[MRASTA]

@Wunram

Kann sein, kann auch nicht sein. Glaube bzw. hoffe eher wenn die durch sind, dass wir die 5 wiedersehen. Aber dass geht alles so schnell und bei den Unmengen an Teilen heute, da wird einem ganz schwindelig.

Weiß der Geier.


@balboa
Spaßvogel, wie ? Schonmal was von Gewinnmitnahmen gehört ?

Was meinste was da für Knete gemacht wurde. Geht doch nicht um uns, da spielen ganz andere die Musik.

bis dann
mrasta

[Wunram]

@MRASTA

ich glaube du hast recht, noch 1 1/2 Stunden.

mein SK-Tipp: $5,19

Wünsch ich dir!

[MRASTA]

@Wunram

ich glaube hier gar nix mehr. Schau Dir mal den Handel an, das ist einfach Irre. Hier ist im Moment überhaupt keine Linie drin. 88 Mio Teile, unglaublich.

Wie auch immer es enden wird, man war zumindest dabei.

bis dann
mrasta

[balboa]

ja klar!
aber bei den news müsste es doch am montag wieder aufwärts gehen.
was meint ihr?
bei den nachrichten.
also da sind die noch unterbewertet.
meinungen?

[mirox]

hi,
lässt euch durch nichts beeinflussen.
Wer investiert ist, soll sich nur freuen und warten.
Ich habe in den letzten 10 Jahren nur 2 " tender" (=x10)gelandet. Das wir ein dritter...
Daher meine Empfehlung:
Hände reiben und warten warten warten. Zuschauen wie die Aktien von zittrigen Händen in die stärkere gewechselt werden. So lange, bis alles transparent ist, Lizenzen platziert und andere Firmen angefangen haben, das Geld zu verdienen.
Ich mache mir jetzt eine meiner besten Flaschen Wein auf.
lg
MIRX

[balboa]

würde sagen das wird sowas wie microsoft!
also: in jedem pc ist windows drin ne?
ja!
also, wird auch in Zukunft in jedem notebook, in jeder digicam, in jedem handy usw. was man sich alles so vorstellen kann was mit batterien läuft, werden diese genialen stücke von Altair drin sein!
mein kursziel für ende 2005 liegt bei 15€!
wenn man den ausmaß dieser sache sich mal im klaren ist...ist da potenzial oooooohne ende drin!
ein kurs unter 15€ wäre lächerlich!
diese aktie hats mir angetan!
am montag könnte es nochmal runter gehen leicht.
aber dann gehts los...
kontinuierlich nach oben.

denke, da sind wir alle einer meinung oder, altair-freaks?
grüße
balboa

[Albatossa]

Hallo balboa,

aber Altair setzt in seiner Bilanz aber kaum mehr Geld um wie eine gut geführte Pommesbude!

Diese Firma ist zur Bilanzsumme bereits um den Faktor 1000 überbewertet. Und sowas halte ich trotz guter Zukunftaussichten und den Paten für maßlos überteuert!

[balboa]

@albtatossa:
ich glaube, du bist dir noch nicht im klaren was diese entwicklung bedeutet:
jeder hersteller von handy und notebook und wo noch akkus reingehören, werden erstmal bei altair klingeln bzw. einen vertrag abschließen müssen dass sie überhaupt die dinger einbauen können!
das bedeutet nach adam rieße:
Kohle kohle kohle...
ohne ende!
da kannst dir mit dem geld ne pommesbudenkette kaufen.
späßle gemacht.
aber ja kein stück abgeben. der kurs haut uns sonst ab.
sagt nicht ich hab euch nicht gewarnt.

[MRASTA]

Moin,

würde sagen, jeder von euch hat Recht.

Das Altair und auch die Phases total überbewertet sind, ist aber nichts neues, dass sind Sie schon seit Jahren.

Im Gegensatz dazu, stellt die Entwicklung im Bereich Li-Ionen Batterie einen echten Meilenstein da. Denkt mal nur an Handys, PDA´s, GPS oder Laptops usw. Kein Memoryeffekt, Laden in ein paar Minuten, Erhöhung der Kapazität um Faktor x, sowie xyz mehr Ladezyklen.

Kommt hinzu, dass Sie ja auch selber noch die Patente dafür besitzen.

Und dann gibt es ja noch Renazorb und Meister Grätzel, also Solarzellen, die Luftreinigung etc. etc.

Fragt sich, was ist das alles Wert ?

mrasta

[opelmanta3]

man sollte jede menge nanotechs kaufen, hier mal ne liste :

XDSL nanobatterien
NANX nanomaterials
EMFP nanomask / nanofilter

ARWR "optionschein" auf diverse nanosparten
FEIC die CSCO des nanotechs
CBMX

TGAL
HGCP venture capital www.icurie.com
Obducat
psivida
ambri

[weltklasse]

wenn ich mir die letzten news der vergangenen 4-5 montaten anschaue, schlummert dort ein gewaltiges potenzial in der company! wenn die ersten großen abnehmer bekannt gegeben werden, gibt es wohl kein halten mehr.... denke mal, dass viele dieses potenzial völlig verkennen und überhaupt nicht diesen durchbruch realisieren können (jedenfalls bislang noch nicht)

mal schauen, was die nächsten tage/wochen so bringen!

gruß

[[KERN]Codex]

opel,


eher NGEN, die sind extrem reboundgefährdet, aber das wird im allgemeinen das Jahr der Nanotechs
ALTI bringt seine neuen AKKUS 12-18 Monate vor XDSL auf den Markt (!)


gruß codex

p.s. stell mal einer den realtimekurs von ALTI rein bitte

[[KERN]Codex]

masta,


kapazität x3
ladezyklen x1000+
ladezeit ein paar mins

[weltklasse]

3,68 euro!

[weltklasse]

3,70

[opelmanta3]

NGEN hat soviel ich weiß nicht wirklich was mit nanotech zu tun....wird auch immer von Us analysten propagiert....


aber ein dicken NANOTECH jahr wird es sicher werden

[balboa]

hey leute!
da sind ja einige wach geworden und begreifen was überhaupt altair für potenzial hat.

mrasta hat vollkommen recht. wenn ihr euch mal die produktpalette überhaupt mal anschaut wo die dinger überall eingesetzt werden können.
dann ist altair auf keinen fall überbewertet sondern einfach nur unterbewertet 3,70€?lächerlich!
aber dazu wird sich das unternehmen in den nächsten wochen bestimmt selber nochmal äussern wann und mit wem usw. die akkus auf den markt kommen werden.
und bis dahin steigt die aktie...bei dieser kursphantasie ist auch nicht anderes zu erwarten.
bleibe dabei, kursziel für ende 2005 15€.

[[KERN]Codex]

Die Chips von NGEN gibt es bald in allen Krankenhäusern und bei jedem Arzt..

Informiert Euch mal was für ein Potenzial dahinter steckt!


Bin ich der einzige der auf INFOS scharf ist???

Altair Nanotechnologies, Inc. Announces Fourth Quarter Financial Results Conference Call
Monday February 14, 8:30 am ET


RENO, NV--(MARKET WIRE)--Feb 14, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) announced today that it will hold a quarterly conference call to discuss fourth quarter and year-end financial results for fiscal 2004 on Thursday, February 24, at 11:00 a.m. Eastern (EST). Shareholders and members of the investment community are invited to participate in the call.
The conference call dial-in number for U.S. callers is 888.245.7013 and the dial-in number for international callers is 973.582.2732. Please dial into the conference 10 minutes before the call is scheduled to begin. As lines are limited, please RSVP your participation by calling Suzanne Schnitzer at McCloud Communications, 949.553.9748. A replay of the conference call will be available until March 3, 2005, and can be accessed by dialing 877.519.4471 and entering conference number 5721762.

Additionally, the conference call is being webcast by ViaVid Communications and can be accessed by visiting www.viavid.net/detailpage.aspx?sid=00002296 or Altair`s web site.

http://www.altairnano.com

[[KERN]Codex]

Am Donnerstag gibt es einen Ausblick, bis dahin sollte ma sich positioniert haben

4,73$

[[KERN]Codex]

ALTI hat sein meinem Post um über 10% zugelegt

4,99$

[dickson]

Lasst euch nicht verarschen !!

Schaut euch IQ Power an,die wollen eine geniale neue Autobatterie einführen und die Aktie schmirgelt nur ab ....
Hier stimmt doich was nicht,was ist dran am "dubiosen Management"-Gerücht,warum gibt es das ?? Hier ist höchste Vorsicht geboten und [kern]codex,Nanogen ist KEINE Nanaotechaktie,das nur nebenbei,bevor du hier abhebst ....

MFG

[MRASTA]

Moin zusammen,

also ich habe gegen den Anstieg in den letzten Tagen nix einzuwenden, egal, was hinten bei rumkommt. Einigen scheint es aber irgendwie nicht zu passen.

Und IQ mit Altair zu vergleichen, ist ja wohl ein Scherz. IMHO hat IQ keine neue Batterie entwickelt sondern eine Hilfelektronik für das Batteriemangement.

Ist aber auch völlig schnuppe.

Richtig ist, dass man immer einem im Sinn haben sollte bei den Jungs. Aber bei einer solchen Meldung kann man keinen Rückzieher mehr machen, dann können Die den Laden auch gleich versenken.

Und wenn heute die 5$ tatsächlich halten sollten, wer will denn da noch rummosern ? Dass verstehe wer will.

mrasta

[[KERN]Codex]

dickson,

du hast einfach kein plan um was es geht

[BrokerJens]

Broker Recs
Current 1 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1
Moderate Buy 1 1 1
Hold 0 0 0
Moderate Hold 0 0 0
Sell 0 0 0
Mean BUY BUY BUY
Avg. Recommend. BUY
Number of Ratings 2
FY Report Date 12/2004
Av. Target Price $4.25
Current Qtrs. Est. $-0.03
Current Yrs. Est. $-0.15
PE on CY Est. -26.79
Next Fisc. Yrs. Est. $-0.15
PE on Next FY -35.10
Last Qtrs Earnings $-0.03
Year-Ago Earnings $-0.19


Gruss BJ

[balboa]

@mrasta:
jawohl!
heute wärs geil die 5$ zu halten.
und morgen nachhaltig die 5 knacken.
dann gehts auf...auf, auf die 6!

gruß
balboa

[BrokerJens]

Übrigens war die Info mit den Brokerempfehlungen von:

http://tools.thestreet.com/tsc/analysis.html?pg=analyst&symb…

Gruss BJ

P.S.: Besonderen Dank an MRASTA und Wunram für den toll geschriebenen Thread-hab ´ne halbe Nacht gebraucht um ihn durchzuarbeiten*gg*-Wunram-ich hoffe, du bist wieder dabei
bei ALTI-hast ja wirklich mehr als Pech gehabt mit deinem Verkauf.

BJ

[[KERN]Codex]

ALTI exetrem stark, hier sind kurzfristig Kurse um 10$ möglich(!)



=> Am Donnerstag gibt es gegen 1100 einen Conference Call, ich erwarte auch einen ausfürhlichen Ausblick für das Jahr 2005

gn8

[balboa]

@kerncodex:
ist das nicht der nächste donnerstag mit dem callconference?
am 24. dachte ich?

[[KERN]Codex]

Form 8-K for ALTAIR NANOTECHNOLOGIES INC


--------------------------------------------------------------------------------

15-Feb-2005

Other Events, Financial Statements and Exhibits



Item 8.01 Other Events.
Altair Nanotechnologies Inc. is filing this Current Report in order that the exhibits hereto may be incorported by reference into the Company`s Registration Statement on Form S-3, registration no. 333-111416.





Item 9.01 Financial Statements and Exhibits.
(c) Exhibits.

1.1 Letter Agreement dated February 11, 2005 between the Company and Maxim Group LLC.

5.1 Legal Opinion of Goodman and Carr LLP

23.1 Consent of Goodman and Carr LLP (included in Exhibit 5.1)

[[KERN]Codex]

Ah Shit bin in der zeit verrutscht

[[KERN]Codex]

dickson,

ich weiss, wird aber im $NNX aufgeführt und der steigt momentan schön, außerdem macht NGEN die Bewegung immer mit, leg die charts mal übereinander..

die chips von ngen gefallen mir einfach und ich sehe darin großes potenzial auch wenn sie auf einer technologie beruhen die etwas größer als one billionth m ist

ngen ist auf diesem niveau ein klarer kauf (!)

[[KERN]Codex]

Altair Nanotechnologies, Inc. Announces Shelf Registration Closing
Tuesday February 15, 9:29 am ET


RENO, NV--(MARKET WIRE)--Feb 15, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) announced today that it has entered into definitive agreements with respect to the sale of five million shares of its common stock to institutional investors at a price of $4.05 per share, for gross proceeds of approximately $20,250,000. Following closing of the financing, which is expected to occur today, Altair expects to receive approximately $19,237,500 after deducting all fees and expenses. With the completion of the placement, Altair will have 56,794,724 shares of common stock issued and outstanding. Maxim Group LLC is acting as placement agent for the transaction. As consideration, Maxim Group LLC is entitled to receive a cash fee equal to 5% of the gross proceeds from the offering and a warrant to purchase 250,000 shares of common stock at an exercise price of $5.265 during a four year term, and is subject to one demand registration right and unlimited incidental registration rights.
ADVERTISEMENT


The proceeds will be used for general corporate purposes, including, but not limited to, working capital, capital expenditures, research and development activities and the acquisition of other technologies.

[dickson]

Mir gefällt vor allem Flamel (FLML)als Nanotechwert,aber
auch Caliper Life Sciences (CALP),über Nanogen kann ich nicht
viel sagen,ausser,dass Affymetrix vielleicht die bessere
ChipAktie ist ...

MFG

[[KERN]Codex]

RPT-Big Pharma missing out on nanotechnology - study
Tue Feb 15, 2005 09:26 AM ET

LOS ANGELES, Feb 15 (Reuters) - Nanotechnology may hold promise in improving how drugs are developed and delivered, but major pharmaceutical companies are committing almost no money or people to the research, a research firm said on Tuesday.
The field involves the use of materials so small that their dimensions can be measured in atoms.

"Nanotech presents many opportunities to pharmaceutical giants, ranging from better delivery of existing drugs to entirely new therapies based on nanomaterials," said Matthew Nordan, vice president research at Lux Research, a New York-based research and consulting firm focused on nanotech.

But, much like the pattern seen with the biotechnology revolution more than 20 years ago, big pharmaceutical companies are not investing in nanotech, a trend that will allow new competitors to take root, the researcher said.

In contrast, the U.S. National Institutes of Health counts nanomedicine as one of its top five priorities, the National Cancer Institute committed $144 million to nanotechnology research in October 2004 and 40 percent of nanotech venture capital since 1998 has gone to life sciences start-ups, according to the report.

The report bases its conclusions on in-depth interviews conducted with individuals accountable for nanotechnology at 33 global corporations with annual revenues exceeding $5 billion.

The data revealed that no life sciences interviewee rated nanotech as a high corporate priority, as opposed to 78 percent of interviewees in electronics and materials.

Nordan attributed the lack of attention to three main factors: an organizational structure that wraps nanotechnology in with other drug discovery technologies; the belief that the companies can always license drug candidates in the future; and a belief by some executives that the technology is not that innovative.

"Big pharma companies typically entrust accountability for nanotechnology to an executive responsible for drug discovery, pharma`s biggest cost driver, but nanotech`s big near-term impact is in drug delivery," Nordan said.

The risk to this attitude is that major drug companies will eventually have to contend with a new wave of drugs some based on generic versions of their biggest brands that will erode market share, according to the researcher.




ALTI 4,48$

[dickson]

mehr als 4,05$ sind die Aktien dann wohl doch nicht wert,dumm gelaufen ...

[balboa]

mein gott dickson,
wenn du keine interesse an der aktie hättest,
was suchst du dann überhaupt in dem tread.
mein gott nein he!
wirst dich noch dumm und deppad ärgern wenns erst so richtig losgeht!
morgen gehts rund, junggeselle!

[dickson]

Erst Battery-News,dann Kapitalerhöhung,wenn die News gefaket
war,nur um den Kurs hochzutreiben,werdet ihr noch euer blaues
Wunder erleben ....

[MRASTA]

@dickson

oller Nörgler

Aber hast ja teilweise recht, das Timing war schon vom aller feinsten. Aber wenn die News ein fake sein sollte, dürften die Instis die die 5 Mio gekauft haben und dass in so einer hauruck Nummer wohl persönlich dort auftauchen und dem CEO die Hölle heiß machen, von dem Rest mal ganz zu schweigen.

In dieser Situation können die sich dass gar nicht erlauben, dass wäre das Ende. Halte Sie manchmal zwar für ein bischen dusselig aber nicht für verblödet.

Weiß auch nicht ob da Haltefristen mit vebunden sind, wenn nicht, dann ziehen Sie sich gerade schlappe 0.40 Cent pro Teil rein. Und da soll noch einer sagen, Geld stinkt.

bis dann
mrasta

[[KERN]Codex]

dickson kauft uns nachher die teile für >10$ ab, wenn das mal keine story wird weiss ich auch nicht

[[KERN]Codex]

huhu,

guckt mal hier:


Top Institutional Holders:

Barclays Bank Plc 580,872 1.17 $2,875,316 14-Feb-05
Hussman Econometrics Advisors, Inc. 565,800 1.13 $2,800,710 14-Feb-05
Vanguard Group, Inc. (The) 272,347 0.55 $1,348,117 14-Feb-05
Condor Capital Management 125,900 0.25 $623,205 14-Feb-05
Northern Trust Corporation 55,622 0.11 $275,328 14-Feb-05
Reynolds Capital Management 51,000 0.1 $252,450 14-Feb-05
Mellon Bank, N.A. 50,800 0.1 $251,460 14-Feb-05
Merrill Lynch & Co., Inc. 46,720 0.09 $231,264 14-Feb-05
Calpers (California-Public Employees Retirement System) 28,250 0.06 $139,837 14-Feb-05
State Street Corporation 27,400 0.05 $135,630 14-Feb-05

Top Mutual Fund Holders:

Hussman Investment Trust-Hussman Strategic Growth Fund 565,800 1.13 $2,800,710 14-Feb-05
Reynolds Fund 35,000 0.07 $173,250 14-Feb-05
Reynolds Opportunity Fund 16,000 0.03 $79,200 14-Feb-05
Spartan Extended Market Index Fund 15,064 0.03 $74,566 14-Feb-05
Quantitative Master Series Tr-Extended Market Index Seri 8,900 0.02 $44,055 14-Feb-05

[balboa]

das muss ne story werden sonst steig ich aus der börse aus und verstreu mein geld fürs fenster raus.
wär dasselbe...
dann würden sich wenigsten paar leute freuen...
aber ALTAIR verhindert das,...
wuhahahaha

[[KERN]Codex]

Wo wohnst du

Altair’s Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. Altair`s Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings, Advanced Materials for Improving Process Technologies, Advanced Materials for Alternative Energy, and other high performance material applications.

The company also boasts a proprietary, leading technological platform for the commercial manufacture of a wide variety of ceramic oxides, including metal oxides, metal titanates and combination crystals, all of which can range in structure from hollow to porous.

This patented platform, scaleable across all industries, is UNIQUE in the marketplace, providing precision control of composition, chemical purity, and particle size.

More on:

http://www.altairnano.com/framesets/devlpmt_unique_frmset.ht…



=> Die haben überall ihre Finger mit im Spiel, wenn das mal kein Matchwinner wird

[[KERN]Codex]

LESEN!

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3276…

Hier ein Auszug (Seite 2)


Advancements in these nanomaterials may ultimately be paired with
advancements in the electrolyte`s ability to carry high current density and
result in batteries that can yield high power and recharge in a shorter time
than currently available batteries. In laboratory experiments, nano-sized
specialty materials have accepted a full charge within less than one minute;
however, further development with a strategic partner in the battery industry
will be necessary before a marketable product could be developed.

=> Anwendungen in folgenden Bereichen:

We believe
that this technology has the potential to become a key component of rapidly
recharging high energy batteries that would be used in standard automobiles,
electric vehicles, and hybrid automobiles; battery-powered power tools; fuel
cells; and solar generation systems.


Recent Developments

In August 2004, we began work under a $100,000 Small Business Innovative
Research grant awarded by the National Science Foundation to fund joint
development work on next generation lithium ion power sources with Hosokawa
Micron`s Nanoparticle Technology Center and Rutgers University`s Energy Storage
Research Group. The work was completed in December 2004 and a report issued on
it in January 2005. Our research indicated that our materials provide a
significant improvement over conventional materials in lithium ion batteries. As
a result, we have submitted a proposal for a second phase project totaling
$500,000 to continue and expand the work of phase 1 by making cathode materials
for use with anode materials already produced. We have also submitted a proposal
for another project in the amount of $100,000 to improve the manufacturing
method for the materials to make it more scalable and efficient. We expect
decisions on these proposals in July 2005. (!)

We have completed a series of tests in collaboration with the EPFL
Switzerland, Heyrovsky Institute in Prague, Czech Republic and the Xoliox
subsidiary of Ntera, a display and battery technology development company.
A joint patent was filed with Xoliox related to electrode performance of
nanomaterials made by Altair. We have extended a marketing agreement with
Nissho Iwai Americas Corporation for marketing this technology in Japan to
leading lithium ion battery manufacturers.

[MRASTA]

Auch wenn schon spät oder früh, wie man es nimmt, egal.

Die Jungs haben es mal wieder geschickt eingefädelt, keine Frage. Aber bitte lest mal die letzte Mitteilung der Finanzierung, da stehen auch andere interessante Dinge drin.

Kein Wunder, dass das Teil in Richtung 4$ marschiert. Noch ist hier gar nix in trockenen Tüchern. Ganz im Gegenteil, dass ist jetzt ein Wettlauf mit der Zeit. Denn auch andere haben Muh gemacht, Altair hat Sie alle aufgescheut.

Die nächsten 4-5 Monaten werden es entscheiden, wer die Nase vorne hat, zumindest im Bereich Batterie.

Und weil wir IQ am Wickel hatten, wenn auch nur so am Rande, sollten sich die jenigen die da drin stecken das allg. Geschehen mal etwas näher ansehen

mrasta

[[KERN]Codex]

[MRASTA]

`InvestWrite` Student Picks are Kraft, Altair and Lockheed Martin

Tuesday , February 22, 2005 01:24 ET

Feb 22, 2005 (financialwire.net via COMTEX) --February 22, 2005 (FinancialWire) Kraft Foods (NYSE: KFT), Altair Nanotechnologies (NASDAQ: ALTI), and Lockheed Martin Corp. (NYSE: LMT) are favorites of the top elementary, middle school and high school financial writers.

Yes, that`s right. These were topics of the winners in the second annual "InvestWrite" competition sponsored by The Stock Market Game Program. Among the prizes are trips to New York or Disney`s (NYSE: DIS) Disney World.

"The `InvestWrite` competition challenges students to apply critical thinking skills to real-world savings and investment situations," said Dr. Lisa A. Donnini, director of education.

Henry Weinstein, of AFund.com, says I believe the top three winners` picks of the 2nd "InvestWrite" stock market student essay competition are as good as any Wall Street analyst."

Grades 4-5 Division: Luke Massaro, Shore Road Intermediate, Bellmore, N.Y., whose love of his grandmother`s homemade cheesecake, with a main ingredient of Philadelphia Cream Cheese, led to an understanding of Kraft`s many popular brands. "There are a few reasons why I would buy stock in Kraft Foods. One reason is that Kraft owns a variety of products that are favorites to many people, including me."

Grades 6-8 Division: James Newby, St. Patrick School, Dallas, Texas, researched a nanotechnology stock, Altair, as the ideal candidate for a long-term investment holding: "Nanotechnology, in general, is a fairly new field of engineering. It has begun a scientific revolution that will impact the entire world and bolster our understanding on the fundamentals of nature. Once nanotechnology becomes a more mature industry, companies such as Altair will no doubt grow radically in size and profits."

Grades 9-12 Division: Andrew Basham, Brunswick School, Greenwich, Conn., considered how Lockheed Martin Corporation, a domestic industry leader in homeland security, would benefit from the new emphasis on updating the post-Cold War military. "With a leadership role in the industry not easily affected by the woes of the domestic economy, Lockheed is capitalizing on increased government spending on the twenty-first century technologies."

The group`s website is http://www.investwrite.info.

[Cyberworker]

Das ist mit Sicherheit keine Nachricht die den Kurs beflügelt.. Naja immerhin ne Nachricht

Vielleicht gibts ja noch bessere News vor der Konferenz die mir den kurzfristigen Ausstieg erleichtert..

Cyberworker

[[KERN]Codex]

Shortsqueeze

[[KERN]Codex]

squeeeze it

4,6$

[MRASTA]

Werden die Zahlen wieder so gruselig ?



Altair Nanotechnologies Reports Project Update in Preparation for Year End Results Announcement

Wednesday, February 23, 2005 10:02 ET

RENO, NV, Feb. 23, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today provided a Company Projects Update in preparation for its financial results conference call scheduled Thursday, February 24, 2005. Management believes that it would be beneficial to provide a project update so that investors will have an opportunity to review this information prior to the call.

"This has been a solid year of performance for the company," commented Altair Nanotechnologies CEO Alan J. Gotcher, Ph.D. "We have made progress in the transition to an emerging growth stage nanotechnology company with revenue from sales of a variety of products. Altair has signed licensing agreements with Western Oil Sands for pigment product technology, Spectrum Pharmaceuticals for nanotechnology-based phosphate binding drugs (signed in January 2005) and entered into commercial collaborations for the development of enabling electrode product technology for a new titanium manufacturing process with Titanium Metals Corporation, the second largest producer of titanium metal in the world. We are making significant advancements on many fronts and plan to discuss our progress during the conference call."

Altair Nanotechnologies Corporate Update for 2004

Altair strengthened its management team, Board of Directors and Scientific Advisory Board and increased its cash holdings:

-- The Company appointed Dr. Alan J. Gotcher, Ph.D., as CEO and member of
the Board of Directors. Roy Graham was named Senior Vice President of
Sales and Marketing on January 7,2005
-- Altair increased the number of independent members of its Board of
Directors adding David King, Ph.D., President, Advanced Technology Group,
Michel Bazinet, M.D., CEO of Replicor and Christopher Jones, Ph.D., Senior
Vice President, Behr Coatings.
-- Altair expanded its Scientific Advisory Board to include Ravi
Thadhani, M.D., a well known kidney dialysis research specialist, and
Michael Graetzel, Ph.D., a renowned alternative energy expert.
-- On February 14, 2005, Altair raised approximately $20 million through
the sale of five million shares of its common stock. Proceeds are expected
to be used for increased working capital, capital expenditures, research
and development activities and acceleration of our commercial development
activities.
-- Management is hosting a financial results conference call February
24th at 11:00 AM Eastern. The dial-in number is 888.245.7013.

Life Sciences Division Update for 2004

The division entered into licensing negotiations on its first product technology, continued to develop intellectual property and began discussions with market partners to license additional product technology:

Pharmaceutical Products

RenaZorb(TM) Products - Nanotechnology-based Drug Candidate for Phosphate Binding in End-Stage Renal Disease

-- Altair`s RenaZorb represents a second-in-class, lanthanum-based drug
candidate for phosphate control in patients with end-stage renal disease
(ESRD).
-- January 31, 2005, Altair signed a licensing agreement with Spectrum
Pharmaceuticals, Inc. (NASDAQ: SPPI) giving them the exclusive worldwide
rights to develop, market and sell RenaZorb for human therapeutic and
diagnostic applications.

Drug Delivery Products

TiNano(R) Spheres(TM) Drug Delivery Systems

-- TiNano Spheres are hollow, porous, high surface area, ceramic
microstructures proposed for use in drug delivery systems. These systems
have demonstrated high levels of drug and chemical loading and rapid drug
and chemical release.
-- Two patent applications have been filed for the drug delivery
technology platform.
-- Research and development efforts continue and discussions have begun
to license this product technology to market partners.

Dental Nano-materials

-- Altair continues to work with a research consortium sponsored by the
National Institutes of Health to strengthen polymer-based dental fillings
utilizing Altair`s nano-zirconia.

Performance Materials Division Update for 2004

The division licensed pigment and electrode product technologies, advanced several companies towards licensing agreements and made substantial progress in the development of new product technology:

Advanced Materials for Paints, Coatings and Sensors

Titanium Dioxide Pigment - Altair`s Hydrochloride Pigment Process (AHPP)

-- Altair has successfully completed 50 percent of Phase l of the Western
Oil Sands project to manufacture TiO2 pigment from tar sand tailings.
-- Discussions progressed with a number of companies which may lead to
new licensing agreements in 2005.
-- January 25, 2005, Altair was awarded a new patent covering "Processing
Aqueous Titanium Solutions to Titanium Dioxide Pigment" by the Australian
Patent Office.

Advanced Ceramic Materials for Coatings

-- Altair was awarded a third contract from a (confidential) Fortune 100
company to supply testing quantities of specialized nano-sized materials
for coatings.

Advanced Ceramic Materials for Sensors

-- Western Michigan University and Altair received a $2 million contract
from DOE for joint development of nanosensors for detecting chemical and
biological weapons. Under terms of the Stage ll contract scheduled to
commence this quarter, Altair will receive $672,000 over a two-year period
for collaborative research and development as a subcontractor.

Air and Water Purification Systems

Altairnano TiHPC Products for Photocatalysis

-- Altair is partnering with Genesis Air to develop specialized surface
activated nano-sized titanium dioxide compounds for use in HVAC air
cleaning systems, specifically Genesis Air`s Photocatalysis technology.

NanoCheck(TM) Products for Binding Phosphate in Water

-- Independent and in-house laboratory testing has shown that Altair`s
unique nano-structured compound, NanoCheck, safely and effectively removes
phosphate from water, preventing algae growth in swimming pools and
reducing the quantity of chemicals currently required for algae prevention.
-- Field testing, focused on evaluating NanoCheck`s effectiveness in
providing an algae-free environment for swimming pools, was delayed due
primarily to hurricanes in the field testing areas. Testing has been
reinitiated and results will be made public when available. Negotiations
with major pool chemical companies for licensing of the product are moving
forward.

Advanced Materials for Improving Process Technologies

Titanium Metal Manufacturing via Electrolysis Processing

-- Altair`s development agreement with Titanium Metals Corporation
(NYSE: TIE), provides Altair the opportunity to supply enough TiO2 micro
porous electrodes to produce 50 pounds of titanium metal per day to meet
the DARPA titanium project goals as outlined by the program. The project
has met its goals and Altair is currently producing materials to order.

High-Performance Materials for Alternative Energy

Lithium Ion Battery Electrode Development

-- Altair has completed research work under a $100,000 SBIR Phase l grant
and has applied for a $500,000 SBIR Phase ll grant from the U.S. National
Science Foundation to continue work on carbon-coated, nano-structured
electrodes for next-generation lithium-ion ultra capacitors with partners
Hosokawa Micron and Rutgers University.
-- Altair was allowed two U.S. patents for the manufacturing of products
used in the development of lithium ion batteries and super capacitors. The
first patent describes a "Process For Making Lithium Titanate," and the
second patent describes a "Process For Making Nano-sized and Sub-micron-
sized Lithium-Transition Metal Oxides."
-- Altair is introducing its battery materials to battery manufacturers.
These materials have the capacity to enable a new generation of
rechargeable battery with three times the power of existing Lithium Ion
batteries, the capability of recharging in minutes instead of hours and
increased battery life.

Hydrogen Generation using Solar Energy

-- University of Nevada, Las Vegas, Altair and Hydrogen Solar, LLC were
awarded a $3,000,000 U.S. Department of Energy grant to pursue joint
research activities related to solar hydrogen production using solar energy
at a refilling station that is under development in Las Vegas. Vehicle
integration, testing and demonstration are included in the project
demonstration.

Thermal Spray Grade Powders

-- Thermal Spray powders have use in a variety of harsh environmental
applications such as aerospace propulsion systems, blades and vanes,
medical applications, boilers, incinerators, and oil and gas industry uses.
During the first quarter of 2004, the National Research Council completed
its report evaluating the Altair thermal spray powders. The report
concluded that Altair`s thermal spray powders were more abrasion resistant
than conventional powders. We continue to supply sample quantities for
customer testing.

ALTAIR NANOTECHNOLOGIES INC.

Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of ceramic, metal oxide-based nanomaterial technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high-performance batteries, fuel cell and photovoltaics) and other high-performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.(R), Altair Nanomaterials(TM), Altairnano(TM), TiNano(R), RenaZorb(TM), NanoCheck(TM), TiNano Spheres(TM) and the Hydrochloride Pigment Process(TM) are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market; that products subject to existing license agreements, including Altair`s pigment process (AHPP) and RenaZorb, will not be commercially developed and, even if developed, will not generate significant royalty payments; and that Altair will not be able to enter into license agreement with respect to TiNano Sphere, Nanocheck, its carbon-coated nano-structured electrodes for lithium-ion capacitors or other products that Altair expects industry partners to develop and market. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

[[KERN]Codex]

4,9$

ALTI bounced ordentlich

[[KERN]Codex]

[[KERN]Codex]

Altair Nanotechnologies Announces New Patent Award Notification

Altair Nanotechnologies, Inc. announced today that it was awarded a new Australian patent covering "Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment" by the Australian Patent Office.

The new patent describes the fundamental technology for a hydrometallurgical process for producing pigment-grade titanium dioxide ("Ti02") containing solutions. The process includes hydrolyzing the solution via complete evaporation in controlled conditions of temperature to form titania oxide of defined characteristics. After hydrolyzing, the titanium oxide is calcined to form either anatase or rutile pigment of the desired particle size. It is then milled for final processing.

"Our patented process provides significant economies of scale and considerable environmental advantages over the existing chloride and sulfate processes," commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "Further, our manufacturing process provides for an environmentally friendly method for pigment companies to streamline operations and reduce costs."

The new patent follows the award of two other patents covering the environmentally friendly process for TiO2 pigment production, an $8 billion industry. Altair`s patent portfolio includes: 1) Processing Titaniferous Ore to Titanium Dioxide Pigment; 2) Processing Aqueous Titanium Chloride Solutions to Ultrafine Titanium Dioxide, and 3) Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment.

Over the past five years, Altair has expended significant resources to pioneer and develop advanced ceramic nanotechnology and currently owns six U.S. Patents and 12 foreign patents with 46 additional pending U.S. and foreign patent applications. Altair is aggressively pursuing licensing and business development programs utilizing its technology, nanomaterials and nano-based products worldwide.

1/25/2005 7:52:00 PM

[MRASTA]

Moin,

so, so wieder ein neues Patent. Fehlen jetzt mal die, die es auch mal umsetzen wollen. Und der gestrige Tag war ja wohl eine Frechheit, dass immer einige mehr wissen.

mrasta

ALTI: Awarded EU Patent for Making Catalyst Structures
Thursday , March 03, 2005 10:07 ET

Altair Nanotechnologies, Inc. (ALTI) announced that it was awarded a new European patent entitled "Method for Producing Catalyst Structures" by the European Patent Office. The new patent describes the process for making microporous structures that can be used as catalyst supports, or as electrode materials, in connection with titanium metal production and other processes.

[MRASTA]

Moin,

mal wieder den Thread nach oben bringen.

Der Druck in Richtung Batterie ist enorm gestiegen, nachdem immer mehr Meldungen auch von anderer Seite kommen. Eine mehr als kitzlige Angelegenheit im Moment, da müssen die einen Brikett drauflegen.

Hauptsache bei dem Update CC kommt nicht so ein Blah, Blah rüber. Aber irgendwas machen müssen Sie wohl.

Schaun wir mal

mrasta

[MRASTA]

naja,

geht doch. Ups, auch nicht schlecht. Obwohl die ganz schön Miese eingefahren usw. Holzauge sei wachsam.

Advanced Battery Technologies, Inc. (OTC BB: ABAT)
Last Trade: 1.900 Change: 1.350 ( +245.455 %)



ABAT/ALTI:, Exclusive Agreement for Lithium Batteries in China
Monday , April 04, 2005 13:58 ET

Altair Nanotechnologies, Inc. (ALTI) and Advanced Battery Technologies, Inc. (ABAT) announced that they have signed a mutually exclusive development agreement for lithium polymer batteries in China. This agreement covers the incorporation of Altair`s battery electrode nano-materials into ABAT`s existing polymer battery product lines. Terms of the agreement were not disclosed.


mrasta

[MRASTA]

erstaunlich,

wenn man mal ein paar Wochen nix postet, keiner mehr da ? Noch jemand die Peilung ?

Die Geschichte ist ja nach dem Abgang von Rudi noch skuriler geworden. Vo allem, und das vermisse ich hier doch sehr, nach dem offenen Brief von Rudi. Ok. mag sein, dass er die Hasskappe auf hat, wäre ja auch nicht weiter verwunderlich aber ein bischen Wahrheit spielt wohl überall mit.

Steht somit alles auf dem Prüfstand und die Jungs sind ziemlich unter Druck geraten auch mal Butter bei die Fische zu tun, sonst schmiert das Teil weiter ab.

Zum Nachdenken ist es auf jedenfall geeignet, Rückschlüsse kann und sollte auch jeder für sich treffen.

bis dann
mrasta


http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3509…

[tntxrxwelle]

Hallo altes "Streitross",

Der Brief ist ja ein Knüller. Nett auch das Photo, wo
die Handschuhe fehlen.
Rudi war für mich das einzige Highlight der Company.
Ten feet pole dürfte nicht ausreichen, um ALTI jetzt noch
anzufassen.

Gut das ich von dem ganzen Schrott nix mehr habe. Wenn
ich bedenke, was aus NPCT geworden ist. Ts,ts,ts...

[MRASTA]

Moin Welle,

dass ist aber nett, das man mal wieder was von Dir hört.

Streitross, wieso bin doch ganz friedlich, gibt eben nicht nur die Schokoladenseiten. Gerade bei Altair nicht. Da ist IMHO mittlerweile die Luft arg dünn geworden. Ein paar Teile halte ich aber noch, wer weiß, vielleicht kommt ja doch noch die Überraschungsmeldung. Glaube zwar nicht wirklich dran aber mal sehen. Verlieren kann ich da sowieso nix mehr.

Tja, die Pierces sind wohl fast am Ende der langen Reise angelangt. War eine nette Zeit, hat aber auch reichlich Geld gekostet. Da sieht man mal wieder, dass jeder für sich selbst verantwortlich ist. Ist aber mittlerweile Schnee von Gestern. Bleibt vielleicht, dass man etwas darauß gelernt hat. Das ist wohl der einzige positive Aspekt den man da ziehen kann.


bis die Tage
mrasta

[tntxrxwelle]

Na dann bleiben wir bei Alter Ego ;-) Streitross war
natürlich positiv gemeint. Im Sinne von streiten für
einen positiven ROI (=return on investment).

Aus der Npct-Geschichte habe ich eine Menge gelernt. Habe zwar schneller kapiert, als andere, aber für meinen Geschmack immer noch zu spät.

Bei ALTI habe ich zu früh kapiert ;-), in diesem Fall wäre
späteres Kapieren besser gewesen. Hatte ich doch runde
6000 St. im Schnitt von 60 Cent. Na ja, immerhin 3000 St.
dann doch noch bei > 2,00 EUR verkloppt.
Kohle hat ALTI ja noch lang, aber lang genug ? Mir drängen
sich arge Parallelen zu NPCT auf. Nette Idee, aber keinen
(Großen) interessierts.
Rudi von Bord und das im Bösen. Das gibt noch böses Blut.
Mit dessen Brief ist Action Class ohnehin Tür und Tor
geöffnet, wenn der Kurs mal abschmiert.

[MRASTA]

Wie auch immer, besser gutes Geld mitnehmen als schlechten noch gutes hinterher werfen. Manchmal hat man halt etwas mehr Glück, manchmal weniger.

Und bei den meisten OTC-BB Werten sollte man sowieso, bis auf wenige Ausnahmen, immer die Asbesthandschuhe anziehen. Die Pierces waren dafür ein gutes Beispiel, wenn auch wahrscheinlich für viele, ein teures Abenteuer.

Was aus Altair nochmal wird, kann ich zur Zeit nicht einschätzen. Irgendwie halten Sie sich ja nun schon eine ganze Ecke mehr oder weniger auf dem gleichen Niveau. Trotzdem ist und bleibt die Bewertung gruselig aber auch das war sie schon immer. Sieht so nach Ruhe vor dem Sturm aus. Ist nur die Gretchenfrage in welche Richtung Sie dann getrieben werden ?

Und wie Rudi sich fühlen dürfte steht ja wohl außer Frage. Die genauen Hintergründe werden wir wohl nie wirklich erfahren. Alle sieben Sinne sollte man aber so oder so beisammen haben.

bis dann
mrasta

[MRASTA]

Die gestrige Update Veranstaltung hat IMHO nix neues gebracht, alles aufgewärmter Kaffee. Dafür gibt es heute etwas Knete. Dürfte für eine kurze Zeit ein wenig Power bringen.

Auf Sicht aber nix neues bei den Herrschaften.

Alles wie immer IMO versteht sich.

mrasta


Altair Nanotechnologies Receives SBIR Phase II Grant From U.S. National Science Foundation
Thursday , June 30, 2005 08:02 ET

RENO, NV., Jun 30, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today that it has been awarded a SBIR Phase II grant from the National Science Foundation (NSF). The grant of $476,850, titled "Carbon-Coated Nano-Structured Electrodes for Next-Generation Lithium-Ion Batteries," will be used for continuation of a research, development and manufacturing program focused on nano-structured Li ion hosts usable in electrodes for lithium ion batteries and super capacitors. This work is to be completed over a 24-month period beginning October 1, 2005.

"We are pleased to announce our latest grant from the U.S. National Science Foundation," said Alan J. Gotcher PhD, CEO and President of Altairnano. "What makes this competitive award significant is the selection of Altairnano by a peer review process, whose selection criteria is heavily weighted on the viability of our battery materials product technology commercialization plan."

Phase I of the NSF grant was used to optimize the Altairnano anode electrode materials. Phase II will be used to develop Altairnano cathode electrode materials resulting in matched Altairnano anode-cathode electrode materials for optimum electrochemical performance.

Under terms of the Small Business Innovation Research Phase ll grant award, proceeds will be used to continue funding of research, development, joint testing and manufacturing development work with Rutgers University`s Energy Storage Research Group and Hosokawa Micron`s Nano Particle Technology Center. Included in the funding is the production of demonstration scale prototype, high-power batteries (0.5 to 6 Ahr) from carbon coated Li-ion hosts developed under the grant.

[weltklasse]

da wird in kürze so einiges auf uns zukommen!!!!


From Briefing.com

09:48 WR Hambrecht previews Nanotechnology June quarter earnings

WR Hambrecht previews ALTI, FEIC, SMMX, and TINY June qtr earnings. For ALTI, they expect good news in the next couple of weeks on the Advanced Batteries deal, and say to buy ALTI here, but not right before the quarterly report, as they say the co has repeatedly steered investors to look at full year numbers rather than the quarterly results. For FEIC, they say to buy going into the call as they believe FEIC could beat numbers. They say to buy SMMX after the call as they believe expectations for the qtr could ba a little hard to beat. Firm says to buy TINY here and build a position as the earnings report is usually a non-event. Firm is waiting for rev growth at NANX and ACCL and reits Holds.

[Cerec]

Ich hab mir heute mal ein paar Altair längerfristig ins Depot gepackt.

Die Umsätze sind zwar nicht zu doll, aber an der Börse wird ja bekanntlich die Zukunft gehandelt.

Die Fondsbeteiligungen an dem Wert sind auch noch nicht so hoch, vielleicht ändert sich das bei einem positiven Newsflow.

Time will tell us...

[schachfrucht]

Hallo!

Erstmal dickes Lob für den sehr informativen und von vielen Usern tiefgründig gestalteten Thread, den ich jetzt komplett durchgearbeitet habe:

Eine Sache verstehe ich nicht:
Am 10.2. verkündet ALTI, daß man revolutionäre Lithium-Ion-Batterien entwickelt habe und in Verbindung mit den Weltmarktführern - genauer gesprochen deren F+E-Abteilungen - stehe... Was ein LiOn-Akku mit knapp 15 Stunden Laufzeit bedeutet, braucht wohl nicht näher dargelegt zu werden...
Im folgenden gibt man am 30.6. einen Deal mit einem OTC BB Wert (ABAT) bekannt für die Vermarktungsrechte in China:
Wenn denn die Technologie wirklich so revolutionär ist, warum hat man es dann nötig, einen Deal mit einer kleinen, unbedeutenden Firma auf die Strecke zu bringen? Warum stehen die großen Firmen nicht in der Schlange, um ALTI die Lizenzen aus der Hand zu reißen?

Ich habe irgendwie keine plausible Antwort darauf gefunden, vielleicht kann mir ja hier jemand auf die Sprünge helfen!?

[tntxrxwelle]

Weil die Technologie vielleicht doch nicht so
der Knaller ist ?
Eigentlich gibt es nur 2 Möglichkeiten :

1) Die Sache hat einen Haken.

2) ALTI wird am langen Arm ausgehungert und dann
für Cents übernommen.

[schachfrucht]

Tja, bzgl. meiner bewußt ohne Vorurteil gestellten Fage, scheint sich ein negatives Szenario abzuzeichnen. Motley Fool tendiert auch eher zu Variante 1 von tntxrwelle (Wie bist Du eigentlich auf diesen nick gekommen, ich dachte scon, meiner wäre ziemlich ungewöhnlich?!???!):

"Motley Fool
Altair Stays the Course
Monday August 15, 4:47 pm ET
By Seth Jayson


Unfortunately for nanotech fans, the jury`s still out on whether Altair Nanotechnologies (Nasdaq: ALTI - News) is the real deal or merely a nano-pretender.
ADVERTISEMENT


On Friday, the firm released a slew of press, the meatiest bit of which described its Q2 2005 financial results. No surprise, the suggested headline -- picked up by editors who aren`t paying that much attention -- was a 226% year-over-year increase in revenues.

I prefer to look to the bottom line, which was slightly less gruesome than in the prior-year period. But let`s start at the top. That big percentage gain needs to be examined a bit more closely. First off, the total at the top is only $503,000 -- and we all know that it`s not too tough to post big increases when you`re starting from such small numbers. Next, the vast majority of that amount comes by way of "contracts and grants," not product sales or other project collaborations.

Moving further down, we see that operating expenses increased by almost 12% to $2.55 million. Offset by a bit of interest income -- on cash raised from a recent placement -- the bottom-line loss totaled $1.9 million, down slightly from the prior-year-quarter`s $2.15 million. Mark the calendar, folks. I`ll give it up for Altair: A smaller loss is better than nothing.

But that`s about as sanguine as I can be. I won`t dwell on my past criticisms of Altair, suffice to say that I don`t think investors should make too much of the continuing cycle of press releases touting the relationship with Advanced Battery (OTC BB: ABAT - News). It`s tough to see too much to brag about in a metric ton of battery testing material for an undercapitalized Chinese partner that`s working on batteries for electric cars.

Altair`s other planned revenue generators -- a nano TiO2 pigment process, a relationship with Spectrum Pharmaceutical (Nasdaq: SPPI - News) for a drug to compete with Genzyme`s (Nasdaq: GENZ - News) Renagel, products for HVAC and pool filtration -- are still in their infancy and don`t seem to support the firm`s market cap.

That said, with $30 million in the bank -- raised in the wake of a PR-initiated stock spike -- and a manageable burn rate, Altair`s not in danger of disappearing, at least not immediately. Investors just need to realize that this is an unproven speculation with a history of hype. Bid on the shares accordingly, if at all.

Seth Jayson watches the nanospace, but at the time of publication, he had positions in no company mentioned. View his stock holdings and Fool profile here. Fool rules are here."

[MRASTA]

Moin,

ja,ja,ja.

Alles wie schon gehabt, mehr Fragen als Antworten.

Die Flucht nach vorne, wie immer kurz vor den Zahlen, :-) ist auch nur bedingt geglückt. Die Lieferungen sollen ja auch erst im September erfolgen.

Den September haben Sie ja selber nun als den Monat bezeichnet, wo zu einigen Dingen mal ein Input kommen soll. Von Renazorb bis zu dem Algenvernichter. Was aus dem Joint Venture mit Bateman Engineering wird steht auch noch in den Sternen. Wenn Western die Finanzierung nicht auf die Reihe bekommen sollte, sieht es auch da düster aus.

Denke mal, die Uhr tickt einfach. Bei den Phases sieht es auch nicht viel besser aus. Viel Nano um nix.

Eigentlich unter dem Strich betrachtet überhaupt nichts relevantes neues.

Da machen andere Firmen wesentlich bessere Fortschritte, allerdings eher im verborgenen.

bis dann
mrasta

[tntxrxwelle]

@Schachtfrucht

Setzt sich zusammen aus meiner Börsenvergangenheit (=
Aktien mit denen ich mal zu tun hatte) und deren u.a.
NYSE-Kürzeln. TNT=Tatneft XRX=Xerox und Welle war irgend-
ein Teil des Namens des Insolvenzverwalters von
Bremer Vulkan.
Ist ja auch für Freund Mrasta u.U. nochmal was Neues ;-)

@Mrasta

Wie kommt man auf Mrasta ?

Ich habe jetzt von diesen ewigen Conference-Calls usw.
so viel Müll aufgeschnappt, ich glaube ich könnte auch
ein virtuelles Unternehmen gründen und mit unendlich
nichtssagendem Newsflow eine vermeintlich rosige Zukunft
malen.

[MRASTA]

Moin,

Mensch tntxrxwelle, was für ein Einfall, daruf muss man erstmal kommen. Bei mir ist es da etwas einfacher. Müßte eigentlich Mr. Asta heißen, und stammt aus dem The Thin Man oder auch hier zu Lande der dünne Mann genannt. Finde die Filme einfach oberwitzig, obwohl schon so olle Kamellen.

Und daher stammt dann auch Mr. Asta, der Terrier, der immer für eine lustige Einlage gut ist.

[/url]



mrasta

[MRASTA]

Um nochmal kurz zu dem Thema hier zurück zu kommen.

Deloitte & Touche hat sich vor 2 Tagen von Altair verabschiedet. Nicht gerade ein sehr gutes Zeichen. Leider erfahren wir die wirklichen Gründe wohl nicht.

mrasta


Altair Nanotechnologies to Engage New Independent Audit Firm
Wednesday, August 24, 2005 19:03 ET

RENO, NV, Aug 24, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies Inc. (NASDAQ: ALTI), today announced that the Audit Committee of the Board of Directors will engage a new independent audit firm as a result of Deloitte & Touche LLP`s resignation as the company`s independent auditor.

The resignation was not the result of any disagreements between Altair and Deloitte on any matter of accounting principles or practices, financial disclosure or audit procedures. Deloitte has served as Altair`s principal accountants since March 2001 and has agreed to provide its full cooperation in the transition to a new audit firm.

"Altair has worked with Deloitte & Touche for over four years and we have been pleased with the relationship," commented Altair Nanotechnologies CEO and President Alan J. Gotcher, Ph.D. "We are in discussion with several independent accounting firms and are confident another high quality accounting firm will be engaged. Evaluation and engagement of accounting firms typically takes several weeks and we expect to have new audit services in place for filing of our third quarter Form 10-Q."

[tntxrxwelle]

Sieht so aus, als mache alles was seriös ist eine kleine
Verpieselung durch die Hintertür.

@Mrasta

Auch nicht schlecht. Hätte mir auch liebend gerne einen
anderen Namen spendiert, aber nachdem mir vom System bei
jedem auch noch so abgefu*kten Namen bekannt gegeben hat,
er sei vergeben, braucht`s eben ein wenig Fantasie.

[MRASTA]

Moin,

Altair gibt mal wieder einen Laut von sich. Für mich sieht die Meldung aus, wie : Arsch auf Grundeis gelandet.

Denen läuft die Zeit unter den Nägeln weg, wie nix gutes. Und nun dieser letzte Kraftakt, 11 neue Leute, muss man sich mal reinziehen. Dürfte wohl auf diesem Gebiet die allerletzte Chance sein. Fragt sich in diesem Zusammenhang auch, was denn die anderen Jungs da mit den Batterien bis dato angestellt haben ? ....will move to a new facility located in central Indiana ??????? Dass scheint bis dato alles völliger Bullshit gewesen zu sein.

Alles IMHO versteht sich.

Die Meldung war immerhin für 12% Pünktchen gut, jedem das seine.

mrasta


Altair Nanotechnologies Expands Battery Initiative for Rapid Implemention of Lithium Ion Battery Electrode Technology
Wednesday, September 28, 2005 13:51 ET

RENO, NV, Sep 28, 2005 (MARKET WIRE via COMTEX) --Altair Nanotechnologies Inc. (NASDAQ: ALTI), today announced that it has expanded its research, product development, manufacturing and marketing groups with the addition of eleven highly qualified advanced battery scientists, engineers, manufacturing and marketing specialists. These battery experts and specialists, mainly comprised of former Delphi and GM employees, have worked for over a decade building expertise in the development and manufacture of advanced lithium battery technologies for automotive applications, including hybrid electric vehicles (HEV), and other consumer, industrial and military applications.

The mission of the expanded Altairnano battery team is to accelerate the development of Altairnano`s proprietary next generation nano-structured battery electrode materials and provide new capabilities to manufacture in-house prototype lithium ion cells, batteries and battery packs and increase Altairnano`s product application testing capabilities. The additional electrode materials research and development personnel will be located in Altairnano`s corporate offices, laboratories and manufacturing facility in Reno, Nevada, augmenting Altairnano`s present R&D and manufacturing teams. New personnel for development, testing and manufacturing of prototype lithium ion cells, batteries and battery packs incorporating Altairnano`s nano-structured electrode materials for application development will move to a new facility located in central Indiana. Business development, marketing and sales personnel will also be located in the Indiana facility, which is in close proximity to target markets and key suppliers.

"We are confident that the addition of this unique battery expertise and skills will strengthen Altairnano`s battery initiative and increase our capability to demonstrate nano-structured electrode materials performance in cells, batteries and battery pack products which will be produced in our in-house manufacturing facility," commented Altairnano CEO and President Alan J. Gotcher, Ph.D., said, "Our patented technology, combined with the additional battery expertise, is expected to accelerate our efforts to bring to the marketplace our electrode materials in innovative lithium ion powered batteries that exhibit rapid charge and discharge, longer life and a safe, environmentally clean (green) alternative energy source capable of replacing battery systems that are environmentally unfriendly and incapable of producing the high charge and discharge rates required to meet many demands for "green" batteries.

Why Altairnano`s Materials Are "Green", Safe and Produce Higher Charge/Discharge Rates

Altairnano`s environmentally friendly nano titanate spinel electrode materials are expected to be combined with other "green" materials that utilize manganese or iron phosphate. These materials are a departure from today`s industrial batteries that contain lead, acid, cobalt, cadmium, nickel and other hazardous materials used in rechargeable batteries currently available in Altairnano`s target markets. Additionally, in contrast with graphite electrodes currently used in lithium ion batteries, the nano titanium-based anode are expected to safely operate in the thermodynamically stable voltage window of available existing electrolytes. The ionic transport capacity through the nano-structured materials provides high charge and discharge rates resulting in high power ratings when needed.

[schachfrucht]

Morgen gibs die Zahlen zum 3. Quartal und eine Web-Konferenz...

vorab wurde schon mal getestet

Advanced Battery Technologies Announces Successful Manufacturing Tests
Thursday November 10, 10:44 am ET


Nano-Structured Lithium Titanate Spinel Electrode Materials Provide Fast Charge and Discharge Rates, Improved Cycle Life for Electric Bus and Auto Projects


HARBIN, CHINA--(MARKET WIRE)--Nov 10, 2005 -- Advanced Battery Technologies, Inc. (OTC BB:ABAT.OB - News) announced today that the manufacturing and product tests using Altair Nanotechnologies Inc.`s (NasdaqSC:ALTI - News) nano-structured lithium titanate spinel electrode materials have been successful. The company announced further progress in its Polymer Lithium Ion Battery Development Program:
1. Advanced Battery Technologies has contracted with Harbin University of
Science and Technology to design the electrical controls and management
system for a sedan conversion using Altair`s advanced nanotechnology
electrode materials in its lithium polymer batteries.

2. Advanced Battery Technologies also has entered into a cooperative
agreement with the Beijing Institute of Technology for the development
and testing of four electric buses to be built by Advanced Battery
as prototypes for the 2008 Olympic Electric Bus Program.
ADVERTISEMENT


The all-electric buses will be manufactured using Advanced Batteries polymer lithium ion batteries under Advanced Battery Technologies` Cooperation Agreement with Beijing Institute of Technology ("BIT") for the development of Easy Access, All Electric Buses. The prototype buses, to be manufactured by Advanced Battery, are to be completed by the first half of 2006 with testing to be completed in August 2006. The results of the tests of the prototypes will be used to determine the companies that will be selected to supply the buses to be used in the 2008 Olympics.

"The buses will provide direct road test comparison of performance, cost, and acceptability," said Advanced Battery Chairman, Zhiguo Fu. "The impact of high power delivery, rapid recharge, and a long cycle life, will be demonstrated in one of the buses using advanced nanomaterials from Altair in the batteries. The use of Altair`s electrode materials in our PLI batteries," continued Mr. Fu, "will enable us to provide battery performance that could present opportunities in new markets that would benefit from batteries with fast charge and discharge times, superior life cycle performance and improved life cycle economics."

ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products.

Altairnano`s robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has scalable manufacturing capability to meet emerging nanomaterials demands. Altairnano`s two divisions, Life Sciences and Performance Materials, are focused on applications where its nanotechnology may enable new high growth markets. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials Division is focused on market applications in advanced materials for paints and coatings; air and water treatment and alternative energy including new lithium ion battery electrode materials. For additional information on Altairnano and its nanomaterials, visit www.altairnano.com.

Advanced Battery Technologies Inc. (ABAT)

ABAT develops, manufactures and distributes rechargeable Polymer Lithium-Ion (PLI) batteries. The Company`s products include rechargeable PLI batteries for mine-use lamps, electric automobiles, motorcycles, cellular phones, notebook computers, walkie-talkies and other personal electronic devices. ABAT`s batteries combine high-energy chemistry with state-of-the-art polymer technology, and overcome many of the shortcomings associated with other types of rechargeable batteries.

The Company began operations in September of 2002 and has made tremendous progress in the past twenty months. ABAT has gone from a startup, to a fully functional, leading edge, technology driven, product development and manufacturing company. ABAT has also accumulated a roster of pending patents for its battery technology and plans on developing additional unique energy related products. The Company operates in the highest growth sector of the battery industry, with PLI batteries projected to account for one fourth of the market for IT and communications devices by 2005.


... und der Staat gibt Geld:


Congress to Fund $2.5 Million in Energy and Water Development Appropriations for Altair Nanotechnologies` Nanoscience Research
Wednesday November 9, 1:42 pm ET


RENO, NV--(MARKET WIRE)--Nov 9, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) has been designated to receive an additional $2.5 million in Federal grant funding during 2006-2007 for the continued development of nanotechnology, nanosensors, and nanomaterials research, development and deployment. The $2.5 million funding was included in the Congressional Energy and Water Development Appropriation for Fiscal Year 2006, which was passed by the U.S. Senate and the U.S. House of Representatives on November 8, 2005. We anticipate the appropriation will be signed by the President within the next week.
The grant will be utilized for funding of the following projects:

1. The continued development of nanosensors for detecting chemical,
biological and radiological agents in the environment.

This project continues as a joint research and development
collaboration involving Altair Nanotechnologies and
Western Michigan University.

2. Development and testing of nano-structured electrode materials for
high-power, quick-charge, quick-discharge, high cycle life lithium
ion batteries.

This project includes the continued joint development of
nano-structured lithium titanate materials for anodes and
nano-structured lithium manganate cathodes for high-performance
batteries with Rutgers University. Altair has concurrently developed
a manufacturing process to produce the materials in bulk for
manufacture of Li(4)Ti(5)O(12) batteries.

3. Development and characterization of nanomaterials for bactericidal
biofilms in non-aqueous environments.

This funding will support research for the characterization of
bactericidal nanoparticles with the ultimate goal of producing
environmentally safe, biocompatible, antimicrobial nanomaterials
for bacteria-resistant surface coatings for sensitive devices and
buildings. The project is a collaboration involving the National
Institute for Occupational Safety and Health, The University of
Nevada, Reno, and The University of California, Santa Barbara.
ADVERTISEMENT


"We are appreciative of the hard work and continued support of numerous individuals including Nevada Senator Harry Reid, the Democratic Leader in the Senate," commented Altair CEO and President Alan J. Gotcher, Ph.D. "We believe these programs will have a positive impact on Altair`s alternative energy initiative, the company`s continued development of homeland security and national defense products, and a new development program to produce environmentally safe bacteria-resistant nanomaterials for providing self-cleaning surfaces."

ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products.

Altairnano`s robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has scalable manufacturing capability to meet emerging nanomaterials demands. Altairnano`s two divisions, Life Sciences and Performance Materials, are focused on applications where its nanotechnology may enable new high growth markets. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials Division is focused on market applications in advanced materials for paints and coatings; air and water treatment and alternative energy including new lithium ion battery electrode materials. For additional information on Altairnano and its nanomaterials, visit www.altairnano.com.